id	sid	tid	token	lemma	pos
brj-24903	1	1	peer	peer	NOUN
brj-24903	1	2	-	-	PUNCT
brj-24903	1	3	review	review	NOUN
brj-24903	1	4	article	article	NOUN
brj-24903	1	5	peer	peer	NOUN
brj-24903	1	6	-	-	PUNCT
brj-24903	1	7	reviewed	review	VERB
brj-24903	1	8	article	article	NOUN
brj-24903	1	9	bioresources.cnr.ncsu.edu	bioresources.cnr.ncsu.edu	X
brj-24903	1	10	gu	gu	VERB
brj-24903	1	11	et	et	PROPN
brj-24903	1	12	al	al	PROPN
brj-24903	1	13	.	.	PROPN
brj-24903	2	1	(	(	PUNCT
brj-24903	2	2	2026	2026	NUM
brj-24903	2	3	)	)	PUNCT
brj-24903	2	4	.	.	PUNCT
brj-24903	3	1	“	"	PUNCT
brj-24903	3	2	astragalus	astragalus	NOUN
brj-24903	3	3	leaf	leaf	NOUN
brj-24903	3	4	extract	extract	NOUN
brj-24903	3	5	vs.	vs.	ADP
brj-24903	3	6	arthritis	arthritis	NOUN
brj-24903	3	7	,	,	PUNCT
brj-24903	3	8	”	"	PUNCT
brj-24903	3	9	bioresources	bioresource	NOUN
brj-24903	3	10	21(1	21(1	NUM
brj-24903	3	11	)	)	PUNCT
brj-24903	3	12	,	,	PUNCT
brj-24903	3	13	160	160	NUM
brj-24903	3	14	-	-	SYM
brj-24903	3	15	177	177	NUM
brj-24903	3	16	.	.	PUNCT
brj-24903	3	17	160	160	NUM
brj-24903	3	18	in	in	ADP
brj-24903	3	19	-	-	PUNCT
brj-24903	3	20	vitro	vitro	X
brj-24903	3	21	and	and	CCONJ
brj-24903	3	22	in	in	ADP
brj-24903	3	23	-	-	PUNCT
brj-24903	3	24	vivo	vivo	NOUN
brj-24903	3	25	antiarthritic	antiarthritic	ADJ
brj-24903	3	26	activity	activity	NOUN
brj-24903	3	27	of	of	ADP
brj-24903	3	28	the	the	DET
brj-24903	3	29	ethanol	ethanol	NOUN
brj-24903	3	30	extracts	extract	NOUN
brj-24903	3	31	of	of	ADP
brj-24903	3	32	leaves	leave	NOUN
brj-24903	3	33	of	of	ADP
brj-24903	3	34	astragalus	astragalus	NOUN
brj-24903	3	35	glycyphyllos	glycyphyllos	NOUN
brj-24903	3	36	in	in	ADP
brj-24903	3	37	cfainduced	cfainduced	ADJ
brj-24903	3	38	arthritis	arthritis	NOUN
brj-24903	3	39	in	in	ADP
brj-24903	3	40	rats	rat	NOUN
brj-24903	3	41	lingli	lingli	PROPN
brj-24903	3	42	gu	gu	PROPN
brj-24903	3	43	,	,	PUNCT
brj-24903	3	44	a	a	PRON
brj-24903	3	45	,	,	PUNCT
brj-24903	3	46	#	#	NOUN
brj-24903	3	47	rong	rong	PROPN
brj-24903	3	48	su	su	PROPN
brj-24903	3	49	,	,	PUNCT
brj-24903	3	50	a	a	DET
brj-24903	3	51	,	,	PUNCT
brj-24903	3	52	#	#	NOUN
brj-24903	3	53	shiyun	shiyun	NOUN
brj-24903	3	54	yin	yin	PROPN
brj-24903	3	55	,	,	PUNCT
brj-24903	3	56	a	a	PRON
brj-24903	3	57	,	,	PUNCT
brj-24903	3	58	#	#	NOUN
brj-24903	3	59	yuanjie	yuanjie	NOUN
brj-24903	3	60	zhou	zhou	PROPN
brj-24903	3	61	,	,	PUNCT
brj-24903	3	62	a	a	DET
brj-24903	3	63	lili	lili	NOUN
brj-24903	3	64	chen	chen	PROPN
brj-24903	3	65	,	,	PUNCT
brj-24903	3	66	a	a	DET
brj-24903	3	67	weichao	weichao	PROPN
brj-24903	3	68	liu	liu	PROPN
brj-24903	3	69	,	,	PUNCT
brj-24903	3	70	a	a	DET
brj-24903	3	71	weitian	weitian	PROPN
brj-24903	3	72	yan	yan	PROPN
brj-24903	3	73	,	,	PUNCT
brj-24903	3	74	b	b	PROPN
brj-24903	3	75	xianna	xianna	PROPN
brj-24903	3	76	yang	yang	PROPN
brj-24903	3	77	,	,	PUNCT
brj-24903	3	78	b	b	PROPN
brj-24903	3	79	jianmei	jianmei	PROPN
brj-24903	3	80	yin	yin	PROPN
brj-24903	3	81	,	,	PUNCT
brj-24903	3	82	b	b	PROPN
brj-24903	3	83	jiangyun	jiangyun	PROPN
brj-24903	3	84	peng	peng	PROPN
brj-24903	3	85	,	,	PUNCT
brj-24903	3	86	a	a	PRON
brj-24903	3	87	,	,	PUNCT
brj-24903	3	88	*	*	PUNCT
brj-24903	3	89	and	and	CCONJ
brj-24903	3	90	wei	wei	PROPN
brj-24903	3	91	jian	jian	PROPN
brj-24903	3	92	zhou	zhou	PROPN
brj-24903	3	93	,	,	PUNCT
brj-24903	3	94	a	a	PRON
brj-24903	3	95	,	,	PUNCT
brj-24903	3	96	*	*	PUNCT
brj-24903	3	97	the	the	DET
brj-24903	3	98	effectiveness	effectiveness	NOUN
brj-24903	3	99	of	of	ADP
brj-24903	3	100	the	the	DET
brj-24903	3	101	ethanolic	ethanolic	ADJ
brj-24903	3	102	extract	extract	NOUN
brj-24903	3	103	of	of	ADP
brj-24903	3	104	a.	a.	NOUN
brj-24903	3	105	glycyphyllos	glycyphyllos	PROPN
brj-24903	3	106	leaves	leave	NOUN
brj-24903	3	107	was	be	AUX
brj-24903	3	108	evaluated	evaluate	VERB
brj-24903	3	109	for	for	ADP
brj-24903	3	110	treating	treat	VERB
brj-24903	3	111	arthritis	arthritis	NOUN
brj-24903	3	112	.	.	PUNCT
brj-24903	4	1	this	this	PRON
brj-24903	4	2	was	be	AUX
brj-24903	4	3	done	do	VERB
brj-24903	4	4	by	by	ADP
brj-24903	4	5	examining	examine	VERB
brj-24903	4	6	its	its	PRON
brj-24903	4	7	ability	ability	NOUN
brj-24903	4	8	to	to	PART
brj-24903	4	9	protect	protect	VERB
brj-24903	4	10	chondrocytes	chondrocyte	NOUN
brj-24903	4	11	(	(	PUNCT
brj-24903	4	12	cartilage	cartilage	NOUN
brj-24903	4	13	cells	cell	NOUN
brj-24903	4	14	)	)	PUNCT
brj-24903	4	15	from	from	ADP
brj-24903	4	16	inflammation	inflammation	NOUN
brj-24903	4	17	caused	cause	VERB
brj-24903	4	18	by	by	ADP
brj-24903	4	19	il-1β	il-1β	PROPN
brj-24903	4	20	stimulation	stimulation	NOUN
brj-24903	4	21	,	,	PUNCT
brj-24903	4	22	as	as	ADV
brj-24903	4	23	well	well	ADV
brj-24903	4	24	as	as	ADP
brj-24903	4	25	its	its	PRON
brj-24903	4	26	ability	ability	NOUN
brj-24903	4	27	to	to	PART
brj-24903	4	28	alleviate	alleviate	VERB
brj-24903	4	29	arthritis	arthritis	NOUN
brj-24903	4	30	generated	generate	VERB
brj-24903	4	31	by	by	ADP
brj-24903	4	32	cfa	cfa	PROPN
brj-24903	4	33	in	in	ADP
brj-24903	4	34	rats	rat	NOUN
brj-24903	4	35	.	.	PUNCT
brj-24903	5	1	rats	rat	NOUN
brj-24903	5	2	in	in	ADP
brj-24903	5	3	the	the	DET
brj-24903	5	4	cfa	cfa	PROPN
brj-24903	5	5	control	control	PROPN
brj-24903	5	6	group	group	PROPN
brj-24903	5	7	exhibited	exhibit	VERB
brj-24903	5	8	increased	increase	VERB
brj-24903	5	9	paw	paw	NOUN
brj-24903	5	10	inflammation	inflammation	NOUN
brj-24903	5	11	on	on	ADP
brj-24903	5	12	days	day	NOUN
brj-24903	5	13	1	1	NUM
brj-24903	5	14	,	,	PUNCT
brj-24903	5	15	7	7	NUM
brj-24903	5	16	,	,	PUNCT
brj-24903	5	17	14	14	NUM
brj-24903	5	18	,	,	PUNCT
brj-24903	5	19	21	21	NUM
brj-24903	5	20	,	,	PUNCT
brj-24903	5	21	and	and	CCONJ
brj-24903	5	22	28	28	NUM
brj-24903	5	23	.	.	PUNCT
brj-24903	6	1	inflammation	inflammation	NOUN
brj-24903	6	2	was	be	AUX
brj-24903	6	3	greatly	greatly	ADV
brj-24903	6	4	reduced	reduce	VERB
brj-24903	6	5	when	when	SCONJ
brj-24903	6	6	treated	treat	VERB
brj-24903	6	7	with	with	ADP
brj-24903	6	8	a.	a.	NOUN
brj-24903	6	9	glycyphyllos	glycyphyllos	PROPN
brj-24903	6	10	extract	extract	NOUN
brj-24903	6	11	at	at	ADP
brj-24903	6	12	doses	dose	NOUN
brj-24903	6	13	of	of	ADP
brj-24903	6	14	100	100	NUM
brj-24903	6	15	and	and	CCONJ
brj-24903	6	16	200	200	NUM
brj-24903	6	17	mg	mg	NUM
brj-24903	6	18	/	/	SYM
brj-24903	6	19	kg	kg	PROPN
brj-24903	6	20	.	.	PUNCT
brj-24903	7	1	there	there	PRON
brj-24903	7	2	was	be	VERB
brj-24903	7	3	a	a	DET
brj-24903	7	4	positive	positive	ADJ
brj-24903	7	5	correlation	correlation	NOUN
brj-24903	7	6	between	between	ADP
brj-24903	7	7	the	the	DET
brj-24903	7	8	extract	extract	NOUN
brj-24903	7	9	dosage	dosage	NOUN
brj-24903	7	10	and	and	CCONJ
brj-24903	7	11	the	the	DET
brj-24903	7	12	rats	rat	NOUN
brj-24903	7	13	’	'	PUNCT
brj-24903	7	14	body	body	NOUN
brj-24903	7	15	weight	weight	NOUN
brj-24903	7	16	.	.	PUNCT
brj-24903	8	1	the	the	DET
brj-24903	8	2	extract	extract	NOUN
brj-24903	8	3	alleviated	alleviate	VERB
brj-24903	8	4	inflammatory	inflammatory	ADJ
brj-24903	8	5	and	and	CCONJ
brj-24903	8	6	arthritic	arthritic	ADJ
brj-24903	8	7	symptoms	symptom	NOUN
brj-24903	8	8	in	in	ADP
brj-24903	8	9	animals	animal	NOUN
brj-24903	8	10	with	with	ADP
brj-24903	8	11	cfa	cfa	PROPN
brj-24903	8	12	,	,	PUNCT
brj-24903	8	13	leading	lead	VERB
brj-24903	8	14	to	to	ADP
brj-24903	8	15	an	an	DET
brj-24903	8	16	improvement	improvement	NOUN
brj-24903	8	17	in	in	ADP
brj-24903	8	18	the	the	DET
brj-24903	8	19	arthritic	arthritic	ADJ
brj-24903	8	20	index	index	NOUN
brj-24903	8	21	.	.	PUNCT
brj-24903	9	1	animals	animal	NOUN
brj-24903	9	2	afflicted	afflict	VERB
brj-24903	9	3	with	with	ADP
brj-24903	9	4	arthritis	arthritis	NOUN
brj-24903	9	5	exhibited	exhibit	VERB
brj-24903	9	6	elevated	elevated	ADJ
brj-24903	9	7	levels	level	NOUN
brj-24903	9	8	of	of	ADP
brj-24903	9	9	inflammatory	inflammatory	ADJ
brj-24903	9	10	markers	marker	NOUN
brj-24903	9	11	(	(	PUNCT
brj-24903	9	12	tnf	tnf	PROPN
brj-24903	9	13	-	-	PUNCT
brj-24903	9	14	α	α	PROPN
brj-24903	9	15	,	,	PUNCT
brj-24903	9	16	il-1β	il-1β	PROPN
brj-24903	9	17	,	,	PUNCT
brj-24903	9	18	and	and	CCONJ
brj-24903	9	19	il-6	il-6	NUM
brj-24903	9	20	)	)	PUNCT
brj-24903	9	21	and	and	CCONJ
brj-24903	9	22	a	a	DET
brj-24903	9	23	decrease	decrease	NOUN
brj-24903	9	24	in	in	ADP
brj-24903	9	25	their	their	PRON
brj-24903	9	26	ability	ability	NOUN
brj-24903	9	27	to	to	PART
brj-24903	9	28	move	move	VERB
brj-24903	9	29	.	.	PUNCT
brj-24903	10	1	the	the	DET
brj-24903	10	2	administration	administration	NOUN
brj-24903	10	3	of	of	ADP
brj-24903	10	4	the	the	DET
brj-24903	10	5	extract	extract	NOUN
brj-24903	10	6	significantly	significantly	ADV
brj-24903	10	7	improved	improve	VERB
brj-24903	10	8	the	the	DET
brj-24903	10	9	locomotor	locomotor	NOUN
brj-24903	10	10	score	score	NOUN
brj-24903	10	11	and	and	CCONJ
brj-24903	10	12	strongly	strongly	ADV
brj-24903	10	13	suppressed	suppress	VERB
brj-24903	10	14	the	the	DET
brj-24903	10	15	activation	activation	NOUN
brj-24903	10	16	of	of	ADP
brj-24903	10	17	inflammatory	inflammatory	ADJ
brj-24903	10	18	markers	marker	NOUN
brj-24903	10	19	.	.	PUNCT
brj-24903	11	1	the	the	DET
brj-24903	11	2	extract	extract	NOUN
brj-24903	11	3	effectively	effectively	ADV
brj-24903	11	4	reduced	reduce	VERB
brj-24903	11	5	the	the	DET
brj-24903	11	6	production	production	NOUN
brj-24903	11	7	of	of	ADP
brj-24903	11	8	no	no	PRON
brj-24903	11	9	,	,	PUNCT
brj-24903	11	10	pge2	pge2	NOUN
brj-24903	11	11	,	,	PUNCT
brj-24903	11	12	mmp1	mmp1	PROPN
brj-24903	11	13	,	,	PUNCT
brj-24903	11	14	and	and	CCONJ
brj-24903	11	15	mmp13	mmp13	NOUN
brj-24903	11	16	in	in	ADP
brj-24903	11	17	il-1β	il-1β	PROPN
brj-24903	11	18	-	-	PUNCT
brj-24903	11	19	stimulated	stimulate	VERB
brj-24903	11	20	prcs	prcs	NOUN
brj-24903	11	21	,	,	PUNCT
brj-24903	11	22	with	with	ADP
brj-24903	11	23	the	the	DET
brj-24903	11	24	extent	extent	NOUN
brj-24903	11	25	of	of	ADP
brj-24903	11	26	reduction	reduction	NOUN
brj-24903	11	27	depending	depend	VERB
brj-24903	11	28	on	on	ADP
brj-24903	11	29	the	the	DET
brj-24903	11	30	dosage	dosage	NOUN
brj-24903	11	31	.	.	PUNCT
brj-24903	12	1	this	this	DET
brj-24903	12	2	investigation	investigation	NOUN
brj-24903	12	3	showcased	showcase	VERB
brj-24903	12	4	the	the	DET
brj-24903	12	5	therapeutic	therapeutic	ADJ
brj-24903	12	6	properties	property	NOUN
brj-24903	12	7	of	of	ADP
brj-24903	12	8	the	the	DET
brj-24903	12	9	a.	a.	NOUN
brj-24903	12	10	glycyphyllos	glycyphyllos	NOUN
brj-24903	12	11	extract	extract	VERB
brj-24903	12	12	in	in	ADP
brj-24903	12	13	treating	treat	VERB
brj-24903	12	14	arthritis	arthritis	NOUN
brj-24903	12	15	.	.	PUNCT
brj-24903	13	1	doi	doi	NOUN
brj-24903	13	2	:	:	PUNCT
brj-24903	13	3	10.15376	10.15376	NUM
brj-24903	13	4	/	/	SYM
brj-24903	13	5	biores.21.1.160	biores.21.1.160	VERB
brj-24903	13	6	-	-	PUNCT
brj-24903	13	7	177	177	NUM
brj-24903	13	8	keywords	keyword	NOUN
brj-24903	13	9	:	:	PUNCT
brj-24903	13	10	cfa	cfa	NOUN
brj-24903	13	11	;	;	PUNCT
brj-24903	13	12	primary	primary	ADJ
brj-24903	13	13	rat	rat	NOUN
brj-24903	13	14	chondrocytes	chondrocyte	NOUN
brj-24903	13	15	(	(	PUNCT
brj-24903	13	16	prc	prc	PROPN
brj-24903	13	17	)	)	PUNCT
brj-24903	13	18	;	;	PUNCT
brj-24903	13	19	paw	paw	NOUN
brj-24903	13	20	inflammation	inflammation	NOUN
brj-24903	13	21	;	;	PUNCT
brj-24903	13	22	arthritic	arthritic	ADJ
brj-24903	13	23	index	index	NOUN
brj-24903	13	24	;	;	PUNCT
brj-24903	13	25	inflammatory	inflammatory	ADJ
brj-24903	13	26	markers	marker	NOUN
brj-24903	13	27	;	;	PUNCT
brj-24903	13	28	il-1β	il-1β	PROPN
brj-24903	13	29	;	;	PUNCT
brj-24903	13	30	no	no	INTJ
brj-24903	13	31	;	;	PUNCT
brj-24903	13	32	pge2	pge2	NOUN
brj-24903	13	33	;	;	PUNCT
brj-24903	13	34	mmp1	mmp1	PROPN
brj-24903	13	35	;	;	PUNCT
brj-24903	13	36	mmp13	mmp13	NOUN
brj-24903	13	37	contact	contact	NOUN
brj-24903	13	38	information	information	NOUN
brj-24903	13	39	:	:	PUNCT
brj-24903	13	40	a	a	DET
brj-24903	13	41	:	:	PUNCT
brj-24903	13	42	department	department	NOUN
brj-24903	13	43	of	of	ADP
brj-24903	13	44	rheumatology	rheumatology	NOUN
brj-24903	13	45	,	,	PUNCT
brj-24903	13	46	the	the	DET
brj-24903	13	47	no.1	no.1	ADJ
brj-24903	13	48	affiliated	affiliated	ADJ
brj-24903	13	49	hospital	hospital	NOUN
brj-24903	13	50	of	of	ADP
brj-24903	13	51	yunnan	yunnan	PROPN
brj-24903	13	52	university	university	PROPN
brj-24903	13	53	of	of	ADP
brj-24903	13	54	traditional	traditional	ADJ
brj-24903	13	55	chinese	chinese	ADJ
brj-24903	13	56	medicine	medicine	NOUN
brj-24903	13	57	,	,	PUNCT
brj-24903	13	58	kunming	kunming	NOUN
brj-24903	13	59	,	,	PUNCT
brj-24903	13	60	650021	650021	NUM
brj-24903	13	61	,	,	PUNCT
brj-24903	13	62	china	china	PROPN
brj-24903	13	63	;	;	PUNCT
brj-24903	13	64	b	b	X
brj-24903	13	65	:	:	PUNCT
brj-24903	13	66	the	the	DET
brj-24903	13	67	first	first	ADJ
brj-24903	13	68	school	school	NOUN
brj-24903	13	69	of	of	ADP
brj-24903	13	70	clinical	clinical	ADJ
brj-24903	13	71	medicine	medicine	NOUN
brj-24903	13	72	,	,	PUNCT
brj-24903	13	73	yunnan	yunnan	PROPN
brj-24903	13	74	university	university	PROPN
brj-24903	13	75	of	of	ADP
brj-24903	13	76	chinese	chinese	ADJ
brj-24903	13	77	medicine	medicine	NOUN
brj-24903	13	78	,	,	PUNCT
brj-24903	13	79	kunming	kunming	NOUN
brj-24903	13	80	,	,	PUNCT
brj-24903	13	81	650021	650021	NUM
brj-24903	13	82	,	,	PUNCT
brj-24903	13	83	china	china	PROPN
brj-24903	13	84	;	;	PUNCT
brj-24903	13	85	#	#	NOUN
brj-24903	13	86	lingli	lingli	NOUN
brj-24903	13	87	gu	gu	PROPN
brj-24903	13	88	,	,	PUNCT
brj-24903	13	89	rong	rong	PROPN
brj-24903	13	90	su	su	PROPN
brj-24903	13	91	,	,	PUNCT
brj-24903	13	92	shiyun	shiyun	VERB
brj-24903	13	93	yin	yin	PROPN
brj-24903	13	94	contributed	contribute	VERB
brj-24903	13	95	equally	equally	ADV
brj-24903	13	96	to	to	ADP
brj-24903	13	97	the	the	DET
brj-24903	13	98	work	work	NOUN
brj-24903	13	99	,	,	PUNCT
brj-24903	13	100	they	they	PRON
brj-24903	13	101	jointly	jointly	ADV
brj-24903	13	102	listed	list	VERB
brj-24903	13	103	as	as	ADP
brj-24903	13	104	first	first	ADJ
brj-24903	13	105	authors	author	NOUN
brj-24903	13	106	.	.	PUNCT
brj-24903	14	1	*	*	PUNCT
brj-24903	14	2	corresponding	correspond	VERB
brj-24903	14	3	authors	author	NOUN
brj-24903	14	4	:	:	PUNCT
brj-24903	14	5	wei	wei	PROPN
brj-24903	14	6	jian	jian	PROPN
brj-24903	14	7	zhou	zhou	PROPN
brj-24903	14	8	,	,	PUNCT
brj-24903	14	9	zhouweijian78@sina.com	zhouweijian78@sina.com	X
brj-24903	14	10	*	*	PUNCT
brj-24903	14	11	co	co	ADJ
brj-24903	14	12	-	-	ADJ
brj-24903	14	13	corresponding	corresponding	ADJ
brj-24903	14	14	authors	author	NOUN
brj-24903	14	15	:	:	PUNCT
brj-24903	14	16	jiangyun	jiangyun	PROPN
brj-24903	14	17	peng	peng	PROPN
brj-24903	14	18	,	,	PUNCT
brj-24903	14	19	pengjiangyun@126.com	pengjiangyun@126.com	PROPN
brj-24903	14	20	introduction	introduction	NOUN
brj-24903	14	21	the	the	DET
brj-24903	14	22	severe	severe	ADJ
brj-24903	14	23	,	,	PUNCT
brj-24903	14	24	incurable	incurable	ADJ
brj-24903	14	25	disease	disease	NOUN
brj-24903	14	26	known	know	VERB
brj-24903	14	27	as	as	ADP
brj-24903	14	28	rheumatoid	rheumatoid	NOUN
brj-24903	14	29	arthritis	arthritis	NOUN
brj-24903	14	30	(	(	PUNCT
brj-24903	14	31	ra	ra	NOUN
brj-24903	14	32	)	)	PUNCT
brj-24903	14	33	is	be	AUX
brj-24903	14	34	characterized	characterize	VERB
brj-24903	14	35	by	by	ADP
brj-24903	14	36	edema	edema	PROPN
brj-24903	14	37	,	,	PUNCT
brj-24903	14	38	pain	pain	NOUN
brj-24903	14	39	,	,	PUNCT
brj-24903	14	40	with	with	ADP
brj-24903	14	41	tightness	tightness	NOUN
brj-24903	14	42	in	in	ADP
brj-24903	14	43	the	the	DET
brj-24903	14	44	synovial	synovial	ADJ
brj-24903	14	45	joints	joint	NOUN
brj-24903	14	46	.	.	PUNCT
brj-24903	15	1	the	the	DET
brj-24903	15	2	exact	exact	ADJ
brj-24903	15	3	etiology	etiology	NOUN
brj-24903	15	4	of	of	ADP
brj-24903	15	5	this	this	DET
brj-24903	15	6	awful	awful	ADJ
brj-24903	15	7	sickness	sickness	NOUN
brj-24903	15	8	is	be	AUX
brj-24903	15	9	unknown	unknown	ADJ
brj-24903	15	10	.	.	PUNCT
brj-24903	16	1	however	however	ADV
brj-24903	16	2	,	,	PUNCT
brj-24903	16	3	it	it	PRON
brj-24903	16	4	shares	share	VERB
brj-24903	16	5	a	a	DET
brj-24903	16	6	tight	tight	ADJ
brj-24903	16	7	relationship	relationship	NOUN
brj-24903	16	8	with	with	ADP
brj-24903	16	9	an	an	DET
brj-24903	16	10	autoimmune	autoimmune	ADJ
brj-24903	16	11	reaction	reaction	NOUN
brj-24903	16	12	triggered	trigger	VERB
brj-24903	16	13	by	by	ADP
brj-24903	16	14	many	many	ADJ
brj-24903	16	15	genetic	genetic	ADJ
brj-24903	16	16	plus	plus	CCONJ
brj-24903	16	17	environmental	environmental	ADJ
brj-24903	16	18	factors	factor	NOUN
brj-24903	16	19	.	.	PUNCT
brj-24903	17	1	the	the	DET
brj-24903	17	2	economy	economy	NOUN
brj-24903	17	3	and	and	CCONJ
brj-24903	17	4	society	society	NOUN
brj-24903	17	5	are	be	AUX
brj-24903	17	6	greatly	greatly	ADV
brj-24903	17	7	impacted	impact	VERB
brj-24903	17	8	by	by	ADP
brj-24903	17	9	chronic	chronic	ADJ
brj-24903	17	10	disease	disease	NOUN
brj-24903	17	11	and	and	CCONJ
brj-24903	17	12	the	the	DET
brj-24903	17	13	deaths	death	NOUN
brj-24903	17	14	that	that	PRON
brj-24903	17	15	follow	follow	VERB
brj-24903	17	16	.	.	PUNCT
brj-24903	18	1	the	the	DET
brj-24903	18	2	pathophysiological	pathophysiological	ADJ
brj-24903	18	3	signs	sign	NOUN
brj-24903	18	4	of	of	ADP
brj-24903	18	5	ra	ra	PROPN
brj-24903	18	6	include	include	VERB
brj-24903	18	7	significant	significant	ADJ
brj-24903	18	8	synovial	synovial	ADJ
brj-24903	18	9	cartilage	cartilage	NOUN
brj-24903	18	10	or	or	CCONJ
brj-24903	18	11	bone	bone	NOUN
brj-24903	18	12	deterioration	deterioration	NOUN
brj-24903	18	13	,	,	PUNCT
brj-24903	18	14	pannus	pannus	ADJ
brj-24903	18	15	formation	formation	NOUN
brj-24903	18	16	,	,	PUNCT
brj-24903	18	17	and	and	CCONJ
brj-24903	18	18	leukocyte	leukocyte	NOUN
brj-24903	18	19	infiltration	infiltration	NOUN
brj-24903	18	20	,	,	PUNCT
brj-24903	18	21	with	with	ADP
brj-24903	18	22	chronic	chronic	ADJ
brj-24903	18	23	inflammation	inflammation	NOUN
brj-24903	18	24	.	.	PUNCT
brj-24903	19	1	nevertheless	nevertheless	ADV
brj-24903	19	2	,	,	PUNCT
brj-24903	19	3	the	the	DET
brj-24903	19	4	real	real	ADJ
brj-24903	19	5	trigger	trigger	NOUN
brj-24903	19	6	of	of	ADP
brj-24903	19	7	ra	ra	PROPN
brj-24903	19	8	is	be	AUX
brj-24903	19	9	yet	yet	ADV
brj-24903	19	10	unidentified	unidentified	ADJ
brj-24903	19	11	(	(	PUNCT
brj-24903	19	12	alamgeer	alamgeer	NOUN
brj-24903	19	13	et	et	PROPN
brj-24903	19	14	al	al	PROPN
brj-24903	19	15	.	.	PROPN
brj-24903	19	16	2017	2017	NUM
brj-24903	19	17	)	)	PUNCT
brj-24903	19	18	.	.	PUNCT
brj-24903	20	1	clinical	clinical	ADJ
brj-24903	20	2	ra	ra	PROPN
brj-24903	20	3	indications	indication	NOUN
brj-24903	20	4	can	can	AUX
brj-24903	20	5	vary	vary	VERB
brj-24903	20	6	from	from	ADP
brj-24903	20	7	small	small	ADJ
brj-24903	20	8	discomfort	discomfort	NOUN
brj-24903	20	9	as	as	ADV
brj-24903	20	10	well	well	ADV
brj-24903	20	11	as	as	ADP
brj-24903	20	12	swelling	swell	VERB
brj-24903	20	13	to	to	ADP
brj-24903	20	14	serious	serious	ADJ
brj-24903	20	15	symptoms	symptom	NOUN
brj-24903	20	16	including	include	VERB
brj-24903	20	17	entirely	entirely	ADV
brj-24903	20	18	or	or	CCONJ
brj-24903	20	19	partial	partial	ADJ
brj-24903	20	20	joint	joint	ADJ
brj-24903	20	21	inactivity	inactivity	NOUN
brj-24903	20	22	as	as	ADV
brj-24903	20	23	well	well	ADV
brj-24903	20	24	as	as	ADP
brj-24903	20	25	muscle	muscle	NOUN
brj-24903	20	26	weakness	weakness	NOUN
brj-24903	20	27	,	,	PUNCT
brj-24903	20	28	such	such	ADJ
brj-24903	20	29	as	as	ADP
brj-24903	20	30	contractions	contraction	NOUN
brj-24903	20	31	,	,	PUNCT
brj-24903	20	32	depending	depend	VERB
brj-24903	20	33	on	on	ADP
brj-24903	20	34	the	the	DET
brj-24903	20	35	individual	individual	NOUN
brj-24903	20	36	.	.	PUNCT
brj-24903	21	1	peer	peer	NOUN
brj-24903	21	2	-	-	PUNCT
brj-24903	21	3	reviewed	review	VERB
brj-24903	21	4	article	article	NOUN
brj-24903	21	5	bioresources.cnr.ncsu.edu	bioresources.cnr.ncsu.edu	X
brj-24903	21	6	gu	gu	VERB
brj-24903	21	7	et	et	PROPN
brj-24903	21	8	al	al	PROPN
brj-24903	21	9	.	.	PROPN
brj-24903	22	1	(	(	PUNCT
brj-24903	22	2	2026	2026	NUM
brj-24903	22	3	)	)	PUNCT
brj-24903	22	4	.	.	PUNCT
brj-24903	23	1	“	"	PUNCT
brj-24903	23	2	astragalus	astragalus	NOUN
brj-24903	23	3	leaf	leaf	NOUN
brj-24903	23	4	extract	extract	NOUN
brj-24903	23	5	vs.	vs.	ADP
brj-24903	23	6	arthritis	arthritis	NOUN
brj-24903	23	7	,	,	PUNCT
brj-24903	23	8	”	"	PUNCT
brj-24903	23	9	bioresources	bioresource	NOUN
brj-24903	23	10	21(1	21(1	NUM
brj-24903	23	11	)	)	PUNCT
brj-24903	23	12	,	,	PUNCT
brj-24903	23	13	160	160	NUM
brj-24903	23	14	-	-	SYM
brj-24903	23	15	177	177	NUM
brj-24903	23	16	.	.	PUNCT
brj-24903	23	17	161	161	NUM
brj-24903	23	18	on	on	ADP
brj-24903	23	19	the	the	DET
brj-24903	23	20	other	other	ADJ
brj-24903	23	21	hand	hand	NOUN
brj-24903	23	22	,	,	PUNCT
brj-24903	23	23	as	as	ADP
brj-24903	23	24	the	the	DET
brj-24903	23	25	only	only	ADJ
brj-24903	23	26	cellular	cellular	ADJ
brj-24903	23	27	component	component	NOUN
brj-24903	23	28	of	of	ADP
brj-24903	23	29	articular	articular	ADJ
brj-24903	23	30	cartilage	cartilage	NOUN
brj-24903	23	31	,	,	PUNCT
brj-24903	23	32	chondrocytes	chondrocyte	NOUN
brj-24903	23	33	are	be	AUX
brj-24903	23	34	in	in	ADP
brj-24903	23	35	charge	charge	NOUN
brj-24903	23	36	of	of	ADP
brj-24903	23	37	maintaining	maintain	VERB
brj-24903	23	38	tissue	tissue	NOUN
brj-24903	23	39	homeostasis	homeostasis	NOUN
brj-24903	23	40	and	and	CCONJ
brj-24903	23	41	synthesizing	synthesize	VERB
brj-24903	23	42	the	the	DET
brj-24903	23	43	substantial	substantial	ADJ
brj-24903	23	44	turnover	turnover	NOUN
brj-24903	23	45	volume	volume	NOUN
brj-24903	23	46	of	of	ADP
brj-24903	23	47	extracellular	extracellular	ADJ
brj-24903	23	48	matrix	matrix	NOUN
brj-24903	23	49	(	(	PUNCT
brj-24903	23	50	ecm	ecm	NOUN
brj-24903	23	51	)	)	PUNCT
brj-24903	23	52	components	component	NOUN
brj-24903	23	53	.	.	PUNCT
brj-24903	24	1	degenerative	degenerative	ADJ
brj-24903	24	2	disorders	disorder	NOUN
brj-24903	24	3	,	,	PUNCT
brj-24903	24	4	including	include	VERB
brj-24903	24	5	osteoarthritis	osteoarthritis	NOUN
brj-24903	24	6	(	(	PUNCT
brj-24903	24	7	oa	oa	NOUN
brj-24903	24	8	)	)	PUNCT
brj-24903	24	9	,	,	PUNCT
brj-24903	24	10	are	be	AUX
brj-24903	24	11	associated	associate	VERB
brj-24903	24	12	with	with	ADP
brj-24903	24	13	chondrocyte	chondrocyte	NOUN
brj-24903	24	14	function	function	NOUN
brj-24903	24	15	impairment	impairment	NOUN
brj-24903	24	16	(	(	PUNCT
brj-24903	24	17	eccleston	eccleston	PROPN
brj-24903	24	18	2023	2023	NUM
brj-24903	24	19	)	)	PUNCT
brj-24903	24	20	.	.	PUNCT
brj-24903	25	1	oa	oa	PROPN
brj-24903	25	2	is	be	AUX
brj-24903	25	3	the	the	DET
brj-24903	25	4	most	most	ADV
brj-24903	25	5	common	common	ADJ
brj-24903	25	6	musculoskeletal	musculoskeletal	ADJ
brj-24903	25	7	illness	illness	NOUN
brj-24903	25	8	,	,	PUNCT
brj-24903	25	9	accounting	account	VERB
brj-24903	25	10	for	for	ADP
brj-24903	25	11	15	15	NUM
brj-24903	25	12	%	%	NOUN
brj-24903	25	13	of	of	ADP
brj-24903	25	14	all	all	DET
brj-24903	25	15	cartilage	cartilage	NOUN
brj-24903	25	16	problems	problem	NOUN
brj-24903	25	17	and	and	CCONJ
brj-24903	25	18	affecting	affect	VERB
brj-24903	25	19	around	around	ADP
brj-24903	25	20	100	100	NUM
brj-24903	25	21	million	million	NUM
brj-24903	25	22	adults	adult	NOUN
brj-24903	25	23	over	over	ADP
brj-24903	25	24	the	the	DET
brj-24903	25	25	age	age	NOUN
brj-24903	25	26	of	of	ADP
brj-24903	25	27	45	45	NUM
brj-24903	25	28	worldwide	worldwide	ADV
brj-24903	25	29	.	.	PUNCT
brj-24903	26	1	the	the	DET
brj-24903	26	2	prevalence	prevalence	NOUN
brj-24903	26	3	of	of	ADP
brj-24903	26	4	arthritis	arthritis	NOUN
brj-24903	26	5	is	be	AUX
brj-24903	26	6	one	one	NUM
brj-24903	26	7	percent	percent	NOUN
brj-24903	26	8	worldwide	worldwide	ADV
brj-24903	26	9	,	,	PUNCT
brj-24903	26	10	and	and	CCONJ
brj-24903	26	11	the	the	DET
brj-24903	26	12	ratio	ratio	NOUN
brj-24903	26	13	of	of	ADP
brj-24903	26	14	affected	affected	ADJ
brj-24903	26	15	women	woman	NOUN
brj-24903	26	16	to	to	PART
brj-24903	26	17	affected	affected	ADJ
brj-24903	26	18	men	man	NOUN
brj-24903	26	19	is	be	AUX
brj-24903	26	20	three	three	NUM
brj-24903	26	21	to	to	ADP
brj-24903	26	22	one	one	NUM
brj-24903	26	23	(	(	PUNCT
brj-24903	26	24	bennell	bennell	NOUN
brj-24903	26	25	et	et	PROPN
brj-24903	26	26	al	al	PROPN
brj-24903	26	27	.	.	PROPN
brj-24903	26	28	2010	2010	NUM
brj-24903	26	29	)	)	PUNCT
brj-24903	26	30	.	.	PUNCT
brj-24903	27	1	inflammatory	inflammatory	ADJ
brj-24903	27	2	cytokines	cytokine	NOUN
brj-24903	27	3	such	such	ADJ
brj-24903	27	4	as	as	ADP
brj-24903	27	5	interleukin-1β	interleukin-1β	NOUN
brj-24903	27	6	(	(	PUNCT
brj-24903	27	7	il-1β	il-1β	PROPN
brj-24903	27	8	)	)	PUNCT
brj-24903	27	9	,	,	PUNCT
brj-24903	27	10	tumor	tumor	NOUN
brj-24903	27	11	necrosis	necrosis	NOUN
brj-24903	27	12	factor	factor	NOUN
brj-24903	27	13	-	-	PUNCT
brj-24903	27	14	α	α	X
brj-24903	27	15	(	(	PUNCT
brj-24903	27	16	tnf	tnf	PROPN
brj-24903	27	17	-	-	PUNCT
brj-24903	27	18	α	α	NOUN
brj-24903	27	19	)	)	PUNCT
brj-24903	27	20	,	,	PUNCT
brj-24903	27	21	or	or	CCONJ
brj-24903	27	22	il-6	il-6	NOUN
brj-24903	27	23	affect	affect	VERB
brj-24903	27	24	inflammation	inflammation	NOUN
brj-24903	27	25	and	and	CCONJ
brj-24903	27	26	joint	joint	ADJ
brj-24903	27	27	damage	damage	NOUN
brj-24903	27	28	as	as	SCONJ
brj-24903	27	29	arthritis	arthritis	NOUN
brj-24903	27	30	progresses	progress	VERB
brj-24903	27	31	.	.	PUNCT
brj-24903	28	1	the	the	DET
brj-24903	28	2	stimulation	stimulation	NOUN
brj-24903	28	3	of	of	ADP
brj-24903	28	4	chondrocyte	chondrocyte	PROPN
brj-24903	28	5	hypertrophy	hypertrophy	NOUN
brj-24903	28	6	by	by	ADP
brj-24903	28	7	interlukin-1β	interlukin-1β	NOUN
brj-24903	28	8	(	(	PUNCT
brj-24903	28	9	il-1β	il-1β	PROPN
brj-24903	28	10	)	)	PUNCT
brj-24903	28	11	results	result	NOUN
brj-24903	28	12	in	in	ADP
brj-24903	28	13	the	the	DET
brj-24903	28	14	production	production	NOUN
brj-24903	28	15	of	of	ADP
brj-24903	28	16	hypertrophic	hypertrophic	ADJ
brj-24903	28	17	markers	marker	NOUN
brj-24903	28	18	such	such	ADJ
brj-24903	28	19	as	as	ADP
brj-24903	28	20	mmp-13	mmp-13	PROPN
brj-24903	28	21	,	,	PUNCT
brj-24903	28	22	colx	colx	NOUN
brj-24903	28	23	,	,	PUNCT
brj-24903	28	24	and	and	CCONJ
brj-24903	28	25	runx2	runx2	NOUN
brj-24903	28	26	.	.	PUNCT
brj-24903	29	1	in	in	ADP
brj-24903	29	2	addition	addition	NOUN
brj-24903	29	3	,	,	PUNCT
brj-24903	29	4	this	this	DET
brj-24903	29	5	stimulation	stimulation	NOUN
brj-24903	29	6	causes	cause	VERB
brj-24903	29	7	the	the	DET
brj-24903	29	8	breakdown	breakdown	NOUN
brj-24903	29	9	of	of	ADP
brj-24903	29	10	the	the	DET
brj-24903	29	11	collagen	collagen	NOUN
brj-24903	29	12	network	network	NOUN
brj-24903	29	13	and	and	CCONJ
brj-24903	29	14	the	the	DET
brj-24903	29	15	death	death	NOUN
brj-24903	29	16	of	of	ADP
brj-24903	29	17	articular	articular	ADJ
brj-24903	29	18	chondrocytes	chondrocyte	NOUN
brj-24903	29	19	by	by	ADP
brj-24903	29	20	increasing	increase	VERB
brj-24903	29	21	the	the	DET
brj-24903	29	22	production	production	NOUN
brj-24903	29	23	of	of	ADP
brj-24903	29	24	neoepitopes	neoepitope	NOUN
brj-24903	29	25	,	,	PUNCT
brj-24903	29	26	inflammatory	inflammatory	ADJ
brj-24903	29	27	mediators	mediator	NOUN
brj-24903	29	28	,	,	PUNCT
brj-24903	29	29	and	and	CCONJ
brj-24903	29	30	neuropeptides	neuropeptide	NOUN
brj-24903	29	31	.	.	PUNCT
brj-24903	30	1	the	the	DET
brj-24903	30	2	production	production	NOUN
brj-24903	30	3	of	of	ADP
brj-24903	30	4	inflammatory	inflammatory	ADJ
brj-24903	30	5	sensitizers	sensitizer	NOUN
brj-24903	30	6	such	such	ADJ
brj-24903	30	7	as	as	ADP
brj-24903	30	8	neuropeptides	neuropeptide	NOUN
brj-24903	30	9	and	and	CCONJ
brj-24903	30	10	cytokines	cytokine	NOUN
brj-24903	30	11	is	be	AUX
brj-24903	30	12	associated	associate	VERB
brj-24903	30	13	with	with	ADP
brj-24903	30	14	this	this	DET
brj-24903	30	15	process	process	NOUN
brj-24903	30	16	,	,	PUNCT
brj-24903	30	17	which	which	PRON
brj-24903	30	18	compromises	compromise	VERB
brj-24903	30	19	the	the	DET
brj-24903	30	20	integrity	integrity	NOUN
brj-24903	30	21	of	of	ADP
brj-24903	30	22	the	the	DET
brj-24903	30	23	cartilage	cartilage	NOUN
brj-24903	30	24	.	.	PUNCT
brj-24903	31	1	the	the	DET
brj-24903	31	2	breakdown	breakdown	NOUN
brj-24903	31	3	of	of	ADP
brj-24903	31	4	the	the	DET
brj-24903	31	5	collagenous	collagenous	ADJ
brj-24903	31	6	framework	framework	NOUN
brj-24903	31	7	includes	include	VERB
brj-24903	31	8	the	the	DET
brj-24903	31	9	production	production	NOUN
brj-24903	31	10	of	of	ADP
brj-24903	31	11	proteolytic	proteolytic	ADJ
brj-24903	31	12	enzymes	enzyme	NOUN
brj-24903	31	13	such	such	ADJ
brj-24903	31	14	as	as	ADP
brj-24903	31	15	mmp-1	mmp-1	PUNCT
brj-24903	31	16	and	and	CCONJ
brj-24903	31	17	mmp-13	mmp-13	PROPN
brj-24903	31	18	and	and	CCONJ
brj-24903	31	19	sequential	sequential	ADJ
brj-24903	31	20	signaling	signal	VERB
brj-24903	31	21	cascades	cascade	NOUN
brj-24903	31	22	.	.	PUNCT
brj-24903	32	1	il-1β	il-1β	ADJ
brj-24903	32	2	-	-	PUNCT
brj-24903	32	3	induced	induce	VERB
brj-24903	32	4	inflammatory	inflammatory	ADJ
brj-24903	32	5	cytokines	cytokine	NOUN
brj-24903	32	6	unregulated	unregulate	VERB
brj-24903	32	7	tnf	tnf	PROPN
brj-24903	32	8	-	-	PUNCT
brj-24903	32	9	α	α	PROPN
brj-24903	32	10	,	,	PUNCT
brj-24903	32	11	il-6	il-6	NOUN
brj-24903	32	12	,	,	PUNCT
brj-24903	32	13	pge	pge	NOUN
brj-24903	32	14	,	,	PUNCT
brj-24903	32	15	nitric	nitric	ADJ
brj-24903	32	16	oxide	oxide	NOUN
brj-24903	32	17	,	,	PUNCT
brj-24903	32	18	and	and	CCONJ
brj-24903	32	19	inos	ino	NOUN
brj-24903	32	20	.	.	PUNCT
brj-24903	33	1	moreover	moreover	ADV
brj-24903	33	2	,	,	PUNCT
brj-24903	33	3	il-1β	il-1β	PROPN
brj-24903	33	4	rises	rise	VERB
brj-24903	33	5	no	no	DET
brj-24903	33	6	generation	generation	NOUN
brj-24903	33	7	,	,	PUNCT
brj-24903	33	8	intensifies	intensify	VERB
brj-24903	33	9	cox-2	cox-2	ADJ
brj-24903	33	10	activity	activity	NOUN
brj-24903	33	11	,	,	PUNCT
brj-24903	33	12	and	and	CCONJ
brj-24903	33	13	up	up	NOUN
brj-24903	33	14	-	-	PUNCT
brj-24903	33	15	regulates	regulate	VERB
brj-24903	33	16	mmp	mmp	PROPN
brj-24903	33	17	expression	expression	NOUN
brj-24903	33	18	—	—	PUNCT
brj-24903	33	19	all	all	PRON
brj-24903	33	20	of	of	ADP
brj-24903	33	21	which	which	PRON
brj-24903	33	22	are	be	AUX
brj-24903	33	23	connected	connect	VERB
brj-24903	33	24	to	to	ADP
brj-24903	33	25	the	the	DET
brj-24903	33	26	deterioration	deterioration	NOUN
brj-24903	33	27	of	of	ADP
brj-24903	33	28	cartilage	cartilage	NOUN
brj-24903	33	29	and	and	CCONJ
brj-24903	33	30	extracellular	extracellular	ADJ
brj-24903	33	31	matrix	matrix	NOUN
brj-24903	33	32	(	(	PUNCT
brj-24903	33	33	thudium	thudium	NOUN
brj-24903	33	34	et	et	PROPN
brj-24903	33	35	al	al	PROPN
brj-24903	33	36	.	.	PROPN
brj-24903	33	37	2019	2019	NUM
brj-24903	33	38	;	;	PUNCT
brj-24903	33	39	mei	mei	PROPN
brj-24903	33	40	et	et	PROPN
brj-24903	33	41	al	al	PROPN
brj-24903	33	42	.	.	PROPN
brj-24903	33	43	2021	2021	NUM
brj-24903	33	44	)	)	PUNCT
brj-24903	33	45	.	.	PUNCT
brj-24903	34	1	the	the	DET
brj-24903	34	2	use	use	NOUN
brj-24903	34	3	of	of	ADP
brj-24903	34	4	nonsteroidal	nonsteroidal	NOUN
brj-24903	34	5	anti	anti	ADJ
brj-24903	34	6	-	-	ADJ
brj-24903	34	7	inflammatory	inflammatory	ADJ
brj-24903	34	8	drugs	drug	NOUN
brj-24903	34	9	(	(	PUNCT
brj-24903	34	10	nsaids	nsaid	NOUN
brj-24903	34	11	)	)	PUNCT
brj-24903	34	12	as	as	ADP
brj-24903	34	13	a	a	DET
brj-24903	34	14	first	first	ADJ
brj-24903	34	15	line	line	NOUN
brj-24903	34	16	of	of	ADP
brj-24903	34	17	treatment	treatment	NOUN
brj-24903	34	18	for	for	ADP
brj-24903	34	19	patients	patient	NOUN
brj-24903	34	20	with	with	ADP
brj-24903	34	21	rheumatoid	rheumatoid	NOUN
brj-24903	34	22	arthritis	arthritis	NOUN
brj-24903	34	23	(	(	PUNCT
brj-24903	34	24	ra	ra	NOUN
brj-24903	34	25	)	)	PUNCT
brj-24903	34	26	is	be	AUX
brj-24903	34	27	well	well	ADV
brj-24903	34	28	-	-	PUNCT
brj-24903	34	29	established	establish	VERB
brj-24903	34	30	.	.	PUNCT
brj-24903	35	1	however	however	ADV
brj-24903	35	2	,	,	PUNCT
brj-24903	35	3	longterm	longterm	ADJ
brj-24903	35	4	use	use	NOUN
brj-24903	35	5	of	of	ADP
brj-24903	35	6	nsaids	nsaid	NOUN
brj-24903	35	7	has	have	AUX
brj-24903	35	8	been	be	AUX
brj-24903	35	9	connected	connect	VERB
brj-24903	35	10	with	with	ADP
brj-24903	35	11	certain	certain	ADJ
brj-24903	35	12	potential	potential	ADJ
brj-24903	35	13	side	side	NOUN
brj-24903	35	14	effects	effect	NOUN
brj-24903	35	15	,	,	PUNCT
brj-24903	35	16	such	such	ADJ
brj-24903	35	17	as	as	ADP
brj-24903	35	18	gastroduodenal	gastroduodenal	ADJ
brj-24903	35	19	issues	issue	NOUN
brj-24903	35	20	and	and	CCONJ
brj-24903	35	21	a	a	DET
brj-24903	35	22	dysfunctional	dysfunctional	ADJ
brj-24903	35	23	kidney	kidney	NOUN
brj-24903	35	24	,	,	PUNCT
brj-24903	35	25	which	which	PRON
brj-24903	35	26	are	be	AUX
brj-24903	35	27	likely	likely	ADV
brj-24903	35	28	caused	cause	VERB
brj-24903	35	29	by	by	ADP
brj-24903	35	30	a	a	DET
brj-24903	35	31	decreased	decrease	VERB
brj-24903	35	32	level	level	NOUN
brj-24903	35	33	of	of	ADP
brj-24903	35	34	cyclo	cyclo	NOUN
brj-24903	35	35	-	-	PUNCT
brj-24903	35	36	oxygenase	oxygenase	NOUN
brj-24903	35	37	for	for	ADP
brj-24903	35	38	a	a	DET
brj-24903	35	39	fall	fall	NOUN
brj-24903	35	40	in	in	ADP
brj-24903	35	41	prostaglandin	prostaglandin	ADJ
brj-24903	35	42	content	content	NOUN
brj-24903	35	43	(	(	PUNCT
brj-24903	35	44	guo	guo	PROPN
brj-24903	35	45	et	et	PROPN
brj-24903	35	46	al	al	PROPN
brj-24903	35	47	.	.	PROPN
brj-24903	35	48	2018	2018	NUM
brj-24903	35	49	;	;	PUNCT
brj-24903	35	50	bullock	bullock	NOUN
brj-24903	35	51	et	et	PROPN
brj-24903	35	52	al	al	PROPN
brj-24903	35	53	.	.	PROPN
brj-24903	35	54	2019	2019	NUM
brj-24903	35	55	;	;	PUNCT
brj-24903	35	56	radu	radu	VERB
brj-24903	35	57	and	and	CCONJ
brj-24903	35	58	bungau	bungau	NOUN
brj-24903	35	59	2021	2021	NUM
brj-24903	35	60	)	)	PUNCT
brj-24903	35	61	.	.	PUNCT
brj-24903	36	1	because	because	SCONJ
brj-24903	36	2	of	of	ADP
brj-24903	36	3	its	its	PRON
brj-24903	36	4	emollient	emollient	NOUN
brj-24903	36	5	,	,	PUNCT
brj-24903	36	6	diuretic	diuretic	NOUN
brj-24903	36	7	,	,	PUNCT
brj-24903	36	8	and	and	CCONJ
brj-24903	36	9	invigorating	invigorate	VERB
brj-24903	36	10	qualities	quality	NOUN
brj-24903	36	11	,	,	PUNCT
brj-24903	36	12	astragalus	astragalus	NOUN
brj-24903	36	13	glycyphyllos	glycyphyllos	NOUN
brj-24903	36	14	is	be	AUX
brj-24903	36	15	a	a	DET
brj-24903	36	16	plant	plant	NOUN
brj-24903	36	17	that	that	PRON
brj-24903	36	18	is	be	AUX
brj-24903	36	19	utilized	utilize	VERB
brj-24903	36	20	in	in	ADP
brj-24903	36	21	several	several	ADJ
brj-24903	36	22	european	european	ADJ
brj-24903	36	23	nations	nation	NOUN
brj-24903	36	24	.	.	PUNCT
brj-24903	37	1	the	the	DET
brj-24903	37	2	leaves	leave	NOUN
brj-24903	37	3	and	and	CCONJ
brj-24903	37	4	seeds	seed	NOUN
brj-24903	37	5	are	be	AUX
brj-24903	37	6	used	use	VERB
brj-24903	37	7	as	as	ADP
brj-24903	37	8	laxatives	laxative	NOUN
brj-24903	37	9	and	and	CCONJ
brj-24903	37	10	to	to	PART
brj-24903	37	11	treat	treat	VERB
brj-24903	37	12	a	a	DET
brj-24903	37	13	variety	variety	NOUN
brj-24903	37	14	of	of	ADP
brj-24903	37	15	illnesses	illness	NOUN
brj-24903	37	16	in	in	ADP
brj-24903	37	17	the	the	DET
brj-24903	37	18	caucasus	caucasus	PROPN
brj-24903	37	19	area	area	NOUN
brj-24903	37	20	,	,	PUNCT
brj-24903	37	21	such	such	ADJ
brj-24903	37	22	as	as	ADP
brj-24903	37	23	urolithiasis	urolithiasis	NOUN
brj-24903	37	24	,	,	PUNCT
brj-24903	37	25	oliguria	oliguria	PROPN
brj-24903	37	26	,	,	PUNCT
brj-24903	37	27	scrofulosis	scrofulosis	NOUN
brj-24903	37	28	,	,	PUNCT
brj-24903	37	29	and	and	CCONJ
brj-24903	37	30	dermatitis	dermatitis	NOUN
brj-24903	37	31	.	.	PUNCT
brj-24903	38	1	aerial	aerial	ADJ
brj-24903	38	2	parts	part	NOUN
brj-24903	38	3	are	be	AUX
brj-24903	38	4	utilized	utilize	VERB
brj-24903	38	5	in	in	ADP
brj-24903	38	6	belarus	belarus	PROPN
brj-24903	38	7	to	to	PART
brj-24903	38	8	treat	treat	VERB
brj-24903	38	9	gastrointestinal	gastrointestinal	ADJ
brj-24903	38	10	ailments	ailment	NOUN
brj-24903	38	11	,	,	PUNCT
brj-24903	38	12	leucorrhoea	leucorrhoea	NOUN
brj-24903	38	13	,	,	PUNCT
brj-24903	38	14	and	and	CCONJ
brj-24903	38	15	uteroptosis	uteroptosis	NOUN
brj-24903	38	16	.	.	PUNCT
brj-24903	39	1	the	the	DET
brj-24903	39	2	herb	herb	NOUN
brj-24903	39	3	is	be	AUX
brj-24903	39	4	utilized	utilize	VERB
brj-24903	39	5	as	as	ADP
brj-24903	39	6	a	a	DET
brj-24903	39	7	laxative	laxative	NOUN
brj-24903	39	8	,	,	PUNCT
brj-24903	39	9	diuretic	diuretic	NOUN
brj-24903	39	10	,	,	PUNCT
brj-24903	39	11	and	and	CCONJ
brj-24903	39	12	mucoactive	mucoactive	ADJ
brj-24903	39	13	agent	agent	NOUN
brj-24903	39	14	in	in	ADP
brj-24903	39	15	ukraine	ukraine	NOUN
brj-24903	39	16	to	to	PART
brj-24903	39	17	treat	treat	VERB
brj-24903	39	18	dermatitis	dermatitis	NOUN
brj-24903	39	19	,	,	PUNCT
brj-24903	39	20	rheumatism	rheumatism	NOUN
brj-24903	39	21	,	,	PUNCT
brj-24903	39	22	and	and	CCONJ
brj-24903	39	23	stds	stds	NOUN
brj-24903	39	24	.	.	PUNCT
brj-24903	40	1	the	the	DET
brj-24903	40	2	herb	herb	NOUN
brj-24903	40	3	grows	grow	VERB
brj-24903	40	4	along	along	ADP
brj-24903	40	5	the	the	DET
brj-24903	40	6	volga	volga	PROPN
brj-24903	40	7	river	river	NOUN
brj-24903	40	8	and	and	CCONJ
brj-24903	40	9	is	be	AUX
brj-24903	40	10	used	use	VERB
brj-24903	40	11	to	to	PART
brj-24903	40	12	treat	treat	VERB
brj-24903	40	13	disorders	disorder	NOUN
brj-24903	40	14	of	of	ADP
brj-24903	40	15	the	the	DET
brj-24903	40	16	central	central	ADJ
brj-24903	40	17	nervous	nervous	ADJ
brj-24903	40	18	system	system	NOUN
brj-24903	40	19	.	.	PUNCT
brj-24903	41	1	the	the	DET
brj-24903	41	2	plant	plant	NOUN
brj-24903	41	3	is	be	AUX
brj-24903	41	4	used	use	VERB
brj-24903	41	5	as	as	ADP
brj-24903	41	6	a	a	DET
brj-24903	41	7	diuretic	diuretic	ADJ
brj-24903	41	8	,	,	PUNCT
brj-24903	41	9	expectorant	expectorant	NOUN
brj-24903	41	10	,	,	PUNCT
brj-24903	41	11	and	and	CCONJ
brj-24903	41	12	in	in	ADP
brj-24903	41	13	gynecology	gynecology	NOUN
brj-24903	41	14	to	to	PART
brj-24903	41	15	induce	induce	VERB
brj-24903	41	16	childbirth	childbirth	NOUN
brj-24903	41	17	and	and	CCONJ
brj-24903	41	18	hasten	hasten	VERB
brj-24903	41	19	placenta	placenta	NOUN
brj-24903	41	20	separation	separation	NOUN
brj-24903	41	21	in	in	ADP
brj-24903	41	22	the	the	DET
brj-24903	41	23	carpathian	carpathian	ADJ
brj-24903	41	24	area	area	NOUN
brj-24903	41	25	.	.	PUNCT
brj-24903	42	1	a.	a.	NOUN
brj-24903	42	2	glycyphyllos	glycyphyllos	PROPN
brj-24903	42	3	has	have	AUX
brj-24903	42	4	been	be	AUX
brj-24903	42	5	shown	show	VERB
brj-24903	42	6	in	in	ADP
brj-24903	42	7	russian	russian	ADJ
brj-24903	42	8	clinical	clinical	ADJ
brj-24903	42	9	research	research	NOUN
brj-24903	42	10	to	to	PART
brj-24903	42	11	possess	possess	VERB
brj-24903	42	12	hypotensive	hypotensive	ADJ
brj-24903	42	13	,	,	PUNCT
brj-24903	42	14	anticoagulant	anticoagulant	NOUN
brj-24903	42	15	,	,	PUNCT
brj-24903	42	16	and	and	CCONJ
brj-24903	42	17	diuretic	diuretic	ADJ
brj-24903	42	18	properties	property	NOUN
brj-24903	42	19	.	.	PUNCT
brj-24903	43	1	the	the	DET
brj-24903	43	2	plant	plant	NOUN
brj-24903	43	3	is	be	AUX
brj-24903	43	4	used	use	VERB
brj-24903	43	5	in	in	ADP
brj-24903	43	6	bulgarian	bulgarian	ADJ
brj-24903	43	7	traditional	traditional	ADJ
brj-24903	43	8	medicine	medicine	NOUN
brj-24903	43	9	to	to	PART
brj-24903	43	10	treat	treat	VERB
brj-24903	43	11	tachycardia	tachycardia	NOUN
brj-24903	43	12	,	,	PUNCT
brj-24903	43	13	renal	renal	ADJ
brj-24903	43	14	inflammation	inflammation	NOUN
brj-24903	43	15	,	,	PUNCT
brj-24903	43	16	cardiac	cardiac	ADJ
brj-24903	43	17	insufficiency	insufficiency	NOUN
brj-24903	43	18	,	,	PUNCT
brj-24903	43	19	calculosis	calculosis	NOUN
brj-24903	43	20	,	,	PUNCT
brj-24903	43	21	elevated	elevated	ADJ
brj-24903	43	22	blood	blood	NOUN
brj-24903	43	23	pressure	pressure	NOUN
brj-24903	43	24	,	,	PUNCT
brj-24903	43	25	and	and	CCONJ
brj-24903	43	26	inflammation	inflammation	NOUN
brj-24903	43	27	of	of	ADP
brj-24903	43	28	the	the	DET
brj-24903	43	29	kidneys	kidney	NOUN
brj-24903	43	30	.	.	PUNCT
brj-24903	44	1	it	it	PRON
brj-24903	44	2	also	also	ADV
brj-24903	44	3	functions	function	VERB
brj-24903	44	4	as	as	ADP
brj-24903	44	5	an	an	DET
brj-24903	44	6	antihypertensive	antihypertensive	ADJ
brj-24903	44	7	and	and	CCONJ
brj-24903	44	8	diuretic	diuretic	ADJ
brj-24903	44	9	(	(	PUNCT
brj-24903	44	10	lysiuk	lysiuk	VERB
brj-24903	44	11	and	and	CCONJ
brj-24903	44	12	darmohray	darmohray	VERB
brj-24903	44	13	2016	2016	NUM
brj-24903	44	14	)	)	PUNCT
brj-24903	44	15	.	.	PUNCT
brj-24903	45	1	this	this	DET
brj-24903	45	2	plant	plant	NOUN
brj-24903	45	3	is	be	AUX
brj-24903	45	4	used	use	VERB
brj-24903	45	5	traditionally	traditionally	ADV
brj-24903	45	6	to	to	PART
brj-24903	45	7	reduce	reduce	VERB
brj-24903	45	8	inflammation	inflammation	NOUN
brj-24903	45	9	and	and	CCONJ
brj-24903	45	10	rheumatism	rheumatism	NOUN
brj-24903	45	11	.	.	PUNCT
brj-24903	46	1	therefore	therefore	ADV
brj-24903	46	2	,	,	PUNCT
brj-24903	46	3	in	in	ADP
brj-24903	46	4	this	this	DET
brj-24903	46	5	study	study	NOUN
brj-24903	46	6	,	,	PUNCT
brj-24903	46	7	an	an	DET
brj-24903	46	8	attempt	attempt	NOUN
brj-24903	46	9	was	be	AUX
brj-24903	46	10	made	make	VERB
brj-24903	46	11	to	to	PART
brj-24903	46	12	evaluate	evaluate	VERB
brj-24903	46	13	the	the	DET
brj-24903	46	14	potency	potency	NOUN
brj-24903	46	15	of	of	ADP
brj-24903	46	16	the	the	DET
brj-24903	46	17	ethanolic	ethanolic	ADJ
brj-24903	46	18	leaves	leave	NOUN
brj-24903	46	19	extract	extract	NOUN
brj-24903	46	20	of	of	ADP
brj-24903	46	21	a.	a.	NOUN
brj-24903	46	22	glycyphyllos	glycyphyllos	NOUN
brj-24903	46	23	in	in	ADP
brj-24903	46	24	experimentally	experimentally	ADV
brj-24903	46	25	induced	induce	VERB
brj-24903	46	26	arthritis	arthritis	NOUN
brj-24903	46	27	in	in	ADP
brj-24903	46	28	vivo	vivo	NOUN
brj-24903	46	29	and	and	CCONJ
brj-24903	46	30	in	in	ADP
brj-24903	46	31	vitro	vitro	X
brj-24903	46	32	models	model	NOUN
brj-24903	46	33	.	.	PUNCT
brj-24903	47	1	peer	peer	NOUN
brj-24903	47	2	-	-	PUNCT
brj-24903	47	3	reviewed	review	VERB
brj-24903	47	4	article	article	NOUN
brj-24903	47	5	bioresources.cnr.ncsu.edu	bioresources.cnr.ncsu.edu	X
brj-24903	47	6	gu	gu	VERB
brj-24903	47	7	et	et	PROPN
brj-24903	47	8	al	al	PROPN
brj-24903	47	9	.	.	PROPN
brj-24903	48	1	(	(	PUNCT
brj-24903	48	2	2026	2026	NUM
brj-24903	48	3	)	)	PUNCT
brj-24903	48	4	.	.	PUNCT
brj-24903	49	1	“	"	PUNCT
brj-24903	49	2	astragalus	astragalus	NOUN
brj-24903	49	3	leaf	leaf	NOUN
brj-24903	49	4	extract	extract	NOUN
brj-24903	49	5	vs.	vs.	ADP
brj-24903	49	6	arthritis	arthritis	NOUN
brj-24903	49	7	,	,	PUNCT
brj-24903	49	8	”	"	PUNCT
brj-24903	49	9	bioresources	bioresource	NOUN
brj-24903	49	10	21(1	21(1	NUM
brj-24903	49	11	)	)	PUNCT
brj-24903	49	12	,	,	PUNCT
brj-24903	49	13	160	160	NUM
brj-24903	49	14	-	-	SYM
brj-24903	49	15	177	177	NUM
brj-24903	49	16	.	.	PUNCT
brj-24903	50	1	162	162	NUM
brj-24903	50	2	experimental	experimental	ADJ
brj-24903	50	3	chemicals	chemical	NOUN
brj-24903	50	4	complete	complete	ADJ
brj-24903	50	5	freund	freund	PROPN
brj-24903	50	6	’s	’s	PART
brj-24903	50	7	adjuvant	adjuvant	NOUN
brj-24903	50	8	(	(	PUNCT
brj-24903	50	9	cfa	cfa	PROPN
brj-24903	50	10	)	)	PUNCT
brj-24903	50	11	,	,	PUNCT
brj-24903	50	12	type	type	NOUN
brj-24903	50	13	iv	iv	NUM
brj-24903	50	14	collagenase	collagenase	NOUN
brj-24903	50	15	,	,	PUNCT
brj-24903	50	16	interleukin-1β	interleukin-1β	X
brj-24903	50	17	(	(	PUNCT
brj-24903	50	18	il-1β	il-1β	PROPN
brj-24903	50	19	)	)	PUNCT
brj-24903	50	20	,	,	PUNCT
brj-24903	50	21	and	and	CCONJ
brj-24903	50	22	enzyme	enzyme	NOUN
brj-24903	50	23	-	-	PUNCT
brj-24903	50	24	linked	link	VERB
brj-24903	50	25	immunosorbent	immunosorbent	NOUN
brj-24903	50	26	assay	assay	PROPN
brj-24903	50	27	(	(	PUNCT
brj-24903	50	28	elisa	elisa	NOUN
brj-24903	50	29	)	)	PUNCT
brj-24903	50	30	kits	kit	NOUN
brj-24903	50	31	for	for	ADP
brj-24903	50	32	nitric	nitric	ADJ
brj-24903	50	33	oxide	oxide	NOUN
brj-24903	50	34	(	(	PUNCT
brj-24903	50	35	no	no	NOUN
brj-24903	50	36	)	)	PUNCT
brj-24903	50	37	,	,	PUNCT
brj-24903	50	38	prostaglandin	prostaglandin	NOUN
brj-24903	50	39	e2	e2	PROPN
brj-24903	50	40	(	(	PUNCT
brj-24903	50	41	pge2	pge2	PROPN
brj-24903	50	42	)	)	PUNCT
brj-24903	50	43	,	,	PUNCT
brj-24903	50	44	matrix	matrix	NOUN
brj-24903	50	45	metalloproteinase-1	metalloproteinase-1	PROPN
brj-24903	50	46	(	(	PUNCT
brj-24903	50	47	mmp-1	mmp-1	NOUN
brj-24903	50	48	)	)	PUNCT
brj-24903	50	49	,	,	PUNCT
brj-24903	50	50	matrix	matrix	NOUN
brj-24903	50	51	metalloproteinase-13	metalloproteinase-13	PROPN
brj-24903	50	52	(	(	PUNCT
brj-24903	50	53	mmp-13	mmp-13	PROPN
brj-24903	50	54	)	)	PUNCT
brj-24903	50	55	,	,	PUNCT
brj-24903	50	56	tumor	tumor	NOUN
brj-24903	50	57	necrosis	necrosis	NOUN
brj-24903	50	58	factor	factor	NOUN
brj-24903	50	59	-	-	PUNCT
brj-24903	50	60	α	α	X
brj-24903	50	61	(	(	PUNCT
brj-24903	50	62	tnf	tnf	PROPN
brj-24903	50	63	-	-	PUNCT
brj-24903	50	64	α	α	NOUN
brj-24903	50	65	)	)	PUNCT
brj-24903	50	66	,	,	PUNCT
brj-24903	50	67	interleukin-1β	interleukin-1β	X
brj-24903	50	68	(	(	PUNCT
brj-24903	50	69	il-1β	il-1β	PROPN
brj-24903	50	70	)	)	PUNCT
brj-24903	50	71	,	,	PUNCT
brj-24903	50	72	and	and	CCONJ
brj-24903	50	73	interleukin-6	interleukin-6	PROPN
brj-24903	50	74	(	(	PUNCT
brj-24903	50	75	il-6	il-6	NOUN
brj-24903	50	76	)	)	PUNCT
brj-24903	50	77	were	be	AUX
brj-24903	50	78	acquired	acquire	VERB
brj-24903	50	79	from	from	ADP
brj-24903	50	80	sigma	sigma	PROPN
brj-24903	50	81	-	-	PUNCT
brj-24903	50	82	aldrich	aldrich	PROPN
brj-24903	50	83	(	(	PUNCT
brj-24903	50	84	st	st	PROPN
brj-24903	50	85	.	.	PROPN
brj-24903	50	86	louis	louis	PROPN
brj-24903	50	87	,	,	PUNCT
brj-24903	50	88	mo	mo	PROPN
brj-24903	50	89	,	,	PUNCT
brj-24903	50	90	usa	usa	PROPN
brj-24903	50	91	)	)	PUNCT
brj-24903	50	92	.	.	PUNCT
brj-24903	51	1	pronase	pronase	PROPN
brj-24903	51	2	was	be	AUX
brj-24903	51	3	purchased	purchase	VERB
brj-24903	51	4	from	from	ADP
brj-24903	51	5	roche	roche	PROPN
brj-24903	51	6	(	(	PUNCT
brj-24903	51	7	basel	basel	PROPN
brj-24903	51	8	,	,	PUNCT
brj-24903	51	9	switzerland	switzerland	PROPN
brj-24903	51	10	)	)	PUNCT
brj-24903	51	11	.	.	PUNCT
brj-24903	52	1	fetal	fetal	ADJ
brj-24903	52	2	bovine	bovine	NOUN
brj-24903	52	3	serum	serum	NOUN
brj-24903	52	4	and	and	CCONJ
brj-24903	52	5	dulbecco	dulbecco	NOUN
brj-24903	52	6	's	's	PART
brj-24903	52	7	modified	modified	PROPN
brj-24903	52	8	eagle	eagle	PROPN
brj-24903	52	9	’s	’s	PART
brj-24903	52	10	medium	medium	NOUN
brj-24903	52	11	were	be	AUX
brj-24903	52	12	purchased	purchase	VERB
brj-24903	52	13	from	from	ADP
brj-24903	52	14	gibco	gibco	PROPN
brj-24903	52	15	inc	inc	PROPN
brj-24903	52	16	.	.	PUNCT
brj-24903	53	1	(	(	PUNCT
brj-24903	53	2	billings	billing	NOUN
brj-24903	53	3	,	,	PUNCT
brj-24903	53	4	mt	mt	PROPN
brj-24903	53	5	,	,	PUNCT
brj-24903	53	6	usa	usa	PROPN
brj-24903	53	7	)	)	PUNCT
brj-24903	53	8	,	,	PUNCT
brj-24903	53	9	and	and	CCONJ
brj-24903	53	10	3-(4,5	3-(4,5	NOUN
brj-24903	53	11	-	-	PUNCT
brj-24903	53	12	dimethylthiazole-2	dimethylthiazole-2	NUM
brj-24903	53	13	-	-	PUNCT
brj-24903	53	14	yl)-2,5diphenyltetrazolium	yl)-2,5diphenyltetrazolium	NOUN
brj-24903	53	15	bromide	bromide	NOUN
brj-24903	53	16	(	(	PUNCT
brj-24903	53	17	mtt	mtt	PROPN
brj-24903	53	18	)	)	PUNCT
brj-24903	53	19	was	be	AUX
brj-24903	53	20	from	from	ADP
brj-24903	53	21	thermo	thermo	PROPN
brj-24903	53	22	fisher	fisher	PROPN
brj-24903	53	23	scientific	scientific	PROPN
brj-24903	53	24	(	(	PUNCT
brj-24903	53	25	waltham	waltham	PROPN
brj-24903	53	26	,	,	PUNCT
brj-24903	53	27	ma	ma	PROPN
brj-24903	53	28	,	,	PUNCT
brj-24903	53	29	usa	usa	PROPN
brj-24903	53	30	)	)	PUNCT
brj-24903	53	31	.	.	PUNCT
brj-24903	54	1	the	the	DET
brj-24903	54	2	cytotoxicity	cytotoxicity	NOUN
brj-24903	54	3	test	test	NOUN
brj-24903	54	4	and	and	CCONJ
brj-24903	54	5	assessment	assessment	NOUN
brj-24903	54	6	of	of	ADP
brj-24903	54	7	inflammatory	inflammatory	ADJ
brj-24903	54	8	markers	marker	NOUN
brj-24903	54	9	were	be	AUX
brj-24903	54	10	conducted	conduct	VERB
brj-24903	54	11	on	on	ADP
brj-24903	54	12	a	a	DET
brj-24903	54	13	microplate	microplate	NOUN
brj-24903	54	14	reader	reader	NOUN
brj-24903	54	15	(	(	PUNCT
brj-24903	54	16	thermo	thermo	NOUN
brj-24903	54	17	fisher	fisher	PROPN
brj-24903	54	18	scientific	scientific	PROPN
brj-24903	54	19	)	)	PUNCT
brj-24903	54	20	.	.	PUNCT
brj-24903	55	1	the	the	DET
brj-24903	55	2	other	other	ADJ
brj-24903	55	3	substances	substance	NOUN
brj-24903	55	4	employed	employ	VERB
brj-24903	55	5	in	in	ADP
brj-24903	55	6	this	this	DET
brj-24903	55	7	investigation	investigation	NOUN
brj-24903	55	8	were	be	AUX
brj-24903	55	9	ar	ar	NOUN
brj-24903	55	10	grade	grade	NOUN
brj-24903	55	11	.	.	PUNCT
brj-24903	56	1	plant	plant	NOUN
brj-24903	56	2	materials	material	NOUN
brj-24903	56	3	in	in	ADP
brj-24903	56	4	february	february	PROPN
brj-24903	56	5	2023	2023	NUM
brj-24903	56	6	,	,	PUNCT
brj-24903	56	7	an	an	DET
brj-24903	56	8	a.	a.	NOUN
brj-24903	56	9	glycyphyllos	glycyphyllos	NOUN
brj-24903	56	10	plant	plant	NOUN
brj-24903	56	11	was	be	AUX
brj-24903	56	12	gathered	gather	VERB
brj-24903	56	13	from	from	ADP
brj-24903	56	14	the	the	DET
brj-24903	56	15	vicinity	vicinity	NOUN
brj-24903	56	16	of	of	ADP
brj-24903	56	17	the	the	DET
brj-24903	56	18	university	university	NOUN
brj-24903	56	19	campus	campus	NOUN
brj-24903	56	20	.	.	PUNCT
brj-24903	57	1	after	after	SCONJ
brj-24903	57	2	the	the	DET
brj-24903	57	3	plant	plant	NOUN
brj-24903	57	4	was	be	AUX
brj-24903	57	5	identified	identify	VERB
brj-24903	57	6	and	and	CCONJ
brj-24903	57	7	verified	verify	VERB
brj-24903	57	8	,	,	PUNCT
brj-24903	57	9	a	a	DET
brj-24903	57	10	sample	sample	NOUN
brj-24903	57	11	voucher	voucher	NOUN
brj-24903	57	12	was	be	AUX
brj-24903	57	13	kept	keep	VERB
brj-24903	57	14	for	for	ADP
brj-24903	57	15	future	future	ADJ
brj-24903	57	16	use	use	NOUN
brj-24903	57	17	and	and	CCONJ
brj-24903	57	18	given	give	VERB
brj-24903	57	19	the	the	DET
brj-24903	57	20	reference	reference	NOUN
brj-24903	57	21	number	number	NOUN
brj-24903	57	22	ag	ag	PROPN
brj-24903	57	23	/	/	SYM
brj-24903	57	24	feb-2023/001	feb-2023/001	NOUN
brj-24903	57	25	.	.	PUNCT
brj-24903	58	1	preparation	preparation	NOUN
brj-24903	58	2	of	of	ADP
brj-24903	58	3	extract	extract	NOUN
brj-24903	58	4	the	the	DET
brj-24903	58	5	leaves	leave	NOUN
brj-24903	58	6	were	be	AUX
brj-24903	58	7	collected	collect	VERB
brj-24903	58	8	and	and	CCONJ
brj-24903	58	9	thoroughly	thoroughly	ADV
brj-24903	58	10	washed	wash	VERB
brj-24903	58	11	with	with	ADP
brj-24903	58	12	distilled	distil	VERB
brj-24903	58	13	water	water	NOUN
brj-24903	58	14	.	.	PUNCT
brj-24903	59	1	subsequently	subsequently	ADV
brj-24903	59	2	,	,	PUNCT
brj-24903	59	3	they	they	PRON
brj-24903	59	4	were	be	AUX
brj-24903	59	5	dried	dry	VERB
brj-24903	59	6	at	at	ADP
brj-24903	59	7	room	room	NOUN
brj-24903	59	8	temperature	temperature	NOUN
brj-24903	59	9	under	under	ADP
brj-24903	59	10	shaded	shaded	ADJ
brj-24903	59	11	conditions	condition	NOUN
brj-24903	59	12	to	to	PART
brj-24903	59	13	avoid	avoid	VERB
brj-24903	59	14	exposure	exposure	NOUN
brj-24903	59	15	to	to	ADP
brj-24903	59	16	direct	direct	ADJ
brj-24903	59	17	sunlight	sunlight	NOUN
brj-24903	59	18	.	.	PUNCT
brj-24903	60	1	the	the	DET
brj-24903	60	2	dried	dry	VERB
brj-24903	60	3	leaves	leave	NOUN
brj-24903	60	4	were	be	AUX
brj-24903	60	5	then	then	ADV
brj-24903	60	6	ground	grind	VERB
brj-24903	60	7	into	into	ADP
brj-24903	60	8	a	a	DET
brj-24903	60	9	fine	fine	ADJ
brj-24903	60	10	powder	powder	NOUN
brj-24903	60	11	and	and	CCONJ
brj-24903	60	12	defatted	defatte	VERB
brj-24903	60	13	with	with	ADP
brj-24903	60	14	petroleum	petroleum	NOUN
brj-24903	60	15	ether	ether	NOUN
brj-24903	60	16	(	(	PUNCT
brj-24903	60	17	60	60	NUM
brj-24903	60	18	to	to	PART
brj-24903	60	19	80	80	NUM
brj-24903	60	20	°	°	NOUN
brj-24903	60	21	c	c	NOUN
brj-24903	60	22	)	)	PUNCT
brj-24903	60	23	for	for	ADP
brj-24903	60	24	72	72	NUM
brj-24903	60	25	hours	hour	NOUN
brj-24903	60	26	.	.	PUNCT
brj-24903	61	1	after	after	SCONJ
brj-24903	61	2	filtration	filtration	NOUN
brj-24903	61	3	to	to	PART
brj-24903	61	4	remove	remove	VERB
brj-24903	61	5	the	the	DET
brj-24903	61	6	petroleum	petroleum	NOUN
brj-24903	61	7	ether	ether	NOUN
brj-24903	61	8	,	,	PUNCT
brj-24903	61	9	the	the	DET
brj-24903	61	10	powder	powder	NOUN
brj-24903	61	11	was	be	AUX
brj-24903	61	12	subjected	subject	VERB
brj-24903	61	13	to	to	ADP
brj-24903	61	14	ethanol	ethanol	NOUN
brj-24903	61	15	extraction	extraction	NOUN
brj-24903	61	16	for	for	ADP
brj-24903	61	17	72	72	NUM
brj-24903	61	18	hours	hour	NOUN
brj-24903	61	19	with	with	ADP
brj-24903	61	20	periodic	periodic	ADJ
brj-24903	61	21	shaking	shaking	NOUN
brj-24903	61	22	.	.	PUNCT
brj-24903	62	1	the	the	DET
brj-24903	62	2	resulting	result	VERB
brj-24903	62	3	filtrate	filtrate	NOUN
brj-24903	62	4	was	be	AUX
brj-24903	62	5	collected	collect	VERB
brj-24903	62	6	,	,	PUNCT
brj-24903	62	7	and	and	CCONJ
brj-24903	62	8	ethanol	ethanol	NOUN
brj-24903	62	9	was	be	AUX
brj-24903	62	10	recovered	recover	VERB
brj-24903	62	11	by	by	ADP
brj-24903	62	12	distillation	distillation	NOUN
brj-24903	62	13	.	.	PUNCT
brj-24903	63	1	the	the	DET
brj-24903	63	2	remaining	remain	VERB
brj-24903	63	3	residue	residue	NOUN
brj-24903	63	4	was	be	AUX
brj-24903	63	5	heated	heat	VERB
brj-24903	63	6	at	at	ADP
brj-24903	63	7	a	a	DET
brj-24903	63	8	low	low	ADJ
brj-24903	63	9	temperature	temperature	NOUN
brj-24903	63	10	of	of	ADP
brj-24903	63	11	40	40	NUM
brj-24903	63	12	°	°	NOUN
brj-24903	63	13	c	c	NOUN
brj-24903	63	14	to	to	PART
brj-24903	63	15	remove	remove	VERB
brj-24903	63	16	residual	residual	ADJ
brj-24903	63	17	alcohol	alcohol	NOUN
brj-24903	63	18	.	.	PUNCT
brj-24903	64	1	a	a	DET
brj-24903	64	2	viscous	viscous	ADJ
brj-24903	64	3	extract	extract	NOUN
brj-24903	64	4	was	be	AUX
brj-24903	64	5	obtained	obtain	VERB
brj-24903	64	6	,	,	PUNCT
brj-24903	64	7	yielding	yield	VERB
brj-24903	64	8	8.25	8.25	NUM
brj-24903	64	9	%	%	NOUN
brj-24903	64	10	w	w	PROPN
brj-24903	64	11	/	/	SYM
brj-24903	64	12	w	w	PROPN
brj-24903	64	13	,	,	PUNCT
brj-24903	64	14	which	which	PRON
brj-24903	64	15	was	be	AUX
brj-24903	64	16	subsequently	subsequently	ADV
brj-24903	64	17	stored	store	VERB
brj-24903	64	18	at	at	ADP
brj-24903	64	19	4	4	NUM
brj-24903	64	20	°	°	NOUN
brj-24903	64	21	c	c	NOUN
brj-24903	64	22	(	(	PUNCT
brj-24903	64	23	firdous	firdous	ADJ
brj-24903	64	24	and	and	CCONJ
brj-24903	64	25	koneri	koneri	PROPN
brj-24903	64	26	2012	2012	NUM
brj-24903	64	27	)	)	PUNCT
brj-24903	64	28	.	.	PUNCT
brj-24903	65	1	experimental	experimental	ADJ
brj-24903	65	2	animals	animal	NOUN
brj-24903	65	3	in	in	ADP
brj-24903	65	4	this	this	DET
brj-24903	65	5	investigation	investigation	NOUN
brj-24903	65	6	,	,	PUNCT
brj-24903	65	7	male	male	ADJ
brj-24903	65	8	albino	albino	NOUN
brj-24903	65	9	wistar	wistar	PROPN
brj-24903	65	10	rats	rat	NOUN
brj-24903	65	11	weighing	weigh	VERB
brj-24903	65	12	180	180	NUM
brj-24903	65	13	to	to	PART
brj-24903	65	14	200	200	NUM
brj-24903	65	15	g	g	NOUN
brj-24903	65	16	were	be	AUX
brj-24903	65	17	employed	employ	VERB
brj-24903	65	18	.	.	PUNCT
brj-24903	66	1	the	the	DET
brj-24903	66	2	animals	animal	NOUN
brj-24903	66	3	were	be	AUX
brj-24903	66	4	kept	keep	VERB
brj-24903	66	5	in	in	ADP
brj-24903	66	6	polypropylene	polypropylene	NOUN
brj-24903	66	7	cages	cage	NOUN
brj-24903	66	8	at	at	ADP
brj-24903	66	9	a	a	DET
brj-24903	66	10	temperature	temperature	NOUN
brj-24903	66	11	of	of	ADP
brj-24903	66	12	22±1	22±1	NOUN
brj-24903	66	13	°	°	ADP
brj-24903	66	14	c	c	NOUN
brj-24903	66	15	and	and	CCONJ
brj-24903	66	16	a	a	DET
brj-24903	66	17	12	12	NUM
brj-24903	66	18	-	-	PUNCT
brj-24903	66	19	h	h	NOUN
brj-24903	66	20	day	day	NOUN
brj-24903	66	21	/	/	SYM
brj-24903	66	22	night	night	NOUN
brj-24903	66	23	cycle	cycle	NOUN
brj-24903	66	24	.	.	PUNCT
brj-24903	67	1	before	before	ADP
brj-24903	67	2	the	the	DET
brj-24903	67	3	trial	trial	NOUN
brj-24903	67	4	,	,	PUNCT
brj-24903	67	5	they	they	PRON
brj-24903	67	6	were	be	AUX
brj-24903	67	7	given	give	VERB
brj-24903	67	8	a	a	DET
brj-24903	67	9	regular	regular	ADJ
brj-24903	67	10	pellet	pellet	NOUN
brj-24903	67	11	diet	diet	NOUN
brj-24903	67	12	,	,	PUNCT
brj-24903	67	13	allowed	allow	VERB
brj-24903	67	14	to	to	PART
brj-24903	67	15	drink	drink	VERB
brj-24903	67	16	water	water	NOUN
brj-24903	67	17	whenever	whenever	SCONJ
brj-24903	67	18	they	they	PRON
brj-24903	67	19	pleased	please	VERB
brj-24903	67	20	,	,	PUNCT
brj-24903	67	21	and	and	CCONJ
brj-24903	67	22	given	give	VERB
brj-24903	67	23	a	a	DET
brj-24903	67	24	week	week	NOUN
brj-24903	67	25	to	to	PART
brj-24903	67	26	acclimate	acclimate	VERB
brj-24903	67	27	.	.	PUNCT
brj-24903	68	1	the	the	DET
brj-24903	68	2	study	study	NOUN
brj-24903	68	3	was	be	AUX
brj-24903	68	4	approved	approve	VERB
brj-24903	68	5	by	by	ADP
brj-24903	68	6	yunan	yunan	PROPN
brj-24903	68	7	zhongkai	zhongkai	PROPN
brj-24903	68	8	animal	animal	NOUN
brj-24903	68	9	experiments	experiment	VERB
brj-24903	68	10	medical	medical	ADJ
brj-24903	68	11	board	board	NOUN
brj-24903	68	12	(	(	PUNCT
brj-24903	68	13	approval	approval	NOUN
brj-24903	68	14	number	number	NOUN
brj-24903	68	15	:	:	PUNCT
brj-24903	68	16	yn9981	yn9981	PROPN
brj-24903	68	17	)	)	PUNCT
brj-24903	68	18	.	.	PUNCT
brj-24903	69	1	grouping	grouping	NOUN
brj-24903	69	2	and	and	CCONJ
brj-24903	69	3	induction	induction	NOUN
brj-24903	69	4	of	of	ADP
brj-24903	69	5	arthritis	arthritis	NOUN
brj-24903	69	6	the	the	DET
brj-24903	69	7	rats	rat	NOUN
brj-24903	69	8	were	be	AUX
brj-24903	69	9	divided	divide	VERB
brj-24903	69	10	into	into	ADP
brj-24903	69	11	five	five	NUM
brj-24903	69	12	groups	group	NOUN
brj-24903	69	13	(	(	PUNCT
brj-24903	69	14	n=6	n=6	NOUN
brj-24903	69	15	)	)	PUNCT
brj-24903	69	16	,	,	PUNCT
brj-24903	69	17	as	as	SCONJ
brj-24903	69	18	follows	follow	VERB
brj-24903	69	19	.	.	PUNCT
brj-24903	70	1	group	group	NOUN
brj-24903	70	2	i	i	PRON
brj-24903	70	3	:	:	PUNCT
brj-24903	70	4	for	for	ADP
brj-24903	70	5	28	28	NUM
brj-24903	70	6	days	day	NOUN
brj-24903	70	7	,	,	PUNCT
brj-24903	70	8	the	the	DET
brj-24903	70	9	animals	animal	NOUN
brj-24903	70	10	were	be	AUX
brj-24903	70	11	given	give	VERB
brj-24903	70	12	0.30	0.30	NUM
brj-24903	70	13	%	%	NOUN
brj-24903	70	14	w	w	PROPN
brj-24903	70	15	/	/	SYM
brj-24903	70	16	v	v	NOUN
brj-24903	70	17	cmc	cmc	NOUN
brj-24903	70	18	(	(	PUNCT
brj-24903	70	19	1	1	NUM
brj-24903	70	20	ml	ml	NOUN
brj-24903	70	21	/	/	SYM
brj-24903	70	22	kg	kg	PROPN
brj-24903	70	23	;	;	PUNCT
brj-24903	70	24	p.o	p.o	PROPN
brj-24903	70	25	.	.	PROPN
brj-24903	70	26	)	)	PUNCT
brj-24903	70	27	and	and	CCONJ
brj-24903	70	28	were	be	AUX
brj-24903	70	29	used	use	VERB
brj-24903	70	30	as	as	ADP
brj-24903	70	31	a	a	DET
brj-24903	70	32	typical	typical	ADJ
brj-24903	70	33	control	control	NOUN
brj-24903	70	34	group	group	NOUN
brj-24903	70	35	.	.	PUNCT
brj-24903	71	1	group	group	PROPN
brj-24903	71	2	ii	ii	PROPN
brj-24903	71	3	:	:	PUNCT
brj-24903	71	4	for	for	ADP
brj-24903	71	5	28	28	NUM
brj-24903	71	6	days	day	NOUN
brj-24903	71	7	,	,	PUNCT
brj-24903	71	8	the	the	DET
brj-24903	71	9	animals	animal	NOUN
brj-24903	71	10	were	be	AUX
brj-24903	71	11	fed	feed	VERB
brj-24903	71	12	cfa	cfa	PROPN
brj-24903	71	13	control	control	NOUN
brj-24903	71	14	(	(	PUNCT
brj-24903	71	15	0.1	0.1	NUM
brj-24903	71	16	ml	ml	NOUN
brj-24903	71	17	of	of	ADP
brj-24903	71	18	cfa	cfa	PROPN
brj-24903	71	19	at	at	ADP
brj-24903	71	20	the	the	DET
brj-24903	71	21	left	left	ADJ
brj-24903	71	22	hind	hind	NOUN
brj-24903	71	23	paw	paw	NOUN
brj-24903	71	24	on	on	ADP
brj-24903	71	25	day	day	NOUN
brj-24903	71	26	1	1	NUM
brj-24903	71	27	+	+	NUM
brj-24903	71	28	0.30	0.30	NUM
brj-24903	71	29	%	%	NOUN
brj-24903	71	30	w	w	PROPN
brj-24903	71	31	/	/	SYM
brj-24903	71	32	v	v	NOUN
brj-24903	71	33	cmc	cmc	NOUN
brj-24903	71	34	(	(	PUNCT
brj-24903	71	35	1	1	NUM
brj-24903	71	36	ml	ml	NOUN
brj-24903	71	37	/	/	SYM
brj-24903	71	38	kg	kg	PROPN
brj-24903	71	39	;	;	PUNCT
brj-24903	71	40	p.o	p.o	PROPN
brj-24903	71	41	.	.	PROPN
brj-24903	71	42	)	)	PUNCT
brj-24903	71	43	.	.	PUNCT
brj-24903	72	1	group	group	PROPN
brj-24903	72	2	iii	iii	PROPN
brj-24903	72	3	:	:	PUNCT
brj-24903	72	4	for	for	ADP
brj-24903	72	5	28	28	NUM
brj-24903	72	6	days	day	NOUN
brj-24903	72	7	,	,	PUNCT
brj-24903	72	8	the	the	DET
brj-24903	72	9	animals	animal	NOUN
brj-24903	72	10	had	have	VERB
brj-24903	72	11	20	20	NUM
brj-24903	72	12	mg	mg	NUM
brj-24903	72	13	/	/	SYM
brj-24903	72	14	kg	kg	PROPN
brj-24903	72	15	of	of	ADP
brj-24903	72	16	intraperitoneal	intraperitoneal	ADJ
brj-24903	72	17	diclofenac	diclofenac	NOUN
brj-24903	72	18	sodium	sodium	NOUN
brj-24903	72	19	in	in	ADP
brj-24903	72	20	addition	addition	NOUN
brj-24903	72	21	to	to	ADP
brj-24903	72	22	0.1	0.1	NUM
brj-24903	72	23	ml	ml	NOUN
brj-24903	72	24	of	of	ADP
brj-24903	72	25	cfa	cfa	PROPN
brj-24903	72	26	at	at	ADP
brj-24903	72	27	the	the	DET
brj-24903	72	28	left	left	ADJ
brj-24903	72	29	hind	hind	NOUN
brj-24903	72	30	paw	paw	NOUN
brj-24903	72	31	on	on	ADP
brj-24903	72	32	day	day	NOUN
brj-24903	72	33	1	1	NUM
brj-24903	72	34	.	.	PUNCT
brj-24903	72	35	group	group	NOUN
brj-24903	72	36	iv	iv	NUM
brj-24903	72	37	:	:	PUNCT
brj-24903	72	38	for	for	ADP
brj-24903	72	39	28	28	NUM
brj-24903	72	40	days	day	NOUN
brj-24903	72	41	,	,	PUNCT
brj-24903	72	42	the	the	DET
brj-24903	72	43	animals	animal	NOUN
brj-24903	72	44	had	have	VERB
brj-24903	72	45	100	100	NUM
brj-24903	72	46	mg	mg	NOUN
brj-24903	72	47	/	/	SYM
brj-24903	72	48	kg	kg	PROPN
brj-24903	72	49	of	of	ADP
brj-24903	72	50	a.	a.	NOUN
brj-24903	72	51	glycyphyllos	glycyphyllos	PROPN
brj-24903	72	52	extract	extract	VERB
brj-24903	72	53	p.o	p.o	PROPN
brj-24903	72	54	.	.	PROPN
brj-24903	72	55	and	and	CCONJ
brj-24903	72	56	0.1	0.1	NUM
brj-24903	72	57	ml	ml	NOUN
brj-24903	72	58	of	of	ADP
brj-24903	72	59	cfa	cfa	PROPN
brj-24903	72	60	at	at	ADP
brj-24903	72	61	the	the	DET
brj-24903	72	62	left	left	ADJ
brj-24903	72	63	hind	hind	NOUN
brj-24903	72	64	paw	paw	NOUN
brj-24903	72	65	on	on	ADP
brj-24903	72	66	day	day	NOUN
brj-24903	72	67	1	1	NUM
brj-24903	72	68	.	.	PUNCT
brj-24903	72	69	peer	peer	NOUN
brj-24903	72	70	-	-	PUNCT
brj-24903	72	71	reviewed	review	VERB
brj-24903	72	72	article	article	NOUN
brj-24903	72	73	bioresources.cnr.ncsu.edu	bioresources.cnr.ncsu.edu	X
brj-24903	72	74	gu	gu	VERB
brj-24903	72	75	et	et	PROPN
brj-24903	72	76	al	al	PROPN
brj-24903	72	77	.	.	PROPN
brj-24903	73	1	(	(	PUNCT
brj-24903	73	2	2026	2026	NUM
brj-24903	73	3	)	)	PUNCT
brj-24903	73	4	.	.	PUNCT
brj-24903	74	1	“	"	PUNCT
brj-24903	74	2	astragalus	astragalus	NOUN
brj-24903	74	3	leaf	leaf	NOUN
brj-24903	74	4	extract	extract	NOUN
brj-24903	74	5	vs.	vs.	ADP
brj-24903	74	6	arthritis	arthritis	NOUN
brj-24903	74	7	,	,	PUNCT
brj-24903	74	8	”	"	PUNCT
brj-24903	74	9	bioresources	bioresource	NOUN
brj-24903	74	10	21(1	21(1	NUM
brj-24903	74	11	)	)	PUNCT
brj-24903	74	12	,	,	PUNCT
brj-24903	74	13	160	160	NUM
brj-24903	74	14	-	-	SYM
brj-24903	74	15	177	177	NUM
brj-24903	74	16	.	.	PUNCT
brj-24903	74	17	163	163	NUM
brj-24903	74	18	group	group	NOUN
brj-24903	74	19	v	v	NOUN
brj-24903	74	20	:	:	PUNCT
brj-24903	74	21	for	for	ADP
brj-24903	74	22	28	28	NUM
brj-24903	74	23	days	day	NOUN
brj-24903	74	24	,	,	PUNCT
brj-24903	74	25	the	the	DET
brj-24903	74	26	animals	animal	NOUN
brj-24903	74	27	had	have	VERB
brj-24903	74	28	200	200	NUM
brj-24903	74	29	mg	mg	NOUN
brj-24903	74	30	/	/	SYM
brj-24903	74	31	kg	kg	PROPN
brj-24903	74	32	of	of	ADP
brj-24903	74	33	a.	a.	NOUN
brj-24903	74	34	glycyphyllos	glycyphyllos	PROPN
brj-24903	74	35	extract	extract	VERB
brj-24903	74	36	p.o	p.o	PROPN
brj-24903	74	37	.	.	PROPN
brj-24903	74	38	and	and	CCONJ
brj-24903	74	39	0.1	0.1	NUM
brj-24903	74	40	ml	ml	NOUN
brj-24903	74	41	of	of	ADP
brj-24903	74	42	cfa	cfa	PROPN
brj-24903	74	43	at	at	ADP
brj-24903	74	44	the	the	DET
brj-24903	74	45	left	left	ADJ
brj-24903	74	46	hind	hind	NOUN
brj-24903	74	47	paw	paw	NOUN
brj-24903	74	48	on	on	ADP
brj-24903	74	49	day	day	NOUN
brj-24903	74	50	1	1	NUM
brj-24903	74	51	.	.	PUNCT
brj-24903	74	52	cfa	cfa	PROPN
brj-24903	74	53	was	be	AUX
brj-24903	74	54	used	use	VERB
brj-24903	74	55	to	to	PART
brj-24903	74	56	develop	develop	VERB
brj-24903	74	57	experimental	experimental	ADJ
brj-24903	74	58	immunological	immunological	ADJ
brj-24903	74	59	arthritis	arthritis	NOUN
brj-24903	74	60	in	in	ADP
brj-24903	74	61	wistar	wistar	PROPN
brj-24903	74	62	rats	rat	NOUN
brj-24903	74	63	with	with	ADP
brj-24903	74	64	a	a	DET
brj-24903	74	65	few	few	ADJ
brj-24903	74	66	minor	minor	ADJ
brj-24903	74	67	group	group	NOUN
brj-24903	74	68	categorization	categorization	NOUN
brj-24903	74	69	adjustments	adjustment	NOUN
brj-24903	74	70	.	.	PUNCT
brj-24903	75	1	all	all	DET
brj-24903	75	2	groups	group	NOUN
brj-24903	75	3	—	—	PUNCT
brj-24903	75	4	aside	aside	ADV
brj-24903	75	5	from	from	ADP
brj-24903	75	6	group	group	NOUN
brj-24903	75	7	i	i	PRON
brj-24903	75	8	—	—	PUNCT
brj-24903	75	9	had	have	VERB
brj-24903	75	10	their	their	PRON
brj-24903	75	11	hind	hind	NOUN
brj-24903	75	12	limbs	limb	NOUN
brj-24903	75	13	clipped	clip	VERB
brj-24903	75	14	and	and	CCONJ
brj-24903	75	15	cleaned	clean	VERB
brj-24903	75	16	with	with	ADP
brj-24903	75	17	70	70	NUM
brj-24903	75	18	%	%	NOUN
brj-24903	75	19	(	(	PUNCT
brj-24903	75	20	v	v	NOUN
brj-24903	75	21	/	/	SYM
brj-24903	75	22	v	v	NOUN
brj-24903	75	23	)	)	PUNCT
brj-24903	75	24	alcohol	alcohol	NOUN
brj-24903	75	25	.	.	PUNCT
brj-24903	76	1	this	this	PRON
brj-24903	76	2	was	be	AUX
brj-24903	76	3	followed	follow	VERB
brj-24903	76	4	by	by	ADP
brj-24903	76	5	a	a	DET
brj-24903	76	6	0.1	0.1	NUM
brj-24903	76	7	ml	ml	NOUN
brj-24903	76	8	cfa	cfa	PROPN
brj-24903	76	9	treatment	treatment	NOUN
brj-24903	76	10	that	that	PRON
brj-24903	76	11	contained	contain	VERB
brj-24903	76	12	10	10	NUM
brj-24903	76	13	mg	mg	NUM
brj-24903	76	14	/	/	SYM
brj-24903	76	15	ml	ml	PROPN
brj-24903	76	16	of	of	ADP
brj-24903	76	17	heat	heat	NOUN
brj-24903	76	18	-	-	PUNCT
brj-24903	76	19	killed	kill	VERB
brj-24903	76	20	mycobacterium	mycobacterium	NOUN
brj-24903	76	21	tuberculosis	tuberculosis	NOUN
brj-24903	76	22	.	.	PUNCT
brj-24903	77	1	before	before	SCONJ
brj-24903	77	2	cfa	cfa	PROPN
brj-24903	77	3	was	be	AUX
brj-24903	77	4	administered	administer	VERB
brj-24903	77	5	into	into	ADP
brj-24903	77	6	the	the	DET
brj-24903	77	7	subplantar	subplantar	ADJ
brj-24903	77	8	region	region	NOUN
brj-24903	77	9	of	of	ADP
brj-24903	77	10	the	the	DET
brj-24903	77	11	left	left	ADJ
brj-24903	77	12	hind	hind	PROPN
brj-24903	77	13	paw	paw	NOUN
brj-24903	77	14	,	,	PUNCT
brj-24903	77	15	each	each	DET
brj-24903	77	16	animal	animal	NOUN
brj-24903	77	17	had	have	VERB
brj-24903	77	18	a	a	DET
brj-24903	77	19	mild	mild	ADJ
brj-24903	77	20	diethyl	diethyl	NOUN
brj-24903	77	21	ether	ether	NOUN
brj-24903	77	22	anesthetic	anesthetic	ADJ
brj-24903	77	23	injection	injection	NOUN
brj-24903	77	24	.	.	PUNCT
brj-24903	78	1	day	day	NOUN
brj-24903	78	2	1	1	NUM
brj-24903	78	3	denotes	denote	VERB
brj-24903	78	4	the	the	DET
brj-24903	78	5	adjuvant	adjuvant	ADJ
brj-24903	78	6	administration	administration	NOUN
brj-24903	78	7	period	period	NOUN
brj-24903	78	8	.	.	PUNCT
brj-24903	79	1	paw	paw	NOUN
brj-24903	79	2	volume	volume	NOUN
brj-24903	79	3	was	be	AUX
brj-24903	79	4	recorded	record	VERB
brj-24903	79	5	from	from	ADP
brj-24903	79	6	day	day	NOUN
brj-24903	79	7	1	1	NUM
brj-24903	79	8	to	to	ADP
brj-24903	79	9	day	day	NOUN
brj-24903	79	10	21	21	NUM
brj-24903	79	11	following	follow	VERB
brj-24903	79	12	oral	oral	ADJ
brj-24903	79	13	delivery	delivery	NOUN
brj-24903	79	14	of	of	ADP
brj-24903	79	15	the	the	DET
brj-24903	79	16	vehicle	vehicle	NOUN
brj-24903	79	17	,	,	PUNCT
brj-24903	79	18	extract	extract	NOUN
brj-24903	79	19	,	,	PUNCT
brj-24903	79	20	and	and	CCONJ
brj-24903	79	21	diclofenac	diclofenac	NOUN
brj-24903	79	22	(	(	PUNCT
brj-24903	79	23	cortés	cortés	NOUN
brj-24903	79	24	et	et	PROPN
brj-24903	79	25	al	al	PROPN
brj-24903	79	26	.	.	PROPN
brj-24903	79	27	2022	2022	NUM
brj-24903	79	28	;	;	PUNCT
brj-24903	79	29	nickels	nickels	NUM
brj-24903	79	30	et	et	PROPN
brj-24903	79	31	al	al	PROPN
brj-24903	79	32	.	.	PROPN
brj-24903	79	33	2023	2023	NUM
brj-24903	79	34	)	)	PUNCT
brj-24903	79	35	.	.	PUNCT
brj-24903	80	1	assessments	assessment	NOUN
brj-24903	80	2	of	of	ADP
brj-24903	80	3	arthritis	arthritis	NOUN
brj-24903	80	4	paw	paw	PROPN
brj-24903	80	5	volume	volume	NOUN
brj-24903	80	6	a	a	DET
brj-24903	80	7	digital	digital	ADJ
brj-24903	80	8	plethysmometer	plethysmometer	NOUN
brj-24903	80	9	(	(	PUNCT
brj-24903	80	10	ugo	ugo	PROPN
brj-24903	80	11	basile	basile	NOUN
brj-24903	80	12	,	,	PUNCT
brj-24903	80	13	37140	37140	NUM
brj-24903	80	14	)	)	PUNCT
brj-24903	80	15	was	be	AUX
brj-24903	80	16	used	use	VERB
brj-24903	80	17	to	to	PART
brj-24903	80	18	measure	measure	VERB
brj-24903	80	19	the	the	DET
brj-24903	80	20	swelling	swelling	NOUN
brj-24903	80	21	of	of	ADP
brj-24903	80	22	both	both	DET
brj-24903	80	23	hind	hind	ADJ
brj-24903	80	24	paws	paw	NOUN
brj-24903	80	25	on	on	ADP
brj-24903	80	26	days	day	NOUN
brj-24903	80	27	1	1	NUM
brj-24903	80	28	,	,	PUNCT
brj-24903	80	29	7	7	NUM
brj-24903	80	30	,	,	PUNCT
brj-24903	80	31	14	14	NUM
brj-24903	80	32	,	,	PUNCT
brj-24903	80	33	21	21	NUM
brj-24903	80	34	,	,	PUNCT
brj-24903	80	35	and	and	CCONJ
brj-24903	80	36	28	28	NUM
brj-24903	80	37	after	after	ADP
brj-24903	80	38	the	the	DET
brj-24903	80	39	cfa	cfa	PROPN
brj-24903	80	40	injection	injection	NOUN
brj-24903	80	41	.	.	PUNCT
brj-24903	81	1	body	body	NOUN
brj-24903	81	2	weight	weight	VERB
brj-24903	81	3	the	the	DET
brj-24903	81	4	body	body	NOUN
brj-24903	81	5	weights	weight	NOUN
brj-24903	81	6	were	be	AUX
brj-24903	81	7	measured	measure	VERB
brj-24903	81	8	after	after	ADP
brj-24903	81	9	the	the	DET
brj-24903	81	10	cfa	cfa	PROPN
brj-24903	81	11	injection	injection	NOUN
brj-24903	81	12	starting	start	VERB
brj-24903	81	13	on	on	ADP
brj-24903	81	14	day	day	NOUN
brj-24903	81	15	three	three	NUM
brj-24903	81	16	and	and	CCONJ
brj-24903	81	17	again	again	ADV
brj-24903	81	18	on	on	ADP
brj-24903	81	19	days	day	NOUN
brj-24903	81	20	7	7	NUM
brj-24903	81	21	,	,	PUNCT
brj-24903	81	22	14	14	NUM
brj-24903	81	23	,	,	PUNCT
brj-24903	81	24	21	21	NUM
brj-24903	81	25	,	,	PUNCT
brj-24903	81	26	and	and	CCONJ
brj-24903	81	27	28	28	NUM
brj-24903	81	28	.	.	PUNCT
brj-24903	82	1	the	the	DET
brj-24903	82	2	weight	weight	NOUN
brj-24903	82	3	change	change	NOUN
brj-24903	82	4	was	be	AUX
brj-24903	82	5	computed	compute	VERB
brj-24903	82	6	as	as	SCONJ
brj-24903	82	7	follows	follow	VERB
brj-24903	82	8	,	,	PUNCT
brj-24903	82	9	%	%	INTJ
brj-24903	82	10	body	body	NOUN
brj-24903	82	11	weight	weight	NOUN
brj-24903	82	12	change	change	NOUN
brj-24903	82	13	=	=	PUNCT
brj-24903	83	1	𝑊𝑡−𝑊1	𝑊𝑡−𝑊1	PROPN
brj-24903	83	2	𝑊𝑡	𝑊𝑡	PROPN
brj-24903	83	3	×	×	PROPN
brj-24903	83	4	100	100	NUM
brj-24903	83	5	(	(	PUNCT
brj-24903	83	6	1	1	NUM
brj-24903	83	7	)	)	PUNCT
brj-24903	83	8	where	where	SCONJ
brj-24903	83	9	w1	w1	NOUN
brj-24903	83	10	is	be	AUX
brj-24903	83	11	the	the	DET
brj-24903	83	12	animal	animal	NOUN
brj-24903	83	13	’s	’s	PART
brj-24903	83	14	bodyweight	bodyweight	NOUN
brj-24903	83	15	on	on	ADP
brj-24903	83	16	day	day	NOUN
brj-24903	83	17	1	1	NUM
brj-24903	83	18	and	and	CCONJ
brj-24903	83	19	wt	wt	PROPN
brj-24903	83	20	is	be	AUX
brj-24903	83	21	the	the	DET
brj-24903	83	22	bodyweight	bodyweight	NOUN
brj-24903	83	23	at	at	ADP
brj-24903	83	24	time	time	NOUN
brj-24903	83	25	t.	t.	X
brj-24903	83	26	arthritic	arthritic	ADJ
brj-24903	83	27	index	index	NOUN
brj-24903	83	28	to	to	PART
brj-24903	83	29	gauge	gauge	VERB
brj-24903	83	30	the	the	DET
brj-24903	83	31	severity	severity	NOUN
brj-24903	83	32	and	and	CCONJ
brj-24903	83	33	course	course	NOUN
brj-24903	83	34	of	of	ADP
brj-24903	83	35	induced	induced	ADJ
brj-24903	83	36	arthritis	arthritis	NOUN
brj-24903	83	37	,	,	PUNCT
brj-24903	83	38	clinical	clinical	ADJ
brj-24903	83	39	symptoms	symptom	NOUN
brj-24903	83	40	and	and	CCONJ
brj-24903	83	41	indicators	indicator	NOUN
brj-24903	83	42	were	be	AUX
brj-24903	83	43	graded	grade	VERB
brj-24903	83	44	visually	visually	ADV
brj-24903	83	45	for	for	ADP
brj-24903	83	46	each	each	DET
brj-24903	83	47	leg	leg	NOUN
brj-24903	83	48	on	on	ADP
brj-24903	83	49	a	a	DET
brj-24903	83	50	range	range	NOUN
brj-24903	83	51	of	of	ADP
brj-24903	83	52	0	0	NUM
brj-24903	83	53	to	to	PART
brj-24903	83	54	4	4	NUM
brj-24903	83	55	.	.	PUNCT
brj-24903	84	1	a	a	DET
brj-24903	84	2	score	score	NOUN
brj-24903	84	3	of	of	ADP
brj-24903	84	4	zero	zero	NUM
brj-24903	84	5	denotes	denote	NOUN
brj-24903	84	6	no	no	DET
brj-24903	84	7	change	change	NOUN
brj-24903	84	8	,	,	PUNCT
brj-24903	84	9	a	a	DET
brj-24903	84	10	score	score	NOUN
brj-24903	84	11	of	of	ADP
brj-24903	84	12	one	one	NUM
brj-24903	84	13	denotes	denote	NOUN
brj-24903	84	14	some	some	DET
brj-24903	84	15	edema	edema	NOUN
brj-24903	84	16	and	and	CCONJ
brj-24903	84	17	erythema	erythema	ADJ
brj-24903	84	18	in	in	ADP
brj-24903	84	19	the	the	DET
brj-24903	84	20	limb	limb	NOUN
brj-24903	84	21	,	,	PUNCT
brj-24903	84	22	a	a	DET
brj-24903	84	23	score	score	NOUN
brj-24903	84	24	of	of	ADP
brj-24903	84	25	two	two	NUM
brj-24903	84	26	denotes	denote	NOUN
brj-24903	84	27	mild	mild	ADJ
brj-24903	84	28	swelling	swelling	NOUN
brj-24903	84	29	and	and	CCONJ
brj-24903	84	30	erythema	erythema	ADJ
brj-24903	84	31	,	,	PUNCT
brj-24903	84	32	a	a	DET
brj-24903	84	33	score	score	NOUN
brj-24903	84	34	of	of	ADP
brj-24903	84	35	three	three	NUM
brj-24903	84	36	denotes	denote	NOUN
brj-24903	84	37	major	major	ADJ
brj-24903	84	38	swelling	swelling	NOUN
brj-24903	84	39	and	and	CCONJ
brj-24903	84	40	erythema	erythema	ADJ
brj-24903	84	41	,	,	PUNCT
brj-24903	84	42	and	and	CCONJ
brj-24903	84	43	a	a	DET
brj-24903	84	44	score	score	NOUN
brj-24903	84	45	of	of	ADP
brj-24903	84	46	four	four	NUM
brj-24903	84	47	denotes	denote	NOUN
brj-24903	84	48	severe	severe	ADJ
brj-24903	84	49	limb	limb	NOUN
brj-24903	84	50	deformity	deformity	NOUN
brj-24903	84	51	and	and	CCONJ
brj-24903	84	52	immobility	immobility	NOUN
brj-24903	84	53	.	.	PUNCT
brj-24903	85	1	a	a	DET
brj-24903	85	2	score	score	NOUN
brj-24903	85	3	of	of	ADP
brj-24903	85	4	more	more	ADJ
brj-24903	85	5	than	than	ADP
brj-24903	85	6	one	one	NUM
brj-24903	85	7	indicates	indicate	VERB
brj-24903	85	8	the	the	DET
brj-24903	85	9	presence	presence	NOUN
brj-24903	85	10	of	of	ADP
brj-24903	85	11	arthritis	arthritis	NOUN
brj-24903	85	12	in	in	ADP
brj-24903	85	13	either	either	PRON
brj-24903	85	14	of	of	ADP
brj-24903	85	15	the	the	DET
brj-24903	85	16	two	two	NUM
brj-24903	85	17	rear	rear	ADJ
brj-24903	85	18	limbs	limb	NOUN
brj-24903	85	19	.	.	PUNCT
brj-24903	86	1	however	however	ADV
brj-24903	86	2	,	,	PUNCT
brj-24903	86	3	the	the	DET
brj-24903	86	4	highest	high	ADJ
brj-24903	86	5	possible	possible	ADJ
brj-24903	86	6	score	score	NOUN
brj-24903	86	7	for	for	ADP
brj-24903	86	8	arthritis	arthritis	NOUN
brj-24903	86	9	is	be	AUX
brj-24903	86	10	8	8	NUM
brj-24903	86	11	.	.	PUNCT
brj-24903	87	1	following	follow	VERB
brj-24903	87	2	the	the	DET
brj-24903	87	3	cfa	cfa	PROPN
brj-24903	87	4	injection	injection	NOUN
brj-24903	87	5	,	,	PUNCT
brj-24903	87	6	the	the	DET
brj-24903	87	7	measurement	measurement	NOUN
brj-24903	87	8	was	be	AUX
brj-24903	87	9	initiated	initiate	VERB
brj-24903	87	10	on	on	ADP
brj-24903	87	11	day	day	NOUN
brj-24903	87	12	3	3	NUM
brj-24903	87	13	and	and	CCONJ
brj-24903	87	14	was	be	AUX
brj-24903	87	15	repeated	repeat	VERB
brj-24903	87	16	on	on	ADP
brj-24903	87	17	days	day	NOUN
brj-24903	87	18	7	7	NUM
brj-24903	87	19	,	,	PUNCT
brj-24903	87	20	14	14	NUM
brj-24903	87	21	,	,	PUNCT
brj-24903	87	22	and	and	CCONJ
brj-24903	87	23	21	21	NUM
brj-24903	87	24	.	.	PUNCT
brj-24903	88	1	locomotion	locomotion	NOUN
brj-24903	88	2	pain	pain	NOUN
brj-24903	88	3	reduces	reduce	VERB
brj-24903	88	4	an	an	DET
brj-24903	88	5	animal	animal	NOUN
brj-24903	88	6	’s	’s	PART
brj-24903	88	7	ability	ability	NOUN
brj-24903	88	8	to	to	PART
brj-24903	88	9	move	move	VERB
brj-24903	88	10	when	when	SCONJ
brj-24903	88	11	they	they	PRON
brj-24903	88	12	have	have	VERB
brj-24903	88	13	arthritis	arthritis	NOUN
brj-24903	88	14	.	.	PUNCT
brj-24903	89	1	an	an	DET
brj-24903	89	2	actophotometer	actophotometer	NOUN
brj-24903	89	3	was	be	AUX
brj-24903	89	4	used	use	VERB
brj-24903	89	5	to	to	PART
brj-24903	89	6	measure	measure	VERB
brj-24903	89	7	the	the	DET
brj-24903	89	8	locomotor	locomotor	ADJ
brj-24903	89	9	activity	activity	NOUN
brj-24903	89	10	of	of	ADP
brj-24903	89	11	the	the	DET
brj-24903	89	12	arthritic	arthritic	ADJ
brj-24903	89	13	animals	animal	NOUN
brj-24903	89	14	in	in	ADP
brj-24903	89	15	each	each	DET
brj-24903	89	16	group	group	NOUN
brj-24903	89	17	for	for	ADP
brj-24903	89	18	5	5	NUM
brj-24903	89	19	min	min	NOUN
brj-24903	89	20	throughout	throughout	ADP
brj-24903	89	21	the	the	DET
brj-24903	89	22	investigation	investigation	NOUN
brj-24903	89	23	.	.	PUNCT
brj-24903	90	1	the	the	DET
brj-24903	90	2	apparatus	apparatus	NOUN
brj-24903	90	3	was	be	AUX
brj-24903	90	4	filled	fill	VERB
brj-24903	90	5	with	with	ADP
brj-24903	90	6	each	each	DET
brj-24903	90	7	animal	animal	NOUN
brj-24903	90	8	and	and	CCONJ
brj-24903	90	9	switched	switch	VERB
brj-24903	90	10	on	on	ADP
brj-24903	90	11	to	to	PART
brj-24903	90	12	measure	measure	VERB
brj-24903	90	13	the	the	DET
brj-24903	90	14	movement	movement	NOUN
brj-24903	90	15	scores	score	NOUN
brj-24903	90	16	.	.	PUNCT
brj-24903	91	1	an	an	DET
brj-24903	91	2	animal	animal	NOUN
brj-24903	91	3	may	may	AUX
brj-24903	91	4	go	go	VERB
brj-24903	91	5	around	around	ADP
brj-24903	91	6	a	a	DET
brj-24903	91	7	square	square	ADJ
brj-24903	91	8	arena	arena	NOUN
brj-24903	91	9	with	with	ADP
brj-24903	91	10	this	this	DET
brj-24903	91	11	equipment	equipment	NOUN
brj-24903	91	12	.	.	PUNCT
brj-24903	92	1	it	it	PRON
brj-24903	92	2	is	be	AUX
brj-24903	92	3	powered	power	VERB
brj-24903	92	4	by	by	ADP
brj-24903	92	5	photoelectric	photoelectric	ADJ
brj-24903	92	6	cells	cell	NOUN
brj-24903	92	7	connected	connect	VERB
brj-24903	92	8	to	to	ADP
brj-24903	92	9	a	a	DET
brj-24903	92	10	circuit	circuit	NOUN
brj-24903	92	11	counter	counter	NOUN
brj-24903	92	12	.	.	PUNCT
brj-24903	93	1	a	a	DET
brj-24903	93	2	count	count	NOUN
brj-24903	93	3	is	be	AUX
brj-24903	93	4	taken	take	VERB
brj-24903	93	5	after	after	SCONJ
brj-24903	93	6	the	the	DET
brj-24903	93	7	animal	animal	NOUN
brj-24903	93	8	breaks	break	VERB
brj-24903	93	9	the	the	DET
brj-24903	93	10	light	light	ADJ
brj-24903	93	11	beam	beam	NOUN
brj-24903	93	12	striking	strike	VERB
brj-24903	93	13	the	the	DET
brj-24903	93	14	photocell	photocell	NOUN
brj-24903	93	15	.	.	PUNCT
brj-24903	94	1	in	in	ADP
brj-24903	94	2	addition	addition	NOUN
brj-24903	94	3	to	to	ADP
brj-24903	94	4	six	six	NUM
brj-24903	94	5	integrated	integrate	VERB
brj-24903	94	6	photo	photo	NOUN
brj-24903	94	7	-	-	PUNCT
brj-24903	94	8	sensors	sensor	NOUN
brj-24903	94	9	,	,	PUNCT
brj-24903	94	10	it	it	PRON
brj-24903	94	11	features	feature	VERB
brj-24903	94	12	a	a	DET
brj-24903	94	13	4	4	NUM
brj-24903	94	14	-	-	PUNCT
brj-24903	94	15	digit	digit	NOUN
brj-24903	94	16	digital	digital	ADJ
brj-24903	94	17	counter	counter	NOUN
brj-24903	94	18	that	that	PRON
brj-24903	94	19	indicates	indicate	VERB
brj-24903	94	20	the	the	DET
brj-24903	94	21	movement	movement	NOUN
brj-24903	94	22	activity	activity	NOUN
brj-24903	94	23	.	.	PUNCT
brj-24903	95	1	the	the	DET
brj-24903	95	2	locomotion	locomotion	NOUN
brj-24903	95	3	activity	activity	NOUN
brj-24903	95	4	was	be	AUX
brj-24903	95	5	measured	measure	VERB
brj-24903	95	6	on	on	ADP
brj-24903	95	7	days	day	NOUN
brj-24903	95	8	1	1	NUM
brj-24903	95	9	,	,	PUNCT
brj-24903	95	10	7	7	NUM
brj-24903	95	11	,	,	PUNCT
brj-24903	95	12	14	14	NUM
brj-24903	95	13	,	,	PUNCT
brj-24903	95	14	21	21	NUM
brj-24903	95	15	,	,	PUNCT
brj-24903	95	16	and	and	CCONJ
brj-24903	95	17	28	28	NUM
brj-24903	95	18	.	.	PUNCT
brj-24903	96	1	cytokines	cytokine	VERB
brj-24903	96	2	measurement	measurement	NOUN
brj-24903	96	3	blood	blood	NOUN
brj-24903	96	4	was	be	AUX
brj-24903	96	5	drawn	draw	VERB
brj-24903	96	6	from	from	ADP
brj-24903	96	7	the	the	DET
brj-24903	96	8	retro	retro	ADJ
brj-24903	96	9	-	-	PUNCT
brj-24903	96	10	orbital	orbital	ADJ
brj-24903	96	11	sinus	sinus	NOUN
brj-24903	96	12	and	and	CCONJ
brj-24903	96	13	put	put	VERB
brj-24903	96	14	into	into	ADP
brj-24903	96	15	eppendorf	eppendorf	PROPN
brj-24903	96	16	tubes	tube	NOUN
brj-24903	96	17	at	at	ADP
brj-24903	96	18	24	24	NUM
brj-24903	96	19	h	h	NOUN
brj-24903	96	20	following	follow	VERB
brj-24903	96	21	the	the	DET
brj-24903	96	22	last	last	ADJ
brj-24903	96	23	dosage	dosage	NOUN
brj-24903	96	24	.	.	PUNCT
brj-24903	97	1	after	after	ADP
brj-24903	97	2	allowing	allow	VERB
brj-24903	97	3	the	the	DET
brj-24903	97	4	blood	blood	NOUN
brj-24903	97	5	to	to	PART
brj-24903	97	6	coagulate	coagulate	VERB
brj-24903	97	7	for	for	ADP
brj-24903	97	8	20	20	NUM
brj-24903	97	9	min	min	NOUN
brj-24903	97	10	at	at	ADP
brj-24903	97	11	room	room	NOUN
brj-24903	97	12	temperature	temperature	NOUN
brj-24903	97	13	,	,	PUNCT
brj-24903	97	14	it	it	PRON
brj-24903	97	15	was	be	AUX
brj-24903	97	16	centrifuged	centrifuge	VERB
brj-24903	97	17	for	for	ADP
brj-24903	97	18	10	10	NUM
brj-24903	97	19	min	min	NOUN
brj-24903	97	20	at	at	ADP
brj-24903	97	21	4	4	NUM
brj-24903	97	22	°	°	ADP
brj-24903	97	23	c	c	NOUN
brj-24903	97	24	at	at	ADP
brj-24903	97	25	4000	4000	NUM
brj-24903	97	26	rpm	rpm	NOUN
brj-24903	97	27	.	.	PUNCT
brj-24903	98	1	serum	serum	PROPN
brj-24903	98	2	was	be	AUX
brj-24903	98	3	separated	separate	VERB
brj-24903	98	4	and	and	CCONJ
brj-24903	98	5	peer	peer	NOUN
brj-24903	98	6	-	-	PUNCT
brj-24903	98	7	reviewed	review	VERB
brj-24903	98	8	article	article	NOUN
brj-24903	98	9	bioresources.cnr.ncsu.edu	bioresources.cnr.ncsu.edu	X
brj-24903	98	10	gu	gu	VERB
brj-24903	98	11	et	et	PROPN
brj-24903	98	12	al	al	PROPN
brj-24903	98	13	.	.	PROPN
brj-24903	99	1	(	(	PUNCT
brj-24903	99	2	2026	2026	NUM
brj-24903	99	3	)	)	PUNCT
brj-24903	99	4	.	.	PUNCT
brj-24903	100	1	“	"	PUNCT
brj-24903	100	2	astragalus	astragalus	NOUN
brj-24903	100	3	leaf	leaf	NOUN
brj-24903	100	4	extract	extract	NOUN
brj-24903	100	5	vs.	vs.	ADP
brj-24903	100	6	arthritis	arthritis	NOUN
brj-24903	100	7	,	,	PUNCT
brj-24903	100	8	”	"	PUNCT
brj-24903	100	9	bioresources	bioresource	NOUN
brj-24903	100	10	21(1	21(1	NUM
brj-24903	100	11	)	)	PUNCT
brj-24903	100	12	,	,	PUNCT
brj-24903	100	13	160	160	NUM
brj-24903	100	14	-	-	SYM
brj-24903	100	15	177	177	NUM
brj-24903	100	16	.	.	NOUN
brj-24903	100	17	164	164	NUM
brj-24903	100	18	cooled	cool	VERB
brj-24903	100	19	to	to	ADP
brj-24903	100	20	-20	-20	PROPN
brj-24903	100	21	°	°	NUM
brj-24903	100	22	c	c	NOUN
brj-24903	100	23	for	for	ADP
brj-24903	100	24	biochemical	biochemical	ADJ
brj-24903	100	25	examination	examination	NOUN
brj-24903	100	26	.	.	PUNCT
brj-24903	101	1	following	follow	VERB
brj-24903	101	2	the	the	DET
brj-24903	101	3	manufacturer	manufacturer	NOUN
brj-24903	101	4	’s	’s	PART
brj-24903	101	5	instructions	instruction	NOUN
brj-24903	101	6	,	,	PUNCT
brj-24903	101	7	pro	pro	ADJ
brj-24903	101	8	-	-	ADJ
brj-24903	101	9	inflammatory	inflammatory	ADJ
brj-24903	101	10	cytokines	cytokine	NOUN
brj-24903	101	11	(	(	PUNCT
brj-24903	101	12	tnf	tnf	PROPN
brj-24903	101	13	-	-	PUNCT
brj-24903	101	14	α	α	PROPN
brj-24903	101	15	,	,	PUNCT
brj-24903	101	16	il1	il1	PROPN
brj-24903	101	17	-	-	X
brj-24903	101	18	β	β	NOUN
brj-24903	101	19	,	,	PUNCT
brj-24903	101	20	and	and	CCONJ
brj-24903	101	21	il-6	il-6	NUM
brj-24903	101	22	)	)	PUNCT
brj-24903	101	23	in	in	ADP
brj-24903	101	24	the	the	DET
brj-24903	101	25	blood	blood	NOUN
brj-24903	101	26	were	be	AUX
brj-24903	101	27	measured	measure	VERB
brj-24903	101	28	using	use	VERB
brj-24903	101	29	readily	readily	ADV
brj-24903	101	30	accessible	accessible	ADJ
brj-24903	101	31	elisa	elisa	NOUN
brj-24903	101	32	kits	kit	NOUN
brj-24903	101	33	(	(	PUNCT
brj-24903	101	34	sigma	sigma	PROPN
brj-24903	101	35	-	-	PUNCT
brj-24903	101	36	aldrich	aldrich	PROPN
brj-24903	101	37	,	,	PUNCT
brj-24903	101	38	usa	usa	PROPN
brj-24903	101	39	)	)	PUNCT
brj-24903	101	40	.	.	PUNCT
brj-24903	102	1	complete	complete	ADJ
brj-24903	102	2	blood	blood	NOUN
brj-24903	102	3	count	count	NOUN
brj-24903	102	4	on	on	ADP
brj-24903	102	5	day	day	NOUN
brj-24903	102	6	21	21	NUM
brj-24903	102	7	,	,	PUNCT
brj-24903	102	8	all	all	DET
brj-24903	102	9	groups	group	NOUN
brj-24903	102	10	had	have	VERB
brj-24903	102	11	heart	heart	NOUN
brj-24903	102	12	punctures	puncture	NOUN
brj-24903	102	13	to	to	PART
brj-24903	102	14	obtain	obtain	VERB
brj-24903	102	15	blood	blood	NOUN
brj-24903	102	16	,	,	PUNCT
brj-24903	102	17	which	which	PRON
brj-24903	102	18	was	be	AUX
brj-24903	102	19	then	then	ADV
brj-24903	102	20	collected	collect	VERB
brj-24903	102	21	in	in	ADP
brj-24903	102	22	the	the	DET
brj-24903	102	23	proper	proper	ADJ
brj-24903	102	24	blood	blood	NOUN
brj-24903	102	25	collection	collection	NOUN
brj-24903	102	26	containers	container	NOUN
brj-24903	102	27	while	while	SCONJ
brj-24903	102	28	under	under	ADP
brj-24903	102	29	a	a	DET
brj-24903	102	30	mild	mild	ADJ
brj-24903	102	31	dosage	dosage	NOUN
brj-24903	102	32	of	of	ADP
brj-24903	102	33	diethyl	diethyl	NOUN
brj-24903	102	34	ether	ether	NOUN
brj-24903	102	35	anesthesia	anesthesia	ADV
brj-24903	102	36	.	.	PUNCT
brj-24903	103	1	a	a	DET
brj-24903	103	2	programmed	program	VERB
brj-24903	103	3	blood	blood	NOUN
brj-24903	103	4	cell	cell	NOUN
brj-24903	103	5	analyzer	analyzer	NOUN
brj-24903	103	6	(	(	PUNCT
brj-24903	103	7	mindray	mindray	PROPN
brj-24903	103	8	,	,	PUNCT
brj-24903	103	9	usa	usa	PROPN
brj-24903	103	10	)	)	PUNCT
brj-24903	103	11	was	be	AUX
brj-24903	103	12	used	use	VERB
brj-24903	103	13	to	to	PART
brj-24903	103	14	measure	measure	VERB
brj-24903	103	15	the	the	DET
brj-24903	103	16	hematological	hematological	ADJ
brj-24903	103	17	variables	variable	NOUN
brj-24903	103	18	immediately	immediately	ADV
brj-24903	103	19	after	after	SCONJ
brj-24903	103	20	the	the	DET
brj-24903	103	21	blood	blood	NOUN
brj-24903	103	22	sample	sample	NOUN
brj-24903	103	23	was	be	AUX
brj-24903	103	24	collected	collect	VERB
brj-24903	103	25	.	.	PUNCT
brj-24903	104	1	these	these	PRON
brj-24903	104	2	included	include	VERB
brj-24903	104	3	hemoglobin	hemoglobin	NOUN
brj-24903	104	4	content	content	NOUN
brj-24903	104	5	(	(	PUNCT
brj-24903	104	6	hgb	hgb	PROPN
brj-24903	104	7	)	)	PUNCT
brj-24903	104	8	,	,	PUNCT
brj-24903	104	9	packed	pack	VERB
brj-24903	104	10	cell	cell	NOUN
brj-24903	104	11	volume	volume	NOUN
brj-24903	104	12	(	(	PUNCT
brj-24903	104	13	%	%	INTJ
brj-24903	104	14	pcv	pcv	NOUN
brj-24903	104	15	)	)	PUNCT
brj-24903	104	16	,	,	PUNCT
brj-24903	104	17	total	total	ADJ
brj-24903	104	18	red	red	ADJ
brj-24903	104	19	blood	blood	NOUN
brj-24903	104	20	count	count	NOUN
brj-24903	104	21	(	(	PUNCT
brj-24903	104	22	rbc	rbc	PROPN
brj-24903	104	23	)	)	PUNCT
brj-24903	104	24	,	,	PUNCT
brj-24903	104	25	total	total	ADJ
brj-24903	104	26	white	white	ADJ
brj-24903	104	27	blood	blood	NOUN
brj-24903	104	28	cell	cell	NOUN
brj-24903	104	29	count	count	NOUN
brj-24903	104	30	(	(	PUNCT
brj-24903	104	31	wbc	wbc	PROPN
brj-24903	104	32	)	)	PUNCT
brj-24903	104	33	,	,	PUNCT
brj-24903	104	34	and	and	CCONJ
brj-24903	104	35	erythrocyte	erythrocyte	NOUN
brj-24903	104	36	sedimentation	sedimentation	NOUN
brj-24903	104	37	rate	rate	NOUN
brj-24903	104	38	(	(	PUNCT
brj-24903	104	39	esr	esr	PROPN
brj-24903	104	40	)	)	PUNCT
brj-24903	104	41	.	.	PUNCT
brj-24903	105	1	chondrocytes	chondrocyte	NOUN
brj-24903	105	2	culture	culture	VERB
brj-24903	105	3	the	the	DET
brj-24903	105	4	tissues	tissue	NOUN
brj-24903	105	5	were	be	AUX
brj-24903	105	6	enzymatically	enzymatically	ADV
brj-24903	105	7	digested	digest	VERB
brj-24903	105	8	with	with	ADP
brj-24903	105	9	10	10	NUM
brj-24903	105	10	g	g	NOUN
brj-24903	105	11	/	/	SYM
brj-24903	105	12	l	l	NOUN
brj-24903	105	13	of	of	ADP
brj-24903	105	14	pronase	pronase	NOUN
brj-24903	105	15	and	and	CCONJ
brj-24903	105	16	1g	1g	NUM
brj-24903	105	17	/	/	SYM
brj-24903	105	18	l	l	NOUN
brj-24903	105	19	of	of	ADP
brj-24903	105	20	type	type	NOUN
brj-24903	105	21	iv	iv	NUM
brj-24903	105	22	collagenase	collagenase	NOUN
brj-24903	105	23	for	for	ADP
brj-24903	105	24	30	30	NUM
brj-24903	105	25	min	min	NOUN
brj-24903	105	26	and	and	CCONJ
brj-24903	105	27	6	6	NUM
brj-24903	105	28	h	h	NOUN
brj-24903	105	29	,	,	PUNCT
brj-24903	105	30	respectively	respectively	ADV
brj-24903	105	31	,	,	PUNCT
brj-24903	105	32	at	at	ADP
brj-24903	105	33	37	37	NUM
brj-24903	105	34	°	°	NOUN
brj-24903	105	35	c	c	NOUN
brj-24903	105	36	,	,	PUNCT
brj-24903	105	37	after	after	SCONJ
brj-24903	105	38	primary	primary	ADJ
brj-24903	105	39	rat	rat	NOUN
brj-24903	105	40	chondrocytes	chondrocyte	NOUN
brj-24903	105	41	(	(	PUNCT
brj-24903	105	42	prcs	prcs	X
brj-24903	105	43	)	)	PUNCT
brj-24903	105	44	were	be	AUX
brj-24903	105	45	extracted	extract	VERB
brj-24903	105	46	from	from	ADP
brj-24903	105	47	the	the	DET
brj-24903	105	48	knee	knee	NOUN
brj-24903	105	49	joints	joint	NOUN
brj-24903	105	50	of	of	ADP
brj-24903	105	51	4	4	NUM
brj-24903	105	52	-	-	PUNCT
brj-24903	105	53	week	week	NOUN
brj-24903	105	54	-	-	PUNCT
brj-24903	105	55	old	old	ADJ
brj-24903	105	56	sprague	sprague	NOUN
brj-24903	105	57	-	-	PUNCT
brj-24903	105	58	dawley	dawley	NOUN
brj-24903	105	59	rats	rat	NOUN
brj-24903	105	60	(	(	PUNCT
brj-24903	105	61	nickels	nickel	NOUN
brj-24903	105	62	et	et	PROPN
brj-24903	105	63	al	al	PROPN
brj-24903	105	64	.	.	PROPN
brj-24903	105	65	2023	2023	NUM
brj-24903	105	66	)	)	PUNCT
brj-24903	105	67	.	.	PUNCT
brj-24903	106	1	the	the	DET
brj-24903	106	2	process	process	NOUN
brj-24903	106	3	of	of	ADP
brj-24903	106	4	filtration	filtration	NOUN
brj-24903	106	5	was	be	AUX
brj-24903	106	6	used	use	VERB
brj-24903	106	7	to	to	PART
brj-24903	106	8	exclude	exclude	VERB
brj-24903	106	9	debris	debris	NOUN
brj-24903	106	10	and	and	CCONJ
brj-24903	106	11	undissociated	undissociated	ADJ
brj-24903	106	12	cells	cell	NOUN
brj-24903	106	13	from	from	ADP
brj-24903	106	14	the	the	DET
brj-24903	106	15	chondrocyte	chondrocyte	ADJ
brj-24903	106	16	single	single	ADJ
brj-24903	106	17	-	-	PUNCT
brj-24903	106	18	cell	cell	NOUN
brj-24903	106	19	suspension	suspension	NOUN
brj-24903	106	20	(	(	PUNCT
brj-24903	106	21	scs	scs	NOUN
brj-24903	106	22	)	)	PUNCT
brj-24903	106	23	.	.	PUNCT
brj-24903	107	1	after	after	ADP
brj-24903	107	2	that	that	PRON
brj-24903	107	3	,	,	PUNCT
brj-24903	107	4	the	the	DET
brj-24903	107	5	obtained	obtain	VERB
brj-24903	107	6	scs	scs	PROPN
brj-24903	107	7	was	be	AUX
brj-24903	107	8	centrifuged	centrifuge	VERB
brj-24903	107	9	for	for	ADP
brj-24903	107	10	10	10	NUM
brj-24903	107	11	min	min	NOUN
brj-24903	107	12	at	at	ADP
brj-24903	107	13	3600	3600	NUM
brj-24903	107	14	rpm	rpm	NOUN
brj-24903	107	15	.	.	PUNCT
brj-24903	108	1	following	follow	VERB
brj-24903	108	2	centrifugation	centrifugation	NOUN
brj-24903	108	3	,	,	PUNCT
brj-24903	108	4	chondrocytes	chondrocyte	NOUN
brj-24903	108	5	were	be	AUX
brj-24903	108	6	resuspended	resuspend	VERB
brj-24903	108	7	in	in	ADP
brj-24903	108	8	“	"	PUNCT
brj-24903	108	9	dulbecco	dulbecco	NOUN
brj-24903	108	10	’s	’s	PART
brj-24903	108	11	modified	modified	PROPN
brj-24903	108	12	eagle	eagle	PROPN
brj-24903	108	13	’s	’s	PART
brj-24903	108	14	medium	medium	NOUN
brj-24903	108	15	”	"	PUNCT
brj-24903	108	16	(	(	PUNCT
brj-24903	108	17	dmem	dmem	ADJ
brj-24903	108	18	)	)	PUNCT
brj-24903	108	19	.	.	PUNCT
brj-24903	109	1	the	the	DET
brj-24903	109	2	cells	cell	NOUN
brj-24903	109	3	were	be	AUX
brj-24903	109	4	seeded	seed	VERB
brj-24903	109	5	in	in	ADP
brj-24903	109	6	culture	culture	NOUN
brj-24903	109	7	flasks	flask	NOUN
brj-24903	109	8	with	with	ADP
brj-24903	109	9	10	10	NUM
brj-24903	109	10	%	%	NOUN
brj-24903	109	11	fetal	fetal	ADJ
brj-24903	109	12	bovine	bovine	NOUN
brj-24903	109	13	serum	serum	NOUN
brj-24903	109	14	(	(	PUNCT
brj-24903	109	15	fbs	fbs	PROPN
brj-24903	109	16	)	)	PUNCT
brj-24903	109	17	and	and	CCONJ
brj-24903	109	18	antibiotic	antibiotic	ADJ
brj-24903	109	19	media	medium	NOUN
brj-24903	109	20	with	with	ADP
brj-24903	109	21	penicillin	penicillin	NOUN
brj-24903	109	22	(	(	PUNCT
brj-24903	109	23	100	100	NUM
brj-24903	109	24	u	u	NOUN
brj-24903	109	25	/	/	SYM
brj-24903	109	26	ml	ml	VERB
brj-24903	109	27	)	)	PUNCT
brj-24903	109	28	and	and	CCONJ
brj-24903	109	29	streptomycin	streptomycin	PROPN
brj-24903	109	30	(	(	PUNCT
brj-24903	109	31	100	100	NUM
brj-24903	109	32	µg	µg	NOUN
brj-24903	109	33	/	/	SYM
brj-24903	109	34	ml	ml	NOUN
brj-24903	109	35	)	)	PUNCT
brj-24903	109	36	.	.	PUNCT
brj-24903	110	1	the	the	DET
brj-24903	110	2	monolayer	monolayer	NOUN
brj-24903	110	3	cultures	culture	NOUN
brj-24903	110	4	were	be	AUX
brj-24903	110	5	established	establish	VERB
brj-24903	110	6	at	at	ADP
brj-24903	110	7	a	a	DET
brj-24903	110	8	concentration	concentration	NOUN
brj-24903	110	9	of	of	ADP
brj-24903	110	10	6×106	6×106	NUM
brj-24903	110	11	cells	cell	NOUN
brj-24903	110	12	/	/	SYM
brj-24903	110	13	ml	ml	NOUN
brj-24903	110	14	.	.	PUNCT
brj-24903	111	1	the	the	DET
brj-24903	111	2	cells	cell	NOUN
brj-24903	111	3	were	be	AUX
brj-24903	111	4	then	then	ADV
brj-24903	111	5	incubated	incubate	VERB
brj-24903	111	6	at	at	ADP
brj-24903	111	7	37	37	NUM
brj-24903	111	8	°	°	SYM
brj-24903	111	9	c	c	NOUN
brj-24903	111	10	in	in	ADP
brj-24903	111	11	a	a	DET
brj-24903	111	12	humidified	humidified	ADJ
brj-24903	111	13	incubator	incubator	NOUN
brj-24903	111	14	with	with	ADP
brj-24903	111	15	5	5	NUM
brj-24903	111	16	%	%	NOUN
brj-24903	111	17	co2	co2	NOUN
brj-24903	111	18	.	.	PUNCT
brj-24903	112	1	every	every	DET
brj-24903	112	2	three	three	NUM
brj-24903	112	3	days	day	NOUN
brj-24903	112	4	,	,	PUNCT
brj-24903	112	5	the	the	DET
brj-24903	112	6	culture	culture	NOUN
brj-24903	112	7	media	medium	NOUN
brj-24903	112	8	were	be	AUX
brj-24903	112	9	changed	change	VERB
brj-24903	112	10	(	(	PUNCT
brj-24903	112	11	li	li	PROPN
brj-24903	112	12	et	et	PROPN
brj-24903	112	13	al	al	PROPN
brj-24903	112	14	.	.	PROPN
brj-24903	112	15	2020	2020	NUM
brj-24903	112	16	)	)	PUNCT
brj-24903	112	17	.	.	PUNCT
brj-24903	113	1	the	the	DET
brj-24903	113	2	prcs	prcs	PROPN
brj-24903	113	3	were	be	AUX
brj-24903	113	4	pre	pre	VERB
brj-24903	113	5	-	-	VERB
brj-24903	113	6	treated	treat	VERB
brj-24903	113	7	with	with	ADP
brj-24903	113	8	0.1	0.1	NUM
brj-24903	113	9	%	%	NOUN
brj-24903	113	10	dimethyl	dimethyl	NOUN
brj-24903	113	11	sulfoxide	sulfoxide	NOUN
brj-24903	113	12	(	(	PUNCT
brj-24903	113	13	dmso	dmso	NOUN
brj-24903	113	14	,	,	PUNCT
brj-24903	113	15	control	control	NOUN
brj-24903	113	16	)	)	PUNCT
brj-24903	113	17	or	or	CCONJ
brj-24903	113	18	different	different	ADJ
brj-24903	113	19	doses	dose	NOUN
brj-24903	113	20	of	of	ADP
brj-24903	113	21	a.	a.	NOUN
brj-24903	113	22	glycyphyllos	glycyphyllos	PROPN
brj-24903	113	23	leaves	leave	NOUN
brj-24903	113	24	extract	extract	VERB
brj-24903	113	25	for	for	ADP
brj-24903	113	26	1	1	NUM
brj-24903	113	27	h	h	NOUN
brj-24903	113	28	,	,	PUNCT
brj-24903	113	29	and	and	CCONJ
brj-24903	113	30	then	then	ADV
brj-24903	113	31	stimulated	stimulate	VERB
brj-24903	113	32	with	with	ADP
brj-24903	113	33	il-1β	il-1β	PROPN
brj-24903	113	34	(	(	PUNCT
brj-24903	113	35	10	10	NUM
brj-24903	113	36	ng	ng	NOUN
brj-24903	113	37	/	/	SYM
brj-24903	113	38	ml	ml	NOUN
brj-24903	113	39	)	)	PUNCT
brj-24903	113	40	for	for	ADP
brj-24903	113	41	24	24	NUM
brj-24903	113	42	h	h	NOUN
brj-24903	113	43	in	in	ADP
brj-24903	113	44	order	order	NOUN
brj-24903	113	45	to	to	PART
brj-24903	113	46	examine	examine	VERB
brj-24903	113	47	the	the	DET
brj-24903	113	48	chondroprotective	chondroprotective	ADJ
brj-24903	113	49	impact	impact	NOUN
brj-24903	113	50	of	of	ADP
brj-24903	113	51	astragalus	astragalus	NOUN
brj-24903	113	52	glycyphyllos	glycyphyllos	NOUN
brj-24903	113	53	.	.	PUNCT
brj-24903	114	1	cell	cell	NOUN
brj-24903	114	2	viability	viability	NOUN
brj-24903	114	3	assay	assay	VERB
brj-24903	114	4	the	the	DET
brj-24903	114	5	isolated	isolated	ADJ
brj-24903	114	6	chondrocytes	chondrocyte	NOUN
brj-24903	114	7	were	be	AUX
brj-24903	114	8	planted	plant	VERB
brj-24903	114	9	at	at	ADP
brj-24903	114	10	a	a	DET
brj-24903	114	11	density	density	NOUN
brj-24903	114	12	of	of	ADP
brj-24903	114	13	5×103	5×103	NUM
brj-24903	114	14	cells	cell	NOUN
brj-24903	114	15	per	per	ADP
brj-24903	114	16	well	well	ADV
brj-24903	114	17	onto	onto	ADP
brj-24903	114	18	a	a	DET
brj-24903	114	19	microplate	microplate	NOUN
brj-24903	114	20	with	with	ADP
brj-24903	114	21	96	96	NUM
brj-24903	114	22	wells	well	NOUN
brj-24903	114	23	.	.	PUNCT
brj-24903	115	1	the	the	DET
brj-24903	115	2	3-(4,5	3-(4,5	NUM
brj-24903	115	3	-	-	PUNCT
brj-24903	115	4	dimethylthiazol-2	dimethylthiazol-2	NUM
brj-24903	115	5	-	-	PUNCT
brj-24903	115	6	yl)-2,5	yl)-2,5	NOUN
brj-24903	115	7	-	-	NOUN
brj-24903	115	8	diphenyl	diphenyl	NOUN
brj-24903	115	9	tetrazolium	tetrazolium	NOUN
brj-24903	115	10	bromide	bromide	NOUN
brj-24903	115	11	,	,	PUNCT
brj-24903	115	12	or	or	CCONJ
brj-24903	115	13	mtt	mtt	NOUN
brj-24903	115	14	test	test	NOUN
brj-24903	115	15	,	,	PUNCT
brj-24903	115	16	was	be	AUX
brj-24903	115	17	used	use	VERB
brj-24903	115	18	to	to	PART
brj-24903	115	19	measure	measure	VERB
brj-24903	115	20	cell	cell	NOUN
brj-24903	115	21	viability	viability	NOUN
brj-24903	115	22	and	and	CCONJ
brj-24903	115	23	gauge	gauge	VERB
brj-24903	115	24	the	the	DET
brj-24903	115	25	cytotoxic	cytotoxic	ADJ
brj-24903	115	26	effects	effect	NOUN
brj-24903	115	27	of	of	ADP
brj-24903	115	28	a.	a.	NOUN
brj-24903	115	29	glycyphyllos	glycyphyllos	NOUN
brj-24903	115	30	leaves	leave	NOUN
brj-24903	115	31	extract	extract	VERB
brj-24903	115	32	following	follow	VERB
brj-24903	115	33	pre	pre	NOUN
brj-24903	115	34	-	-	NOUN
brj-24903	115	35	treatment	treatment	NOUN
brj-24903	115	36	with	with	ADP
brj-24903	115	37	a.	a.	NOUN
brj-24903	115	38	glycyphyllos	glycyphyllos	PROPN
brj-24903	115	39	leaves	leave	NOUN
brj-24903	115	40	extract	extract	VERB
brj-24903	115	41	and	and	CCONJ
brj-24903	115	42	il-1β	il-1β	PROPN
brj-24903	115	43	stimulation	stimulation	NOUN
brj-24903	115	44	.	.	PUNCT
brj-24903	116	1	by	by	ADP
brj-24903	116	2	the	the	DET
brj-24903	116	3	manufacturer	manufacturer	NOUN
brj-24903	116	4	’s	’s	PART
brj-24903	116	5	protocol	protocol	NOUN
brj-24903	116	6	,	,	PUNCT
brj-24903	116	7	this	this	PRON
brj-24903	116	8	was	be	AUX
brj-24903	116	9	completed	complete	VERB
brj-24903	116	10	.	.	PUNCT
brj-24903	117	1	100	100	NUM
brj-24903	117	2	μl	μl	ADP
brj-24903	117	3	of	of	ADP
brj-24903	117	4	mtt	mtt	NOUN
brj-24903	117	5	was	be	AUX
brj-24903	117	6	added	add	VERB
brj-24903	117	7	to	to	ADP
brj-24903	117	8	each	each	PRON
brj-24903	117	9	well	well	ADV
brj-24903	117	10	,	,	PUNCT
brj-24903	117	11	and	and	CCONJ
brj-24903	117	12	the	the	DET
brj-24903	117	13	mixture	mixture	NOUN
brj-24903	117	14	was	be	AUX
brj-24903	117	15	incubated	incubate	VERB
brj-24903	117	16	for	for	ADP
brj-24903	117	17	4	4	NUM
brj-24903	117	18	h.	h.	PROPN
brj-24903	117	19	supernatants	supernatant	NOUN
brj-24903	117	20	were	be	AUX
brj-24903	117	21	supplied	supply	VERB
brj-24903	117	22	with	with	ADP
brj-24903	117	23	150	150	NUM
brj-24903	117	24	µl	µl	ADP
brj-24903	117	25	dmso	dmso	NOUN
brj-24903	117	26	to	to	PART
brj-24903	117	27	dissolve	dissolve	VERB
brj-24903	117	28	the	the	DET
brj-24903	117	29	crystals	crystal	NOUN
brj-24903	117	30	,	,	PUNCT
brj-24903	117	31	and	and	CCONJ
brj-24903	117	32	then	then	ADV
brj-24903	117	33	agitated	agitate	VERB
brj-24903	117	34	for	for	ADP
brj-24903	117	35	10	10	NUM
brj-24903	117	36	min	min	NOUN
brj-24903	117	37	.	.	PROPN
brj-24903	117	38	absorbance	absorbance	NOUN
brj-24903	117	39	at	at	ADP
brj-24903	117	40	490	490	NUM
brj-24903	117	41	nm	nm	NOUN
brj-24903	117	42	was	be	AUX
brj-24903	117	43	measured	measure	VERB
brj-24903	117	44	using	use	VERB
brj-24903	117	45	a	a	DET
brj-24903	117	46	microplate	microplate	NOUN
brj-24903	117	47	reader	reader	NOUN
brj-24903	117	48	.	.	PUNCT
brj-24903	118	1	percent	percent	NOUN
brj-24903	118	2	viability	viability	NOUN
brj-24903	118	3	was	be	AUX
brj-24903	118	4	estimated	estimate	VERB
brj-24903	118	5	using	use	VERB
brj-24903	118	6	the	the	DET
brj-24903	118	7	formula	formula	NOUN
brj-24903	118	8	:	:	PUNCT
brj-24903	118	9	%	%	NOUN
brj-24903	118	10	viability	viability	NOUN
brj-24903	118	11	(	(	PUNCT
brj-24903	118	12	survival	survival	NOUN
brj-24903	118	13	)	)	PUNCT
brj-24903	118	14	=	=	VERB
brj-24903	118	15	odtest	odt	ADJ
brj-24903	118	16	/odcontrol	/odcontrol	PUNCT
brj-24903	118	17	,	,	PUNCT
brj-24903	118	18	where	where	SCONJ
brj-24903	118	19	od	od	PROPN
brj-24903	118	20	indicates	indicate	VERB
brj-24903	118	21	optical	optical	ADJ
brj-24903	118	22	density	density	NOUN
brj-24903	118	23	(	(	PUNCT
brj-24903	118	24	srivastava	srivastava	PROPN
brj-24903	118	25	et	et	PROPN
brj-24903	118	26	al	al	PROPN
brj-24903	118	27	.	.	PROPN
brj-24903	118	28	2017	2017	NUM
brj-24903	118	29	)	)	PUNCT
brj-24903	118	30	.	.	PUNCT
brj-24903	119	1	no	no	DET
brj-24903	119	2	assay	assay	NOUN
brj-24903	119	3	using	use	VERB
brj-24903	119	4	griess	griess	NOUN
brj-24903	119	5	reagent	reagent	NOUN
brj-24903	119	6	(	(	PUNCT
brj-24903	119	7	gr	gr	NOUN
brj-24903	119	8	)	)	PUNCT
brj-24903	119	9	to	to	PART
brj-24903	119	10	quantify	quantify	VERB
brj-24903	119	11	the	the	DET
brj-24903	119	12	nitrite	nitrite	NOUN
brj-24903	119	13	concentrations	concentration	NOUN
brj-24903	119	14	in	in	ADP
brj-24903	119	15	the	the	DET
brj-24903	119	16	supernatant	supernatant	NOUN
brj-24903	119	17	cell	cell	NOUN
brj-24903	119	18	culture	culture	NOUN
brj-24903	119	19	in	in	ADP
brj-24903	119	20	accordance	accordance	NOUN
brj-24903	119	21	with	with	ADP
brj-24903	119	22	the	the	DET
brj-24903	119	23	manufacturer	manufacturer	NOUN
brj-24903	119	24	's	's	PART
brj-24903	119	25	instructions	instruction	NOUN
brj-24903	119	26	,	,	PUNCT
brj-24903	119	27	no	no	DET
brj-24903	119	28	generation	generation	NOUN
brj-24903	119	29	was	be	AUX
brj-24903	119	30	assessed	assess	VERB
brj-24903	119	31	spectrophotometrically	spectrophotometrically	ADV
brj-24903	119	32	.	.	PUNCT
brj-24903	120	1	after	after	ADP
brj-24903	120	2	receiving	receive	VERB
brj-24903	120	3	a	a	DET
brj-24903	120	4	2	2	NUM
brj-24903	120	5	-	-	PUNCT
brj-24903	120	6	h	h	NOUN
brj-24903	120	7	pretreatment	pretreatment	NOUN
brj-24903	120	8	with	with	ADP
brj-24903	120	9	a.	a.	NOUN
brj-24903	120	10	glycyphyllos	glycyphyllos	PROPN
brj-24903	120	11	leaves	leave	NOUN
brj-24903	120	12	extract	extract	VERB
brj-24903	120	13	,	,	PUNCT
brj-24903	120	14	chondrocytes	chondrocyte	NOUN
brj-24903	120	15	were	be	AUX
brj-24903	120	16	stimulated	stimulate	VERB
brj-24903	120	17	with	with	ADP
brj-24903	120	18	10	10	NUM
brj-24903	120	19	ηg	ηg	NOUN
brj-24903	120	20	/	/	SYM
brj-24903	120	21	ml	ml	NOUN
brj-24903	120	22	of	of	ADP
brj-24903	120	23	il-1β	il-1β	PROPN
brj-24903	120	24	.	.	PUNCT
brj-24903	121	1	following	follow	VERB
brj-24903	121	2	a	a	DET
brj-24903	121	3	24	24	NUM
brj-24903	121	4	-	-	PUNCT
brj-24903	121	5	h	h	NOUN
brj-24903	121	6	period	period	NOUN
brj-24903	121	7	,	,	PUNCT
brj-24903	121	8	the	the	DET
brj-24903	121	9	supernatants	supernatant	NOUN
brj-24903	121	10	were	be	AUX
brj-24903	121	11	extracted	extract	VERB
brj-24903	121	12	.	.	PUNCT
brj-24903	122	1	each	each	DET
brj-24903	122	2	supernatant	supernatant	NOUN
brj-24903	122	3	was	be	AUX
brj-24903	122	4	then	then	ADV
brj-24903	122	5	combined	combine	VERB
brj-24903	122	6	with	with	ADP
brj-24903	122	7	an	an	DET
brj-24903	122	8	equivalent	equivalent	ADJ
brj-24903	122	9	volume	volume	NOUN
brj-24903	122	10	of	of	ADP
brj-24903	122	11	gr	gr	PROPN
brj-24903	122	12	(	(	PUNCT
brj-24903	122	13	150	150	NUM
brj-24903	122	14	µl	µl	NOUN
brj-24903	122	15	)	)	PUNCT
brj-24903	122	16	and	and	CCONJ
brj-24903	122	17	allowed	allow	VERB
brj-24903	122	18	to	to	PART
brj-24903	122	19	incubate	incubate	VERB
brj-24903	122	20	for	for	ADP
brj-24903	122	21	five	five	NUM
brj-24903	122	22	min	min	NOUN
brj-24903	122	23	at	at	ADP
brj-24903	122	24	room	room	NOUN
brj-24903	122	25	temperature	temperature	NOUN
brj-24903	122	26	.	.	PUNCT
brj-24903	123	1	then	then	ADV
brj-24903	123	2	,	,	PUNCT
brj-24903	123	3	at	at	ADP
brj-24903	123	4	540	540	NUM
brj-24903	123	5	nm	nm	NOUN
brj-24903	123	6	,	,	PUNCT
brj-24903	123	7	absorbance	absorbance	NOUN
brj-24903	123	8	was	be	AUX
brj-24903	123	9	measured	measure	VERB
brj-24903	123	10	(	(	PUNCT
brj-24903	123	11	liu	liu	PROPN
brj-24903	123	12	et	et	PROPN
brj-24903	123	13	al	al	PROPN
brj-24903	123	14	.	.	PROPN
brj-24903	123	15	2017	2017	NUM
brj-24903	123	16	)	)	PUNCT
brj-24903	123	17	.	.	PUNCT
brj-24903	124	1	peer	peer	NOUN
brj-24903	124	2	-	-	PUNCT
brj-24903	124	3	reviewed	review	VERB
brj-24903	124	4	article	article	NOUN
brj-24903	124	5	bioresources.cnr.ncsu.edu	bioresources.cnr.ncsu.edu	X
brj-24903	124	6	gu	gu	VERB
brj-24903	124	7	et	et	PROPN
brj-24903	124	8	al	al	PROPN
brj-24903	124	9	.	.	PROPN
brj-24903	125	1	(	(	PUNCT
brj-24903	125	2	2026	2026	NUM
brj-24903	125	3	)	)	PUNCT
brj-24903	125	4	.	.	PUNCT
brj-24903	126	1	“	"	PUNCT
brj-24903	126	2	astragalus	astragalus	NOUN
brj-24903	126	3	leaf	leaf	NOUN
brj-24903	126	4	extract	extract	NOUN
brj-24903	126	5	vs.	vs.	ADP
brj-24903	126	6	arthritis	arthritis	NOUN
brj-24903	126	7	,	,	PUNCT
brj-24903	126	8	”	"	PUNCT
brj-24903	126	9	bioresources	bioresource	NOUN
brj-24903	126	10	21(1	21(1	NUM
brj-24903	126	11	)	)	PUNCT
brj-24903	126	12	,	,	PUNCT
brj-24903	126	13	160	160	NUM
brj-24903	126	14	-	-	SYM
brj-24903	126	15	177	177	NUM
brj-24903	126	16	.	.	PUNCT
brj-24903	127	1	165	165	NUM
brj-24903	127	2	elisa	elisa	NOUN
brj-24903	127	3	chondrocytes	chondrocytes	AUX
brj-24903	127	4	pre	pre	VERB
brj-24903	127	5	-	-	VERB
brj-24903	127	6	treated	treat	VERB
brj-24903	127	7	with	with	ADP
brj-24903	127	8	a.	a.	NOUN
brj-24903	127	9	glycyphyllos	glycyphyllos	PROPN
brj-24903	127	10	extract	extract	VERB
brj-24903	127	11	and	and	CCONJ
brj-24903	127	12	stimulated	stimulate	VERB
brj-24903	127	13	with	with	ADP
brj-24903	127	14	il	il	PROPN
brj-24903	127	15	-	-	PROPN
brj-24903	127	16	β	β	X
brj-24903	127	17	(	(	PUNCT
brj-24903	127	18	10	10	NUM
brj-24903	127	19	ng	ng	PROPN
brj-24903	127	20	/	/	SYM
brj-24903	127	21	ml	ml	PROPN
brj-24903	127	22	)	)	PUNCT
brj-24903	127	23	had	have	VERB
brj-24903	127	24	their	their	PRON
brj-24903	127	25	cell	cell	NOUN
brj-24903	127	26	supernatant	supernatant	NOUN
brj-24903	127	27	collected	collect	VERB
brj-24903	127	28	.	.	PUNCT
brj-24903	128	1	the	the	DET
brj-24903	128	2	tests	test	NOUN
brj-24903	128	3	were	be	AUX
brj-24903	128	4	conducted	conduct	VERB
brj-24903	128	5	in	in	ADP
brj-24903	128	6	accordance	accordance	NOUN
brj-24903	128	7	with	with	ADP
brj-24903	128	8	the	the	DET
brj-24903	128	9	manufacturer	manufacturer	NOUN
brj-24903	128	10	’s	’s	PART
brj-24903	128	11	protocol	protocol	NOUN
brj-24903	128	12	sigma	sigma	PROPN
brj-24903	128	13	-	-	PUNCT
brj-24903	128	14	aldrich	aldrich	PROPN
brj-24903	128	15	,	,	PUNCT
brj-24903	128	16	usa	usa	PROPN
brj-24903	128	17	,	,	PUNCT
brj-24903	128	18	and	and	CCONJ
brj-24903	128	19	sandwich	sandwich	NOUN
brj-24903	128	20	elisas	elisas	PROPN
brj-24903	128	21	were	be	AUX
brj-24903	128	22	used	use	VERB
brj-24903	128	23	to	to	PART
brj-24903	128	24	validate	validate	VERB
brj-24903	128	25	the	the	DET
brj-24903	128	26	levels	level	NOUN
brj-24903	128	27	of	of	ADP
brj-24903	128	28	pge2	pge2	NOUN
brj-24903	128	29	,	,	PUNCT
brj-24903	128	30	mmp-1	mmp-1	ADP
brj-24903	128	31	,	,	PUNCT
brj-24903	128	32	and	and	CCONJ
brj-24903	128	33	mmp-13	mmp-13	VERB
brj-24903	128	34	released	release	VERB
brj-24903	128	35	by	by	ADP
brj-24903	128	36	the	the	DET
brj-24903	128	37	chondrocytes	chondrocyte	NOUN
brj-24903	128	38	.	.	PUNCT
brj-24903	129	1	statistical	statistical	ADJ
brj-24903	129	2	analysis	analysis	NOUN
brj-24903	129	3	every	every	DET
brj-24903	129	4	group	group	NOUN
brj-24903	129	5	’s	’s	PART
brj-24903	129	6	outcome	outcome	NOUN
brj-24903	129	7	was	be	AUX
brj-24903	129	8	presented	present	VERB
brj-24903	129	9	as	as	ADP
brj-24903	129	10	mean	mean	NOUN
brj-24903	129	11	±	±	NUM
brj-24903	129	12	se	se	X
brj-24903	129	13	.	.	PUNCT
brj-24903	130	1	the	the	DET
brj-24903	130	2	groups	group	NOUN
brj-24903	130	3	were	be	AUX
brj-24903	130	4	compared	compare	VERB
brj-24903	130	5	using	use	VERB
brj-24903	130	6	a	a	DET
brj-24903	130	7	one	one	NUM
brj-24903	130	8	-	-	PUNCT
brj-24903	130	9	way	way	NOUN
brj-24903	130	10	analysis	analysis	NOUN
brj-24903	130	11	of	of	ADP
brj-24903	130	12	variance	variance	NOUN
brj-24903	130	13	(	(	PUNCT
brj-24903	130	14	anova	anova	PROPN
brj-24903	130	15	)	)	PUNCT
brj-24903	130	16	,	,	PUNCT
brj-24903	130	17	and	and	CCONJ
brj-24903	130	18	p	p	NOUN
brj-24903	130	19	values	value	NOUN
brj-24903	130	20	of	of	ADP
brj-24903	130	21	less	less	ADJ
brj-24903	130	22	than	than	ADP
brj-24903	130	23	0.05	0.05	NUM
brj-24903	130	24	were	be	AUX
brj-24903	130	25	considered	consider	VERB
brj-24903	130	26	statistically	statistically	ADV
brj-24903	130	27	significant	significant	ADJ
brj-24903	130	28	.	.	PUNCT
brj-24903	131	1	the	the	DET
brj-24903	131	2	“	"	PUNCT
brj-24903	131	3	tukey	tukey	NOUN
brj-24903	131	4	multiple	multiple	ADJ
brj-24903	131	5	comparison	comparison	NOUN
brj-24903	131	6	test	test	NOUN
brj-24903	131	7	”	"	PUNCT
brj-24903	131	8	was	be	AUX
brj-24903	131	9	then	then	ADV
brj-24903	131	10	conducted	conduct	VERB
brj-24903	131	11	with	with	ADP
brj-24903	131	12	version	version	NOUN
brj-24903	131	13	8.1	8.1	NUM
brj-24903	131	14	of	of	ADP
brj-24903	131	15	graph	graph	NOUN
brj-24903	131	16	pad	pad	NOUN
brj-24903	131	17	prism	prism	NOUN
brj-24903	131	18	.	.	PUNCT
brj-24903	132	1	results	result	VERB
brj-24903	132	2	effect	effect	NOUN
brj-24903	132	3	of	of	ADP
brj-24903	132	4	a.	a.	NOUN
brj-24903	132	5	glycyphyllos	glycyphyllos	PROPN
brj-24903	132	6	extract	extract	VERB
brj-24903	132	7	on	on	ADP
brj-24903	132	8	inflammation	inflammation	NOUN
brj-24903	132	9	in	in	ADP
brj-24903	132	10	arthritic	arthritic	ADJ
brj-24903	132	11	animals	animal	NOUN
brj-24903	132	12	figure	figure	VERB
brj-24903	132	13	1	1	NUM
brj-24903	132	14	illustrates	illustrate	VERB
brj-24903	132	15	the	the	DET
brj-24903	132	16	impact	impact	NOUN
brj-24903	132	17	of	of	ADP
brj-24903	132	18	an	an	DET
brj-24903	132	19	ethanolic	ethanolic	ADJ
brj-24903	132	20	extract	extract	NOUN
brj-24903	132	21	of	of	ADP
brj-24903	132	22	a.	a.	NOUN
brj-24903	132	23	glycyphyllos	glycyphyllos	PROPN
brj-24903	132	24	leaves	leave	VERB
brj-24903	132	25	on	on	ADP
brj-24903	132	26	paw	paw	PROPN
brj-24903	132	27	inflammation	inflammation	NOUN
brj-24903	132	28	in	in	ADP
brj-24903	132	29	rats	rat	NOUN
brj-24903	132	30	given	give	VERB
brj-24903	132	31	a	a	DET
brj-24903	132	32	cfa	cfa	NOUN
brj-24903	132	33	challenge	challenge	NOUN
brj-24903	132	34	.	.	PUNCT
brj-24903	133	1	a	a	DET
brj-24903	133	2	b	b	X
brj-24903	133	3	c	c	NOUN
brj-24903	133	4	d	d	X
brj-24903	133	5	fig	fig	NOUN
brj-24903	133	6	.	.	PUNCT
brj-24903	134	1	1	1	NUM
brj-24903	134	2	(	(	PUNCT
brj-24903	134	3	a	a	NOUN
brj-24903	134	4	-	-	PUNCT
brj-24903	134	5	d	d	NOUN
brj-24903	134	6	)	)	PUNCT
brj-24903	134	7	.	.	PUNCT
brj-24903	135	1	effect	effect	NOUN
brj-24903	135	2	of	of	ADP
brj-24903	135	3	a.	a.	NOUN
brj-24903	135	4	glycyphyllos	glycyphyllos	PROPN
brj-24903	135	5	leaves	leave	VERB
brj-24903	135	6	extract	extract	VERB
brj-24903	135	7	on	on	ADP
brj-24903	135	8	paw	paw	NOUN
brj-24903	135	9	inflammation	inflammation	NOUN
brj-24903	135	10	in	in	ADP
brj-24903	135	11	cfa	cfa	PROPN
brj-24903	135	12	challenged	challenge	VERB
brj-24903	135	13	arthritic	arthritic	ADJ
brj-24903	135	14	animals	animal	NOUN
brj-24903	135	15	.	.	PUNCT
brj-24903	136	1	(	(	PUNCT
brj-24903	136	2	a	a	X
brj-24903	136	3	)	)	PUNCT
brj-24903	136	4	day	day	NOUN
brj-24903	136	5	3,(b	3,(b	NUM
brj-24903	136	6	)	)	PUNCT
brj-24903	136	7	day	day	NOUN
brj-24903	136	8	7	7	NUM
brj-24903	136	9	,	,	PUNCT
brj-24903	136	10	(	(	PUNCT
brj-24903	136	11	c	c	NOUN
brj-24903	136	12	)	)	PUNCT
brj-24903	136	13	day	day	NOUN
brj-24903	136	14	14	14	NUM
brj-24903	136	15	,	,	PUNCT
brj-24903	136	16	(	(	PUNCT
brj-24903	136	17	d	d	NOUN
brj-24903	136	18	)	)	PUNCT
brj-24903	136	19	day	day	NOUN
brj-24903	136	20	21	21	NUM
brj-24903	136	21	,	,	PUNCT
brj-24903	136	22	(	(	PUNCT
brj-24903	136	23	e	e	NOUN
brj-24903	136	24	)	)	PUNCT
brj-24903	136	25	day	day	NOUN
brj-24903	136	26	28	28	NUM
brj-24903	136	27	.	.	PUNCT
brj-24903	137	1	mean	mean	PROPN
brj-24903	137	2	±sem	±sem	NOUN
brj-24903	137	3	(	(	PUNCT
brj-24903	137	4	n=	n=	ADJ
brj-24903	137	5	6	6	NUM
brj-24903	137	6	)	)	PUNCT
brj-24903	137	7	.	.	PUNCT
brj-24903	138	1	#	#	SYM
brj-24903	138	2	#	#	SYM
brj-24903	138	3	#	#	AUX
brj-24903	138	4	p<0.001	p<0.001	VERB
brj-24903	138	5	considered	consider	VERB
brj-24903	138	6	statistically	statistically	ADV
brj-24903	138	7	noteworthy	noteworthy	ADJ
brj-24903	138	8	as	as	SCONJ
brj-24903	138	9	judged	judge	VERB
brj-24903	138	10	against	against	ADP
brj-24903	138	11	normal	normal	ADJ
brj-24903	138	12	control	control	NOUN
brj-24903	138	13	group	group	NOUN
brj-24903	138	14	;	;	PUNCT
brj-24903	138	15	*	*	PUNCT
brj-24903	138	16	*	*	PUNCT
brj-24903	138	17	p<0.01	p<0.01	PRON
brj-24903	138	18	as	as	ADV
brj-24903	138	19	well	well	ADV
brj-24903	138	20	as	as	ADP
brj-24903	138	21	*	*	NOUN
brj-24903	138	22	*	*	PUNCT
brj-24903	138	23	*	*	PUNCT
brj-24903	138	24	p<0.001	p<0.001	AUX
brj-24903	138	25	considered	consider	VERB
brj-24903	138	26	statistically	statistically	ADV
brj-24903	138	27	noteworthy	noteworthy	ADJ
brj-24903	138	28	as	as	SCONJ
brj-24903	138	29	judged	judge	VERB
brj-24903	138	30	against	against	ADP
brj-24903	138	31	cfa	cfa	PROPN
brj-24903	138	32	control	control	PROPN
brj-24903	138	33	group	group	PROPN
brj-24903	138	34	.	.	PUNCT
brj-24903	139	1	i	i	PRON
brj-24903	139	2	ii	ii	VERB
brj-24903	139	3	iii	iii	NUM
brj-24903	139	4	iv	iv	NUM
brj-24903	139	5	v	v	ADP
brj-24903	139	6	0.0	0.0	NUM
brj-24903	139	7	0.5	0.5	NUM
brj-24903	139	8	1.0	1.0	NUM
brj-24903	139	9	1.5	1.5	NUM
brj-24903	139	10	day	day	NOUN
brj-24903	139	11	1	1	NUM
brj-24903	139	12	groups	group	NOUN
brj-24903	139	13	p	p	X
brj-24903	139	14	a	a	PRON
brj-24903	139	15	w	w	NOUN
brj-24903	139	16	v	v	NOUN
brj-24903	139	17	o	o	NOUN
brj-24903	140	1	lu	lu	NOUN
brj-24903	140	2	m	m	VERB
brj-24903	140	3	e	e	NOUN
brj-24903	140	4	(	(	PUNCT
brj-24903	140	5	m	m	PROPN
brj-24903	140	6	l	l	NOUN
brj-24903	140	7	)	)	PUNCT
brj-24903	141	1	i	i	PRON
brj-24903	141	2	ii	ii	VERB
brj-24903	141	3	iii	iii	NUM
brj-24903	141	4	iv	iv	NUM
brj-24903	141	5	v	v	ADP
brj-24903	141	6	0.0	0.0	NUM
brj-24903	141	7	0.5	0.5	NUM
brj-24903	141	8	1.0	1.0	NUM
brj-24903	141	9	1.5	1.5	NUM
brj-24903	141	10	2.0	2.0	NUM
brj-24903	141	11	day	day	NOUN
brj-24903	141	12	7	7	NUM
brj-24903	141	13	groups	group	NOUN
brj-24903	141	14	p	p	X
brj-24903	141	15	a	a	PRON
brj-24903	141	16	w	w	NOUN
brj-24903	141	17	v	v	NOUN
brj-24903	141	18	o	o	NOUN
brj-24903	141	19	lu	lu	NOUN
brj-24903	141	20	m	m	VERB
brj-24903	141	21	e	e	NOUN
brj-24903	141	22	(	(	PUNCT
brj-24903	141	23	m	m	PROPN
brj-24903	141	24	l	l	NOUN
brj-24903	141	25	)	)	PUNCT
brj-24903	141	26	*	*	PUNCT
brj-24903	142	1	*	*	PUNCT
brj-24903	142	2	*	*	PUNCT
brj-24903	143	1	#	#	SYM
brj-24903	143	2	#	#	SYM
brj-24903	143	3	#	#	NOUN
brj-24903	143	4	*	*	NOUN
brj-24903	143	5	*	*	PUNCT
brj-24903	144	1	*	*	PUNCT
brj-24903	144	2	*	*	PUNCT
brj-24903	145	1	i	i	PRON
brj-24903	145	2	ii	ii	VERB
brj-24903	145	3	iii	iii	NUM
brj-24903	145	4	iv	iv	NUM
brj-24903	145	5	v	v	ADP
brj-24903	145	6	0.0	0.0	NUM
brj-24903	145	7	0.5	0.5	NUM
brj-24903	145	8	1.0	1.0	NUM
brj-24903	145	9	1.5	1.5	NUM
brj-24903	145	10	2.0	2.0	NUM
brj-24903	145	11	2.5	2.5	NUM
brj-24903	145	12	day	day	NOUN
brj-24903	145	13	14	14	NUM
brj-24903	145	14	groups	group	NOUN
brj-24903	145	15	p	p	X
brj-24903	145	16	a	a	DET
brj-24903	145	17	w	w	NOUN
brj-24903	145	18	v	v	NOUN
brj-24903	145	19	o	o	NOUN
brj-24903	145	20	lu	lu	NOUN
brj-24903	145	21	m	m	VERB
brj-24903	145	22	e	e	NOUN
brj-24903	145	23	(	(	PUNCT
brj-24903	145	24	m	m	PROPN
brj-24903	145	25	l	l	NOUN
brj-24903	145	26	)	)	PUNCT
brj-24903	145	27	*	*	PUNCT
brj-24903	146	1	*	*	PUNCT
brj-24903	146	2	*	*	PUNCT
brj-24903	147	1	#	#	SYM
brj-24903	147	2	#	#	SYM
brj-24903	147	3	#	#	NOUN
brj-24903	147	4	*	*	NOUN
brj-24903	147	5	*	*	PUNCT
brj-24903	148	1	*	*	PUNCT
brj-24903	148	2	*	*	PUNCT
brj-24903	149	1	i	i	PRON
brj-24903	149	2	ii	ii	VERB
brj-24903	149	3	iii	iii	NUM
brj-24903	149	4	iv	iv	NUM
brj-24903	149	5	v	v	NOUN
brj-24903	149	6	0	0	NUM
brj-24903	149	7	1	1	NUM
brj-24903	149	8	2	2	NUM
brj-24903	149	9	3	3	NUM
brj-24903	149	10	day	day	NOUN
brj-24903	149	11	21	21	NUM
brj-24903	149	12	groups	group	NOUN
brj-24903	149	13	p	p	X
brj-24903	149	14	a	a	DET
brj-24903	149	15	w	w	NOUN
brj-24903	149	16	v	v	NOUN
brj-24903	149	17	o	o	NOUN
brj-24903	149	18	lu	lu	NOUN
brj-24903	149	19	m	m	VERB
brj-24903	149	20	e	e	NOUN
brj-24903	149	21	(	(	PUNCT
brj-24903	149	22	m	m	PROPN
brj-24903	149	23	l	l	NOUN
brj-24903	149	24	)	)	PUNCT
brj-24903	149	25	*	*	PUNCT
brj-24903	150	1	*	*	PUNCT
brj-24903	150	2	*	*	PUNCT
brj-24903	151	1	#	#	SYM
brj-24903	151	2	#	#	SYM
brj-24903	151	3	#	#	NOUN
brj-24903	151	4	*	*	NOUN
brj-24903	151	5	*	*	PUNCT
brj-24903	152	1	*	*	PUNCT
brj-24903	152	2	*	*	PUNCT
brj-24903	152	3	*	*	NOUN
brj-24903	152	4	peer	peer	NOUN
brj-24903	152	5	-	-	PUNCT
brj-24903	152	6	reviewed	review	VERB
brj-24903	152	7	article	article	NOUN
brj-24903	152	8	bioresources.cnr.ncsu.edu	bioresources.cnr.ncsu.edu	X
brj-24903	152	9	gu	gu	VERB
brj-24903	152	10	et	et	PROPN
brj-24903	152	11	al	al	PROPN
brj-24903	152	12	.	.	PROPN
brj-24903	152	13	(	(	PUNCT
brj-24903	152	14	2026	2026	NUM
brj-24903	152	15	)	)	PUNCT
brj-24903	152	16	.	.	PUNCT
brj-24903	153	1	“	"	PUNCT
brj-24903	153	2	astragalus	astragalus	NOUN
brj-24903	153	3	leaf	leaf	NOUN
brj-24903	153	4	extract	extract	NOUN
brj-24903	153	5	vs.	vs.	ADP
brj-24903	153	6	arthritis	arthritis	NOUN
brj-24903	153	7	,	,	PUNCT
brj-24903	153	8	”	"	PUNCT
brj-24903	153	9	bioresources	bioresource	NOUN
brj-24903	153	10	21(1	21(1	NUM
brj-24903	153	11	)	)	PUNCT
brj-24903	153	12	,	,	PUNCT
brj-24903	153	13	160	160	NUM
brj-24903	153	14	-	-	SYM
brj-24903	153	15	177	177	NUM
brj-24903	153	16	.	.	PUNCT
brj-24903	154	1	166	166	NUM
brj-24903	154	2	fig	fig	NOUN
brj-24903	154	3	.	.	PUNCT
brj-24903	155	1	1	1	NUM
brj-24903	155	2	(	(	PUNCT
brj-24903	155	3	e	e	NOUN
brj-24903	155	4	)	)	PUNCT
brj-24903	155	5	.	.	PUNCT
brj-24903	156	1	effect	effect	NOUN
brj-24903	156	2	of	of	ADP
brj-24903	156	3	a.	a.	NOUN
brj-24903	156	4	glycyphyllos	glycyphyllos	PROPN
brj-24903	156	5	leaves	leave	VERB
brj-24903	156	6	extract	extract	VERB
brj-24903	156	7	on	on	ADP
brj-24903	156	8	paw	paw	NOUN
brj-24903	156	9	inflammation	inflammation	NOUN
brj-24903	156	10	in	in	ADP
brj-24903	156	11	cfa	cfa	PROPN
brj-24903	156	12	challenged	challenge	VERB
brj-24903	156	13	arthritic	arthritic	ADJ
brj-24903	156	14	animals	animal	NOUN
brj-24903	156	15	.	.	PUNCT
brj-24903	157	1	(	(	PUNCT
brj-24903	157	2	a	a	X
brj-24903	157	3	)	)	PUNCT
brj-24903	157	4	day	day	NOUN
brj-24903	157	5	3,(b	3,(b	NUM
brj-24903	157	6	)	)	PUNCT
brj-24903	157	7	day	day	NOUN
brj-24903	157	8	7	7	NUM
brj-24903	157	9	,	,	PUNCT
brj-24903	157	10	(	(	PUNCT
brj-24903	157	11	c	c	NOUN
brj-24903	157	12	)	)	PUNCT
brj-24903	157	13	day	day	NOUN
brj-24903	157	14	14	14	NUM
brj-24903	157	15	,	,	PUNCT
brj-24903	157	16	(	(	PUNCT
brj-24903	157	17	d	d	NOUN
brj-24903	157	18	)	)	PUNCT
brj-24903	157	19	day	day	NOUN
brj-24903	157	20	21	21	NUM
brj-24903	157	21	,	,	PUNCT
brj-24903	157	22	(	(	PUNCT
brj-24903	157	23	e	e	NOUN
brj-24903	157	24	)	)	PUNCT
brj-24903	157	25	day	day	NOUN
brj-24903	157	26	28	28	NUM
brj-24903	157	27	.	.	PUNCT
brj-24903	158	1	data	datum	NOUN
brj-24903	158	2	are	be	AUX
brj-24903	158	3	represented	represent	VERB
brj-24903	158	4	as	as	ADP
brj-24903	158	5	mean	mean	ADJ
brj-24903	158	6	±sem	±sem	NOUN
brj-24903	158	7	(	(	PUNCT
brj-24903	158	8	n=	n=	ADJ
brj-24903	158	9	6	6	NUM
brj-24903	158	10	)	)	PUNCT
brj-24903	158	11	.	.	PUNCT
brj-24903	159	1	#	#	SYM
brj-24903	159	2	#	#	SYM
brj-24903	159	3	#	#	AUX
brj-24903	159	4	p<0.001	p<0.001	VERB
brj-24903	159	5	considered	consider	VERB
brj-24903	159	6	statistically	statistically	ADV
brj-24903	159	7	noteworthy	noteworthy	ADJ
brj-24903	159	8	as	as	SCONJ
brj-24903	159	9	judged	judge	VERB
brj-24903	159	10	against	against	ADP
brj-24903	159	11	normal	normal	ADJ
brj-24903	159	12	control	control	NOUN
brj-24903	159	13	group	group	NOUN
brj-24903	159	14	;	;	PUNCT
brj-24903	159	15	*	*	PUNCT
brj-24903	159	16	*	*	PUNCT
brj-24903	159	17	p<0.01	p<0.01	PRON
brj-24903	159	18	as	as	ADV
brj-24903	159	19	well	well	ADV
brj-24903	159	20	as	as	ADP
brj-24903	159	21	*	*	NOUN
brj-24903	159	22	*	*	PUNCT
brj-24903	159	23	*	*	PUNCT
brj-24903	159	24	p<0.001	p<0.001	AUX
brj-24903	159	25	considered	consider	VERB
brj-24903	159	26	statistically	statistically	ADV
brj-24903	159	27	noteworthy	noteworthy	ADJ
brj-24903	159	28	as	as	SCONJ
brj-24903	159	29	judged	judge	VERB
brj-24903	159	30	against	against	ADP
brj-24903	159	31	cfa	cfa	PROPN
brj-24903	159	32	control	control	PROPN
brj-24903	159	33	group	group	PROPN
brj-24903	159	34	.	.	PUNCT
brj-24903	160	1	when	when	SCONJ
brj-24903	160	2	comparing	compare	VERB
brj-24903	160	3	the	the	DET
brj-24903	160	4	cfa	cfa	PROPN
brj-24903	160	5	-	-	PUNCT
brj-24903	160	6	challenged	challenge	VERB
brj-24903	160	7	rats	rat	NOUN
brj-24903	160	8	treated	treat	VERB
brj-24903	160	9	with	with	ADP
brj-24903	160	10	a.	a.	NOUN
brj-24903	160	11	glycyphyllos	glycyphyllos	PROPN
brj-24903	160	12	extract	extract	NOUN
brj-24903	160	13	(	(	PUNCT
brj-24903	160	14	100	100	NUM
brj-24903	160	15	and	and	CCONJ
brj-24903	160	16	200	200	NUM
brj-24903	160	17	mg	mg	NUM
brj-24903	160	18	/	/	SYM
brj-24903	160	19	kg	kg	NOUN
brj-24903	160	20	)	)	PUNCT
brj-24903	160	21	to	to	ADP
brj-24903	160	22	the	the	DET
brj-24903	160	23	animals	animal	NOUN
brj-24903	160	24	in	in	ADP
brj-24903	160	25	the	the	DET
brj-24903	160	26	cfa	cfa	PROPN
brj-24903	160	27	control	control	PROPN
brj-24903	160	28	group	group	PROPN
brj-24903	160	29	at	at	ADP
brj-24903	160	30	days	day	NOUN
brj-24903	160	31	7	7	NUM
brj-24903	160	32	,	,	PUNCT
brj-24903	160	33	14	14	NUM
brj-24903	160	34	,	,	PUNCT
brj-24903	160	35	21	21	NUM
brj-24903	160	36	,	,	PUNCT
brj-24903	160	37	and	and	CCONJ
brj-24903	160	38	28	28	NUM
brj-24903	160	39	,	,	PUNCT
brj-24903	160	40	a	a	DET
brj-24903	160	41	progressive	progressive	ADJ
brj-24903	160	42	decrease	decrease	NOUN
brj-24903	160	43	in	in	ADP
brj-24903	160	44	paw	paw	PROPN
brj-24903	160	45	inflammation	inflammation	NOUN
brj-24903	160	46	was	be	AUX
brj-24903	160	47	observed	observe	VERB
brj-24903	160	48	.	.	PUNCT
brj-24903	161	1	when	when	SCONJ
brj-24903	161	2	comparing	compare	VERB
brj-24903	161	3	day	day	NOUN
brj-24903	161	4	1	1	NUM
brj-24903	161	5	to	to	ADP
brj-24903	161	6	day	day	NOUN
brj-24903	161	7	7	7	NUM
brj-24903	161	8	,	,	PUNCT
brj-24903	161	9	it	it	PRON
brj-24903	161	10	was	be	AUX
brj-24903	161	11	observed	observe	VERB
brj-24903	161	12	that	that	SCONJ
brj-24903	161	13	the	the	DET
brj-24903	161	14	mice	mouse	NOUN
brj-24903	161	15	in	in	ADP
brj-24903	161	16	the	the	DET
brj-24903	161	17	cfa	cfa	PROPN
brj-24903	161	18	control	control	PROPN
brj-24903	161	19	group	group	PROPN
brj-24903	161	20	had	have	VERB
brj-24903	161	21	1.5	1.5	NUM
brj-24903	161	22	times	time	NOUN
brj-24903	161	23	more	more	ADJ
brj-24903	161	24	paw	paw	PROPN
brj-24903	161	25	inflammation	inflammation	NOUN
brj-24903	161	26	on	on	ADP
brj-24903	161	27	day	day	NOUN
brj-24903	161	28	7	7	NUM
brj-24903	161	29	.	.	PUNCT
brj-24903	162	1	on	on	ADP
brj-24903	162	2	the	the	DET
brj-24903	162	3	other	other	ADJ
brj-24903	162	4	hand	hand	NOUN
brj-24903	162	5	,	,	PUNCT
brj-24903	162	6	the	the	DET
brj-24903	162	7	extract	extract	NOUN
brj-24903	162	8	(	(	PUNCT
brj-24903	162	9	100	100	NUM
brj-24903	162	10	and	and	CCONJ
brj-24903	162	11	200	200	NUM
brj-24903	162	12	mg	mg	NUM
brj-24903	162	13	/	/	SYM
brj-24903	162	14	kg	kg	PROPN
brj-24903	162	15	)	)	PUNCT
brj-24903	162	16	was	be	AUX
brj-24903	162	17	found	find	VERB
brj-24903	162	18	to	to	ADP
brj-24903	162	19	significantly	significantly	ADV
brj-24903	162	20	(	(	PUNCT
brj-24903	162	21	p<0.01	p<0.01	PROPN
brj-24903	162	22	)	)	PUNCT
brj-24903	162	23	reduce	reduce	VERB
brj-24903	162	24	inflammation	inflammation	NOUN
brj-24903	162	25	when	when	SCONJ
brj-24903	162	26	compared	compare	VERB
brj-24903	162	27	to	to	ADP
brj-24903	162	28	the	the	DET
brj-24903	162	29	rats	rat	NOUN
brj-24903	162	30	in	in	ADP
brj-24903	162	31	the	the	DET
brj-24903	162	32	cfa	cfa	PROPN
brj-24903	162	33	control	control	PROPN
brj-24903	162	34	group	group	PROPN
brj-24903	162	35	.	.	PUNCT
brj-24903	163	1	on	on	ADP
brj-24903	163	2	days	day	NOUN
brj-24903	163	3	14	14	NUM
brj-24903	163	4	,	,	PUNCT
brj-24903	163	5	21	21	NUM
brj-24903	163	6	,	,	PUNCT
brj-24903	163	7	and	and	CCONJ
brj-24903	163	8	28	28	NUM
brj-24903	163	9	,	,	PUNCT
brj-24903	163	10	it	it	PRON
brj-24903	163	11	was	be	AUX
brj-24903	163	12	noted	note	VERB
brj-24903	163	13	that	that	SCONJ
brj-24903	163	14	the	the	DET
brj-24903	163	15	extract	extract	NOUN
brj-24903	163	16	(	(	PUNCT
brj-24903	163	17	at	at	ADP
brj-24903	163	18	100	100	NUM
brj-24903	163	19	and	and	CCONJ
brj-24903	163	20	200	200	NUM
brj-24903	163	21	mg	mg	NUM
brj-24903	163	22	/	/	SYM
brj-24903	163	23	kg	kg	PROPN
brj-24903	163	24	)	)	PUNCT
brj-24903	163	25	had	have	VERB
brj-24903	163	26	the	the	DET
brj-24903	163	27	same	same	ADJ
brj-24903	163	28	general	general	ADJ
brj-24903	163	29	pattern	pattern	NOUN
brj-24903	163	30	of	of	ADP
brj-24903	163	31	impact	impact	NOUN
brj-24903	163	32	on	on	ADP
brj-24903	163	33	paw	paw	NOUN
brj-24903	163	34	inflammation	inflammation	NOUN
brj-24903	163	35	in	in	ADP
brj-24903	163	36	arthritic	arthritic	ADJ
brj-24903	163	37	animals	animal	NOUN
brj-24903	163	38	.	.	PUNCT
brj-24903	164	1	the	the	DET
brj-24903	164	2	period	period	NOUN
brj-24903	164	3	between	between	ADP
brj-24903	164	4	days	day	NOUN
brj-24903	164	5	14	14	NUM
brj-24903	164	6	and	and	CCONJ
brj-24903	164	7	28	28	NUM
brj-24903	164	8	had	have	VERB
brj-24903	164	9	an	an	DET
brj-24903	164	10	increase	increase	NOUN
brj-24903	164	11	in	in	ADP
brj-24903	164	12	inflammation	inflammation	NOUN
brj-24903	164	13	.	.	PUNCT
brj-24903	165	1	when	when	SCONJ
brj-24903	165	2	comparing	compare	VERB
brj-24903	165	3	day	day	NOUN
brj-24903	165	4	1	1	NUM
brj-24903	165	5	to	to	ADP
brj-24903	165	6	day	day	NOUN
brj-24903	165	7	28	28	NUM
brj-24903	165	8	,	,	PUNCT
brj-24903	165	9	the	the	DET
brj-24903	165	10	animals	animal	NOUN
brj-24903	165	11	in	in	ADP
brj-24903	165	12	the	the	DET
brj-24903	165	13	cfa	cfa	PROPN
brj-24903	165	14	control	control	PROPN
brj-24903	165	15	group	group	PROPN
brj-24903	165	16	had	have	VERB
brj-24903	165	17	an	an	DET
brj-24903	165	18	increase	increase	NOUN
brj-24903	165	19	in	in	ADP
brj-24903	165	20	inflammation	inflammation	NOUN
brj-24903	165	21	of	of	ADP
brj-24903	165	22	more	more	ADJ
brj-24903	165	23	than	than	ADP
brj-24903	165	24	twice	twice	ADV
brj-24903	165	25	as	as	ADV
brj-24903	165	26	much	much	ADJ
brj-24903	165	27	.	.	PUNCT
brj-24903	166	1	in	in	ADP
brj-24903	166	2	contrast	contrast	NOUN
brj-24903	166	3	,	,	PUNCT
brj-24903	166	4	compared	compare	VERB
brj-24903	166	5	to	to	ADP
brj-24903	166	6	the	the	DET
brj-24903	166	7	animals	animal	NOUN
brj-24903	166	8	in	in	ADP
brj-24903	166	9	the	the	DET
brj-24903	166	10	cfa	cfa	PROPN
brj-24903	166	11	control	control	PROPN
brj-24903	166	12	group	group	PROPN
brj-24903	166	13	,	,	PUNCT
brj-24903	166	14	the	the	DET
brj-24903	166	15	animals	animal	NOUN
brj-24903	166	16	that	that	PRON
brj-24903	166	17	were	be	AUX
brj-24903	166	18	given	give	VERB
brj-24903	166	19	the	the	DET
brj-24903	166	20	extract	extract	NOUN
brj-24903	166	21	(	(	PUNCT
brj-24903	166	22	at	at	ADP
brj-24903	166	23	doses	dose	NOUN
brj-24903	166	24	of	of	ADP
brj-24903	166	25	100	100	NUM
brj-24903	166	26	and	and	CCONJ
brj-24903	166	27	200	200	NUM
brj-24903	166	28	mg	mg	NUM
brj-24903	166	29	/	/	SYM
brj-24903	166	30	kg	kg	PROPN
brj-24903	166	31	)	)	PUNCT
brj-24903	166	32	and	and	CCONJ
brj-24903	166	33	were	be	AUX
brj-24903	166	34	cfa	cfa	PROPN
brj-24903	166	35	-	-	PUNCT
brj-24903	166	36	challenged	challenge	VERB
brj-24903	166	37	showed	show	VERB
brj-24903	166	38	a	a	DET
brj-24903	166	39	substantial	substantial	ADJ
brj-24903	166	40	(	(	PUNCT
brj-24903	166	41	p<0.01	p<0.01	PROPN
brj-24903	166	42	)	)	PUNCT
brj-24903	166	43	reduction	reduction	NOUN
brj-24903	166	44	in	in	ADP
brj-24903	166	45	inflammation	inflammation	NOUN
brj-24903	166	46	.	.	PUNCT
brj-24903	167	1	body	body	NOUN
brj-24903	167	2	weight	weight	NOUN
brj-24903	167	3	changes	change	NOUN
brj-24903	167	4	in	in	ADP
brj-24903	167	5	arthritic	arthritic	ADJ
brj-24903	167	6	animals	animal	NOUN
brj-24903	167	7	after	after	SCONJ
brj-24903	167	8	a.	a.	NOUN
brj-24903	167	9	glycyphyllos	glycyphyllos	PROPN
brj-24903	167	10	treatment	treatment	VERB
brj-24903	167	11	the	the	DET
brj-24903	167	12	effects	effect	NOUN
brj-24903	167	13	of	of	ADP
brj-24903	167	14	a.	a.	NOUN
brj-24903	167	15	glycyphyllos	glycyphyllos	PROPN
brj-24903	167	16	extract	extract	NOUN
brj-24903	167	17	(	(	PUNCT
brj-24903	167	18	100	100	NUM
brj-24903	167	19	and	and	CCONJ
brj-24903	167	20	200	200	NUM
brj-24903	167	21	mg	mg	NUM
brj-24903	167	22	/	/	SYM
brj-24903	167	23	kg	kg	NOUN
brj-24903	167	24	)	)	PUNCT
brj-24903	167	25	on	on	ADP
brj-24903	167	26	the	the	DET
brj-24903	167	27	body	body	NOUN
brj-24903	167	28	weight	weight	NOUN
brj-24903	167	29	of	of	ADP
brj-24903	167	30	arthritic	arthritic	ADJ
brj-24903	167	31	animals	animal	NOUN
brj-24903	167	32	with	with	ADP
brj-24903	167	33	cfa	cfa	NOUN
brj-24903	167	34	challenges	challenge	NOUN
brj-24903	167	35	are	be	AUX
brj-24903	167	36	shown	show	VERB
brj-24903	167	37	in	in	ADP
brj-24903	167	38	table	table	NOUN
brj-24903	167	39	1	1	NUM
brj-24903	167	40	.	.	PUNCT
brj-24903	167	41	days	day	NOUN
brj-24903	167	42	1	1	NUM
brj-24903	167	43	and	and	CCONJ
brj-24903	167	44	28	28	NUM
brj-24903	167	45	were	be	AUX
brj-24903	167	46	used	use	VERB
brj-24903	167	47	to	to	PART
brj-24903	167	48	measure	measure	VERB
brj-24903	167	49	the	the	DET
brj-24903	167	50	body	body	NOUN
brj-24903	167	51	weight	weight	NOUN
brj-24903	167	52	.	.	PUNCT
brj-24903	168	1	on	on	ADP
brj-24903	168	2	day	day	NOUN
brj-24903	168	3	28	28	NUM
brj-24903	168	4	,	,	PUNCT
brj-24903	168	5	it	it	PRON
brj-24903	168	6	was	be	AUX
brj-24903	168	7	discovered	discover	VERB
brj-24903	168	8	that	that	SCONJ
brj-24903	168	9	the	the	DET
brj-24903	168	10	body	body	NOUN
brj-24903	168	11	weight	weight	NOUN
brj-24903	168	12	of	of	ADP
brj-24903	168	13	the	the	DET
brj-24903	168	14	normal	normal	ADJ
brj-24903	168	15	control	control	NOUN
brj-24903	168	16	mice	mouse	NOUN
brj-24903	168	17	had	have	AUX
brj-24903	168	18	increased	increase	VERB
brj-24903	168	19	(	(	PUNCT
brj-24903	168	20	13.5	13.5	NUM
brj-24903	168	21	%	%	NOUN
brj-24903	168	22	)	)	PUNCT
brj-24903	168	23	.	.	PUNCT
brj-24903	169	1	when	when	SCONJ
brj-24903	169	2	compared	compare	VERB
brj-24903	169	3	to	to	ADP
brj-24903	169	4	normal	normal	ADJ
brj-24903	169	5	control	control	NOUN
brj-24903	169	6	animals	animal	NOUN
brj-24903	169	7	,	,	PUNCT
brj-24903	169	8	the	the	DET
brj-24903	169	9	cfa	cfa	PROPN
brj-24903	169	10	control	control	PROPN
brj-24903	169	11	group	group	PROPN
brj-24903	169	12	’s	’s	PART
brj-24903	169	13	body	body	NOUN
brj-24903	169	14	weight	weight	NOUN
brj-24903	169	15	had	have	AUX
brj-24903	169	16	significantly	significantly	ADV
brj-24903	169	17	(	(	PUNCT
brj-24903	169	18	p<0.001	p<0.001	PROPN
brj-24903	169	19	)	)	PUNCT
brj-24903	169	20	decreased	decrease	VERB
brj-24903	169	21	.	.	PUNCT
brj-24903	170	1	the	the	DET
brj-24903	170	2	body	body	NOUN
brj-24903	170	3	weight	weight	NOUN
brj-24903	170	4	of	of	ADP
brj-24903	170	5	the	the	DET
brj-24903	170	6	cfa	cfa	PROPN
brj-24903	170	7	animals	animal	NOUN
brj-24903	170	8	decreased	decrease	VERB
brj-24903	170	9	significantly	significantly	ADV
brj-24903	170	10	.	.	PUNCT
brj-24903	171	1	however	however	ADV
brj-24903	171	2	,	,	PUNCT
brj-24903	171	3	arthritic	arthritic	ADJ
brj-24903	171	4	animals	animal	NOUN
brj-24903	171	5	treated	treat	VERB
brj-24903	171	6	with	with	ADP
brj-24903	171	7	the	the	DET
brj-24903	171	8	a.	a.	NOUN
brj-24903	171	9	glycyphyllos	glycyphyllos	NOUN
brj-24903	171	10	extract	extract	NOUN
brj-24903	171	11	(	(	PUNCT
brj-24903	171	12	100	100	NUM
brj-24903	171	13	and	and	CCONJ
brj-24903	171	14	200	200	NUM
brj-24903	171	15	mg	mg	NUM
brj-24903	171	16	/	/	SYM
brj-24903	171	17	kg	kg	PROPN
brj-24903	171	18	)	)	PUNCT
brj-24903	171	19	showed	show	VERB
brj-24903	171	20	a	a	DET
brj-24903	171	21	significant	significant	ADJ
brj-24903	171	22	(	(	PUNCT
brj-24903	171	23	p<0.01	p<0.01	PROPN
brj-24903	171	24	)	)	PUNCT
brj-24903	171	25	increase	increase	NOUN
brj-24903	171	26	in	in	ADP
brj-24903	171	27	body	body	NOUN
brj-24903	171	28	weight	weight	NOUN
brj-24903	171	29	.	.	PUNCT
brj-24903	172	1	i	i	PRON
brj-24903	172	2	ii	ii	VERB
brj-24903	172	3	iii	iii	NUM
brj-24903	172	4	iv	iv	NUM
brj-24903	172	5	v	v	NOUN
brj-24903	172	6	0	0	NUM
brj-24903	172	7	1	1	NUM
brj-24903	172	8	2	2	NUM
brj-24903	172	9	3	3	NUM
brj-24903	172	10	4	4	NUM
brj-24903	172	11	day	day	NOUN
brj-24903	172	12	28	28	NUM
brj-24903	172	13	groups	group	NOUN
brj-24903	172	14	p	p	X
brj-24903	172	15	a	a	PRON
brj-24903	172	16	w	w	NOUN
brj-24903	172	17	v	v	NOUN
brj-24903	172	18	o	o	NOUN
brj-24903	172	19	lu	lu	NOUN
brj-24903	172	20	m	m	VERB
brj-24903	172	21	e	e	NOUN
brj-24903	172	22	(	(	PUNCT
brj-24903	172	23	m	m	PROPN
brj-24903	172	24	l	l	NOUN
brj-24903	172	25	)	)	PUNCT
brj-24903	172	26	*	*	PUNCT
brj-24903	173	1	*	*	PUNCT
brj-24903	173	2	*	*	PUNCT
brj-24903	174	1	#	#	SYM
brj-24903	174	2	#	#	SYM
brj-24903	174	3	#	#	NOUN
brj-24903	174	4	*	*	NOUN
brj-24903	174	5	*	*	PUNCT
brj-24903	174	6	*	*	PUNCT
brj-24903	174	7	*	*	PUNCT
brj-24903	174	8	*	*	PUNCT
brj-24903	174	9	*	*	NOUN
brj-24903	174	10	peer	peer	NOUN
brj-24903	174	11	-	-	PUNCT
brj-24903	174	12	reviewed	review	VERB
brj-24903	174	13	article	article	NOUN
brj-24903	174	14	bioresources.cnr.ncsu.edu	bioresources.cnr.ncsu.edu	X
brj-24903	174	15	gu	gu	VERB
brj-24903	174	16	et	et	PROPN
brj-24903	174	17	al	al	PROPN
brj-24903	174	18	.	.	PROPN
brj-24903	175	1	(	(	PUNCT
brj-24903	175	2	2026	2026	NUM
brj-24903	175	3	)	)	PUNCT
brj-24903	175	4	.	.	PUNCT
brj-24903	176	1	“	"	PUNCT
brj-24903	176	2	astragalus	astragalus	NOUN
brj-24903	176	3	leaf	leaf	NOUN
brj-24903	176	4	extract	extract	NOUN
brj-24903	176	5	vs.	vs.	ADP
brj-24903	176	6	arthritis	arthritis	NOUN
brj-24903	176	7	,	,	PUNCT
brj-24903	176	8	”	"	PUNCT
brj-24903	176	9	bioresources	bioresource	NOUN
brj-24903	176	10	21(1	21(1	NUM
brj-24903	176	11	)	)	PUNCT
brj-24903	176	12	,	,	PUNCT
brj-24903	176	13	160	160	NUM
brj-24903	176	14	-	-	SYM
brj-24903	176	15	177	177	NUM
brj-24903	176	16	.	.	PUNCT
brj-24903	177	1	167	167	NUM
brj-24903	177	2	table	table	NOUN
brj-24903	177	3	1	1	NUM
brj-24903	177	4	.	.	PUNCT
brj-24903	177	5	following	follow	VERB
brj-24903	177	6	a.	a.	NOUN
brj-24903	177	7	glycyphyllos	glycyphyllos	PROPN
brj-24903	177	8	therapy	therapy	NOUN
brj-24903	177	9	change	change	NOUN
brj-24903	177	10	in	in	ADP
brj-24903	177	11	the	the	DET
brj-24903	177	12	body	body	NOUN
brj-24903	177	13	weight	weight	NOUN
brj-24903	177	14	of	of	ADP
brj-24903	177	15	arthritic	arthritic	ADJ
brj-24903	177	16	animals	animal	NOUN
brj-24903	177	17	groups	group	NOUN
brj-24903	177	18	treatment	treatment	NOUN
brj-24903	177	19	body	body	NOUN
brj-24903	177	20	weight	weight	NOUN
brj-24903	177	21	(	(	PUNCT
brj-24903	177	22	gm	gm	NOUN
brj-24903	177	23	)	)	PUNCT
brj-24903	177	24	%	%	NOUN
brj-24903	177	25	changes	change	NOUN
brj-24903	177	26	day	day	NOUN
brj-24903	177	27	1	1	NUM
brj-24903	177	28	day	day	NOUN
brj-24903	177	29	28	28	NUM
brj-24903	177	30	i	i	PRON
brj-24903	177	31	normal	normal	ADJ
brj-24903	177	32	control	control	VERB
brj-24903	177	33	195.92±5.03	195.92±5.03	PROPN
brj-24903	177	34	326.48±5.22	326.48±5.22	NUM
brj-24903	177	35	13.49	13.49	NUM
brj-24903	177	36	ii	ii	PROPN
brj-24903	177	37	cfa	cfa	PROPN
brj-24903	177	38	control	control	VERB
brj-24903	177	39	193.76±4.63	193.76±4.63	NUM
brj-24903	177	40	252.60±8.51	252.60±8.51	ADV
brj-24903	177	41	#	#	SYM
brj-24903	177	42	#	#	SYM
brj-24903	177	43	#	#	NOUN
brj-24903	177	44	-26.97	-26.97	NOUN
brj-24903	177	45	iii	iii	NUM
brj-24903	177	46	diclofenac	diclofenac	ADJ
brj-24903	177	47	sodium	sodium	NOUN
brj-24903	177	48	(	(	PUNCT
brj-24903	177	49	10	10	NUM
brj-24903	177	50	mg	mg	NUM
brj-24903	177	51	/	/	SYM
brj-24903	177	52	kg	kg	PROPN
brj-24903	177	53	;	;	PUNCT
brj-24903	177	54	i.p	i.p	PROPN
brj-24903	177	55	.	.	PROPN
brj-24903	177	56	)	)	PUNCT
brj-24903	178	1	192.55±4.98	192.55±4.98	NUM
brj-24903	179	1	301.64±4.16	301.64±4.16	NUM
brj-24903	179	2	*	*	PUNCT
brj-24903	179	3	*	*	PUNCT
brj-24903	179	4	*	*	PUNCT
brj-24903	179	5	4.50	4.50	NUM
brj-24903	179	6	iv	iv	NOUN
brj-24903	179	7	a.	a.	NOUN
brj-24903	179	8	glycyphyllos	glycyphyllos	NOUN
brj-24903	179	9	extract	extract	NOUN
brj-24903	179	10	(	(	PUNCT
brj-24903	179	11	100	100	NUM
brj-24903	179	12	mg	mg	NUM
brj-24903	179	13	/	/	SYM
brj-24903	179	14	kg	kg	PROPN
brj-24903	179	15	;	;	PUNCT
brj-24903	179	16	p.o	p.o	PROPN
brj-24903	179	17	.	.	PROPN
brj-24903	179	18	)	)	PUNCT
brj-24903	179	19	196.02±4.61	196.02±4.61	NUM
brj-24903	179	20	306.82±3.62	306.82±3.62	NUM
brj-24903	179	21	*	*	PUNCT
brj-24903	179	22	*	*	PUNCT
brj-24903	179	23	*	*	PUNCT
brj-24903	179	24	5.22	5.22	NUM
brj-24903	179	25	v	v	NOUN
brj-24903	179	26	a.	a.	NOUN
brj-24903	179	27	glycyphyllos	glycyphyllos	NOUN
brj-24903	179	28	extract	extract	NOUN
brj-24903	179	29	(	(	PUNCT
brj-24903	179	30	200	200	NUM
brj-24903	179	31	mg	mg	NUM
brj-24903	179	32	/	/	SYM
brj-24903	179	33	kg	kg	PROPN
brj-24903	179	34	;	;	PUNCT
brj-24903	179	35	p.o	p.o	PROPN
brj-24903	179	36	.	.	PUNCT
brj-24903	179	37	)	)	PUNCT
brj-24903	180	1	195.75±5.16	195.75±5.16	NUM
brj-24903	180	2	316.50±4.02	316.50±4.02	NUM
brj-24903	180	3	9.58	9.58	NUM
brj-24903	180	4	data	datum	NOUN
brj-24903	180	5	are	be	AUX
brj-24903	180	6	represented	represent	VERB
brj-24903	180	7	as	as	ADP
brj-24903	180	8	mean	mean	ADJ
brj-24903	180	9	±sem	±sem	NOUN
brj-24903	180	10	(	(	PUNCT
brj-24903	180	11	n=	n=	ADJ
brj-24903	180	12	6	6	NUM
brj-24903	180	13	)	)	PUNCT
brj-24903	180	14	.	.	PUNCT
brj-24903	181	1	#	#	SYM
brj-24903	181	2	#	#	SYM
brj-24903	181	3	#	#	AUX
brj-24903	181	4	p<0.001	p<0.001	VERB
brj-24903	181	5	considered	consider	VERB
brj-24903	181	6	statistically	statistically	ADV
brj-24903	181	7	noteworthy	noteworthy	ADJ
brj-24903	181	8	as	as	SCONJ
brj-24903	181	9	judged	judge	VERB
brj-24903	181	10	against	against	ADP
brj-24903	181	11	normal	normal	ADJ
brj-24903	181	12	control	control	NOUN
brj-24903	181	13	group	group	NOUN
brj-24903	181	14	;	;	PUNCT
brj-24903	181	15	*	*	PUNCT
brj-24903	181	16	p<0.05	p<0.05	NOUN
brj-24903	181	17	considered	consider	VERB
brj-24903	181	18	statistically	statistically	ADV
brj-24903	181	19	noteworthy	noteworthy	ADJ
brj-24903	181	20	as	as	SCONJ
brj-24903	181	21	judged	judge	VERB
brj-24903	181	22	against	against	ADP
brj-24903	181	23	cfa	cfa	PROPN
brj-24903	181	24	control	control	PROPN
brj-24903	181	25	group	group	PROPN
brj-24903	181	26	.	.	PUNCT
brj-24903	182	1	table	table	NOUN
brj-24903	182	2	2	2	NUM
brj-24903	182	3	.	.	PUNCT
brj-24903	182	4	effect	effect	NOUN
brj-24903	182	5	of	of	ADP
brj-24903	182	6	a.	a.	NOUN
brj-24903	182	7	glycyphyllos	glycyphyllos	PROPN
brj-24903	182	8	leaves	leave	VERB
brj-24903	182	9	extract	extract	VERB
brj-24903	182	10	on	on	ADP
brj-24903	182	11	locomotor	locomotor	ADJ
brj-24903	182	12	activity	activity	NOUN
brj-24903	182	13	of	of	ADP
brj-24903	182	14	arthritic	arthritic	ADJ
brj-24903	182	15	animals	animal	NOUN
brj-24903	182	16	groups	group	NOUN
brj-24903	182	17	treatment	treatment	NOUN
brj-24903	182	18	locomotor	locomotor	NOUN
brj-24903	182	19	score	score	NOUN
brj-24903	182	20	day	day	NOUN
brj-24903	182	21	1	1	NUM
brj-24903	182	22	day	day	NOUN
brj-24903	182	23	7	7	NUM
brj-24903	182	24	day	day	NOUN
brj-24903	182	25	14	14	NUM
brj-24903	182	26	day	day	NOUN
brj-24903	182	27	21	21	NUM
brj-24903	182	28	day	day	NOUN
brj-24903	182	29	28	28	NUM
brj-24903	182	30	i	i	PRON
brj-24903	182	31	normal	normal	ADJ
brj-24903	182	32	control	control	NOUN
brj-24903	182	33	462.27±10.78	462.27±10.78	VERB
brj-24903	183	1	484.08±10.17	484.08±10.17	NUM
brj-24903	183	2	471.29±9.91	471.29±9.91	NUM
brj-24903	183	3	486.21±8.74	486.21±8.74	NUM
brj-24903	183	4	479.50±8.92	479.50±8.92	PROPN
brj-24903	183	5	ii	ii	PROPN
brj-24903	183	6	cfa	cfa	PROPN
brj-24903	183	7	control	control	NOUN
brj-24903	183	8	454.83±13.23	454.83±13.23	NOUN
brj-24903	183	9	201.45±6.28	201.45±6.28	NOUN
brj-24903	183	10	#	#	SYM
brj-24903	183	11	#	#	SYM
brj-24903	183	12	#	#	NOUN
brj-24903	183	13	188.04±5.44	188.04±5.44	NUM
brj-24903	183	14	#	#	SYM
brj-24903	183	15	#	#	SYM
brj-24903	183	16	#	#	NOUN
brj-24903	183	17	151.38±3.92	151.38±3.92	NUM
brj-24903	183	18	#	#	SYM
brj-24903	183	19	#	#	SYM
brj-24903	183	20	#	#	NOUN
brj-24903	183	21	137.06±3.40	137.06±3.40	NUM
brj-24903	183	22	*	*	NOUN
brj-24903	183	23	*	*	PUNCT
brj-24903	183	24	*	*	PUNCT
brj-24903	183	25	iii	iii	NUM
brj-24903	183	26	diclofenac	diclofenac	ADJ
brj-24903	183	27	sodium	sodium	NOUN
brj-24903	183	28	(	(	PUNCT
brj-24903	183	29	10	10	NUM
brj-24903	183	30	mg	mg	NUM
brj-24903	183	31	/	/	SYM
brj-24903	183	32	kg	kg	PROPN
brj-24903	183	33	;	;	PUNCT
brj-24903	183	34	i.p	i.p	PROPN
brj-24903	183	35	.	.	PUNCT
brj-24903	183	36	)	)	PUNCT
brj-24903	184	1	470.24±11.66	470.24±11.66	NUM
brj-24903	184	2	314.33±7.55	314.33±7.55	NUM
brj-24903	184	3	*	*	PUNCT
brj-24903	184	4	*	*	PUNCT
brj-24903	184	5	*	*	NOUN
brj-24903	185	1	318.63±5.01	318.63±5.01	NUM
brj-24903	185	2	*	*	PUNCT
brj-24903	185	3	*	*	PUNCT
brj-24903	185	4	*	*	PUNCT
brj-24903	185	5	352.60±3.65	352.60±3.65	NUM
brj-24903	185	6	*	*	NOUN
brj-24903	185	7	*	*	PUNCT
brj-24903	185	8	*	*	PUNCT
brj-24903	185	9	369.63±4.78	369.63±4.78	NUM
brj-24903	185	10	*	*	PUNCT
brj-24903	185	11	*	*	PUNCT
brj-24903	185	12	*	*	PUNCT
brj-24903	185	13	iv	iv	NUM
brj-24903	185	14	a.	a.	NOUN
brj-24903	185	15	glycyphyllos	glycyphyllos	NOUN
brj-24903	185	16	extract	extract	NOUN
brj-24903	185	17	(	(	PUNCT
brj-24903	185	18	100	100	NUM
brj-24903	185	19	mg	mg	NUM
brj-24903	185	20	/	/	SYM
brj-24903	185	21	kg	kg	PROPN
brj-24903	185	22	;	;	PUNCT
brj-24903	185	23	p.o	p.o	PROPN
brj-24903	185	24	.	.	PROPN
brj-24903	185	25	)	)	PUNCT
brj-24903	186	1	468.16±8.54	468.16±8.54	PROPN
brj-24903	187	1	302.93±5.15	302.93±5.15	NUM
brj-24903	187	2	*	*	PUNCT
brj-24903	187	3	*	*	PUNCT
brj-24903	187	4	*	*	NOUN
brj-24903	188	1	325.95±5.51	325.95±5.51	NOUN
brj-24903	188	2	*	*	PUNCT
brj-24903	188	3	*	*	PUNCT
brj-24903	188	4	*	*	PUNCT
brj-24903	188	5	345.12±4.65	345.12±4.65	NUM
brj-24903	188	6	*	*	NOUN
brj-24903	188	7	*	*	PUNCT
brj-24903	188	8	*	*	PUNCT
brj-24903	188	9	360.38±4.40	360.38±4.40	NUM
brj-24903	188	10	*	*	NOUN
brj-24903	188	11	*	*	PUNCT
brj-24903	188	12	*	*	PROPN
brj-24903	188	13	v	v	NUM
brj-24903	188	14	a.	a.	NOUN
brj-24903	188	15	glycyphyllos	glycyphyllos	NOUN
brj-24903	188	16	extract	extract	NOUN
brj-24903	188	17	(	(	PUNCT
brj-24903	188	18	200	200	NUM
brj-24903	188	19	mg	mg	NUM
brj-24903	188	20	/	/	SYM
brj-24903	188	21	kg	kg	PROPN
brj-24903	188	22	;	;	PUNCT
brj-24903	188	23	p.o	p.o	PROPN
brj-24903	188	24	.	.	PROPN
brj-24903	188	25	)	)	PUNCT
brj-24903	188	26	458.28±9.32	458.28±9.32	ADP
brj-24903	188	27	358.28±5.49	358.28±5.49	NOUN
brj-24903	188	28	*	*	NOUN
brj-24903	188	29	*	*	PUNCT
brj-24903	188	30	*	*	PUNCT
brj-24903	189	1	352.18±4.11	352.18±4.11	NUM
brj-24903	189	2	*	*	NOUN
brj-24903	189	3	*	*	PUNCT
brj-24903	189	4	*	*	PUNCT
brj-24903	189	5	370.26±4.85	370.26±4.85	NUM
brj-24903	189	6	*	*	NOUN
brj-24903	189	7	*	*	PUNCT
brj-24903	189	8	*	*	PUNCT
brj-24903	189	9	392.46±5.17	392.46±5.17	NUM
brj-24903	189	10	*	*	PUNCT
brj-24903	189	11	*	*	PUNCT
brj-24903	189	12	*	*	NOUN
brj-24903	189	13	data	datum	NOUN
brj-24903	189	14	are	be	AUX
brj-24903	189	15	represented	represent	VERB
brj-24903	189	16	as	as	ADP
brj-24903	189	17	mean	mean	ADJ
brj-24903	189	18	±sem	±sem	NOUN
brj-24903	189	19	(	(	PUNCT
brj-24903	189	20	n=	n=	ADJ
brj-24903	189	21	6	6	NUM
brj-24903	189	22	)	)	PUNCT
brj-24903	189	23	.	.	PUNCT
brj-24903	190	1	#	#	SYM
brj-24903	190	2	#	#	SYM
brj-24903	190	3	#	#	AUX
brj-24903	190	4	p<0.001	p<0.001	VERB
brj-24903	190	5	considered	consider	VERB
brj-24903	190	6	statistically	statistically	ADV
brj-24903	190	7	noteworthy	noteworthy	ADJ
brj-24903	190	8	as	as	SCONJ
brj-24903	190	9	judged	judge	VERB
brj-24903	190	10	against	against	ADP
brj-24903	190	11	normal	normal	ADJ
brj-24903	190	12	control	control	NOUN
brj-24903	190	13	group	group	NOUN
brj-24903	190	14	;	;	PUNCT
brj-24903	190	15	*	*	PUNCT
brj-24903	190	16	*	*	PUNCT
brj-24903	190	17	*	*	PUNCT
brj-24903	190	18	p<0.001	p<0.001	AUX
brj-24903	190	19	considered	consider	VERB
brj-24903	190	20	statistically	statistically	ADV
brj-24903	190	21	noteworthy	noteworthy	ADJ
brj-24903	190	22	as	as	SCONJ
brj-24903	190	23	judged	judge	VERB
brj-24903	190	24	against	against	ADP
brj-24903	190	25	cfa	cfa	PROPN
brj-24903	190	26	control	control	PROPN
brj-24903	190	27	group	group	PROPN
brj-24903	190	28	.	.	PUNCT
brj-24903	191	1	peer	peer	NOUN
brj-24903	191	2	-	-	PUNCT
brj-24903	191	3	reviewed	review	VERB
brj-24903	191	4	article	article	NOUN
brj-24903	191	5	bioresources.cnr.ncsu.edu	bioresources.cnr.ncsu.edu	X
brj-24903	191	6	gu	gu	VERB
brj-24903	191	7	et	et	PROPN
brj-24903	191	8	al	al	PROPN
brj-24903	191	9	.	.	PROPN
brj-24903	192	1	(	(	PUNCT
brj-24903	192	2	2026	2026	NUM
brj-24903	192	3	)	)	PUNCT
brj-24903	192	4	.	.	PUNCT
brj-24903	193	1	“	"	PUNCT
brj-24903	193	2	astragalus	astragalus	NOUN
brj-24903	193	3	leaf	leaf	NOUN
brj-24903	193	4	extract	extract	NOUN
brj-24903	193	5	vs.	vs.	ADP
brj-24903	193	6	arthritis	arthritis	NOUN
brj-24903	193	7	,	,	PUNCT
brj-24903	193	8	”	"	PUNCT
brj-24903	193	9	bioresources	bioresource	NOUN
brj-24903	193	10	21(1	21(1	NUM
brj-24903	193	11	)	)	PUNCT
brj-24903	193	12	,	,	PUNCT
brj-24903	193	13	160	160	NUM
brj-24903	193	14	-	-	SYM
brj-24903	193	15	177	177	NUM
brj-24903	193	16	.	.	PUNCT
brj-24903	194	1	168	168	NUM
brj-24903	194	2	effect	effect	NOUN
brj-24903	194	3	of	of	ADP
brj-24903	194	4	a.	a.	NOUN
brj-24903	194	5	glycyphyllos	glycyphyllos	PROPN
brj-24903	194	6	extract	extract	VERB
brj-24903	194	7	on	on	ADP
brj-24903	194	8	arthritic	arthritic	ADJ
brj-24903	194	9	index	index	NOUN
brj-24903	194	10	in	in	ADP
brj-24903	194	11	arthritic	arthritic	ADJ
brj-24903	194	12	animals	animal	NOUN
brj-24903	194	13	the	the	DET
brj-24903	194	14	arthritic	arthritic	ADJ
brj-24903	194	15	index	index	NOUN
brj-24903	194	16	was	be	AUX
brj-24903	194	17	determined	determine	VERB
brj-24903	194	18	on	on	ADP
brj-24903	194	19	the	the	DET
brj-24903	194	20	third	third	ADJ
brj-24903	194	21	day	day	NOUN
brj-24903	194	22	after	after	ADP
brj-24903	194	23	the	the	DET
brj-24903	194	24	cfa	cfa	PROPN
brj-24903	194	25	injection	injection	NOUN
brj-24903	194	26	by	by	ADP
brj-24903	194	27	measuring	measure	VERB
brj-24903	194	28	the	the	DET
brj-24903	194	29	thickness	thickness	NOUN
brj-24903	194	30	of	of	ADP
brj-24903	194	31	the	the	DET
brj-24903	194	32	hind	hind	NOUN
brj-24903	194	33	paw	paw	NOUN
brj-24903	194	34	,	,	PUNCT
brj-24903	194	35	the	the	DET
brj-24903	194	36	swelling	swelling	NOUN
brj-24903	194	37	and	and	CCONJ
brj-24903	194	38	redness	redness	NOUN
brj-24903	194	39	of	of	ADP
brj-24903	194	40	the	the	DET
brj-24903	194	41	paw	paw	NOUN
brj-24903	194	42	phalanges	phalanx	NOUN
brj-24903	194	43	,	,	PUNCT
brj-24903	194	44	and	and	CCONJ
brj-24903	194	45	the	the	DET
brj-24903	194	46	signs	sign	NOUN
brj-24903	194	47	of	of	ADP
brj-24903	194	48	inflammation	inflammation	NOUN
brj-24903	194	49	on	on	ADP
brj-24903	194	50	the	the	DET
brj-24903	194	51	nose	nose	NOUN
brj-24903	194	52	,	,	PUNCT
brj-24903	194	53	mouth	mouth	NOUN
brj-24903	194	54	,	,	PUNCT
brj-24903	194	55	ears	ear	NOUN
brj-24903	194	56	,	,	PUNCT
brj-24903	194	57	tail	tail	NOUN
brj-24903	194	58	,	,	PUNCT
brj-24903	194	59	and	and	CCONJ
brj-24903	194	60	eyes	eye	NOUN
brj-24903	194	61	.	.	PUNCT
brj-24903	195	1	the	the	DET
brj-24903	195	2	arthritic	arthritic	ADJ
brj-24903	195	3	index	index	NOUN
brj-24903	195	4	significantly	significantly	ADV
brj-24903	195	5	(	(	PUNCT
brj-24903	195	6	p<0.01	p<0.01	PROPN
brj-24903	195	7	)	)	PUNCT
brj-24903	195	8	decreased	decrease	VERB
brj-24903	195	9	in	in	ADP
brj-24903	195	10	the	the	DET
brj-24903	195	11	diclofenac	diclofenac	NOUN
brj-24903	195	12	and	and	CCONJ
brj-24903	195	13	extract	extract	NOUN
brj-24903	195	14	-	-	PUNCT
brj-24903	195	15	treated	treat	VERB
brj-24903	195	16	groups	group	NOUN
brj-24903	195	17	(	(	PUNCT
brj-24903	195	18	100	100	NUM
brj-24903	195	19	and	and	CCONJ
brj-24903	195	20	200	200	NUM
brj-24903	195	21	mg	mg	NUM
brj-24903	195	22	/	/	SYM
brj-24903	195	23	kg	kg	NOUN
brj-24903	195	24	)	)	PUNCT
brj-24903	195	25	compared	compare	VERB
brj-24903	195	26	to	to	ADP
brj-24903	195	27	the	the	DET
brj-24903	195	28	cfa	cfa	NOUN
brj-24903	195	29	-	-	PUNCT
brj-24903	195	30	control	control	NOUN
brj-24903	195	31	group	group	NOUN
brj-24903	195	32	(	(	PUNCT
brj-24903	195	33	fig	fig	NOUN
brj-24903	195	34	.	.	PUNCT
brj-24903	196	1	2	2	NUM
brj-24903	196	2	)	)	PUNCT
brj-24903	196	3	.	.	PUNCT
brj-24903	197	1	the	the	DET
brj-24903	197	2	animal	animal	NOUN
brj-24903	197	3	groups	group	NOUN
brj-24903	197	4	with	with	ADP
brj-24903	197	5	arthritis	arthriti	NOUN
brj-24903	197	6	that	that	PRON
brj-24903	197	7	were	be	AUX
brj-24903	197	8	given	give	VERB
brj-24903	197	9	a.	a.	NOUN
brj-24903	197	10	glycyphyllos	glycyphyllos	NOUN
brj-24903	197	11	extract	extract	NOUN
brj-24903	197	12	(	(	PUNCT
brj-24903	197	13	200	200	NUM
brj-24903	197	14	mg	mg	NUM
brj-24903	197	15	/	/	SYM
brj-24903	197	16	kg	kg	PROPN
brj-24903	197	17	)	)	PUNCT
brj-24903	197	18	showed	show	VERB
brj-24903	197	19	fewer	few	ADJ
brj-24903	197	20	clinical	clinical	ADJ
brj-24903	197	21	signs	sign	NOUN
brj-24903	197	22	of	of	ADP
brj-24903	197	23	arthritis	arthritis	NOUN
brj-24903	197	24	than	than	ADP
brj-24903	197	25	the	the	DET
brj-24903	197	26	animal	animal	NOUN
brj-24903	197	27	groups	group	NOUN
brj-24903	197	28	that	that	PRON
brj-24903	197	29	were	be	AUX
brj-24903	197	30	given	give	VERB
brj-24903	197	31	diclofenac	diclofenac	NOUN
brj-24903	197	32	(	(	PUNCT
brj-24903	197	33	100	100	NUM
brj-24903	197	34	mg	mg	NUM
brj-24903	197	35	/	/	SYM
brj-24903	197	36	kg	kg	PROPN
brj-24903	197	37	)	)	PUNCT
brj-24903	197	38	.	.	PUNCT
brj-24903	198	1	on	on	ADP
brj-24903	198	2	day	day	NOUN
brj-24903	198	3	28	28	NUM
brj-24903	198	4	,	,	PUNCT
brj-24903	198	5	the	the	DET
brj-24903	198	6	cfa	cfa	PROPN
brj-24903	198	7	control	control	NOUN
brj-24903	198	8	animals	animal	NOUN
brj-24903	198	9	had	have	VERB
brj-24903	198	10	the	the	DET
brj-24903	198	11	highest	high	ADJ
brj-24903	198	12	arthritic	arthritic	ADJ
brj-24903	198	13	index	index	NOUN
brj-24903	198	14	.	.	PUNCT
brj-24903	199	1	a	a	DET
brj-24903	199	2	b	b	NOUN
brj-24903	199	3	i	i	PRON
brj-24903	199	4	ii	ii	PROPN
brj-24903	199	5	iii	iii	NUM
brj-24903	199	6	iv	iv	NUM
brj-24903	199	7	v	v	NOUN
brj-24903	199	8	0	0	NUM
brj-24903	199	9	1	1	NUM
brj-24903	199	10	2	2	NUM
brj-24903	199	11	3	3	NUM
brj-24903	199	12	4	4	NUM
brj-24903	199	13	day	day	NOUN
brj-24903	199	14	3	3	NUM
brj-24903	199	15	groups	group	NOUN
brj-24903	199	16	a	a	DET
brj-24903	199	17	rt	rt	NOUN
brj-24903	199	18	h	h	NOUN
brj-24903	199	19	ri	ri	NOUN
brj-24903	200	1	ti	ti	INTJ
brj-24903	200	2	c	c	NOUN
brj-24903	200	3	i	i	PRON
brj-24903	200	4	n	n	VERB
brj-24903	200	5	d	d	X
brj-24903	200	6	e	e	X
brj-24903	200	7	x	x	PUNCT
brj-24903	200	8	*	*	PUNCT
brj-24903	200	9	*	*	PUNCT
brj-24903	200	10	#	#	SYM
brj-24903	200	11	#	#	SYM
brj-24903	200	12	#	#	NOUN
brj-24903	200	13	*	*	NOUN
brj-24903	200	14	*	*	PUNCT
brj-24903	201	1	i	i	PRON
brj-24903	201	2	ii	ii	VERB
brj-24903	201	3	iii	iii	NUM
brj-24903	201	4	iv	iv	NUM
brj-24903	201	5	v	v	NOUN
brj-24903	201	6	0	0	NUM
brj-24903	201	7	1	1	NUM
brj-24903	201	8	2	2	NUM
brj-24903	201	9	3	3	NUM
brj-24903	201	10	4	4	NUM
brj-24903	201	11	day	day	NOUN
brj-24903	201	12	7	7	NUM
brj-24903	201	13	groups	group	NOUN
brj-24903	201	14	a	a	DET
brj-24903	201	15	rt	rt	NOUN
brj-24903	201	16	h	h	NOUN
brj-24903	201	17	ri	ri	NOUN
brj-24903	201	18	ti	ti	INTJ
brj-24903	202	1	c	c	NOUN
brj-24903	202	2	i	i	PRON
brj-24903	202	3	n	n	VERB
brj-24903	202	4	d	d	X
brj-24903	202	5	e	e	X
brj-24903	202	6	x	x	PUNCT
brj-24903	202	7	*	*	PUNCT
brj-24903	202	8	*	*	PUNCT
brj-24903	203	1	#	#	SYM
brj-24903	203	2	#	#	SYM
brj-24903	203	3	#	#	NOUN
brj-24903	203	4	*	*	PUNCT
brj-24903	204	1	*	*	PUNCT
brj-24903	204	2	*	*	PUNCT
brj-24903	204	3	c	c	X
brj-24903	205	1	d	d	X
brj-24903	205	2	i	i	PRON
brj-24903	205	3	ii	ii	PROPN
brj-24903	205	4	iii	iii	NUM
brj-24903	205	5	iv	iv	NUM
brj-24903	205	6	v	v	NOUN
brj-24903	205	7	0	0	NUM
brj-24903	205	8	1	1	NUM
brj-24903	205	9	2	2	NUM
brj-24903	205	10	3	3	NUM
brj-24903	205	11	4	4	NUM
brj-24903	205	12	day	day	NOUN
brj-24903	205	13	14	14	NUM
brj-24903	205	14	groups	group	NOUN
brj-24903	205	15	a	a	DET
brj-24903	205	16	rt	rt	NOUN
brj-24903	205	17	h	h	NOUN
brj-24903	205	18	ri	ri	NOUN
brj-24903	205	19	ti	ti	INTJ
brj-24903	205	20	c	c	NOUN
brj-24903	205	21	i	i	PRON
brj-24903	205	22	n	n	VERB
brj-24903	205	23	d	d	X
brj-24903	205	24	e	e	X
brj-24903	205	25	x	x	PUNCT
brj-24903	205	26	*	*	PUNCT
brj-24903	205	27	*	*	PUNCT
brj-24903	206	1	#	#	SYM
brj-24903	206	2	#	#	SYM
brj-24903	206	3	#	#	NOUN
brj-24903	206	4	*	*	PUNCT
brj-24903	207	1	*	*	PUNCT
brj-24903	207	2	*	*	PUNCT
brj-24903	208	1	i	i	PRON
brj-24903	208	2	ii	ii	VERB
brj-24903	208	3	iii	iii	NUM
brj-24903	208	4	iv	iv	NUM
brj-24903	208	5	v	v	NOUN
brj-24903	208	6	0	0	NUM
brj-24903	208	7	2	2	NUM
brj-24903	208	8	4	4	NUM
brj-24903	208	9	6	6	NUM
brj-24903	208	10	day	day	NOUN
brj-24903	208	11	21	21	NUM
brj-24903	208	12	groups	group	NOUN
brj-24903	208	13	a	a	DET
brj-24903	208	14	rt	rt	NOUN
brj-24903	208	15	h	h	NOUN
brj-24903	208	16	ri	ri	NOUN
brj-24903	209	1	ti	ti	INTJ
brj-24903	210	1	c	c	NOUN
brj-24903	211	1	i	i	PRON
brj-24903	212	1	n	n	VERB
brj-24903	212	2	d	d	X
brj-24903	212	3	e	e	X
brj-24903	212	4	x	x	PUNCT
brj-24903	213	1	*	*	PUNCT
brj-24903	213	2	*	*	PUNCT
brj-24903	213	3	*	*	PUNCT
brj-24903	214	1	#	#	SYM
brj-24903	214	2	#	#	SYM
brj-24903	214	3	#	#	NOUN
brj-24903	214	4	*	*	NOUN
brj-24903	214	5	*	*	PUNCT
brj-24903	214	6	*	*	PUNCT
brj-24903	215	1	*	*	PUNCT
brj-24903	215	2	*	*	PUNCT
brj-24903	215	3	*	*	PUNCT
brj-24903	216	1	e	e	X
brj-24903	216	2	i	i	PRON
brj-24903	216	3	ii	ii	PROPN
brj-24903	216	4	iii	iii	NUM
brj-24903	216	5	iv	iv	NUM
brj-24903	216	6	v	v	NOUN
brj-24903	216	7	0	0	NUM
brj-24903	216	8	2	2	NUM
brj-24903	216	9	4	4	NUM
brj-24903	216	10	6	6	NUM
brj-24903	216	11	8	8	NUM
brj-24903	216	12	day	day	NOUN
brj-24903	216	13	28	28	NUM
brj-24903	216	14	groups	group	NOUN
brj-24903	216	15	a	a	DET
brj-24903	216	16	rt	rt	NOUN
brj-24903	216	17	h	h	NOUN
brj-24903	216	18	ri	ri	NOUN
brj-24903	216	19	ti	ti	INTJ
brj-24903	216	20	c	c	NOUN
brj-24903	216	21	i	i	PRON
brj-24903	216	22	n	n	VERB
brj-24903	216	23	d	d	X
brj-24903	216	24	e	e	X
brj-24903	216	25	x	x	PUNCT
brj-24903	216	26	#	#	SYM
brj-24903	216	27	#	#	SYM
brj-24903	216	28	#	#	NOUN
brj-24903	216	29	*	*	NOUN
brj-24903	216	30	*	*	PUNCT
brj-24903	217	1	*	*	PUNCT
brj-24903	218	1	*	*	PUNCT
brj-24903	218	2	*	*	PUNCT
brj-24903	218	3	*	*	PUNCT
brj-24903	218	4	*	*	PUNCT
brj-24903	218	5	*	*	PUNCT
brj-24903	218	6	*	*	PUNCT
brj-24903	218	7	fig	fig	NOUN
brj-24903	218	8	.	.	PUNCT
brj-24903	219	1	2	2	X
brj-24903	219	2	.	.	X
brj-24903	219	3	effect	effect	NOUN
brj-24903	219	4	of	of	ADP
brj-24903	219	5	a.	a.	NOUN
brj-24903	219	6	glycyphyllos	glycyphyllos	PROPN
brj-24903	219	7	leaves	leave	NOUN
brj-24903	219	8	extract	extract	VERB
brj-24903	219	9	on	on	ADP
brj-24903	219	10	arthritic	arthritic	ADJ
brj-24903	219	11	index	index	NOUN
brj-24903	219	12	in	in	ADP
brj-24903	219	13	cfa	cfa	PROPN
brj-24903	219	14	challenged	challenge	VERB
brj-24903	219	15	arthritic	arthritic	ADJ
brj-24903	219	16	animals	animal	NOUN
brj-24903	219	17	on	on	ADP
brj-24903	219	18	days	day	NOUN
brj-24903	219	19	(	(	PUNCT
brj-24903	219	20	a	a	NOUN
brj-24903	219	21	)	)	PUNCT
brj-24903	219	22	3	3	NUM
brj-24903	219	23	,	,	PUNCT
brj-24903	219	24	(	(	PUNCT
brj-24903	219	25	b	b	X
brj-24903	219	26	)	)	PUNCT
brj-24903	219	27	7	7	NUM
brj-24903	219	28	,	,	PUNCT
brj-24903	219	29	(	(	PUNCT
brj-24903	219	30	c	c	NOUN
brj-24903	219	31	)	)	PUNCT
brj-24903	219	32	14	14	NUM
brj-24903	219	33	,	,	PUNCT
brj-24903	219	34	(	(	PUNCT
brj-24903	219	35	d	d	X
brj-24903	219	36	)	)	PUNCT
brj-24903	219	37	21	21	NUM
brj-24903	219	38	,	,	PUNCT
brj-24903	219	39	and	and	CCONJ
brj-24903	219	40	(	(	PUNCT
brj-24903	219	41	e	e	NOUN
brj-24903	219	42	)	)	PUNCT
brj-24903	219	43	28	28	NUM
brj-24903	219	44	.	.	PUNCT
brj-24903	220	1	data	datum	NOUN
brj-24903	220	2	are	be	AUX
brj-24903	220	3	represented	represent	VERB
brj-24903	220	4	as	as	ADP
brj-24903	220	5	mean	mean	ADJ
brj-24903	220	6	±sem	±sem	NOUN
brj-24903	220	7	(	(	PUNCT
brj-24903	220	8	n=	n=	ADJ
brj-24903	220	9	6	6	NUM
brj-24903	220	10	)	)	PUNCT
brj-24903	220	11	.	.	PUNCT
brj-24903	221	1	#	#	SYM
brj-24903	221	2	#	#	SYM
brj-24903	221	3	#	#	AUX
brj-24903	221	4	p<0.001	p<0.001	VERB
brj-24903	221	5	considered	consider	VERB
brj-24903	221	6	statistically	statistically	ADV
brj-24903	221	7	significant	significant	ADJ
brj-24903	221	8	versus	versus	ADP
brj-24903	221	9	normal	normal	ADJ
brj-24903	221	10	control	control	NOUN
brj-24903	221	11	group	group	NOUN
brj-24903	221	12	;	;	PUNCT
brj-24903	221	13	*	*	PUNCT
brj-24903	221	14	p<0.05	p<0.05	NOUN
brj-24903	221	15	,	,	PUNCT
brj-24903	221	16	*	*	PUNCT
brj-24903	221	17	*	*	PUNCT
brj-24903	221	18	p<0.01	p<0.01	PRON
brj-24903	221	19	as	as	ADV
brj-24903	221	20	well	well	ADV
brj-24903	221	21	as	as	ADP
brj-24903	221	22	*	*	NOUN
brj-24903	221	23	*	*	PUNCT
brj-24903	221	24	*	*	PUNCT
brj-24903	221	25	p<0.001	p<0.001	AUX
brj-24903	221	26	considered	consider	VERB
brj-24903	221	27	statistically	statistically	ADV
brj-24903	221	28	significant	significant	ADJ
brj-24903	221	29	versus	versus	ADP
brj-24903	221	30	cfa	cfa	PROPN
brj-24903	221	31	control	control	PROPN
brj-24903	221	32	group	group	PROPN
brj-24903	221	33	.	.	PUNCT
brj-24903	222	1	peer	peer	NOUN
brj-24903	222	2	-	-	PUNCT
brj-24903	222	3	reviewed	review	VERB
brj-24903	222	4	article	article	NOUN
brj-24903	222	5	bioresources.cnr.ncsu.edu	bioresources.cnr.ncsu.edu	X
brj-24903	222	6	gu	gu	VERB
brj-24903	222	7	et	et	PROPN
brj-24903	222	8	al	al	PROPN
brj-24903	222	9	.	.	PROPN
brj-24903	223	1	(	(	PUNCT
brj-24903	223	2	2026	2026	NUM
brj-24903	223	3	)	)	PUNCT
brj-24903	223	4	.	.	PUNCT
brj-24903	224	1	“	"	PUNCT
brj-24903	224	2	astragalus	astragalus	NOUN
brj-24903	224	3	leaf	leaf	NOUN
brj-24903	224	4	extract	extract	NOUN
brj-24903	224	5	vs.	vs.	ADP
brj-24903	224	6	arthritis	arthritis	NOUN
brj-24903	224	7	,	,	PUNCT
brj-24903	224	8	”	"	PUNCT
brj-24903	224	9	bioresources	bioresource	NOUN
brj-24903	224	10	21(1	21(1	NUM
brj-24903	224	11	)	)	PUNCT
brj-24903	224	12	,	,	PUNCT
brj-24903	224	13	160	160	NUM
brj-24903	224	14	-	-	SYM
brj-24903	224	15	177	177	NUM
brj-24903	224	16	.	.	NOUN
brj-24903	224	17	169	169	NUM
brj-24903	224	18	a.	a.	NOUN
brj-24903	224	19	glycyphyllos	glycyphyllos	NOUN
brj-24903	224	20	leaves	leave	NOUN
brj-24903	224	21	extract	extract	VERB
brj-24903	224	22	restructure	restructure	NOUN
brj-24903	224	23	the	the	DET
brj-24903	224	24	locomotor	locomotor	ADJ
brj-24903	224	25	activity	activity	NOUN
brj-24903	224	26	of	of	ADP
brj-24903	224	27	arthritic	arthritic	ADJ
brj-24903	224	28	animals	animal	NOUN
brj-24903	224	29	table	table	VERB
brj-24903	224	30	2	2	NUM
brj-24903	224	31	shows	show	VERB
brj-24903	224	32	the	the	DET
brj-24903	224	33	locomotor	locomotor	NOUN
brj-24903	224	34	scores	score	NOUN
brj-24903	224	35	of	of	ADP
brj-24903	224	36	the	the	DET
brj-24903	224	37	animals	animal	NOUN
brj-24903	224	38	treated	treat	VERB
brj-24903	224	39	with	with	ADP
brj-24903	224	40	a.	a.	NOUN
brj-24903	224	41	glycyphyllos	glycyphyllos	PROPN
brj-24903	224	42	extract	extract	NOUN
brj-24903	224	43	(	(	PUNCT
brj-24903	224	44	100	100	NUM
brj-24903	224	45	and	and	CCONJ
brj-24903	224	46	200	200	NUM
brj-24903	224	47	mg	mg	NUM
brj-24903	224	48	/	/	SYM
brj-24903	224	49	kg	kg	PROPN
brj-24903	224	50	)	)	PUNCT
brj-24903	224	51	.	.	PUNCT
brj-24903	225	1	compared	compare	VERB
brj-24903	225	2	with	with	ADP
brj-24903	225	3	the	the	DET
brj-24903	225	4	animals	animal	NOUN
brj-24903	225	5	in	in	ADP
brj-24903	225	6	the	the	DET
brj-24903	225	7	cfa	cfa	PROPN
brj-24903	225	8	control	control	PROPN
brj-24903	225	9	group	group	PROPN
brj-24903	225	10	,	,	PUNCT
brj-24903	225	11	there	there	PRON
brj-24903	225	12	were	be	VERB
brj-24903	225	13	significant	significant	ADJ
brj-24903	225	14	improvements	improvement	NOUN
brj-24903	225	15	in	in	ADP
brj-24903	225	16	the	the	DET
brj-24903	225	17	locomotion	locomotion	NOUN
brj-24903	225	18	scores	score	NOUN
brj-24903	225	19	of	of	ADP
brj-24903	225	20	the	the	DET
brj-24903	225	21	animals	animal	NOUN
brj-24903	225	22	challenged	challenge	VERB
brj-24903	225	23	with	with	ADP
brj-24903	225	24	cfa	cfa	PROPN
brj-24903	225	25	.	.	PUNCT
brj-24903	226	1	the	the	DET
brj-24903	226	2	cfa	cfa	PROPN
brj-24903	226	3	control	control	PROPN
brj-24903	226	4	group	group	PROPN
brj-24903	226	5	’s	’s	PART
brj-24903	226	6	animals	animal	NOUN
brj-24903	226	7	had	have	VERB
brj-24903	226	8	severe	severe	ADJ
brj-24903	226	9	movement	movement	NOUN
brj-24903	226	10	impairment	impairment	NOUN
brj-24903	226	11	,	,	PUNCT
brj-24903	226	12	which	which	PRON
brj-24903	226	13	may	may	AUX
brj-24903	226	14	have	have	AUX
brj-24903	226	15	been	be	AUX
brj-24903	226	16	brought	bring	VERB
brj-24903	226	17	on	on	ADP
brj-24903	226	18	by	by	ADP
brj-24903	226	19	discomfort	discomfort	NOUN
brj-24903	226	20	,	,	PUNCT
brj-24903	226	21	and	and	CCONJ
brj-24903	226	22	their	their	PRON
brj-24903	226	23	locomotion	locomotion	NOUN
brj-24903	226	24	was	be	AUX
brj-24903	226	25	drastically	drastically	ADV
brj-24903	226	26	reduced	reduce	VERB
brj-24903	226	27	by	by	ADP
brj-24903	226	28	day	day	NOUN
brj-24903	226	29	28	28	NUM
brj-24903	226	30	.	.	PUNCT
brj-24903	227	1	spontaneous	spontaneous	ADJ
brj-24903	227	2	motility	motility	NOUN
brj-24903	227	3	significantly	significantly	ADV
brj-24903	227	4	increased	increase	VERB
brj-24903	227	5	with	with	ADP
brj-24903	227	6	both	both	DET
brj-24903	227	7	dosages	dosage	NOUN
brj-24903	227	8	of	of	ADP
brj-24903	227	9	a.	a.	NOUN
brj-24903	227	10	glycyphyllos	glycyphyllos	NOUN
brj-24903	227	11	extract	extract	NOUN
brj-24903	227	12	.	.	PUNCT
brj-24903	228	1	a.	a.	NOUN
brj-24903	228	2	glycyphyllos	glycyphyllos	PROPN
brj-24903	228	3	leaves	leave	NOUN
brj-24903	228	4	extract	extract	VERB
brj-24903	228	5	ameliorate	ameliorate	VERB
brj-24903	228	6	the	the	DET
brj-24903	228	7	serum	serum	NOUN
brj-24903	228	8	inflammatory	inflammatory	ADJ
brj-24903	228	9	cytokines	cytokine	NOUN
brj-24903	228	10	in	in	ADP
brj-24903	228	11	arthritic	arthritic	ADJ
brj-24903	228	12	animals	animal	NOUN
brj-24903	228	13	early	early	ADJ
brj-24903	228	14	ra	ra	PROPN
brj-24903	228	15	may	may	AUX
brj-24903	228	16	become	become	VERB
brj-24903	228	17	more	more	ADV
brj-24903	228	18	inflammatory	inflammatory	ADJ
brj-24903	228	19	due	due	ADP
brj-24903	228	20	to	to	ADP
brj-24903	228	21	the	the	DET
brj-24903	228	22	increase	increase	NOUN
brj-24903	228	23	in	in	ADP
brj-24903	228	24	plasma	plasma	NOUN
brj-24903	228	25	tnf	tnf	PROPN
brj-24903	228	26	-	-	PUNCT
brj-24903	228	27	α	α	PROPN
brj-24903	228	28	.	.	PUNCT
brj-24903	229	1	furthermore	furthermore	ADV
brj-24903	229	2	,	,	PUNCT
brj-24903	229	3	the	the	DET
brj-24903	229	4	induction	induction	NOUN
brj-24903	229	5	of	of	ADP
brj-24903	229	6	inflammation	inflammation	NOUN
brj-24903	229	7	and	and	CCONJ
brj-24903	229	8	the	the	DET
brj-24903	229	9	transition	transition	NOUN
brj-24903	229	10	from	from	ADP
brj-24903	229	11	acute	acute	NOUN
brj-24903	229	12	to	to	ADP
brj-24903	229	13	chronic	chronic	ADJ
brj-24903	229	14	inflammation	inflammation	NOUN
brj-24903	229	15	depend	depend	VERB
brj-24903	229	16	on	on	ADP
brj-24903	229	17	il-1β	il-1β	PROPN
brj-24903	229	18	and	and	CCONJ
brj-24903	229	19	il-6	il-6	NOUN
brj-24903	229	20	.	.	PUNCT
brj-24903	230	1	in	in	ADP
brj-24903	230	2	this	this	DET
brj-24903	230	3	experiment	experiment	NOUN
brj-24903	230	4	,	,	PUNCT
brj-24903	230	5	the	the	DET
brj-24903	230	6	rats	rat	NOUN
brj-24903	230	7	in	in	ADP
brj-24903	230	8	the	the	DET
brj-24903	230	9	cfa	cfa	PROPN
brj-24903	230	10	control	control	PROPN
brj-24903	230	11	group	group	PROPN
brj-24903	230	12	had	have	VERB
brj-24903	230	13	significantly	significantly	ADV
brj-24903	230	14	higher	high	ADJ
brj-24903	230	15	levels	level	NOUN
brj-24903	230	16	of	of	ADP
brj-24903	230	17	the	the	DET
brj-24903	230	18	inflammatory	inflammatory	ADJ
brj-24903	230	19	markers	marker	NOUN
brj-24903	230	20	listed	list	VERB
brj-24903	230	21	above	above	ADV
brj-24903	230	22	(	(	PUNCT
brj-24903	230	23	fig	fig	NOUN
brj-24903	230	24	.	.	PUNCT
brj-24903	231	1	3	3	NUM
brj-24903	231	2	)	)	PUNCT
brj-24903	231	3	.	.	PUNCT
brj-24903	232	1	when	when	SCONJ
brj-24903	232	2	compared	compare	VERB
brj-24903	232	3	to	to	ADP
brj-24903	232	4	rats	rat	NOUN
brj-24903	232	5	in	in	ADP
brj-24903	232	6	the	the	DET
brj-24903	232	7	cfa	cfa	PROPN
brj-24903	232	8	control	control	PROPN
brj-24903	232	9	group	group	PROPN
brj-24903	232	10	,	,	PUNCT
brj-24903	232	11	animals	animal	NOUN
brj-24903	232	12	treated	treat	VERB
brj-24903	232	13	with	with	ADP
brj-24903	232	14	a.	a.	NOUN
brj-24903	232	15	glycyphyllos	glycyphyllos	PROPN
brj-24903	232	16	extract	extract	NOUN
brj-24903	232	17	(	(	PUNCT
brj-24903	232	18	100	100	NUM
brj-24903	232	19	and	and	CCONJ
brj-24903	232	20	200	200	NUM
brj-24903	232	21	mg	mg	NUM
brj-24903	232	22	/	/	SYM
brj-24903	232	23	kg	kg	PROPN
brj-24903	232	24	)	)	PUNCT
brj-24903	232	25	exhibited	exhibit	VERB
brj-24903	232	26	a	a	DET
brj-24903	232	27	significant	significant	ADJ
brj-24903	232	28	(	(	PUNCT
brj-24903	232	29	p<0.01	p<0.01	PROPN
brj-24903	232	30	)	)	PUNCT
brj-24903	232	31	reduction	reduction	NOUN
brj-24903	232	32	in	in	ADP
brj-24903	232	33	tnf	tnf	PROPN
brj-24903	232	34	-	-	PUNCT
brj-24903	232	35	α	α	PROPN
brj-24903	232	36	,	,	PUNCT
brj-24903	232	37	il-1β	il-1β	PROPN
brj-24903	232	38	,	,	PUNCT
brj-24903	232	39	and	and	CCONJ
brj-24903	232	40	il-6	il-6	NOUN
brj-24903	232	41	.	.	PUNCT
brj-24903	233	1	in	in	ADP
brj-24903	233	2	cfa	cfa	PROPN
brj-24903	233	3	-	-	PUNCT
brj-24903	233	4	challenged	challenge	VERB
brj-24903	233	5	arthritic	arthritic	ADJ
brj-24903	233	6	mice	mouse	NOUN
brj-24903	233	7	,	,	PUNCT
brj-24903	233	8	the	the	DET
brj-24903	233	9	greatest	great	ADJ
brj-24903	233	10	dose	dose	NOUN
brj-24903	233	11	of	of	ADP
brj-24903	233	12	the	the	DET
brj-24903	233	13	extract	extract	NOUN
brj-24903	233	14	demonstrated	demonstrate	VERB
brj-24903	233	15	a	a	DET
brj-24903	233	16	stronger	strong	ADJ
brj-24903	233	17	potential	potential	ADJ
brj-24903	233	18	impact	impact	NOUN
brj-24903	233	19	against	against	ADP
brj-24903	233	20	the	the	DET
brj-24903	233	21	rise	rise	NOUN
brj-24903	233	22	in	in	ADP
brj-24903	233	23	inflammatory	inflammatory	ADJ
brj-24903	233	24	markers	marker	NOUN
brj-24903	233	25	.	.	PUNCT
brj-24903	234	1	a	a	DET
brj-24903	234	2	b	b	NOUN
brj-24903	234	3	c	c	NOUN
brj-24903	234	4	i	i	PRON
brj-24903	234	5	ii	ii	VERB
brj-24903	234	6	iii	iii	NUM
brj-24903	234	7	iv	iv	NUM
brj-24903	234	8	v	v	ADP
brj-24903	234	9	0	0	NUM
brj-24903	234	10	10	10	NUM
brj-24903	234	11	20	20	NUM
brj-24903	234	12	30	30	NUM
brj-24903	234	13	40	40	NUM
brj-24903	234	14	il-6	il-6	NOUN
brj-24903	234	15	groups	group	NOUN
brj-24903	234	16	p	p	X
brj-24903	234	17	g	g	NOUN
brj-24903	234	18	/m	/m	PUNCT
brj-24903	234	19	l	l	NOUN
brj-24903	235	1	*	*	PUNCT
brj-24903	236	1	*	*	PUNCT
brj-24903	236	2	*	*	PUNCT
brj-24903	237	1	#	#	SYM
brj-24903	237	2	#	#	SYM
brj-24903	237	3	#	#	NOUN
brj-24903	237	4	*	*	NOUN
brj-24903	237	5	*	*	PUNCT
brj-24903	237	6	*	*	PUNCT
brj-24903	238	1	*	*	PUNCT
brj-24903	238	2	*	*	PUNCT
brj-24903	238	3	*	*	PUNCT
brj-24903	238	4	fig	fig	NOUN
brj-24903	238	5	.	.	PUNCT
brj-24903	239	1	3	3	X
brj-24903	239	2	.	.	X
brj-24903	239	3	effect	effect	NOUN
brj-24903	239	4	of	of	ADP
brj-24903	239	5	a.	a.	NOUN
brj-24903	239	6	glycyphyllos	glycyphyllos	PROPN
brj-24903	239	7	leaves	leave	VERB
brj-24903	239	8	extract	extract	VERB
brj-24903	239	9	on	on	ADP
brj-24903	239	10	inflammatory	inflammatory	ADJ
brj-24903	239	11	cytokines	cytokine	NOUN
brj-24903	239	12	(	(	PUNCT
brj-24903	239	13	a	a	X
brj-24903	239	14	)	)	PUNCT
brj-24903	239	15	tnf	tnf	PROPN
brj-24903	239	16	-	-	PUNCT
brj-24903	239	17	α,(b	α,(b	NOUN
brj-24903	239	18	)	)	PUNCT
brj-24903	240	1	il-1β	il-1β	PROPN
brj-24903	240	2	,	,	PUNCT
brj-24903	240	3	(	(	PUNCT
brj-24903	240	4	c	c	NOUN
brj-24903	240	5	)	)	PUNCT
brj-24903	240	6	il-6	il-6	NOUN
brj-24903	240	7	in	in	ADP
brj-24903	240	8	cfa	cfa	PROPN
brj-24903	240	9	challenged	challenge	VERB
brj-24903	240	10	arthritic	arthritic	ADJ
brj-24903	240	11	animals	animal	NOUN
brj-24903	240	12	.	.	PUNCT
brj-24903	241	1	data	datum	NOUN
brj-24903	241	2	are	be	AUX
brj-24903	241	3	represented	represent	VERB
brj-24903	241	4	as	as	ADP
brj-24903	241	5	mean	mean	ADJ
brj-24903	241	6	±sem	±sem	NOUN
brj-24903	241	7	(	(	PUNCT
brj-24903	241	8	n=	n=	ADJ
brj-24903	241	9	6	6	NUM
brj-24903	241	10	)	)	PUNCT
brj-24903	241	11	.	.	PUNCT
brj-24903	242	1	#	#	SYM
brj-24903	242	2	#	#	SYM
brj-24903	242	3	#	#	AUX
brj-24903	242	4	p<0.001	p<0.001	VERB
brj-24903	242	5	considered	consider	VERB
brj-24903	242	6	statistically	statistically	ADV
brj-24903	242	7	noteworthy	noteworthy	ADJ
brj-24903	242	8	as	as	SCONJ
brj-24903	242	9	judged	judge	VERB
brj-24903	242	10	against	against	ADP
brj-24903	242	11	normal	normal	ADJ
brj-24903	242	12	control	control	NOUN
brj-24903	242	13	group	group	NOUN
brj-24903	242	14	;	;	PUNCT
brj-24903	242	15	*	*	PUNCT
brj-24903	242	16	*	*	PUNCT
brj-24903	242	17	p<0.01	p<0.01	PRON
brj-24903	242	18	as	as	ADV
brj-24903	242	19	well	well	ADV
brj-24903	242	20	as	as	ADP
brj-24903	242	21	*	*	NOUN
brj-24903	242	22	*	*	PUNCT
brj-24903	242	23	*	*	PUNCT
brj-24903	242	24	p<0.001	p<0.001	AUX
brj-24903	242	25	considered	consider	VERB
brj-24903	242	26	statistically	statistically	ADV
brj-24903	242	27	noteworthy	noteworthy	ADJ
brj-24903	242	28	as	as	SCONJ
brj-24903	242	29	judged	judge	VERB
brj-24903	242	30	against	against	ADP
brj-24903	242	31	cfa	cfa	PROPN
brj-24903	242	32	control	control	PROPN
brj-24903	242	33	group	group	PROPN
brj-24903	242	34	.	.	PUNCT
brj-24903	243	1	i	i	PRON
brj-24903	243	2	ii	ii	VERB
brj-24903	243	3	iii	iii	NUM
brj-24903	243	4	iv	iv	NUM
brj-24903	243	5	v	v	ADP
brj-24903	243	6	0	0	NUM
brj-24903	243	7	10	10	NUM
brj-24903	243	8	20	20	NUM
brj-24903	243	9	30	30	NUM
brj-24903	243	10	40	40	NUM
brj-24903	243	11	50	50	NUM
brj-24903	243	12	tnf	tnf	PROPN
brj-24903	243	13	-	-	PUNCT
brj-24903	243	14	α	α	NOUN
brj-24903	243	15	groups	group	NOUN
brj-24903	243	16	p	p	X
brj-24903	243	17	g	g	NOUN
brj-24903	243	18	/m	/m	PUNCT
brj-24903	243	19	l	l	NOUN
brj-24903	244	1	*	*	PUNCT
brj-24903	244	2	*	*	PUNCT
brj-24903	245	1	#	#	SYM
brj-24903	245	2	#	#	SYM
brj-24903	245	3	#	#	NOUN
brj-24903	245	4	*	*	NOUN
brj-24903	245	5	*	*	PUNCT
brj-24903	245	6	*	*	PUNCT
brj-24903	246	1	*	*	PUNCT
brj-24903	246	2	*	*	PUNCT
brj-24903	247	1	*	*	PUNCT
brj-24903	247	2	i	i	PRON
brj-24903	247	3	ii	ii	VERB
brj-24903	247	4	iii	iii	NUM
brj-24903	247	5	iv	iv	NUM
brj-24903	247	6	v	v	ADP
brj-24903	247	7	0	0	NUM
brj-24903	247	8	20	20	NUM
brj-24903	247	9	40	40	NUM
brj-24903	247	10	60	60	NUM
brj-24903	247	11	il-1β	il-1β	PROPN
brj-24903	247	12	groups	group	NOUN
brj-24903	247	13	p	p	NOUN
brj-24903	247	14	g	g	NOUN
brj-24903	247	15	/m	/m	PUNCT
brj-24903	247	16	l	l	NOUN
brj-24903	248	1	*	*	PUNCT
brj-24903	248	2	*	*	PUNCT
brj-24903	249	1	#	#	SYM
brj-24903	249	2	#	#	SYM
brj-24903	249	3	#	#	NOUN
brj-24903	249	4	*	*	NOUN
brj-24903	249	5	*	*	PUNCT
brj-24903	249	6	*	*	PUNCT
brj-24903	249	7	*	*	PUNCT
brj-24903	249	8	*	*	PUNCT
brj-24903	249	9	*	*	NOUN
brj-24903	249	10	peer	peer	NOUN
brj-24903	249	11	-	-	PUNCT
brj-24903	249	12	reviewed	review	VERB
brj-24903	249	13	article	article	NOUN
brj-24903	249	14	bioresources.cnr.ncsu.edu	bioresources.cnr.ncsu.edu	X
brj-24903	249	15	gu	gu	VERB
brj-24903	249	16	et	et	PROPN
brj-24903	249	17	al	al	PROPN
brj-24903	249	18	.	.	PROPN
brj-24903	250	1	(	(	PUNCT
brj-24903	250	2	2026	2026	NUM
brj-24903	250	3	)	)	PUNCT
brj-24903	250	4	.	.	PUNCT
brj-24903	251	1	“	"	PUNCT
brj-24903	251	2	astragalus	astragalus	NOUN
brj-24903	251	3	leaf	leaf	NOUN
brj-24903	251	4	extract	extract	NOUN
brj-24903	251	5	vs.	vs.	ADP
brj-24903	251	6	arthritis	arthritis	NOUN
brj-24903	251	7	,	,	PUNCT
brj-24903	251	8	”	"	PUNCT
brj-24903	251	9	bioresources	bioresource	NOUN
brj-24903	251	10	21(1	21(1	NUM
brj-24903	251	11	)	)	PUNCT
brj-24903	251	12	,	,	PUNCT
brj-24903	251	13	160	160	NUM
brj-24903	251	14	-	-	SYM
brj-24903	251	15	177	177	NUM
brj-24903	251	16	.	.	PUNCT
brj-24903	252	1	170	170	NUM
brj-24903	252	2	a	a	DET
brj-24903	252	3	b	b	NOUN
brj-24903	252	4	c	c	NOUN
brj-24903	253	1	i	i	PRON
brj-24903	253	2	ii	ii	VERB
brj-24903	253	3	iii	iii	NUM
brj-24903	253	4	iv	iv	NUM
brj-24903	253	5	v	v	NOUN
brj-24903	253	6	0	0	NUM
brj-24903	253	7	5	5	NUM
brj-24903	253	8	10	10	NUM
brj-24903	253	9	15	15	NUM
brj-24903	253	10	20	20	NUM
brj-24903	253	11	hgb	hgb	NOUN
brj-24903	253	12	groups	group	NOUN
brj-24903	253	13	g	g	PROPN
brj-24903	253	14	/d	/d	PUNCT
brj-24903	253	15	l	l	PUNCT
brj-24903	253	16	*	*	PUNCT
brj-24903	253	17	*	*	PUNCT
brj-24903	253	18	*	*	PUNCT
brj-24903	253	19	#	#	SYM
brj-24903	253	20	#	#	SYM
brj-24903	253	21	#	#	NOUN
brj-24903	253	22	*	*	NOUN
brj-24903	253	23	*	*	PUNCT
brj-24903	254	1	*	*	PUNCT
brj-24903	254	2	*	*	PUNCT
brj-24903	254	3	*	*	PUNCT
brj-24903	254	4	i	i	PRON
brj-24903	254	5	ii	ii	VERB
brj-24903	254	6	iii	iii	NUM
brj-24903	254	7	iv	iv	NUM
brj-24903	254	8	v	v	ADP
brj-24903	254	9	0	0	NUM
brj-24903	254	10	10	10	NUM
brj-24903	254	11	20	20	NUM
brj-24903	254	12	30	30	NUM
brj-24903	254	13	40	40	NUM
brj-24903	254	14	50	50	NUM
brj-24903	254	15	pcv	pcv	NOUN
brj-24903	254	16	groups	group	NOUN
brj-24903	254	17	%	%	INTJ
brj-24903	254	18	*	*	PUNCT
brj-24903	254	19	*	*	PUNCT
brj-24903	255	1	#	#	SYM
brj-24903	255	2	#	#	SYM
brj-24903	255	3	#	#	NOUN
brj-24903	255	4	*	*	NOUN
brj-24903	255	5	*	*	PUNCT
brj-24903	256	1	*	*	PUNCT
brj-24903	256	2	*	*	PUNCT
brj-24903	257	1	*	*	PUNCT
brj-24903	257	2	i	i	PRON
brj-24903	257	3	ii	ii	VERB
brj-24903	257	4	iii	iii	NUM
brj-24903	257	5	iv	iv	NUM
brj-24903	257	6	v	v	NOUN
brj-24903	257	7	0	0	NUM
brj-24903	257	8	2	2	NUM
brj-24903	257	9	4	4	NUM
brj-24903	257	10	6	6	NUM
brj-24903	257	11	8	8	NUM
brj-24903	257	12	10	10	NUM
brj-24903	257	13	rbc	rbc	PROPN
brj-24903	257	14	groups	group	NOUN
brj-24903	257	15	m	m	VERB
brj-24903	257	16	il	il	PROPN
brj-24903	257	17	li	li	PROPN
brj-24903	257	18	o	o	PROPN
brj-24903	258	1	n	n	PROPN
brj-24903	258	2	s	s	NOUN
brj-24903	258	3	/c	/c	PUNCT
brj-24903	258	4	u	u	PROPN
brj-24903	258	5	b	b	PROPN
brj-24903	258	6	ic	ic	INTJ
brj-24903	258	7	m	m	VERB
brj-24903	258	8	il	il	PROPN
brj-24903	258	9	il	il	PROPN
brj-24903	258	10	it	it	PRON
brj-24903	259	1	e	e	ADP
brj-24903	259	2	r	r	NOUN
brj-24903	259	3	*	*	PUNCT
brj-24903	259	4	*	*	PUNCT
brj-24903	259	5	#	#	SYM
brj-24903	259	6	#	#	SYM
brj-24903	259	7	#	#	NOUN
brj-24903	259	8	*	*	NOUN
brj-24903	259	9	*	*	PUNCT
brj-24903	260	1	*	*	PUNCT
brj-24903	260	2	*	*	PUNCT
brj-24903	260	3	*	*	PUNCT
brj-24903	260	4	d	d	X
brj-24903	260	5	e	e	X
brj-24903	260	6	i	i	PRON
brj-24903	260	7	ii	ii	VERB
brj-24903	260	8	iii	iii	NUM
brj-24903	260	9	iv	iv	NUM
brj-24903	260	10	v	v	NOUN
brj-24903	260	11	0	0	NUM
brj-24903	260	12	5	5	NUM
brj-24903	260	13	10	10	NUM
brj-24903	260	14	15	15	NUM
brj-24903	260	15	wbc	wbc	PROPN
brj-24903	260	16	groups	group	NOUN
brj-24903	260	17	1	1	NUM
brj-24903	260	18	0	0	NUM
brj-24903	260	19	9	9	NUM
brj-24903	260	20	/l	/l	PUNCT
brj-24903	261	1	*	*	PUNCT
brj-24903	261	2	*	*	PUNCT
brj-24903	262	1	#	#	SYM
brj-24903	262	2	#	#	SYM
brj-24903	262	3	#	#	NOUN
brj-24903	262	4	*	*	NOUN
brj-24903	262	5	*	*	PUNCT
brj-24903	263	1	*	*	PUNCT
brj-24903	264	1	*	*	PUNCT
brj-24903	264	2	*	*	PUNCT
brj-24903	264	3	i	i	PRON
brj-24903	264	4	ii	ii	VERB
brj-24903	264	5	iii	iii	NUM
brj-24903	264	6	iv	iv	NUM
brj-24903	264	7	v	v	ADP
brj-24903	264	8	0.0	0.0	NUM
brj-24903	264	9	0.5	0.5	NUM
brj-24903	264	10	1.0	1.0	NUM
brj-24903	264	11	1.5	1.5	NUM
brj-24903	264	12	2.0	2.0	NUM
brj-24903	264	13	2.5	2.5	NUM
brj-24903	264	14	esr	esr	PROPN
brj-24903	264	15	groups	group	NOUN
brj-24903	264	16	m	m	VERB
brj-24903	264	17	m	m	VERB
brj-24903	264	18	/h	/h	ADJ
brj-24903	264	19	*	*	PUNCT
brj-24903	264	20	*	*	PUNCT
brj-24903	264	21	*	*	PUNCT
brj-24903	264	22	#	#	SYM
brj-24903	264	23	#	#	SYM
brj-24903	264	24	#	#	NOUN
brj-24903	264	25	*	*	NOUN
brj-24903	264	26	*	*	PUNCT
brj-24903	264	27	*	*	PUNCT
brj-24903	265	1	*	*	PUNCT
brj-24903	265	2	*	*	PUNCT
brj-24903	265	3	*	*	PUNCT
brj-24903	265	4	fig	fig	NOUN
brj-24903	265	5	.	.	PUNCT
brj-24903	266	1	4	4	X
brj-24903	266	2	.	.	X
brj-24903	266	3	effect	effect	NOUN
brj-24903	266	4	of	of	ADP
brj-24903	266	5	a.	a.	NOUN
brj-24903	266	6	glycyphyllos	glycyphyllos	PROPN
brj-24903	266	7	leaves	leave	VERB
brj-24903	266	8	extract	extract	VERB
brj-24903	266	9	on	on	ADP
brj-24903	266	10	hematological	hematological	ADJ
brj-24903	266	11	parameters	parameter	NOUN
brj-24903	266	12	(	(	PUNCT
brj-24903	266	13	a	a	PRON
brj-24903	266	14	)	)	PUNCT
brj-24903	266	15	hgb	hgb	PROPN
brj-24903	266	16	,	,	PUNCT
brj-24903	266	17	(	(	PUNCT
brj-24903	266	18	b	b	X
brj-24903	266	19	)	)	PUNCT
brj-24903	266	20	pcv	pcv	NOUN
brj-24903	266	21	,	,	PUNCT
brj-24903	266	22	(	(	PUNCT
brj-24903	266	23	c	c	X
brj-24903	266	24	)	)	PUNCT
brj-24903	266	25	rbc	rbc	PROPN
brj-24903	266	26	,	,	PUNCT
brj-24903	266	27	(	(	PUNCT
brj-24903	266	28	d	d	X
brj-24903	266	29	)	)	PUNCT
brj-24903	266	30	wbc	wbc	PROPN
brj-24903	266	31	,	,	PUNCT
brj-24903	266	32	(	(	PUNCT
brj-24903	266	33	e	e	NOUN
brj-24903	266	34	)	)	PUNCT
brj-24903	266	35	esr	esr	PROPN
brj-24903	266	36	in	in	ADP
brj-24903	266	37	cfa	cfa	PROPN
brj-24903	266	38	challenged	challenge	VERB
brj-24903	266	39	arthritic	arthritic	ADJ
brj-24903	266	40	animals	animal	NOUN
brj-24903	266	41	.	.	PUNCT
brj-24903	267	1	data	datum	NOUN
brj-24903	267	2	are	be	AUX
brj-24903	267	3	mean	mean	ADJ
brj-24903	267	4	±sem	±sem	NOUN
brj-24903	267	5	(	(	PUNCT
brj-24903	267	6	n=	n=	ADJ
brj-24903	267	7	6	6	NUM
brj-24903	267	8	)	)	PUNCT
brj-24903	267	9	.	.	PUNCT
brj-24903	268	1	#	#	SYM
brj-24903	268	2	#	#	SYM
brj-24903	268	3	#	#	AUX
brj-24903	268	4	p<0.001	p<0.001	VERB
brj-24903	268	5	considered	consider	VERB
brj-24903	268	6	statistically	statistically	ADV
brj-24903	268	7	noteworthy	noteworthy	ADJ
brj-24903	268	8	as	as	SCONJ
brj-24903	268	9	judged	judge	VERB
brj-24903	268	10	against	against	ADP
brj-24903	268	11	normal	normal	ADJ
brj-24903	268	12	control	control	NOUN
brj-24903	268	13	group	group	NOUN
brj-24903	268	14	;	;	PUNCT
brj-24903	268	15	*	*	PUNCT
brj-24903	268	16	*	*	PUNCT
brj-24903	268	17	p<0.01	p<0.01	PRON
brj-24903	268	18	as	as	ADV
brj-24903	268	19	well	well	ADV
brj-24903	268	20	as	as	ADP
brj-24903	268	21	*	*	NOUN
brj-24903	268	22	*	*	PUNCT
brj-24903	268	23	*	*	PUNCT
brj-24903	268	24	p<0.001	p<0.001	AUX
brj-24903	268	25	considered	consider	VERB
brj-24903	268	26	statistically	statistically	ADV
brj-24903	268	27	noteworthy	noteworthy	ADJ
brj-24903	268	28	as	as	SCONJ
brj-24903	268	29	judged	judge	VERB
brj-24903	268	30	against	against	ADP
brj-24903	268	31	cfa	cfa	PROPN
brj-24903	268	32	control	control	PROPN
brj-24903	268	33	group	group	PROPN
brj-24903	268	34	.	.	PUNCT
brj-24903	269	1	effect	effect	NOUN
brj-24903	269	2	of	of	ADP
brj-24903	269	3	a.	a.	NOUN
brj-24903	269	4	glycyphyllos	glycyphyllos	PROPN
brj-24903	269	5	leaves	leave	VERB
brj-24903	269	6	extract	extract	VERB
brj-24903	269	7	on	on	ADP
brj-24903	269	8	hematological	hematological	ADJ
brj-24903	269	9	parameters	parameter	NOUN
brj-24903	269	10	in	in	ADP
brj-24903	269	11	arthritic	arthritic	ADJ
brj-24903	269	12	animals	animal	NOUN
brj-24903	269	13	figure	figure	VERB
brj-24903	269	14	4	4	NUM
brj-24903	269	15	displays	display	VERB
brj-24903	269	16	the	the	DET
brj-24903	269	17	hematological	hematological	ADJ
brj-24903	269	18	parameters	parameter	NOUN
brj-24903	269	19	evaluated	evaluate	VERB
brj-24903	269	20	in	in	ADP
brj-24903	269	21	animals	animal	NOUN
brj-24903	269	22	challenged	challenge	VERB
brj-24903	269	23	with	with	ADP
brj-24903	269	24	cfa	cfa	PROPN
brj-24903	269	25	.	.	PUNCT
brj-24903	270	1	comparing	compare	VERB
brj-24903	270	2	the	the	DET
brj-24903	270	3	cfa	cfa	PROPN
brj-24903	270	4	control	control	PROPN
brj-24903	270	5	group	group	PROPN
brj-24903	270	6	to	to	ADP
brj-24903	270	7	the	the	DET
brj-24903	270	8	normal	normal	ADJ
brj-24903	270	9	control	control	NOUN
brj-24903	270	10	group	group	NOUN
brj-24903	270	11	,	,	PUNCT
brj-24903	270	12	there	there	PRON
brj-24903	270	13	was	be	VERB
brj-24903	270	14	a	a	DET
brj-24903	270	15	large	large	ADJ
brj-24903	270	16	rise	rise	NOUN
brj-24903	270	17	in	in	ADP
brj-24903	270	18	wbc	wbc	PROPN
brj-24903	270	19	and	and	CCONJ
brj-24903	270	20	esr	esr	PROPN
brj-24903	270	21	and	and	CCONJ
brj-24903	270	22	a	a	DET
brj-24903	270	23	significant	significant	ADJ
brj-24903	270	24	decrease	decrease	NOUN
brj-24903	270	25	in	in	ADP
brj-24903	270	26	hbg	hbg	PROPN
brj-24903	270	27	,	,	PUNCT
brj-24903	270	28	pvc	pvc	NOUN
brj-24903	270	29	,	,	PUNCT
brj-24903	270	30	and	and	CCONJ
brj-24903	270	31	rbc	rbc	PROPN
brj-24903	270	32	.	.	PROPN
brj-24903	271	1	nonetheless	nonetheless	ADV
brj-24903	271	2	,	,	PUNCT
brj-24903	271	3	the	the	DET
brj-24903	271	4	hbg	hbg	PROPN
brj-24903	271	5	level	level	NOUN
brj-24903	271	6	,	,	PUNCT
brj-24903	271	7	pvc	pvc	ADJ
brj-24903	271	8	percentage	percentage	NOUN
brj-24903	271	9	,	,	PUNCT
brj-24903	271	10	and	and	CCONJ
brj-24903	271	11	rbc	rbc	PROPN
brj-24903	271	12	count	count	NOUN
brj-24903	271	13	all	all	ADV
brj-24903	271	14	significantly	significantly	ADV
brj-24903	271	15	(	(	PUNCT
brj-24903	271	16	p<0.01	p<0.01	PROPN
brj-24903	271	17	)	)	PUNCT
brj-24903	271	18	improved	improve	VERB
brj-24903	271	19	after	after	ADP
brj-24903	271	20	receiving	receive	VERB
brj-24903	271	21	therapy	therapy	NOUN
brj-24903	271	22	with	with	ADP
brj-24903	271	23	a.	a.	NOUN
brj-24903	271	24	glycyphyllos	glycyphyllos	PROPN
brj-24903	271	25	extract	extract	NOUN
brj-24903	271	26	(	(	PUNCT
brj-24903	271	27	100	100	NUM
brj-24903	271	28	and	and	CCONJ
brj-24903	271	29	200	200	NUM
brj-24903	271	30	mg	mg	NUM
brj-24903	271	31	/	/	SYM
brj-24903	271	32	kg	kg	PROPN
brj-24903	271	33	)	)	PUNCT
brj-24903	271	34	.	.	PUNCT
brj-24903	272	1	moreover	moreover	ADV
brj-24903	272	2	,	,	PUNCT
brj-24903	272	3	both	both	DET
brj-24903	272	4	dosages	dosage	NOUN
brj-24903	272	5	markedly	markedly	ADV
brj-24903	272	6	reduced	reduce	VERB
brj-24903	272	7	the	the	DET
brj-24903	272	8	esr	esr	PROPN
brj-24903	272	9	and	and	CCONJ
brj-24903	272	10	wbc	wbc	PROPN
brj-24903	272	11	count	count	NOUN
brj-24903	272	12	.	.	PUNCT
brj-24903	273	1	in	in	ADP
brj-24903	273	2	arthritic	arthritic	ADJ
brj-24903	273	3	animals	animal	NOUN
brj-24903	273	4	with	with	ADP
brj-24903	273	5	cfa	cfa	PROPN
brj-24903	273	6	challenges	challenge	NOUN
brj-24903	273	7	,	,	PUNCT
brj-24903	273	8	the	the	DET
brj-24903	273	9	greatest	great	ADJ
brj-24903	273	10	dose	dose	NOUN
brj-24903	273	11	of	of	ADP
brj-24903	273	12	the	the	DET
brj-24903	273	13	extract	extract	NOUN
brj-24903	273	14	had	have	VERB
brj-24903	273	15	a	a	DET
brj-24903	273	16	more	more	ADV
brj-24903	273	17	pronounced	pronounced	ADJ
brj-24903	273	18	benefit	benefit	NOUN
brj-24903	273	19	against	against	ADP
brj-24903	273	20	the	the	DET
brj-24903	273	21	hematological	hematological	ADJ
brj-24903	273	22	artifact	artifact	NOUN
brj-24903	273	23	.	.	PUNCT
brj-24903	274	1	effect	effect	NOUN
brj-24903	274	2	of	of	ADP
brj-24903	274	3	a.	a.	NOUN
brj-24903	274	4	glycyphyllos	glycyphyllos	PROPN
brj-24903	274	5	extract	extract	VERB
brj-24903	274	6	on	on	ADP
brj-24903	274	7	il-1β	il-1β	PROPN
brj-24903	274	8	-	-	PUNCT
brj-24903	274	9	stimulated	stimulate	VERB
brj-24903	274	10	prcs	prcs	PROPN
brj-24903	274	11	cell	cell	NOUN
brj-24903	274	12	viability	viability	NOUN
brj-24903	274	13	the	the	DET
brj-24903	274	14	effects	effect	NOUN
brj-24903	274	15	of	of	ADP
brj-24903	274	16	a.	a.	NOUN
brj-24903	274	17	glycyphyllos	glycyphyllos	PROPN
brj-24903	274	18	extract	extract	NOUN
brj-24903	274	19	at	at	ADP
brj-24903	274	20	different	different	ADJ
brj-24903	274	21	doses	dose	NOUN
brj-24903	274	22	(	(	PUNCT
brj-24903	274	23	50	50	NUM
brj-24903	274	24	,	,	PUNCT
brj-24903	274	25	100	100	NUM
brj-24903	274	26	,	,	PUNCT
brj-24903	274	27	200	200	NUM
brj-24903	274	28	,	,	PUNCT
brj-24903	274	29	300	300	NUM
brj-24903	274	30	,	,	PUNCT
brj-24903	274	31	500	500	NUM
brj-24903	274	32	,	,	PUNCT
brj-24903	274	33	1000	1000	NUM
brj-24903	274	34	,	,	PUNCT
brj-24903	274	35	and	and	CCONJ
brj-24903	274	36	2000	2000	NUM
brj-24903	274	37	μg	μg	NOUN
brj-24903	274	38	/	/	SYM
brj-24903	274	39	ml	ml	NOUN
brj-24903	274	40	)	)	PUNCT
brj-24903	274	41	in	in	ADP
brj-24903	274	42	prcs	prcs	PROPN
brj-24903	274	43	were	be	AUX
brj-24903	274	44	determined	determine	VERB
brj-24903	274	45	using	use	VERB
brj-24903	274	46	the	the	DET
brj-24903	274	47	mtt	mtt	NOUN
brj-24903	274	48	test	test	NOUN
brj-24903	274	49	(	(	PUNCT
brj-24903	274	50	table	table	NOUN
brj-24903	274	51	3	3	NUM
brj-24903	274	52	)	)	PUNCT
brj-24903	274	53	.	.	PUNCT
brj-24903	275	1	table	table	NOUN
brj-24903	276	1	3	3	NUM
brj-24903	276	2	.	.	X
brj-24903	276	3	outcome	outcome	NOUN
brj-24903	276	4	of	of	ADP
brj-24903	276	5	a.	a.	NOUN
brj-24903	276	6	glycyphyllos	glycyphyllos	PROPN
brj-24903	276	7	leaves	leave	NOUN
brj-24903	276	8	extract	extract	VERB
brj-24903	276	9	on	on	ADP
brj-24903	276	10	viability	viability	NOUN
brj-24903	276	11	of	of	ADP
brj-24903	276	12	prcs	prcs	PROPN
brj-24903	276	13	a.	a.	PROPN
brj-24903	276	14	glycyphyllos	glycyphyllos	PROPN
brj-24903	276	15	leaves	leave	VERB
brj-24903	276	16	extract	extract	VERB
brj-24903	276	17	(	(	PUNCT
brj-24903	276	18	μg	μg	NOUN
brj-24903	276	19	/	/	SYM
brj-24903	276	20	ml	ml	NOUN
brj-24903	276	21	)	)	PUNCT
brj-24903	276	22	%	%	NOUN
brj-24903	276	23	of	of	ADP
brj-24903	276	24	viable	viable	ADJ
brj-24903	276	25	prcs	prcs	NOUN
brj-24903	276	26	50	50	NUM
brj-24903	276	27	99.97±0.13	99.97±0.13	NUM
brj-24903	276	28	100	100	NUM
brj-24903	276	29	99.93±0.15	99.93±0.15	NUM
brj-24903	276	30	200	200	NUM
brj-24903	276	31	94.32±0.17	94.32±0.17	NUM
brj-24903	276	32	300	300	NUM
brj-24903	276	33	89.65±0.20	89.65±0.20	NUM
brj-24903	276	34	500	500	NUM
brj-24903	276	35	70.09±0.23	70.09±0.23	NUM
brj-24903	276	36	1000	1000	NUM
brj-24903	276	37	51.33±0.21	51.33±0.21	NUM
brj-24903	276	38	2000	2000	NUM
brj-24903	276	39	24.54±0.19	24.54±0.19	NUM
brj-24903	277	1	data	datum	NOUN
brj-24903	277	2	are	be	AUX
brj-24903	277	3	shown	show	VERB
brj-24903	277	4	in	in	ADP
brj-24903	277	5	a	a	DET
brj-24903	277	6	triplicate	triplicate	NOUN
brj-24903	277	7	manner	manner	NOUN
brj-24903	277	8	(	(	PUNCT
brj-24903	277	9	mean±sem	mean±sem	NOUN
brj-24903	277	10	)	)	PUNCT
brj-24903	277	11	peer	peer	NOUN
brj-24903	277	12	-	-	PUNCT
brj-24903	277	13	reviewed	review	VERB
brj-24903	277	14	article	article	NOUN
brj-24903	277	15	bioresources.cnr.ncsu.edu	bioresources.cnr.ncsu.edu	X
brj-24903	277	16	gu	gu	VERB
brj-24903	277	17	et	et	PROPN
brj-24903	277	18	al	al	PROPN
brj-24903	277	19	.	.	PROPN
brj-24903	278	1	(	(	PUNCT
brj-24903	278	2	2026	2026	NUM
brj-24903	278	3	)	)	PUNCT
brj-24903	278	4	.	.	PUNCT
brj-24903	279	1	“	"	PUNCT
brj-24903	279	2	astragalus	astragalus	NOUN
brj-24903	279	3	leaf	leaf	NOUN
brj-24903	279	4	extract	extract	NOUN
brj-24903	279	5	vs.	vs.	ADP
brj-24903	279	6	arthritis	arthritis	NOUN
brj-24903	279	7	,	,	PUNCT
brj-24903	279	8	”	"	PUNCT
brj-24903	279	9	bioresources	bioresource	NOUN
brj-24903	279	10	21(1	21(1	NUM
brj-24903	279	11	)	)	PUNCT
brj-24903	279	12	,	,	PUNCT
brj-24903	279	13	160	160	NUM
brj-24903	279	14	-	-	SYM
brj-24903	279	15	177	177	NUM
brj-24903	279	16	.	.	PUNCT
brj-24903	280	1	171	171	NUM
brj-24903	280	2	it	it	PRON
brj-24903	280	3	was	be	AUX
brj-24903	280	4	found	find	VERB
brj-24903	280	5	that	that	SCONJ
brj-24903	280	6	chondrocyte	chondrocyte	PROPN
brj-24903	280	7	viability	viability	NOUN
brj-24903	280	8	was	be	AUX
brj-24903	280	9	unaffected	unaffected	ADJ
brj-24903	280	10	by	by	ADP
brj-24903	280	11	a.	a.	NOUN
brj-24903	280	12	glycyphyllos	glycyphyllos	PROPN
brj-24903	280	13	extract	extract	VERB
brj-24903	280	14	at	at	ADP
brj-24903	280	15	concentrations	concentration	NOUN
brj-24903	280	16	of	of	ADP
brj-24903	280	17	50	50	NUM
brj-24903	280	18	and	and	CCONJ
brj-24903	280	19	100	100	NUM
brj-24903	280	20	μg	μg	NOUN
brj-24903	280	21	/	/	SYM
brj-24903	280	22	ml	ml	NOUN
brj-24903	280	23	.	.	PUNCT
brj-24903	281	1	thus	thus	ADV
brj-24903	281	2	,	,	PUNCT
brj-24903	281	3	50	50	NUM
brj-24903	281	4	and	and	CCONJ
brj-24903	281	5	100	100	NUM
brj-24903	281	6	μg	μg	NOUN
brj-24903	281	7	/	/	SYM
brj-24903	281	8	ml	ml	PROPN
brj-24903	281	9	doses	dose	NOUN
brj-24903	281	10	were	be	AUX
brj-24903	281	11	selected	select	VERB
brj-24903	281	12	for	for	ADP
brj-24903	281	13	more	more	ADJ
brj-24903	281	14	research	research	NOUN
brj-24903	281	15	.	.	PUNCT
brj-24903	282	1	extract	extract	VERB
brj-24903	282	2	from	from	ADP
brj-24903	282	3	a.	a.	NOUN
brj-24903	282	4	glycyphyllos	glycyphyllos	PROPN
brj-24903	282	5	leaves	leave	NOUN
brj-24903	282	6	reduces	reduce	VERB
brj-24903	282	7	the	the	DET
brj-24903	282	8	levels	level	NOUN
brj-24903	282	9	of	of	ADP
brj-24903	282	10	no	no	PRON
brj-24903	282	11	,	,	PUNCT
brj-24903	282	12	pge2	pge2	NOUN
brj-24903	282	13	,	,	PUNCT
brj-24903	282	14	and	and	CCONJ
brj-24903	282	15	enzymes	enzyme	NOUN
brj-24903	282	16	that	that	PRON
brj-24903	282	17	break	break	VERB
brj-24903	282	18	down	down	ADP
brj-24903	282	19	the	the	DET
brj-24903	282	20	matrix	matrix	NOUN
brj-24903	282	21	in	in	ADP
brj-24903	282	22	prcs	prcs	PROPN
brj-24903	282	23	when	when	SCONJ
brj-24903	282	24	exposed	expose	VERB
brj-24903	282	25	to	to	ADP
brj-24903	282	26	il-1β	il-1β	PROPN
brj-24903	282	27	in	in	ADP
brj-24903	282	28	prcs	prcs	PROPN
brj-24903	282	29	,	,	PUNCT
brj-24903	282	30	il-1β	il-1β	PROPN
brj-24903	282	31	induction	induction	NOUN
brj-24903	282	32	results	result	VERB
brj-24903	282	33	in	in	ADP
brj-24903	282	34	an	an	DET
brj-24903	282	35	inflammatory	inflammatory	ADJ
brj-24903	282	36	response	response	NOUN
brj-24903	282	37	that	that	PRON
brj-24903	282	38	is	be	AUX
brj-24903	282	39	both	both	CCONJ
brj-24903	282	40	excessive	excessive	ADJ
brj-24903	282	41	and	and	CCONJ
brj-24903	282	42	long	long	ADV
brj-24903	282	43	-	-	PUNCT
brj-24903	282	44	lasting	last	VERB
brj-24903	282	45	.	.	PUNCT
brj-24903	283	1	chondrocyte	chondrocyte	ADJ
brj-24903	283	2	destruction	destruction	NOUN
brj-24903	283	3	may	may	AUX
brj-24903	283	4	be	be	AUX
brj-24903	283	5	induced	induce	VERB
brj-24903	283	6	by	by	ADP
brj-24903	283	7	the	the	DET
brj-24903	283	8	rise	rise	NOUN
brj-24903	283	9	in	in	ADP
brj-24903	283	10	no	no	PRON
brj-24903	283	11	and	and	CCONJ
brj-24903	283	12	pge2	pge2	NOUN
brj-24903	283	13	levels	level	NOUN
brj-24903	283	14	brought	bring	VERB
brj-24903	283	15	on	on	ADP
brj-24903	283	16	by	by	ADP
brj-24903	283	17	il-1β	il-1β	PROPN
brj-24903	283	18	;	;	PUNCT
brj-24903	283	19	however	however	ADV
brj-24903	283	20	,	,	PUNCT
brj-24903	283	21	the	the	DET
brj-24903	283	22	destruction	destruction	NOUN
brj-24903	283	23	may	may	AUX
brj-24903	283	24	be	be	AUX
brj-24903	283	25	prevented	prevent	VERB
brj-24903	283	26	by	by	ADP
brj-24903	283	27	inhibiting	inhibit	VERB
brj-24903	283	28	the	the	DET
brj-24903	283	29	activation	activation	NOUN
brj-24903	283	30	of	of	ADP
brj-24903	283	31	these	these	DET
brj-24903	283	32	inflammatory	inflammatory	ADJ
brj-24903	283	33	mediators	mediator	NOUN
brj-24903	283	34	(	(	PUNCT
brj-24903	283	35	aury	aury	ADJ
brj-24903	283	36	-	-	PUNCT
brj-24903	283	37	landas	landa	NOUN
brj-24903	283	38	et	et	PROPN
brj-24903	283	39	al	al	PROPN
brj-24903	283	40	.	.	PROPN
brj-24903	283	41	2017	2017	NUM
brj-24903	283	42	)	)	PUNCT
brj-24903	283	43	.	.	PUNCT
brj-24903	284	1	thus	thus	ADV
brj-24903	284	2	,	,	PUNCT
brj-24903	284	3	it	it	PRON
brj-24903	284	4	was	be	AUX
brj-24903	284	5	determined	determine	VERB
brj-24903	284	6	whether	whether	SCONJ
brj-24903	284	7	the	the	DET
brj-24903	284	8	extract	extract	NOUN
brj-24903	284	9	might	might	AUX
brj-24903	284	10	lower	lower	VERB
brj-24903	284	11	the	the	DET
brj-24903	284	12	high	high	ADJ
brj-24903	284	13	levels	level	NOUN
brj-24903	284	14	of	of	ADP
brj-24903	284	15	inflammatory	inflammatory	ADJ
brj-24903	284	16	mediators	mediator	NOUN
brj-24903	284	17	no	no	INTJ
brj-24903	284	18	and	and	CCONJ
brj-24903	284	19	pge2	pge2	VERB
brj-24903	284	20	by	by	ADP
brj-24903	284	21	examining	examine	VERB
brj-24903	284	22	its	its	PRON
brj-24903	284	23	influence	influence	NOUN
brj-24903	284	24	on	on	ADP
brj-24903	284	25	the	the	DET
brj-24903	284	26	il-1β	il-1β	PROPN
brj-24903	284	27	-	-	PUNCT
brj-24903	284	28	induced	induce	VERB
brj-24903	284	29	inflammatory	inflammatory	ADJ
brj-24903	284	30	response	response	NOUN
brj-24903	284	31	in	in	ADP
brj-24903	284	32	prcs	prcs	PROPN
brj-24903	284	33	.	.	PUNCT
brj-24903	285	1	the	the	DET
brj-24903	285	2	griess	griess	NOUN
brj-24903	285	3	reagent	reagent	NOUN
brj-24903	285	4	and	and	CCONJ
brj-24903	285	5	the	the	DET
brj-24903	285	6	sandwiched	sandwich	VERB
brj-24903	285	7	elisa	elisa	NOUN
brj-24903	285	8	method	method	NOUN
brj-24903	285	9	were	be	AUX
brj-24903	285	10	used	use	VERB
brj-24903	285	11	,	,	PUNCT
brj-24903	285	12	respectively	respectively	ADV
brj-24903	285	13	,	,	PUNCT
brj-24903	285	14	to	to	PART
brj-24903	285	15	evaluate	evaluate	VERB
brj-24903	285	16	these	these	PRON
brj-24903	285	17	.	.	PUNCT
brj-24903	286	1	the	the	DET
brj-24903	286	2	findings	finding	NOUN
brj-24903	286	3	show	show	VERB
brj-24903	286	4	that	that	SCONJ
brj-24903	286	5	expression	expression	NOUN
brj-24903	286	6	of	of	ADP
brj-24903	286	7	nitric	nitric	ADJ
brj-24903	286	8	oxide	oxide	NOUN
brj-24903	286	9	(	(	PUNCT
brj-24903	286	10	no	no	NOUN
brj-24903	286	11	)	)	PUNCT
brj-24903	286	12	and	and	CCONJ
brj-24903	286	13	prostaglandin	prostaglandin	PROPN
brj-24903	286	14	e2	e2	PROPN
brj-24903	286	15	(	(	PUNCT
brj-24903	286	16	pge2	pge2	PROPN
brj-24903	286	17	)	)	PUNCT
brj-24903	286	18	was	be	AUX
brj-24903	286	19	significantly	significantly	ADV
brj-24903	286	20	elevated	elevate	VERB
brj-24903	286	21	in	in	ADP
brj-24903	286	22	the	the	DET
brj-24903	286	23	il-1β	il-1β	PROPN
brj-24903	286	24	-	-	PUNCT
brj-24903	286	25	treated	treat	VERB
brj-24903	286	26	group	group	NOUN
brj-24903	286	27	.	.	PUNCT
brj-24903	287	1	nevertheless	nevertheless	ADV
brj-24903	287	2	,	,	PUNCT
brj-24903	287	3	the	the	DET
brj-24903	287	4	increase	increase	NOUN
brj-24903	287	5	of	of	ADP
brj-24903	287	6	no	no	PRON
brj-24903	287	7	and	and	CCONJ
brj-24903	287	8	pge2	pge2	NOUN
brj-24903	287	9	was	be	AUX
brj-24903	287	10	reduced	reduce	VERB
brj-24903	287	11	in	in	ADP
brj-24903	287	12	a	a	DET
brj-24903	287	13	dose	dose	NOUN
brj-24903	287	14	-	-	PUNCT
brj-24903	287	15	dependent	dependent	ADJ
brj-24903	287	16	manner	manner	NOUN
brj-24903	287	17	by	by	ADP
brj-24903	287	18	pre	pre	ADJ
brj-24903	287	19	-	-	NOUN
brj-24903	287	20	treatment	treatment	NOUN
brj-24903	287	21	with	with	ADP
brj-24903	287	22	a.	a.	NOUN
brj-24903	287	23	glycyphyllos	glycyphyllos	PROPN
brj-24903	287	24	leaves	leave	NOUN
brj-24903	287	25	extract	extract	VERB
brj-24903	287	26	(	(	PUNCT
brj-24903	287	27	table	table	NOUN
brj-24903	287	28	4	4	NUM
brj-24903	287	29	)	)	PUNCT
brj-24903	287	30	.	.	PUNCT
brj-24903	288	1	furthermore	furthermore	ADV
brj-24903	288	2	,	,	PUNCT
brj-24903	288	3	it	it	PRON
brj-24903	288	4	is	be	AUX
brj-24903	288	5	well	well	ADV
brj-24903	288	6	known	know	VERB
brj-24903	288	7	that	that	SCONJ
brj-24903	288	8	inos	ino	NOUN
brj-24903	288	9	is	be	AUX
brj-24903	288	10	the	the	DET
brj-24903	288	11	primary	primary	ADJ
brj-24903	288	12	catalyst	catalyst	NOUN
brj-24903	288	13	for	for	ADP
brj-24903	288	14	no	no	DET
brj-24903	288	15	production	production	NOUN
brj-24903	288	16	(	(	PUNCT
brj-24903	288	17	liu	liu	PROPN
brj-24903	288	18	et	et	PROPN
brj-24903	288	19	al	al	PROPN
brj-24903	288	20	.	.	PROPN
brj-24903	288	21	2017	2017	NUM
brj-24903	288	22	)	)	PUNCT
brj-24903	288	23	;	;	PUNCT
brj-24903	288	24	as	as	ADP
brj-24903	288	25	a	a	DET
brj-24903	288	26	result	result	NOUN
brj-24903	288	27	,	,	PUNCT
brj-24903	288	28	the	the	DET
brj-24903	288	29	downregulation	downregulation	NOUN
brj-24903	288	30	of	of	ADP
brj-24903	288	31	inos	ino	NOUN
brj-24903	288	32	by	by	ADP
brj-24903	288	33	the	the	DET
brj-24903	288	34	extract	extract	NOUN
brj-24903	288	35	may	may	AUX
brj-24903	288	36	be	be	AUX
brj-24903	288	37	the	the	DET
brj-24903	288	38	cause	cause	NOUN
brj-24903	288	39	of	of	ADP
brj-24903	288	40	the	the	DET
brj-24903	288	41	decrease	decrease	NOUN
brj-24903	288	42	in	in	ADP
brj-24903	288	43	no	no	DET
brj-24903	288	44	levels	level	NOUN
brj-24903	288	45	in	in	ADP
brj-24903	288	46	prcs	prcs	PROPN
brj-24903	288	47	.	.	PUNCT
brj-24903	289	1	the	the	DET
brj-24903	289	2	release	release	NOUN
brj-24903	289	3	of	of	ADP
brj-24903	289	4	mmps	mmp	NOUN
brj-24903	289	5	and	and	CCONJ
brj-24903	289	6	adamtss	adamtss	PRON
brj-24903	289	7	(	(	PUNCT
brj-24903	289	8	short	short	ADJ
brj-24903	289	9	for	for	ADP
brj-24903	289	10	a	a	DET
brj-24903	289	11	disintegrin	disintegrin	NOUN
brj-24903	289	12	and	and	CCONJ
brj-24903	289	13	mmp	mmp	PROPN
brj-24903	289	14	with	with	ADP
brj-24903	289	15	thrombospondin	thrombospondin	VERB
brj-24903	289	16	shapes	shape	NOUN
brj-24903	289	17	or	or	CCONJ
brj-24903	289	18	motifs	motif	NOUN
brj-24903	289	19	)	)	PUNCT
brj-24903	289	20	is	be	AUX
brj-24903	289	21	triggered	trigger	VERB
brj-24903	289	22	by	by	ADP
brj-24903	289	23	inflammatory	inflammatory	ADJ
brj-24903	289	24	mediators	mediator	NOUN
brj-24903	289	25	,	,	PUNCT
brj-24903	289	26	no	no	INTJ
brj-24903	289	27	,	,	PUNCT
brj-24903	289	28	and	and	CCONJ
brj-24903	289	29	pge2	pge2	NOUN
brj-24903	289	30	.	.	PUNCT
brj-24903	290	1	this	this	DET
brj-24903	290	2	process	process	NOUN
brj-24903	290	3	further	far	ADV
brj-24903	290	4	destroys	destroy	VERB
brj-24903	290	5	collagen	collagen	NOUN
brj-24903	290	6	and	and	CCONJ
brj-24903	290	7	aggrecan	aggrecan	ADJ
brj-24903	290	8	,	,	PUNCT
brj-24903	290	9	which	which	PRON
brj-24903	290	10	are	be	AUX
brj-24903	290	11	crucial	crucial	ADJ
brj-24903	290	12	components	component	NOUN
brj-24903	290	13	of	of	ADP
brj-24903	290	14	the	the	DET
brj-24903	290	15	cartilage	cartilage	NOUN
brj-24903	290	16	matrix	matrix	NOUN
brj-24903	290	17	(	(	PUNCT
brj-24903	290	18	aury	aury	NOUN
brj-24903	290	19	-	-	PUNCT
brj-24903	290	20	landas	landa	NOUN
brj-24903	290	21	et	et	PROPN
brj-24903	290	22	al	al	PROPN
brj-24903	290	23	.	.	PROPN
brj-24903	290	24	2017	2017	NUM
brj-24903	290	25	)	)	PUNCT
brj-24903	290	26	.	.	PUNCT
brj-24903	291	1	consequently	consequently	ADV
brj-24903	291	2	,	,	PUNCT
brj-24903	291	3	elisa	elisa	VERB
brj-24903	291	4	assays	assay	NOUN
brj-24903	291	5	were	be	AUX
brj-24903	291	6	used	use	VERB
brj-24903	291	7	to	to	PART
brj-24903	291	8	determine	determine	VERB
brj-24903	291	9	the	the	DET
brj-24903	291	10	impact	impact	NOUN
brj-24903	291	11	of	of	ADP
brj-24903	291	12	the	the	DET
brj-24903	291	13	extract	extract	NOUN
brj-24903	291	14	on	on	ADP
brj-24903	291	15	the	the	PRON
brj-24903	291	16	mmp-1	mmp-1	PUNCT
brj-24903	291	17	and	and	CCONJ
brj-24903	291	18	mmp-13	mmp-13	VERB
brj-24903	291	19	levels	level	NOUN
brj-24903	291	20	of	of	ADP
brj-24903	291	21	il-1β	il-1β	PROPN
brj-24903	291	22	-	-	PUNCT
brj-24903	291	23	challenged	challenge	VERB
brj-24903	291	24	prcs	prcs	PROPN
brj-24903	291	25	.	.	PUNCT
brj-24903	292	1	the	the	DET
brj-24903	292	2	outcomes	outcome	NOUN
brj-24903	292	3	showed	show	VERB
brj-24903	292	4	that	that	SCONJ
brj-24903	292	5	following	follow	VERB
brj-24903	292	6	il-1β	il-1β	PROPN
brj-24903	292	7	therapy	therapy	NOUN
brj-24903	292	8	,	,	PUNCT
brj-24903	292	9	mmp-1	mmp-1	PUNCT
brj-24903	292	10	and	and	CCONJ
brj-24903	292	11	mmp-13	mmp-13	VERB
brj-24903	292	12	levels	level	NOUN
brj-24903	292	13	dramatically	dramatically	ADV
brj-24903	292	14	rose	rise	VERB
brj-24903	292	15	.	.	PUNCT
brj-24903	293	1	on	on	ADP
brj-24903	293	2	the	the	DET
brj-24903	293	3	other	other	ADJ
brj-24903	293	4	hand	hand	NOUN
brj-24903	293	5	,	,	PUNCT
brj-24903	293	6	extract	extract	VERB
brj-24903	293	7	pre	pre	ADJ
brj-24903	293	8	-	-	ADJ
brj-24903	293	9	treatment	treatment	ADJ
brj-24903	293	10	dose	dose	NOUN
brj-24903	293	11	-	-	PUNCT
brj-24903	293	12	dependently	dependently	ADV
brj-24903	293	13	reduced	reduce	VERB
brj-24903	293	14	mmp-1	mmp-1	PUNCT
brj-24903	293	15	and	and	CCONJ
brj-24903	293	16	mmp-13	mmp-13	VERB
brj-24903	293	17	levels	level	NOUN
brj-24903	293	18	caused	cause	VERB
brj-24903	293	19	by	by	ADP
brj-24903	293	20	il-1β	il-1β	PROPN
brj-24903	293	21	(	(	PUNCT
brj-24903	293	22	table	table	NOUN
brj-24903	293	23	4	4	NUM
brj-24903	293	24	)	)	PUNCT
brj-24903	293	25	.	.	PUNCT
brj-24903	294	1	table	table	NOUN
brj-24903	294	2	4	4	NUM
brj-24903	294	3	.	.	PUNCT
brj-24903	294	4	effect	effect	NOUN
brj-24903	294	5	of	of	ADP
brj-24903	294	6	a.	a.	NOUN
brj-24903	294	7	glycyphyllos	glycyphyllos	PROPN
brj-24903	294	8	leaves	leave	NOUN
brj-24903	294	9	extract	extract	VERB
brj-24903	294	10	on	on	ADP
brj-24903	294	11	no	no	DET
brj-24903	294	12	,	,	PUNCT
brj-24903	294	13	pge2	pge2	NOUN
brj-24903	294	14	,	,	PUNCT
brj-24903	294	15	mmp-1	mmp-1	PUNCT
brj-24903	294	16	and	and	CCONJ
brj-24903	294	17	mmp-13	mmp-13	VERB
brj-24903	294	18	levels	level	NOUN
brj-24903	294	19	in	in	ADP
brj-24903	294	20	prcs	prcs	PROPN
brj-24903	294	21	treatment	treatment	NOUN
brj-24903	294	22	no	no	PRON
brj-24903	294	23	(	(	PUNCT
brj-24903	294	24	μmol	μmol	NOUN
brj-24903	294	25	)	)	PUNCT
brj-24903	294	26	pge2	pge2	NOUN
brj-24903	294	27	(	(	PUNCT
brj-24903	294	28	ρg	ρg	NOUN
brj-24903	294	29	/	/	SYM
brj-24903	294	30	ml	ml	NOUN
brj-24903	294	31	)	)	PUNCT
brj-24903	294	32	mmp-1	mmp-1	PUNCT
brj-24903	294	33	(	(	PUNCT
brj-24903	294	34	ηg	ηg	NOUN
brj-24903	294	35	/	/	SYM
brj-24903	294	36	ml	ml	NOUN
brj-24903	294	37	)	)	PUNCT
brj-24903	294	38	mmp-13	mmp-13	PROPN
brj-24903	294	39	(	(	PUNCT
brj-24903	294	40	ηg	ηg	NOUN
brj-24903	294	41	/	/	SYM
brj-24903	294	42	ml	ml	NOUN
brj-24903	294	43	)	)	PUNCT
brj-24903	294	44	control	control	NOUN
brj-24903	294	45	(	(	PUNCT
brj-24903	294	46	il-1β	il-1β	PROPN
brj-24903	294	47	)	)	PUNCT
brj-24903	294	48	90.62±2.59	90.62±2.59	NUM
brj-24903	294	49	985.21±14.70	985.21±14.70	NUM
brj-24903	294	50	254.10±2.90	254.10±2.90	NUM
brj-24903	294	51	219.27±2.45	219.27±2.45	NUM
brj-24903	294	52	a.	a.	NOUN
brj-24903	294	53	glycyphyllos	glycyphyllos	NOUN
brj-24903	294	54	(	(	PUNCT
brj-24903	294	55	50	50	NUM
brj-24903	294	56	μg	μg	NOUN
brj-24903	294	57	/	/	SYM
brj-24903	294	58	ml	ml	NOUN
brj-24903	294	59	)	)	PUNCT
brj-24903	294	60	62.58±1.81	62.58±1.81	NUM
brj-24903	294	61	*	*	PUNCT
brj-24903	294	62	*	*	PUNCT
brj-24903	294	63	702.26±15.28	702.26±15.28	NUM
brj-24903	294	64	*	*	NOUN
brj-24903	294	65	116.36±2.15	116.36±2.15	NOUN
brj-24903	294	66	*	*	NOUN
brj-24903	294	67	*	*	PUNCT
brj-24903	294	68	*	*	PUNCT
brj-24903	294	69	90.36±1.47	90.36±1.47	X
brj-24903	294	70	*	*	PUNCT
brj-24903	294	71	*	*	PUNCT
brj-24903	294	72	*	*	PUNCT
brj-24903	294	73	a.	a.	NOUN
brj-24903	294	74	glycyphyllos	glycyphyllos	NOUN
brj-24903	294	75	(	(	PUNCT
brj-24903	294	76	100	100	NUM
brj-24903	294	77	μg	μg	NOUN
brj-24903	294	78	/	/	SYM
brj-24903	294	79	ml	ml	NOUN
brj-24903	294	80	)	)	PUNCT
brj-24903	294	81	40.72±1.05	40.72±1.05	NOUN
brj-24903	294	82	*	*	PUNCT
brj-24903	294	83	*	*	PUNCT
brj-24903	294	84	*	*	PUNCT
brj-24903	295	1	412.37±16.30	412.37±16.30	NUM
brj-24903	295	2	*	*	PUNCT
brj-24903	295	3	*	*	PUNCT
brj-24903	295	4	*	*	PUNCT
brj-24903	295	5	76.27±1.22	76.27±1.22	X
brj-24903	295	6	*	*	PUNCT
brj-24903	295	7	*	*	PUNCT
brj-24903	295	8	*	*	PUNCT
brj-24903	295	9	60.82±0.81	60.82±0.81	NUM
brj-24903	295	10	*	*	PUNCT
brj-24903	295	11	*	*	PUNCT
brj-24903	295	12	*	*	NOUN
brj-24903	295	13	data	datum	NOUN
brj-24903	295	14	are	be	AUX
brj-24903	295	15	represented	represent	VERB
brj-24903	295	16	as	as	ADP
brj-24903	295	17	mean	mean	ADJ
brj-24903	295	18	±sem	±sem	NOUN
brj-24903	295	19	(	(	PUNCT
brj-24903	295	20	n=	n=	ADJ
brj-24903	295	21	6	6	NUM
brj-24903	295	22	)	)	PUNCT
brj-24903	295	23	.	.	PUNCT
brj-24903	296	1	#	#	SYM
brj-24903	296	2	#	#	SYM
brj-24903	296	3	#	#	AUX
brj-24903	296	4	p<0.001	p<0.001	VERB
brj-24903	296	5	considered	consider	VERB
brj-24903	296	6	statistically	statistically	ADV
brj-24903	296	7	noteworthy	noteworthy	ADJ
brj-24903	296	8	as	as	SCONJ
brj-24903	296	9	judged	judge	VERB
brj-24903	296	10	against	against	ADP
brj-24903	296	11	normal	normal	ADJ
brj-24903	296	12	control	control	NOUN
brj-24903	296	13	group	group	NOUN
brj-24903	296	14	;	;	PUNCT
brj-24903	296	15	*	*	PUNCT
brj-24903	296	16	p<0.05	p<0.05	NOUN
brj-24903	296	17	,	,	PUNCT
brj-24903	296	18	*	*	PUNCT
brj-24903	296	19	*	*	PUNCT
brj-24903	296	20	p<0.01	p<0.01	PRON
brj-24903	296	21	as	as	ADV
brj-24903	296	22	well	well	ADV
brj-24903	296	23	as	as	ADP
brj-24903	296	24	*	*	NOUN
brj-24903	296	25	*	*	PUNCT
brj-24903	296	26	*	*	PUNCT
brj-24903	296	27	p<0.001	p<0.001	AUX
brj-24903	296	28	considered	consider	VERB
brj-24903	296	29	statistically	statistically	ADV
brj-24903	296	30	noteworthy	noteworthy	ADJ
brj-24903	296	31	as	as	SCONJ
brj-24903	296	32	judged	judge	VERB
brj-24903	296	33	against	against	ADP
brj-24903	296	34	control	control	NOUN
brj-24903	296	35	group	group	PROPN
brj-24903	296	36	.	.	PUNCT
brj-24903	297	1	discussion	discussion	NOUN
brj-24903	297	2	multifactorial	multifactorial	ADJ
brj-24903	297	3	autoimmune	autoimmune	ADJ
brj-24903	297	4	arthritis	arthritis	NOUN
brj-24903	297	5	is	be	AUX
brj-24903	297	6	characterized	characterize	VERB
brj-24903	297	7	by	by	ADP
brj-24903	297	8	persistent	persistent	ADJ
brj-24903	297	9	swelling	swelling	NOUN
brj-24903	297	10	in	in	ADP
brj-24903	297	11	several	several	ADJ
brj-24903	297	12	joints	joint	NOUN
brj-24903	297	13	accompanied	accompany	VERB
brj-24903	297	14	by	by	ADP
brj-24903	297	15	inflammatory	inflammatory	ADJ
brj-24903	297	16	cells	cell	NOUN
brj-24903	297	17	.	.	PUNCT
brj-24903	298	1	nsaids	nsaid	NOUN
brj-24903	298	2	are	be	AUX
brj-24903	298	3	commonly	commonly	ADV
brj-24903	298	4	used	use	VERB
brj-24903	298	5	as	as	ADP
brj-24903	298	6	monotherapy	monotherapy	NOUN
brj-24903	298	7	or	or	CCONJ
brj-24903	298	8	in	in	ADP
brj-24903	298	9	conjunction	conjunction	NOUN
brj-24903	298	10	with	with	ADP
brj-24903	298	11	other	other	ADJ
brj-24903	298	12	therapies	therapy	NOUN
brj-24903	298	13	to	to	PART
brj-24903	298	14	treat	treat	VERB
brj-24903	298	15	arthritis	arthritis	NOUN
brj-24903	298	16	.	.	PUNCT
brj-24903	299	1	however	however	ADV
brj-24903	299	2	,	,	PUNCT
brj-24903	299	3	their	their	PRON
brj-24903	299	4	severe	severe	ADJ
brj-24903	299	5	side	side	NOUN
brj-24903	299	6	effects	effect	NOUN
brj-24903	299	7	make	make	VERB
brj-24903	299	8	finding	find	VERB
brj-24903	299	9	more	more	ADV
brj-24903	299	10	effective	effective	ADJ
brj-24903	299	11	and	and	CCONJ
brj-24903	299	12	secure	secure	ADJ
brj-24903	299	13	treatments	treatment	NOUN
brj-24903	299	14	difficult	difficult	ADJ
brj-24903	299	15	(	(	PUNCT
brj-24903	299	16	khurana	khurana	NOUN
brj-24903	299	17	and	and	CCONJ
brj-24903	299	18	berney	berney	NOUN
brj-24903	299	19	2005	2005	NUM
brj-24903	299	20	;	;	PUNCT
brj-24903	299	21	ferreira	ferreira	PROPN
brj-24903	299	22	et	et	PROPN
brj-24903	299	23	al	al	PROPN
brj-24903	299	24	.	.	PROPN
brj-24903	299	25	2016	2016	NUM
brj-24903	299	26	)	)	PUNCT
brj-24903	299	27	.	.	PUNCT
brj-24903	300	1	clinical	clinical	ADJ
brj-24903	300	2	trials	trial	NOUN
brj-24903	300	3	have	have	AUX
brj-24903	300	4	employed	employ	VERB
brj-24903	300	5	medicinal	medicinal	ADJ
brj-24903	300	6	plants	plant	NOUN
brj-24903	300	7	to	to	PART
brj-24903	300	8	treat	treat	VERB
brj-24903	300	9	peer	peer	NOUN
brj-24903	300	10	-	-	PUNCT
brj-24903	300	11	reviewed	review	VERB
brj-24903	300	12	article	article	NOUN
brj-24903	300	13	bioresources.cnr.ncsu.edu	bioresources.cnr.ncsu.edu	X
brj-24903	300	14	gu	gu	VERB
brj-24903	300	15	et	et	PROPN
brj-24903	300	16	al	al	PROPN
brj-24903	300	17	.	.	PROPN
brj-24903	301	1	(	(	PUNCT
brj-24903	301	2	2026	2026	NUM
brj-24903	301	3	)	)	PUNCT
brj-24903	301	4	.	.	PUNCT
brj-24903	302	1	“	"	PUNCT
brj-24903	302	2	astragalus	astragalus	NOUN
brj-24903	302	3	leaf	leaf	NOUN
brj-24903	302	4	extract	extract	NOUN
brj-24903	302	5	vs.	vs.	ADP
brj-24903	302	6	arthritis	arthritis	NOUN
brj-24903	302	7	,	,	PUNCT
brj-24903	302	8	”	"	PUNCT
brj-24903	302	9	bioresources	bioresource	NOUN
brj-24903	302	10	21(1	21(1	NUM
brj-24903	302	11	)	)	PUNCT
brj-24903	302	12	,	,	PUNCT
brj-24903	302	13	160	160	NUM
brj-24903	302	14	-	-	SYM
brj-24903	302	15	177	177	NUM
brj-24903	302	16	.	.	PUNCT
brj-24903	303	1	172	172	NUM
brj-24903	303	2	arthralgia	arthralgia	NOUN
brj-24903	303	3	,	,	PUNCT
brj-24903	303	4	which	which	PRON
brj-24903	303	5	is	be	AUX
brj-24903	303	6	more	more	ADV
brj-24903	303	7	convenient	convenient	ADJ
brj-24903	303	8	and	and	CCONJ
brj-24903	303	9	well	well	ADV
brj-24903	303	10	-	-	PUNCT
brj-24903	303	11	tolerated	tolerate	VERB
brj-24903	303	12	for	for	ADP
brj-24903	303	13	individuals	individual	NOUN
brj-24903	303	14	with	with	ADP
brj-24903	303	15	arthritis	arthritis	NOUN
brj-24903	303	16	(	(	PUNCT
brj-24903	303	17	kaur	kaur	PROPN
brj-24903	303	18	et	et	PROPN
brj-24903	303	19	al	al	PROPN
brj-24903	303	20	.	.	PROPN
brj-24903	303	21	2012	2012	NUM
brj-24903	303	22	)	)	PUNCT
brj-24903	303	23	.	.	PUNCT
brj-24903	304	1	in	in	ADP
brj-24903	304	2	rats	rat	NOUN
brj-24903	304	3	with	with	ADP
brj-24903	304	4	cfa	cfa	PROPN
brj-24903	304	5	exposure	exposure	NOUN
brj-24903	304	6	,	,	PUNCT
brj-24903	304	7	the	the	DET
brj-24903	304	8	anti	anti	ADJ
brj-24903	304	9	-	-	ADJ
brj-24903	304	10	arthritic	arthritic	ADJ
brj-24903	304	11	properties	property	NOUN
brj-24903	304	12	of	of	ADP
brj-24903	304	13	a.	a.	NOUN
brj-24903	304	14	glycyphyllos	glycyphyllos	PROPN
brj-24903	304	15	leaf	leaf	NOUN
brj-24903	304	16	extract	extract	NOUN
brj-24903	304	17	(	(	PUNCT
brj-24903	304	18	100	100	NUM
brj-24903	304	19	and	and	CCONJ
brj-24903	304	20	200	200	NUM
brj-24903	304	21	mg	mg	NUM
brj-24903	304	22	/	/	SYM
brj-24903	304	23	kg	kg	PROPN
brj-24903	304	24	)	)	PUNCT
brj-24903	304	25	were	be	AUX
brj-24903	304	26	examined	examine	VERB
brj-24903	304	27	in	in	ADP
brj-24903	304	28	this	this	DET
brj-24903	304	29	work	work	NOUN
brj-24903	304	30	.	.	PUNCT
brj-24903	305	1	the	the	DET
brj-24903	305	2	results	result	NOUN
brj-24903	305	3	showed	show	VERB
brj-24903	305	4	that	that	SCONJ
brj-24903	305	5	the	the	DET
brj-24903	305	6	extract	extract	NOUN
brj-24903	305	7	from	from	ADP
brj-24903	305	8	a.	a.	NOUN
brj-24903	305	9	glycyphyllos	glycyphyllos	PROPN
brj-24903	305	10	prevented	prevent	VERB
brj-24903	305	11	inflammatory	inflammatory	ADJ
brj-24903	305	12	paw	paw	NOUN
brj-24903	305	13	edema	edema	NOUN
brj-24903	305	14	in	in	ADP
brj-24903	305	15	both	both	CCONJ
brj-24903	305	16	the	the	DET
brj-24903	305	17	acute	acute	ADJ
brj-24903	305	18	and	and	CCONJ
brj-24903	305	19	chronic	chronic	ADJ
brj-24903	305	20	phases	phase	NOUN
brj-24903	305	21	of	of	ADP
brj-24903	305	22	arthritis	arthritis	NOUN
brj-24903	305	23	caused	cause	VERB
brj-24903	305	24	by	by	ADP
brj-24903	305	25	cfa	cfa	PROPN
brj-24903	305	26	.	.	PUNCT
brj-24903	306	1	the	the	DET
brj-24903	306	2	cfa	cfa	PROPN
brj-24903	306	3	-	-	PUNCT
brj-24903	306	4	induced	induce	VERB
brj-24903	306	5	ra	ra	PROPN
brj-24903	306	6	model	model	NOUN
brj-24903	306	7	was	be	AUX
brj-24903	306	8	used	use	VERB
brj-24903	306	9	to	to	PART
brj-24903	306	10	evaluate	evaluate	VERB
brj-24903	306	11	the	the	DET
brj-24903	306	12	anti	anti	ADJ
brj-24903	306	13	-	-	ADJ
brj-24903	306	14	arthritic	arthritic	ADJ
brj-24903	306	15	efficacy	efficacy	NOUN
brj-24903	306	16	as	as	ADV
brj-24903	306	17	well	well	ADV
brj-24903	306	18	as	as	ADP
brj-24903	306	19	the	the	DET
brj-24903	306	20	physiological	physiological	ADJ
brj-24903	306	21	or	or	CCONJ
brj-24903	306	22	therapeutic	therapeutic	ADJ
brj-24903	306	23	modulation	modulation	NOUN
brj-24903	306	24	of	of	ADP
brj-24903	306	25	systems	system	NOUN
brj-24903	306	26	connected	connect	VERB
brj-24903	306	27	to	to	ADP
brj-24903	306	28	inflammation	inflammation	NOUN
brj-24903	306	29	.	.	PUNCT
brj-24903	307	1	after	after	ADP
brj-24903	307	2	cfa	cfa	PROPN
brj-24903	307	3	induction	induction	NOUN
brj-24903	307	4	,	,	PUNCT
brj-24903	307	5	there	there	PRON
brj-24903	307	6	was	be	VERB
brj-24903	307	7	localized	localized	ADJ
brj-24903	307	8	inflammation	inflammation	NOUN
brj-24903	307	9	for	for	ADP
brj-24903	307	10	the	the	DET
brj-24903	307	11	first	first	ADJ
brj-24903	307	12	two	two	NUM
brj-24903	307	13	to	to	PART
brj-24903	307	14	four	four	NUM
brj-24903	307	15	days	day	NOUN
brj-24903	307	16	,	,	PUNCT
brj-24903	307	17	followed	follow	VERB
brj-24903	307	18	by	by	ADP
brj-24903	307	19	chronic	chronic	ADJ
brj-24903	307	20	inflammation	inflammation	NOUN
brj-24903	307	21	that	that	PRON
brj-24903	307	22	lasts	last	VERB
brj-24903	307	23	for	for	ADP
brj-24903	307	24	many	many	ADJ
brj-24903	307	25	weeks	week	NOUN
brj-24903	307	26	.	.	PUNCT
brj-24903	308	1	multiple	multiple	ADJ
brj-24903	308	2	immunological	immunological	ADJ
brj-24903	308	3	,	,	PUNCT
brj-24903	308	4	clinical	clinical	ADJ
brj-24903	308	5	,	,	PUNCT
brj-24903	308	6	and	and	CCONJ
brj-24903	308	7	chronic	chronic	ADJ
brj-24903	308	8	features	feature	NOUN
brj-24903	308	9	of	of	ADP
brj-24903	308	10	cfa	cfa	PROPN
brj-24903	308	11	have	have	AUX
brj-24903	308	12	been	be	AUX
brj-24903	308	13	connected	connect	VERB
brj-24903	308	14	to	to	ADP
brj-24903	308	15	arthritis	arthritis	NOUN
brj-24903	308	16	in	in	ADP
brj-24903	308	17	humans	human	NOUN
brj-24903	308	18	(	(	PUNCT
brj-24903	308	19	gupta	gupta	PROPN
brj-24903	308	20	et	et	PROPN
brj-24903	308	21	al	al	PROPN
brj-24903	308	22	.	.	PROPN
brj-24903	308	23	2020	2020	NUM
brj-24903	308	24	;	;	PUNCT
brj-24903	308	25	weng	weng	PROPN
brj-24903	308	26	et	et	PROPN
brj-24903	308	27	al	al	PROPN
brj-24903	308	28	.	.	PROPN
brj-24903	308	29	2021	2021	NUM
brj-24903	308	30	)	)	PUNCT
brj-24903	308	31	.	.	PUNCT
brj-24903	309	1	the	the	DET
brj-24903	309	2	arthritic	arthritic	ADJ
brj-24903	309	3	grade	grade	NOUN
brj-24903	309	4	,	,	PUNCT
brj-24903	309	5	a	a	DET
brj-24903	309	6	gauge	gauge	NOUN
brj-24903	309	7	of	of	ADP
brj-24903	309	8	joint	joint	ADJ
brj-24903	309	9	inflammation	inflammation	NOUN
brj-24903	309	10	,	,	PUNCT
brj-24903	309	11	indicates	indicate	VERB
brj-24903	309	12	the	the	DET
brj-24903	309	13	severity	severity	NOUN
brj-24903	309	14	of	of	ADP
brj-24903	309	15	arthritis	arthritis	NOUN
brj-24903	309	16	.	.	PUNCT
brj-24903	310	1	increased	increase	VERB
brj-24903	310	2	inflammatory	inflammatory	ADJ
brj-24903	310	3	processes	process	NOUN
brj-24903	310	4	,	,	PUNCT
brj-24903	310	5	the	the	DET
brj-24903	310	6	formation	formation	NOUN
brj-24903	310	7	of	of	ADP
brj-24903	310	8	arthritic	arthritic	ADJ
brj-24903	310	9	nodules	nodule	NOUN
brj-24903	310	10	in	in	ADP
brj-24903	310	11	the	the	DET
brj-24903	310	12	tail	tail	NOUN
brj-24903	310	13	and	and	CCONJ
brj-24903	310	14	ear	ear	NOUN
brj-24903	310	15	,	,	PUNCT
brj-24903	310	16	the	the	DET
brj-24903	310	17	continuation	continuation	NOUN
brj-24903	310	18	of	of	ADP
brj-24903	310	19	swelling	swell	VERB
brj-24903	310	20	on	on	ADP
brj-24903	310	21	the	the	DET
brj-24903	310	22	opposing	opposing	ADJ
brj-24903	310	23	side	side	NOUN
brj-24903	310	24	,	,	PUNCT
brj-24903	310	25	and	and	CCONJ
brj-24903	310	26	a	a	DET
brj-24903	310	27	protracted	protract	VERB
brj-24903	310	28	secondary	secondary	ADJ
brj-24903	310	29	reaction	reaction	NOUN
brj-24903	310	30	were	be	AUX
brj-24903	310	31	among	among	ADP
brj-24903	310	32	the	the	DET
brj-24903	310	33	cfa	cfa	NOUN
brj-24903	310	34	’s	’s	PART
brj-24903	310	35	early	early	ADJ
brj-24903	310	36	reactions	reaction	NOUN
brj-24903	310	37	.	.	PUNCT
brj-24903	311	1	in	in	ADP
brj-24903	311	2	the	the	DET
brj-24903	311	3	present	present	ADJ
brj-24903	311	4	investigation	investigation	NOUN
brj-24903	311	5	,	,	PUNCT
brj-24903	311	6	at	at	ADP
brj-24903	311	7	days	day	NOUN
brj-24903	311	8	7	7	NUM
brj-24903	311	9	,	,	PUNCT
brj-24903	311	10	14	14	NUM
brj-24903	311	11	,	,	PUNCT
brj-24903	311	12	21	21	NUM
brj-24903	311	13	,	,	PUNCT
brj-24903	311	14	and	and	CCONJ
brj-24903	311	15	28	28	NUM
brj-24903	311	16	,	,	PUNCT
brj-24903	311	17	the	the	DET
brj-24903	311	18	extract	extract	NOUN
brj-24903	311	19	from	from	ADP
brj-24903	311	20	a.	a.	NOUN
brj-24903	311	21	glycyphyllos	glycyphyllos	PROPN
brj-24903	311	22	leaves	leave	NOUN
brj-24903	311	23	(	(	PUNCT
brj-24903	311	24	100	100	NUM
brj-24903	311	25	and	and	CCONJ
brj-24903	311	26	200	200	NUM
brj-24903	311	27	mg	mg	NUM
brj-24903	311	28	/	/	SYM
brj-24903	311	29	kg	kg	NOUN
brj-24903	311	30	)	)	PUNCT
brj-24903	311	31	significantly	significantly	ADV
brj-24903	311	32	reduced	reduce	VERB
brj-24903	311	33	paw	paw	NOUN
brj-24903	311	34	inflammation	inflammation	NOUN
brj-24903	311	35	.	.	PUNCT
brj-24903	312	1	furthermore	furthermore	ADV
brj-24903	312	2	,	,	PUNCT
brj-24903	312	3	the	the	DET
brj-24903	312	4	arthritic	arthritic	ADJ
brj-24903	312	5	index	index	NOUN
brj-24903	312	6	values	value	NOUN
brj-24903	312	7	were	be	AUX
brj-24903	312	8	dramatically	dramatically	ADV
brj-24903	312	9	lowered	lower	VERB
brj-24903	312	10	by	by	ADP
brj-24903	312	11	both	both	DET
brj-24903	312	12	a.	a.	NOUN
brj-24903	312	13	glycyphyllos	glycyphyllos	PROPN
brj-24903	312	14	extract	extract	VERB
brj-24903	312	15	dosages	dosage	NOUN
brj-24903	312	16	.	.	PUNCT
brj-24903	313	1	in	in	ADP
brj-24903	313	2	comparison	comparison	NOUN
brj-24903	313	3	to	to	ADP
brj-24903	313	4	the	the	DET
brj-24903	313	5	animal	animal	NOUN
brj-24903	313	6	group	group	NOUN
brj-24903	313	7	that	that	PRON
brj-24903	313	8	supplemented	supplement	VERB
brj-24903	313	9	with	with	ADP
brj-24903	313	10	diclofenac	diclofenac	NOUN
brj-24903	313	11	,	,	PUNCT
brj-24903	313	12	the	the	DET
brj-24903	313	13	group	group	NOUN
brj-24903	313	14	that	that	PRON
brj-24903	313	15	received	receive	VERB
brj-24903	313	16	a.	a.	NOUN
brj-24903	313	17	glycyphyllos	glycyphyllos	PROPN
brj-24903	313	18	extract	extract	VERB
brj-24903	313	19	at	at	ADP
brj-24903	313	20	a	a	DET
brj-24903	313	21	dosage	dosage	NOUN
brj-24903	313	22	of	of	ADP
brj-24903	313	23	200	200	NUM
brj-24903	313	24	mg	mg	NOUN
brj-24903	313	25	/	/	SYM
brj-24903	313	26	kg	kg	PROPN
brj-24903	313	27	experienced	experience	VERB
brj-24903	313	28	an	an	DET
brj-24903	313	29	increase	increase	NOUN
brj-24903	313	30	in	in	ADP
brj-24903	313	31	body	body	NOUN
brj-24903	313	32	weight	weight	NOUN
brj-24903	313	33	,	,	PUNCT
brj-24903	313	34	indicating	indicate	VERB
brj-24903	313	35	its	its	PRON
brj-24903	313	36	safety	safety	NOUN
brj-24903	313	37	,	,	PUNCT
brj-24903	313	38	moderate	moderate	ADJ
brj-24903	313	39	toxic	toxic	ADJ
brj-24903	313	40	effects	effect	NOUN
brj-24903	313	41	,	,	PUNCT
brj-24903	313	42	or	or	CCONJ
brj-24903	313	43	reduced	reduce	VERB
brj-24903	313	44	side	side	NOUN
brj-24903	313	45	effects	effect	NOUN
brj-24903	313	46	.	.	PUNCT
brj-24903	314	1	due	due	ADP
brj-24903	314	2	to	to	ADP
brj-24903	314	3	the	the	DET
brj-24903	314	4	ulcerative	ulcerative	ADJ
brj-24903	314	5	or	or	CCONJ
brj-24903	314	6	gastrointestinal	gastrointestinal	ADJ
brj-24903	314	7	disturbance	disturbance	NOUN
brj-24903	314	8	side	side	NOUN
brj-24903	314	9	effects	effect	NOUN
brj-24903	314	10	of	of	ADP
brj-24903	314	11	diclofenac	diclofenac	NOUN
brj-24903	314	12	,	,	PUNCT
brj-24903	314	13	it	it	PRON
brj-24903	314	14	’s	’	VERB
brj-24903	314	15	possible	possible	ADJ
brj-24903	314	16	that	that	SCONJ
brj-24903	314	17	the	the	DET
brj-24903	314	18	animal	animal	NOUN
brj-24903	314	19	group	group	NOUN
brj-24903	314	20	that	that	PRON
brj-24903	314	21	took	take	VERB
brj-24903	314	22	the	the	DET
brj-24903	314	23	medication	medication	NOUN
brj-24903	314	24	had	have	VERB
brj-24903	314	25	a	a	DET
brj-24903	314	26	modest	modest	ADJ
brj-24903	314	27	increase	increase	NOUN
brj-24903	314	28	in	in	ADP
brj-24903	314	29	body	body	NOUN
brj-24903	314	30	weight	weight	NOUN
brj-24903	314	31	.	.	PUNCT
brj-24903	315	1	in	in	ADP
brj-24903	315	2	the	the	DET
brj-24903	315	3	cfa	cfa	PROPN
brj-24903	315	4	control	control	PROPN
brj-24903	315	5	group	group	PROPN
brj-24903	315	6	,	,	PUNCT
brj-24903	315	7	there	there	PRON
brj-24903	315	8	was	be	VERB
brj-24903	315	9	a	a	DET
brj-24903	315	10	noticeable	noticeable	ADJ
brj-24903	315	11	decrease	decrease	NOUN
brj-24903	315	12	in	in	ADP
brj-24903	315	13	body	body	NOUN
brj-24903	315	14	weight	weight	NOUN
brj-24903	315	15	.	.	PUNCT
brj-24903	316	1	however	however	ADV
brj-24903	316	2	,	,	PUNCT
brj-24903	316	3	a.	a.	NOUN
brj-24903	316	4	glycyphyllos	glycyphyllos	PROPN
brj-24903	316	5	extract	extract	VERB
brj-24903	316	6	at	at	ADP
brj-24903	316	7	a	a	DET
brj-24903	316	8	dosage	dosage	NOUN
brj-24903	316	9	of	of	ADP
brj-24903	316	10	200	200	NUM
brj-24903	316	11	mg	mg	NOUN
brj-24903	316	12	/	/	SYM
brj-24903	316	13	kg	kg	PROPN
brj-24903	316	14	showed	show	VERB
brj-24903	316	15	a	a	DET
brj-24903	316	16	better	well	ADJ
brj-24903	316	17	percentage	percentage	NOUN
brj-24903	316	18	of	of	ADP
brj-24903	316	19	body	body	NOUN
brj-24903	316	20	weight	weight	NOUN
brj-24903	316	21	growth	growth	NOUN
brj-24903	316	22	than	than	ADP
brj-24903	316	23	a.	a.	NOUN
brj-24903	316	24	glycyphyllos	glycyphyllos	PROPN
brj-24903	316	25	extract	extract	NOUN
brj-24903	316	26	(	(	PUNCT
brj-24903	316	27	100	100	NUM
brj-24903	316	28	mg	mg	NUM
brj-24903	316	29	/	/	SYM
brj-24903	316	30	kg	kg	NOUN
brj-24903	316	31	)	)	PUNCT
brj-24903	316	32	or	or	CCONJ
brj-24903	316	33	the	the	DET
brj-24903	316	34	diclofenac	diclofenac	NOUN
brj-24903	316	35	group	group	NOUN
brj-24903	316	36	.	.	PUNCT
brj-24903	317	1	the	the	DET
brj-24903	317	2	results	result	NOUN
brj-24903	317	3	of	of	ADP
brj-24903	317	4	the	the	DET
brj-24903	317	5	locomotion	locomotion	NOUN
brj-24903	317	6	scoring	scoring	NOUN
brj-24903	317	7	demonstrate	demonstrate	VERB
brj-24903	317	8	how	how	SCONJ
brj-24903	317	9	the	the	DET
brj-24903	317	10	cfa	cfa	PROPN
brj-24903	317	11	-	-	PUNCT
brj-24903	317	12	control	control	PROPN
brj-24903	317	13	group	group	NOUN
brj-24903	317	14	’s	’s	PART
brj-24903	317	15	chronic	chronic	ADJ
brj-24903	317	16	ra	ra	PROPN
brj-24903	317	17	progressed	progress	VERB
brj-24903	317	18	and	and	CCONJ
brj-24903	317	19	how	how	SCONJ
brj-24903	317	20	it	it	PRON
brj-24903	317	21	impaired	impaired	ADJ
brj-24903	317	22	mobility	mobility	NOUN
brj-24903	317	23	.	.	PUNCT
brj-24903	318	1	on	on	ADP
brj-24903	318	2	the	the	DET
brj-24903	318	3	other	other	ADJ
brj-24903	318	4	hand	hand	NOUN
brj-24903	318	5	,	,	PUNCT
brj-24903	318	6	the	the	DET
brj-24903	318	7	animal	animal	NOUN
brj-24903	318	8	species	specie	NOUN
brj-24903	318	9	that	that	PRON
brj-24903	318	10	received	receive	VERB
brj-24903	318	11	a.	a.	NOUN
brj-24903	318	12	glycyphyllos	glycyphyllos	PROPN
brj-24903	318	13	extract	extract	NOUN
brj-24903	318	14	showed	show	VERB
brj-24903	318	15	a	a	DET
brj-24903	318	16	noticeable	noticeable	ADJ
brj-24903	318	17	increase	increase	NOUN
brj-24903	318	18	in	in	ADP
brj-24903	318	19	motility	motility	NOUN
brj-24903	318	20	.	.	PUNCT
brj-24903	319	1	consequently	consequently	ADV
brj-24903	319	2	,	,	PUNCT
brj-24903	319	3	it	it	PRON
brj-24903	319	4	was	be	AUX
brj-24903	319	5	shown	show	VERB
brj-24903	319	6	that	that	SCONJ
brj-24903	319	7	,	,	PUNCT
brj-24903	319	8	in	in	ADP
brj-24903	319	9	comparison	comparison	NOUN
brj-24903	319	10	to	to	ADP
brj-24903	319	11	the	the	DET
brj-24903	319	12	cfa	cfa	PROPN
brj-24903	319	13	control	control	PROPN
brj-24903	319	14	group	group	NOUN
brj-24903	319	15	animals	animal	NOUN
brj-24903	319	16	,	,	PUNCT
brj-24903	319	17	rats	rat	NOUN
brj-24903	319	18	with	with	ADP
brj-24903	319	19	cfa	cfa	NOUN
brj-24903	319	20	challenges	challenge	NOUN
brj-24903	319	21	who	who	PRON
brj-24903	319	22	were	be	AUX
brj-24903	319	23	given	give	VERB
brj-24903	319	24	a.	a.	NOUN
brj-24903	319	25	glycyphyllos	glycyphyllos	NOUN
brj-24903	319	26	extract	extract	NOUN
brj-24903	319	27	(	(	PUNCT
brj-24903	319	28	at	at	ADP
brj-24903	319	29	doses	dose	NOUN
brj-24903	319	30	of	of	ADP
brj-24903	319	31	100	100	NUM
brj-24903	319	32	and	and	CCONJ
brj-24903	319	33	200	200	NUM
brj-24903	319	34	mg	mg	NUM
brj-24903	319	35	/	/	SYM
brj-24903	319	36	kg	kg	NOUN
brj-24903	319	37	)	)	PUNCT
brj-24903	319	38	between	between	ADP
brj-24903	319	39	days	day	NOUN
brj-24903	319	40	7	7	NUM
brj-24903	319	41	and	and	CCONJ
brj-24903	319	42	21	21	NUM
brj-24903	319	43	had	have	VERB
brj-24903	319	44	a	a	DET
brj-24903	319	45	noteworthy	noteworthy	ADJ
brj-24903	319	46	enhancement	enhancement	NOUN
brj-24903	319	47	in	in	ADP
brj-24903	319	48	their	their	PRON
brj-24903	319	49	locomotor	locomotor	NOUN
brj-24903	319	50	score	score	NOUN
brj-24903	319	51	.	.	PUNCT
brj-24903	320	1	this	this	PRON
brj-24903	320	2	implies	imply	VERB
brj-24903	320	3	that	that	SCONJ
brj-24903	320	4	the	the	DET
brj-24903	320	5	a.	a.	NOUN
brj-24903	320	6	glycyphyllos	glycyphyllos	PROPN
brj-24903	320	7	extract	extract	NOUN
brj-24903	320	8	helped	help	VERB
brj-24903	320	9	delay	delay	VERB
brj-24903	320	10	the	the	DET
brj-24903	320	11	start	start	NOUN
brj-24903	320	12	of	of	ADP
brj-24903	320	13	ra	ra	PROPN
brj-24903	320	14	or	or	CCONJ
brj-24903	320	15	,	,	PUNCT
brj-24903	320	16	at	at	ADP
brj-24903	320	17	a	a	DET
brj-24903	320	18	minimum	minimum	NOUN
brj-24903	320	19	,	,	PUNCT
brj-24903	320	20	reduced	reduce	VERB
brj-24903	320	21	the	the	DET
brj-24903	320	22	severity	severity	NOUN
brj-24903	320	23	of	of	ADP
brj-24903	320	24	the	the	DET
brj-24903	320	25	illness	illness	NOUN
brj-24903	320	26	.	.	PUNCT
brj-24903	321	1	there	there	PRON
brj-24903	321	2	is	be	VERB
brj-24903	321	3	no	no	DET
brj-24903	321	4	denying	deny	VERB
brj-24903	321	5	the	the	DET
brj-24903	321	6	substantial	substantial	ADJ
brj-24903	321	7	role	role	NOUN
brj-24903	321	8	inflammation	inflammation	NOUN
brj-24903	321	9	plays	play	VERB
brj-24903	321	10	in	in	ADP
brj-24903	321	11	ra	ra	PROPN
brj-24903	321	12	,	,	PUNCT
brj-24903	321	13	and	and	CCONJ
brj-24903	321	14	proinflammatory	proinflammatory	ADJ
brj-24903	321	15	cytokines	cytokine	NOUN
brj-24903	321	16	are	be	AUX
brj-24903	321	17	believed	believe	VERB
brj-24903	321	18	to	to	PART
brj-24903	321	19	be	be	AUX
brj-24903	321	20	key	key	ADJ
brj-24903	321	21	participants	participant	NOUN
brj-24903	321	22	in	in	ADP
brj-24903	321	23	the	the	DET
brj-24903	321	24	pathogenesis	pathogenesis	NOUN
brj-24903	321	25	of	of	ADP
brj-24903	321	26	the	the	DET
brj-24903	321	27	illness	illness	NOUN
brj-24903	321	28	.	.	PUNCT
brj-24903	322	1	according	accord	VERB
brj-24903	322	2	to	to	ADP
brj-24903	322	3	an	an	DET
brj-24903	322	4	overwhelming	overwhelming	ADJ
brj-24903	322	5	amount	amount	NOUN
brj-24903	322	6	of	of	ADP
brj-24903	322	7	evidence	evidence	NOUN
brj-24903	322	8	,	,	PUNCT
brj-24903	322	9	these	these	DET
brj-24903	322	10	cytokines	cytokine	NOUN
brj-24903	322	11	can	can	AUX
brj-24903	322	12	cause	cause	VERB
brj-24903	322	13	immune	immune	ADJ
brj-24903	322	14	cell	cell	NOUN
brj-24903	322	15	infiltration	infiltration	NOUN
brj-24903	322	16	.	.	PUNCT
brj-24903	323	1	this	this	PRON
brj-24903	323	2	is	be	AUX
brj-24903	323	3	followed	follow	VERB
brj-24903	323	4	by	by	ADP
brj-24903	323	5	the	the	DET
brj-24903	323	6	release	release	NOUN
brj-24903	323	7	of	of	ADP
brj-24903	323	8	matrix	matrix	NOUN
brj-24903	323	9	metalloproteinases	metalloproteinase	NOUN
brj-24903	323	10	,	,	PUNCT
brj-24903	323	11	which	which	PRON
brj-24903	323	12	are	be	AUX
brj-24903	323	13	mostly	mostly	ADV
brj-24903	323	14	in	in	ADP
brj-24903	323	15	charge	charge	NOUN
brj-24903	323	16	of	of	ADP
brj-24903	323	17	breaking	break	VERB
brj-24903	323	18	down	down	ADP
brj-24903	323	19	cartilage	cartilage	NOUN
brj-24903	323	20	in	in	ADP
brj-24903	323	21	disorders	disorder	NOUN
brj-24903	323	22	like	like	ADP
brj-24903	323	23	osteoarthritis	osteoarthritis	NOUN
brj-24903	323	24	and	and	CCONJ
brj-24903	323	25	arthritic	arthritic	ADJ
brj-24903	323	26	conditions	condition	NOUN
brj-24903	323	27	(	(	PUNCT
brj-24903	323	28	stambolov	stambolov	NOUN
brj-24903	323	29	et	et	PROPN
brj-24903	323	30	al	al	PROPN
brj-24903	323	31	.	.	PROPN
brj-24903	323	32	2023	2023	NUM
brj-24903	323	33	)	)	PUNCT
brj-24903	323	34	.	.	PUNCT
brj-24903	324	1	moreover	moreover	ADV
brj-24903	324	2	,	,	PUNCT
brj-24903	324	3	they	they	PRON
brj-24903	324	4	can	can	AUX
brj-24903	324	5	trigger	trigger	VERB
brj-24903	324	6	the	the	DET
brj-24903	324	7	nf	nf	ADJ
brj-24903	324	8	-	-	PUNCT
brj-24903	324	9	κb	κb	NOUN
brj-24903	324	10	pathway	pathway	NOUN
brj-24903	324	11	,	,	PUNCT
brj-24903	324	12	which	which	PRON
brj-24903	324	13	amplifies	amplify	VERB
brj-24903	324	14	the	the	DET
brj-24903	324	15	inflammatory	inflammatory	ADJ
brj-24903	324	16	cascade	cascade	NOUN
brj-24903	324	17	and	and	CCONJ
brj-24903	324	18	raises	raise	VERB
brj-24903	324	19	proinflammatory	proinflammatory	ADJ
brj-24903	324	20	cytokine	cytokine	NOUN
brj-24903	324	21	levels	level	NOUN
brj-24903	324	22	even	even	ADV
brj-24903	324	23	more	more	ADV
brj-24903	324	24	.	.	PUNCT
brj-24903	325	1	the	the	DET
brj-24903	325	2	inflammatory	inflammatory	ADJ
brj-24903	325	3	response	response	NOUN
brj-24903	325	4	in	in	ADP
brj-24903	325	5	ra	ra	PROPN
brj-24903	325	6	can	can	AUX
brj-24903	325	7	be	be	AUX
brj-24903	325	8	made	make	VERB
brj-24903	325	9	worse	bad	ADJ
brj-24903	325	10	by	by	ADP
brj-24903	325	11	macrophages	macrophage	NOUN
brj-24903	325	12	,	,	PUNCT
brj-24903	325	13	immune	immune	ADJ
brj-24903	325	14	cells	cell	NOUN
brj-24903	325	15	,	,	PUNCT
brj-24903	325	16	and	and	CCONJ
brj-24903	325	17	t	t	NOUN
brj-24903	325	18	cells	cell	NOUN
brj-24903	325	19	,	,	PUNCT
brj-24903	325	20	thereby	thereby	ADV
brj-24903	325	21	producing	produce	VERB
brj-24903	325	22	more	more	ADJ
brj-24903	325	23	tnf	tnf	PROPN
brj-24903	325	24	-	-	PUNCT
brj-24903	325	25	α	α	PROPN
brj-24903	325	26	and	and	CCONJ
brj-24903	325	27	il-6	il-6	NOUN
brj-24903	325	28	.	.	PUNCT
brj-24903	326	1	the	the	DET
brj-24903	326	2	results	result	NOUN
brj-24903	326	3	showed	show	VERB
brj-24903	326	4	that	that	SCONJ
brj-24903	326	5	a.	a.	NOUN
brj-24903	326	6	glycyphyllos	glycyphyllos	PROPN
brj-24903	326	7	extract	extract	NOUN
brj-24903	326	8	reduced	reduce	VERB
brj-24903	326	9	tnf	tnf	PROPN
brj-24903	326	10	-	-	PUNCT
brj-24903	326	11	α	α	PROPN
brj-24903	326	12	,	,	PUNCT
brj-24903	326	13	il-1β	il-1β	PROPN
brj-24903	326	14	,	,	PUNCT
brj-24903	326	15	and	and	CCONJ
brj-24903	326	16	il-6	il-6	NOUN
brj-24903	326	17	blood	blood	NOUN
brj-24903	326	18	levels	level	NOUN
brj-24903	326	19	in	in	ADP
brj-24903	326	20	the	the	DET
brj-24903	326	21	treated	treat	VERB
brj-24903	326	22	ra	ra	PROPN
brj-24903	326	23	rats	rat	NOUN
brj-24903	326	24	,	,	PUNCT
brj-24903	326	25	suggesting	suggest	VERB
brj-24903	326	26	that	that	SCONJ
brj-24903	326	27	the	the	DET
brj-24903	326	28	anti	anti	ADJ
brj-24903	326	29	-	-	ADJ
brj-24903	326	30	inflammatory	inflammatory	ADJ
brj-24903	326	31	qualities	quality	NOUN
brj-24903	326	32	of	of	ADP
brj-24903	326	33	a.	a.	NOUN
brj-24903	326	34	glycyphyllos	glycyphyllos	PROPN
brj-24903	326	35	extract	extract	NOUN
brj-24903	326	36	may	may	AUX
brj-24903	326	37	be	be	AUX
brj-24903	326	38	useful	useful	ADJ
brj-24903	326	39	in	in	ADP
brj-24903	326	40	lowering	lower	VERB
brj-24903	326	41	ra	ra	PROPN
brj-24903	326	42	.	.	PROPN
brj-24903	326	43	peer	peer	NOUN
brj-24903	326	44	-	-	PUNCT
brj-24903	326	45	reviewed	review	VERB
brj-24903	326	46	article	article	NOUN
brj-24903	326	47	bioresources.cnr.ncsu.edu	bioresources.cnr.ncsu.edu	X
brj-24903	326	48	gu	gu	VERB
brj-24903	326	49	et	et	PROPN
brj-24903	326	50	al	al	PROPN
brj-24903	326	51	.	.	PROPN
brj-24903	327	1	(	(	PUNCT
brj-24903	327	2	2026	2026	NUM
brj-24903	327	3	)	)	PUNCT
brj-24903	327	4	.	.	PUNCT
brj-24903	328	1	“	"	PUNCT
brj-24903	328	2	astragalus	astragalus	NOUN
brj-24903	328	3	leaf	leaf	NOUN
brj-24903	328	4	extract	extract	NOUN
brj-24903	328	5	vs.	vs.	ADP
brj-24903	328	6	arthritis	arthritis	NOUN
brj-24903	328	7	,	,	PUNCT
brj-24903	328	8	”	"	PUNCT
brj-24903	328	9	bioresources	bioresource	NOUN
brj-24903	328	10	21(1	21(1	NUM
brj-24903	328	11	)	)	PUNCT
brj-24903	328	12	,	,	PUNCT
brj-24903	328	13	160	160	NUM
brj-24903	328	14	-	-	SYM
brj-24903	328	15	177	177	NUM
brj-24903	328	16	.	.	PUNCT
brj-24903	329	1	173	173	NUM
brj-24903	329	2	iron	iron	NOUN
brj-24903	329	3	deficiency	deficiency	NOUN
brj-24903	329	4	anemia	anemia	NOUN
brj-24903	329	5	is	be	AUX
brj-24903	329	6	one	one	NUM
brj-24903	329	7	hematological	hematological	ADJ
brj-24903	329	8	indication	indication	NOUN
brj-24903	329	9	of	of	ADP
brj-24903	329	10	ra	ra	PROPN
brj-24903	329	11	.	.	PUNCT
brj-24903	330	1	changes	change	NOUN
brj-24903	330	2	in	in	ADP
brj-24903	330	3	hematological	hematological	ADJ
brj-24903	330	4	and	and	CCONJ
brj-24903	330	5	biochemical	biochemical	ADJ
brj-24903	330	6	indicators	indicator	NOUN
brj-24903	330	7	were	be	AUX
brj-24903	330	8	also	also	ADV
brj-24903	330	9	observed	observe	VERB
brj-24903	330	10	throughout	throughout	ADP
brj-24903	330	11	this	this	DET
brj-24903	330	12	experiment	experiment	NOUN
brj-24903	330	13	.	.	PUNCT
brj-24903	331	1	usually	usually	ADV
brj-24903	331	2	,	,	PUNCT
brj-24903	331	3	low	low	ADJ
brj-24903	331	4	hb	hb	PROPN
brj-24903	331	5	and	and	CCONJ
brj-24903	331	6	rbc	rbc	PROPN
brj-24903	331	7	levels	level	NOUN
brj-24903	331	8	cause	cause	VERB
brj-24903	331	9	anemia	anemia	NOUN
brj-24903	331	10	.	.	PUNCT
brj-24903	332	1	this	this	PRON
brj-24903	332	2	results	result	VERB
brj-24903	332	3	from	from	ADP
brj-24903	332	4	an	an	DET
brj-24903	332	5	aberrant	aberrant	ADJ
brj-24903	332	6	bone	bone	NOUN
brj-24903	332	7	marrow	marrow	NOUN
brj-24903	332	8	,	,	PUNCT
brj-24903	332	9	erythropoietin	erythropoietin	NOUN
brj-24903	332	10	insufficiency	insufficiency	NOUN
brj-24903	332	11	,	,	PUNCT
brj-24903	332	12	and	and	CCONJ
brj-24903	332	13	erythrocyte	erythrocyte	NOUN
brj-24903	332	14	loss	loss	NOUN
brj-24903	332	15	triggered	trigger	VERB
brj-24903	332	16	by	by	ADP
brj-24903	332	17	elevated	elevated	ADJ
brj-24903	332	18	il-1β	il-1β	PROPN
brj-24903	332	19	in	in	ADP
brj-24903	332	20	mice	mice	NOUN
brj-24903	332	21	with	with	ADP
brj-24903	332	22	arthritis	arthritis	NOUN
brj-24903	332	23	(	(	PUNCT
brj-24903	332	24	alamgeer	alamgeer	NOUN
brj-24903	332	25	et	et	PROPN
brj-24903	332	26	al	al	PROPN
brj-24903	332	27	.	.	PROPN
brj-24903	332	28	2017	2017	NUM
brj-24903	332	29	)	)	PUNCT
brj-24903	332	30	.	.	PUNCT
brj-24903	333	1	it	it	PRON
brj-24903	333	2	was	be	AUX
brj-24903	333	3	found	find	VERB
brj-24903	333	4	that	that	SCONJ
brj-24903	333	5	while	while	SCONJ
brj-24903	333	6	wbc	wbc	PROPN
brj-24903	333	7	and	and	CCONJ
brj-24903	333	8	esr	esr	PROPN
brj-24903	333	9	levels	level	NOUN
brj-24903	333	10	were	be	AUX
brj-24903	333	11	raised	raise	VERB
brj-24903	333	12	,	,	PUNCT
brj-24903	333	13	the	the	DET
brj-24903	333	14	hbg	hbg	PROPN
brj-24903	333	15	,	,	PUNCT
brj-24903	333	16	pvc	pvc	NOUN
brj-24903	333	17	,	,	PUNCT
brj-24903	333	18	and	and	CCONJ
brj-24903	333	19	rbc	rbc	PROPN
brj-24903	333	20	levels	level	NOUN
brj-24903	333	21	in	in	ADP
brj-24903	333	22	the	the	DET
brj-24903	333	23	cfa	cfa	PROPN
brj-24903	333	24	control	control	PROPN
brj-24903	333	25	group	group	PROPN
brj-24903	333	26	were	be	AUX
brj-24903	333	27	considerably	considerably	ADV
brj-24903	333	28	lower	low	ADJ
brj-24903	333	29	than	than	ADP
brj-24903	333	30	those	those	PRON
brj-24903	333	31	in	in	ADP
brj-24903	333	32	the	the	DET
brj-24903	333	33	normal	normal	ADJ
brj-24903	333	34	control	control	NOUN
brj-24903	333	35	group	group	NOUN
brj-24903	333	36	.	.	PUNCT
brj-24903	334	1	however	however	ADV
brj-24903	334	2	,	,	PUNCT
brj-24903	334	3	following	follow	VERB
brj-24903	334	4	the	the	DET
brj-24903	334	5	consumption	consumption	NOUN
brj-24903	334	6	of	of	ADP
brj-24903	334	7	a.	a.	NOUN
brj-24903	334	8	glycyphyllos	glycyphyllos	PROPN
brj-24903	334	9	extract	extract	NOUN
brj-24903	334	10	(	(	PUNCT
brj-24903	334	11	100	100	NUM
brj-24903	334	12	and	and	CCONJ
brj-24903	334	13	200	200	NUM
brj-24903	334	14	mg	mg	NUM
brj-24903	334	15	/	/	SYM
brj-24903	334	16	kg	kg	PROPN
brj-24903	334	17	)	)	PUNCT
brj-24903	334	18	,	,	PUNCT
brj-24903	334	19	the	the	DET
brj-24903	334	20	hbg	hbg	PROPN
brj-24903	334	21	level	level	NOUN
brj-24903	334	22	,	,	PUNCT
brj-24903	334	23	pvc	pvc	ADJ
brj-24903	334	24	percentage	percentage	NOUN
brj-24903	334	25	,	,	PUNCT
brj-24903	334	26	and	and	CCONJ
brj-24903	334	27	rbc	rbc	PROPN
brj-24903	334	28	count	count	NOUN
brj-24903	334	29	considerably	considerably	ADV
brj-24903	334	30	recovered	recover	VERB
brj-24903	334	31	.	.	PUNCT
brj-24903	335	1	both	both	DET
brj-24903	335	2	doses	dose	NOUN
brj-24903	335	3	resulted	result	VERB
brj-24903	335	4	in	in	ADP
brj-24903	335	5	significant	significant	ADJ
brj-24903	335	6	drops	drop	NOUN
brj-24903	335	7	in	in	ADP
brj-24903	335	8	the	the	DET
brj-24903	335	9	wbc	wbc	PROPN
brj-24903	335	10	count	count	NOUN
brj-24903	335	11	and	and	CCONJ
brj-24903	335	12	esr	esr	NOUN
brj-24903	335	13	.	.	PUNCT
brj-24903	336	1	at	at	ADP
brj-24903	336	2	the	the	DET
brj-24903	336	3	maximum	maximum	ADJ
brj-24903	336	4	dosage	dosage	NOUN
brj-24903	336	5	,	,	PUNCT
brj-24903	336	6	the	the	DET
brj-24903	336	7	extract	extract	NOUN
brj-24903	336	8	’s	’s	PART
brj-24903	336	9	effect	effect	NOUN
brj-24903	336	10	against	against	ADP
brj-24903	336	11	the	the	DET
brj-24903	336	12	hematological	hematological	ADJ
brj-24903	336	13	abnormality	abnormality	NOUN
brj-24903	336	14	in	in	ADP
brj-24903	336	15	cfachallenged	cfachallenged	ADJ
brj-24903	336	16	arthritic	arthritic	ADJ
brj-24903	336	17	rats	rat	NOUN
brj-24903	336	18	was	be	AUX
brj-24903	336	19	more	more	ADV
brj-24903	336	20	noticeable	noticeable	ADJ
brj-24903	336	21	.	.	PUNCT
brj-24903	337	1	one	one	NUM
brj-24903	337	2	of	of	ADP
brj-24903	337	3	the	the	DET
brj-24903	337	4	main	main	ADJ
brj-24903	337	5	factors	factor	NOUN
brj-24903	337	6	thought	think	VERB
brj-24903	337	7	to	to	PART
brj-24903	337	8	be	be	AUX
brj-24903	337	9	responsible	responsible	ADJ
brj-24903	337	10	for	for	ADP
brj-24903	337	11	the	the	DET
brj-24903	337	12	prcs	prcs	PROPN
brj-24903	337	13	’	'	PUNCT
brj-24903	337	14	destruction	destruction	NOUN
brj-24903	337	15	and	and	CCONJ
brj-24903	337	16	oa	oa	PROPN
brj-24903	337	17	development	development	NOUN
brj-24903	337	18	is	be	AUX
brj-24903	337	19	il-1β	il-1β	ADJ
brj-24903	337	20	.	.	PUNCT
brj-24903	338	1	under	under	ADP
brj-24903	338	2	normal	normal	ADJ
brj-24903	338	3	circumstances	circumstance	NOUN
brj-24903	338	4	,	,	PUNCT
brj-24903	338	5	chondrocytes	chondrocyte	NOUN
brj-24903	338	6	,	,	PUNCT
brj-24903	338	7	which	which	PRON
brj-24903	338	8	are	be	AUX
brj-24903	338	9	components	component	NOUN
brj-24903	338	10	of	of	ADP
brj-24903	338	11	cellular	cellular	ADJ
brj-24903	338	12	cartilage	cartilage	NOUN
brj-24903	338	13	,	,	PUNCT
brj-24903	338	14	balance	balance	NOUN
brj-24903	338	15	anabolic	anabolic	NOUN
brj-24903	338	16	and	and	CCONJ
brj-24903	338	17	catabolic	catabolic	ADJ
brj-24903	338	18	metabolism	metabolism	NOUN
brj-24903	338	19	and	and	CCONJ
brj-24903	338	20	maintain	maintain	VERB
brj-24903	338	21	the	the	DET
brj-24903	338	22	extracellular	extracellular	ADJ
brj-24903	338	23	matrix	matrix	NOUN
brj-24903	338	24	(	(	PUNCT
brj-24903	338	25	ecm	ecm	PROPN
brj-24903	338	26	)	)	PUNCT
brj-24903	338	27	(	(	PUNCT
brj-24903	338	28	zhao	zhao	PROPN
brj-24903	338	29	et	et	PROPN
brj-24903	338	30	al	al	PROPN
brj-24903	338	31	.	.	PROPN
brj-24903	338	32	2023	2023	NUM
brj-24903	338	33	)	)	PUNCT
brj-24903	338	34	.	.	PUNCT
brj-24903	339	1	regarding	regard	VERB
brj-24903	339	2	the	the	DET
brj-24903	339	3	articular	articular	ADJ
brj-24903	339	4	cartilage	cartilage	NOUN
brj-24903	339	5	along	along	ADP
brj-24903	339	6	with	with	ADP
brj-24903	339	7	other	other	ADJ
brj-24903	339	8	joint	joint	ADJ
brj-24903	339	9	components	component	NOUN
brj-24903	339	10	,	,	PUNCT
brj-24903	339	11	il-1β	il-1β	PROPN
brj-24903	339	12	,	,	PUNCT
brj-24903	339	13	both	both	CCONJ
brj-24903	339	14	alone	alone	ADJ
brj-24903	339	15	and	and	CCONJ
brj-24903	339	16	in	in	ADP
brj-24903	339	17	concert	concert	NOUN
brj-24903	339	18	with	with	ADP
brj-24903	339	19	specific	specific	ADJ
brj-24903	339	20	mediators	mediator	NOUN
brj-24903	339	21	,	,	PUNCT
brj-24903	339	22	induces	induce	VERB
brj-24903	339	23	inflammatory	inflammatory	ADJ
brj-24903	339	24	and	and	CCONJ
brj-24903	339	25	catabolic	catabolic	ADJ
brj-24903	339	26	responses	response	NOUN
brj-24903	339	27	.	.	PUNCT
brj-24903	340	1	the	the	DET
brj-24903	340	2	action	action	NOUN
brj-24903	340	3	of	of	ADP
brj-24903	340	4	il-1β	il-1β	PROPN
brj-24903	340	5	blocks	block	NOUN
brj-24903	340	6	chondrocytes	chondrocyte	NOUN
brj-24903	340	7	in	in	ADP
brj-24903	340	8	the	the	DET
brj-24903	340	9	context	context	NOUN
brj-24903	340	10	of	of	ADP
brj-24903	340	11	ecm	ecm	PROPN
brj-24903	340	12	component	component	NOUN
brj-24903	340	13	synthesis	synthesis	NOUN
brj-24903	340	14	and	and	CCONJ
brj-24903	340	15	interferes	interfere	VERB
brj-24903	340	16	with	with	ADP
brj-24903	340	17	the	the	DET
brj-24903	340	18	synthesis	synthesis	NOUN
brj-24903	340	19	of	of	ADP
brj-24903	340	20	main	main	ADJ
brj-24903	340	21	structural	structural	ADJ
brj-24903	340	22	proteins	protein	NOUN
brj-24903	340	23	,	,	PUNCT
brj-24903	340	24	such	such	ADJ
brj-24903	340	25	as	as	ADP
brj-24903	340	26	type	type	NOUN
brj-24903	340	27	-	-	PUNCT
brj-24903	340	28	ii	ii	NOUN
brj-24903	340	29	collagen	collagen	NOUN
brj-24903	340	30	and	and	CCONJ
brj-24903	340	31	aggrecan	aggrecan	ADJ
brj-24903	340	32	.	.	PUNCT
brj-24903	341	1	inflammatory	inflammatory	ADJ
brj-24903	341	2	cytokines	cytokine	NOUN
brj-24903	341	3	primarily	primarily	ADV
brj-24903	341	4	harm	harm	VERB
brj-24903	341	5	articular	articular	ADJ
brj-24903	341	6	cartilage	cartilage	NOUN
brj-24903	341	7	(	(	PUNCT
brj-24903	341	8	wojdasiewicz	wojdasiewicz	NOUN
brj-24903	341	9	et	et	PROPN
brj-24903	341	10	al	al	PROPN
brj-24903	341	11	.	.	PROPN
brj-24903	341	12	2014	2014	NUM
brj-24903	341	13	)	)	PUNCT
brj-24903	341	14	.	.	PUNCT
brj-24903	342	1	furthermore	furthermore	ADV
brj-24903	342	2	,	,	PUNCT
brj-24903	342	3	the	the	DET
brj-24903	342	4	function	function	NOUN
brj-24903	342	5	of	of	ADP
brj-24903	342	6	chondrocytes	chondrocyte	NOUN
brj-24903	342	7	in	in	ADP
brj-24903	342	8	the	the	DET
brj-24903	342	9	synthesis	synthesis	NOUN
brj-24903	342	10	of	of	ADP
brj-24903	342	11	mmps	mmp	NOUN
brj-24903	342	12	,	,	PUNCT
brj-24903	342	13	particularly	particularly	ADV
brj-24903	342	14	interstitial	interstitial	ADJ
brj-24903	342	15	collagenase	collagenase	NOUN
brj-24903	342	16	(	(	PUNCT
brj-24903	342	17	mmp-1	mmp-1	NOUN
brj-24903	342	18	)	)	PUNCT
brj-24903	342	19	,	,	PUNCT
brj-24903	342	20	stromelysin-1	stromelysin-1	PROPN
brj-24903	342	21	(	(	PUNCT
brj-24903	342	22	mmp-3	mmp-3	NOUN
brj-24903	342	23	)	)	PUNCT
brj-24903	342	24	,	,	PUNCT
brj-24903	342	25	and	and	CCONJ
brj-24903	342	26	collagenase	collagenase	NOUN
brj-24903	342	27	3	3	NUM
brj-24903	342	28	(	(	PUNCT
brj-24903	342	29	mmp-13	mmp-13	NOUN
brj-24903	342	30	)	)	PUNCT
brj-24903	342	31	,	,	PUNCT
brj-24903	342	32	is	be	AUX
brj-24903	342	33	influenced	influence	VERB
brj-24903	342	34	by	by	ADP
brj-24903	342	35	il-1β	il-1β	PROPN
brj-24903	342	36	.	.	PUNCT
brj-24903	343	1	these	these	DET
brj-24903	343	2	mmps	mmp	NOUN
brj-24903	343	3	have	have	VERB
brj-24903	343	4	a	a	DET
brj-24903	343	5	significant	significant	ADJ
brj-24903	343	6	effect	effect	NOUN
brj-24903	343	7	on	on	ADP
brj-24903	343	8	cartilage	cartilage	NOUN
brj-24903	343	9	components	component	NOUN
brj-24903	343	10	(	(	PUNCT
brj-24903	343	11	vincenti	vincenti	X
brj-24903	343	12	and	and	CCONJ
brj-24903	343	13	brinckerhoff	brinckerhoff	ADJ
brj-24903	343	14	2002	2002	NUM
brj-24903	343	15	)	)	PUNCT
brj-24903	343	16	.	.	PUNCT
brj-24903	344	1	therefore	therefore	ADV
brj-24903	344	2	,	,	PUNCT
brj-24903	344	3	a	a	DET
brj-24903	344	4	novel	novel	ADJ
brj-24903	344	5	treatment	treatment	NOUN
brj-24903	344	6	agent	agent	NOUN
brj-24903	344	7	for	for	ADP
brj-24903	344	8	oa	oa	PRON
brj-24903	344	9	may	may	AUX
brj-24903	344	10	be	be	AUX
brj-24903	344	11	an	an	DET
brj-24903	344	12	agent	agent	NOUN
brj-24903	344	13	that	that	PRON
brj-24903	344	14	prevents	prevent	VERB
brj-24903	344	15	the	the	DET
brj-24903	344	16	production	production	NOUN
brj-24903	344	17	of	of	ADP
brj-24903	344	18	mmps	mmp	NOUN
brj-24903	344	19	and	and	CCONJ
brj-24903	344	20	inflammatory	inflammatory	ADJ
brj-24903	344	21	cytokines	cytokine	NOUN
brj-24903	344	22	.	.	PUNCT
brj-24903	345	1	the	the	DET
brj-24903	345	2	results	result	NOUN
brj-24903	345	3	of	of	ADP
brj-24903	345	4	this	this	DET
brj-24903	345	5	study	study	NOUN
brj-24903	345	6	showed	show	VERB
brj-24903	345	7	that	that	SCONJ
brj-24903	345	8	extract	extract	NOUN
brj-24903	345	9	therapy	therapy	NOUN
brj-24903	345	10	decreased	decrease	VERB
brj-24903	345	11	the	the	DET
brj-24903	345	12	elevated	elevated	ADJ
brj-24903	345	13	levels	level	NOUN
brj-24903	345	14	of	of	ADP
brj-24903	345	15	mmp1	mmp1	PROPN
brj-24903	345	16	and	and	CCONJ
brj-24903	345	17	mmp-13	mmp-13	NOUN
brj-24903	345	18	.	.	PROPN
brj-24903	345	19	when	when	SCONJ
brj-24903	345	20	there	there	PRON
brj-24903	345	21	is	be	VERB
brj-24903	345	22	an	an	DET
brj-24903	345	23	inflammatory	inflammatory	ADJ
brj-24903	345	24	response	response	NOUN
brj-24903	345	25	,	,	PUNCT
brj-24903	345	26	arachidonic	arachidonic	ADJ
brj-24903	345	27	acid	acid	NOUN
brj-24903	345	28	stimulates	stimulate	NOUN
brj-24903	345	29	cox-2	cox-2	ADJ
brj-24903	345	30	to	to	PART
brj-24903	345	31	create	create	VERB
brj-24903	345	32	pge2	pge2	NOUN
brj-24903	345	33	.	.	PUNCT
brj-24903	346	1	no	no	PRON
brj-24903	346	2	is	be	AUX
brj-24903	346	3	produced	produce	VERB
brj-24903	346	4	from	from	ADP
brj-24903	346	5	the	the	DET
brj-24903	346	6	amino	amino	NOUN
brj-24903	346	7	acid	acid	NOUN
brj-24903	346	8	l	l	NOUN
brj-24903	346	9	-	-	NOUN
brj-24903	346	10	arginine	arginine	NOUN
brj-24903	346	11	by	by	ADP
brj-24903	346	12	the	the	DET
brj-24903	346	13	enzymatic	enzymatic	ADJ
brj-24903	346	14	action	action	NOUN
brj-24903	346	15	of	of	ADP
brj-24903	346	16	inos	ino	NOUN
brj-24903	346	17	,	,	PUNCT
brj-24903	346	18	which	which	PRON
brj-24903	346	19	is	be	AUX
brj-24903	346	20	triggered	trigger	VERB
brj-24903	346	21	by	by	ADP
brj-24903	346	22	inflammatory	inflammatory	ADJ
brj-24903	346	23	stimuli	stimulus	NOUN
brj-24903	346	24	.	.	PUNCT
brj-24903	347	1	this	this	PRON
brj-24903	347	2	suggests	suggest	VERB
brj-24903	347	3	that	that	SCONJ
brj-24903	347	4	proinflammatory	proinflammatory	ADJ
brj-24903	347	5	genes	gene	NOUN
brj-24903	347	6	,	,	PUNCT
brj-24903	347	7	such	such	ADJ
brj-24903	347	8	as	as	ADP
brj-24903	347	9	cox-2	cox-2	NUM
brj-24903	347	10	and	and	CCONJ
brj-24903	347	11	inos	ino	NOUN
brj-24903	347	12	,	,	PUNCT
brj-24903	347	13	are	be	AUX
brj-24903	347	14	upregulated	upregulate	VERB
brj-24903	347	15	in	in	ADP
brj-24903	347	16	chondrocytes	chondrocyte	NOUN
brj-24903	347	17	and	and	CCONJ
brj-24903	347	18	are	be	AUX
brj-24903	347	19	in	in	ADP
brj-24903	347	20	charge	charge	NOUN
brj-24903	347	21	of	of	ADP
brj-24903	347	22	initiating	initiate	VERB
brj-24903	347	23	the	the	DET
brj-24903	347	24	destruction	destruction	NOUN
brj-24903	347	25	of	of	ADP
brj-24903	347	26	prcs	prcs	PROPN
brj-24903	347	27	stimulated	stimulate	VERB
brj-24903	347	28	by	by	ADP
brj-24903	347	29	il-1β	il-1β	PROPN
brj-24903	347	30	(	(	PUNCT
brj-24903	347	31	choy	choy	NOUN
brj-24903	347	32	and	and	CCONJ
brj-24903	347	33	panayi	panayi	NOUN
brj-24903	347	34	2001	2001	NUM
brj-24903	347	35	;	;	PUNCT
brj-24903	347	36	mohammed	mohammed	PROPN
brj-24903	347	37	2003	2003	NUM
brj-24903	347	38	;	;	PUNCT
brj-24903	347	39	sweeney	sweeney	NOUN
brj-24903	347	40	and	and	CCONJ
brj-24903	347	41	firestein	firestein	ADJ
brj-24903	347	42	2004	2004	NUM
brj-24903	347	43	)	)	PUNCT
brj-24903	347	44	.	.	PUNCT
brj-24903	348	1	thus	thus	ADV
brj-24903	348	2	,	,	PUNCT
brj-24903	348	3	the	the	DET
brj-24903	348	4	impact	impact	NOUN
brj-24903	348	5	of	of	ADP
brj-24903	348	6	extract	extract	NOUN
brj-24903	348	7	on	on	ADP
brj-24903	348	8	no	no	PRON
brj-24903	348	9	and	and	CCONJ
brj-24903	348	10	pge2	pge2	VERB
brj-24903	348	11	secretion	secretion	NOUN
brj-24903	348	12	from	from	ADP
brj-24903	348	13	prcs	prcs	PROPN
brj-24903	348	14	in	in	ADP
brj-24903	348	15	the	the	DET
brj-24903	348	16	presence	presence	NOUN
brj-24903	348	17	of	of	ADP
brj-24903	348	18	il-1β	il-1β	PROPN
brj-24903	348	19	was	be	AUX
brj-24903	348	20	studied	study	VERB
brj-24903	348	21	.	.	PUNCT
brj-24903	349	1	the	the	DET
brj-24903	349	2	extract	extract	NOUN
brj-24903	349	3	was	be	AUX
brj-24903	349	4	discovered	discover	VERB
brj-24903	349	5	to	to	PART
brj-24903	349	6	drastically	drastically	ADV
brj-24903	349	7	lower	lower	VERB
brj-24903	349	8	inflammatory	inflammatory	ADJ
brj-24903	349	9	mediators	mediator	NOUN
brj-24903	349	10	like	like	ADP
brj-24903	349	11	no	no	INTJ
brj-24903	349	12	and	and	CCONJ
brj-24903	349	13	pge2	pge2	NOUN
brj-24903	349	14	in	in	ADP
brj-24903	349	15	prcs	prcs	PROPN
brj-24903	349	16	,	,	PUNCT
brj-24903	349	17	which	which	PRON
brj-24903	349	18	was	be	AUX
brj-24903	349	19	likely	likely	ADV
brj-24903	349	20	caused	cause	VERB
brj-24903	349	21	by	by	ADP
brj-24903	349	22	a	a	DET
brj-24903	349	23	decline	decline	NOUN
brj-24903	349	24	in	in	ADP
brj-24903	349	25	the	the	DET
brj-24903	349	26	expression	expression	NOUN
brj-24903	349	27	of	of	ADP
brj-24903	349	28	inos	ino	NOUN
brj-24903	349	29	and	and	CCONJ
brj-24903	349	30	cox-2	cox-2	NUM
brj-24903	349	31	(	(	PUNCT
brj-24903	349	32	hochberg	hochberg	PROPN
brj-24903	349	33	2002	2002	NUM
brj-24903	349	34	;	;	PUNCT
brj-24903	349	35	yoon	yoon	PROPN
brj-24903	349	36	et	et	PROPN
brj-24903	349	37	al	al	PROPN
brj-24903	349	38	.	.	PROPN
brj-24903	349	39	2013	2013	NUM
brj-24903	349	40	;	;	PUNCT
brj-24903	349	41	fan	fan	PROPN
brj-24903	349	42	et	et	PROPN
brj-24903	349	43	al	al	PROPN
brj-24903	349	44	.	.	PROPN
brj-24903	349	45	2015	2015	NUM
brj-24903	349	46	)	)	PUNCT
brj-24903	349	47	.	.	PUNCT
brj-24903	350	1	flavonoids	flavonoid	NOUN
brj-24903	350	2	,	,	PUNCT
brj-24903	350	3	the	the	DET
brj-24903	350	4	most	most	ADV
brj-24903	350	5	common	common	ADJ
brj-24903	350	6	kind	kind	NOUN
brj-24903	350	7	of	of	ADP
brj-24903	350	8	natural	natural	ADJ
brj-24903	350	9	polyphenols	polyphenol	NOUN
brj-24903	350	10	,	,	PUNCT
brj-24903	350	11	contain	contain	VERB
brj-24903	350	12	several	several	ADJ
brj-24903	350	13	pharmacological	pharmacological	ADJ
brj-24903	350	14	properties	property	NOUN
brj-24903	350	15	,	,	PUNCT
brj-24903	350	16	most	most	ADV
brj-24903	350	17	notably	notably	ADV
brj-24903	350	18	anti	anti	ADJ
brj-24903	350	19	-	-	ADJ
brj-24903	350	20	inflammatory	inflammatory	ADJ
brj-24903	350	21	properties	property	NOUN
brj-24903	350	22	.	.	PUNCT
brj-24903	351	1	several	several	ADJ
brj-24903	351	2	studies	study	NOUN
brj-24903	351	3	demonstrate	demonstrate	VERB
brj-24903	351	4	that	that	SCONJ
brj-24903	351	5	naturally	naturally	ADV
brj-24903	351	6	occurring	occur	VERB
brj-24903	351	7	flavonoids	flavonoid	NOUN
brj-24903	351	8	stop	stop	VERB
brj-24903	351	9	the	the	DET
brj-24903	351	10	onset	onset	NOUN
brj-24903	351	11	of	of	ADP
brj-24903	351	12	ra	ra	NOUN
brj-24903	351	13	by	by	ADP
brj-24903	351	14	blocking	block	VERB
brj-24903	351	15	the	the	DET
brj-24903	351	16	nfκb	nfκb	NOUN
brj-24903	351	17	signaling	signal	VERB
brj-24903	351	18	cascade	cascade	NOUN
brj-24903	351	19	and	and	CCONJ
brj-24903	351	20	reducing	reduce	VERB
brj-24903	351	21	the	the	DET
brj-24903	351	22	release	release	NOUN
brj-24903	351	23	of	of	ADP
brj-24903	351	24	inflammatory	inflammatory	ADJ
brj-24903	351	25	cytokines	cytokine	NOUN
brj-24903	351	26	(	(	PUNCT
brj-24903	351	27	behl	behl	PROPN
brj-24903	351	28	et	et	PROPN
brj-24903	351	29	al	al	PROPN
brj-24903	351	30	.	.	PROPN
brj-24903	351	31	2021	2021	NUM
brj-24903	351	32	)	)	PUNCT
brj-24903	351	33	.	.	PUNCT
brj-24903	352	1	the	the	DET
brj-24903	352	2	inflammatory	inflammatory	ADJ
brj-24903	352	3	processes	process	NOUN
brj-24903	352	4	that	that	PRON
brj-24903	352	5	result	result	VERB
brj-24903	352	6	in	in	ADP
brj-24903	352	7	arthritis	arthritis	NOUN
brj-24903	352	8	depend	depend	VERB
brj-24903	352	9	on	on	ADP
brj-24903	352	10	the	the	DET
brj-24903	352	11	nf	nf	ADJ
brj-24903	352	12	-	-	PUNCT
brj-24903	352	13	κb	κb	ADJ
brj-24903	352	14	signaling	signal	VERB
brj-24903	352	15	system	system	NOUN
brj-24903	352	16	.	.	PUNCT
brj-24903	353	1	the	the	DET
brj-24903	353	2	transcriptional	transcriptional	ADJ
brj-24903	353	3	targets	target	NOUN
brj-24903	353	4	of	of	ADP
brj-24903	353	5	the	the	DET
brj-24903	353	6	nf	nf	ADJ
brj-24903	353	7	-	-	PUNCT
brj-24903	353	8	κb	κb	NOUN
brj-24903	353	9	pathway	pathway	NOUN
brj-24903	353	10	include	include	VERB
brj-24903	353	11	tnf	tnf	PROPN
brj-24903	353	12	-	-	PUNCT
brj-24903	353	13	α	α	PROPN
brj-24903	353	14	and	and	CCONJ
brj-24903	353	15	il-6	il-6	NOUN
brj-24903	353	16	,	,	PUNCT
brj-24903	353	17	two	two	NUM
brj-24903	353	18	inflammatory	inflammatory	ADJ
brj-24903	353	19	cytokines	cytokine	NOUN
brj-24903	353	20	.	.	PUNCT
brj-24903	354	1	since	since	SCONJ
brj-24903	354	2	the	the	DET
brj-24903	354	3	pathogenic	pathogenic	ADJ
brj-24903	354	4	changes	change	NOUN
brj-24903	354	5	of	of	ADP
brj-24903	354	6	arthritis	arthritis	NOUN
brj-24903	354	7	are	be	AUX
brj-24903	354	8	associated	associate	VERB
brj-24903	354	9	with	with	ADP
brj-24903	354	10	enhanced	enhanced	ADJ
brj-24903	354	11	nf	nf	ADJ
brj-24903	354	12	-	-	PUNCT
brj-24903	354	13	κb	κb	NOUN
brj-24903	354	14	pathway	pathway	NOUN
brj-24903	354	15	activation	activation	NOUN
brj-24903	354	16	,	,	PUNCT
brj-24903	354	17	targeting	target	VERB
brj-24903	354	18	this	this	DET
brj-24903	354	19	pathway	pathway	NOUN
brj-24903	354	20	has	have	AUX
brj-24903	354	21	been	be	AUX
brj-24903	354	22	demonstrated	demonstrate	VERB
brj-24903	354	23	to	to	PART
brj-24903	354	24	be	be	AUX
brj-24903	354	25	an	an	DET
brj-24903	354	26	effective	effective	ADJ
brj-24903	354	27	therapy	therapy	NOUN
brj-24903	354	28	technique	technique	NOUN
brj-24903	354	29	.	.	PUNCT
brj-24903	355	1	in	in	ADP
brj-24903	355	2	addition	addition	NOUN
brj-24903	355	3	,	,	PUNCT
brj-24903	355	4	there	there	PRON
brj-24903	355	5	is	be	VERB
brj-24903	355	6	mounting	mount	VERB
brj-24903	355	7	data	datum	NOUN
brj-24903	355	8	that	that	DET
brj-24903	355	9	natural	natural	ADJ
brj-24903	355	10	flavonoids	flavonoid	NOUN
brj-24903	355	11	,	,	PUNCT
brj-24903	355	12	through	through	ADP
brj-24903	355	13	their	their	PRON
brj-24903	355	14	inhibition	inhibition	NOUN
brj-24903	355	15	of	of	ADP
brj-24903	355	16	the	the	DET
brj-24903	355	17	nf	nf	NOUN
brj-24903	355	18	-	-	PUNCT
brj-24903	355	19	κb	κb	NOUN
brj-24903	355	20	signaling	signal	VERB
brj-24903	355	21	pathway	pathway	NOUN
brj-24903	355	22	,	,	PUNCT
brj-24903	355	23	have	have	VERB
brj-24903	355	24	protective	protective	ADJ
brj-24903	355	25	effects	effect	NOUN
brj-24903	355	26	against	against	ADP
brj-24903	355	27	the	the	DET
brj-24903	355	28	pathological	pathological	ADJ
brj-24903	355	29	alterations	alteration	NOUN
brj-24903	355	30	associated	associate	VERB
brj-24903	355	31	with	with	ADP
brj-24903	355	32	oa	oa	PROPN
brj-24903	355	33	(	(	PUNCT
brj-24903	355	34	jin	jin	PROPN
brj-24903	355	35	et	et	PROPN
brj-24903	355	36	al	al	PROPN
brj-24903	355	37	.	.	PROPN
brj-24903	355	38	2010	2010	NUM
brj-24903	355	39	;	;	PUNCT
brj-24903	355	40	panche	panche	NOUN
brj-24903	355	41	et	et	PROPN
brj-24903	355	42	al	al	PROPN
brj-24903	355	43	.	.	PROPN
brj-24903	355	44	2016	2016	NUM
brj-24903	355	45	;	;	PUNCT
brj-24903	355	46	yadav	yadav	PROPN
brj-24903	355	47	peer	peer	NOUN
brj-24903	355	48	-	-	PUNCT
brj-24903	355	49	reviewed	review	VERB
brj-24903	355	50	article	article	NOUN
brj-24903	355	51	bioresources.cnr.ncsu.edu	bioresources.cnr.ncsu.edu	X
brj-24903	355	52	gu	gu	VERB
brj-24903	355	53	et	et	PROPN
brj-24903	355	54	al	al	PROPN
brj-24903	355	55	.	.	PROPN
brj-24903	356	1	(	(	PUNCT
brj-24903	356	2	2026	2026	NUM
brj-24903	356	3	)	)	PUNCT
brj-24903	356	4	.	.	PUNCT
brj-24903	357	1	“	"	PUNCT
brj-24903	357	2	astragalus	astragalus	NOUN
brj-24903	357	3	leaf	leaf	NOUN
brj-24903	357	4	extract	extract	NOUN
brj-24903	357	5	vs.	vs.	ADP
brj-24903	357	6	arthritis	arthritis	NOUN
brj-24903	357	7	,	,	PUNCT
brj-24903	357	8	”	"	PUNCT
brj-24903	357	9	bioresources	bioresource	NOUN
brj-24903	357	10	21(1	21(1	NUM
brj-24903	357	11	)	)	PUNCT
brj-24903	357	12	,	,	PUNCT
brj-24903	357	13	160	160	NUM
brj-24903	357	14	-	-	SYM
brj-24903	357	15	177	177	NUM
brj-24903	357	16	.	.	PUNCT
brj-24903	358	1	174	174	NUM
brj-24903	358	2	et	et	PROPN
brj-24903	358	3	al	al	PROPN
brj-24903	358	4	.	.	PROPN
brj-24903	358	5	2020	2020	NUM
brj-24903	358	6	)	)	PUNCT
brj-24903	358	7	.	.	PUNCT
brj-24903	359	1	natural	natural	ADJ
brj-24903	359	2	flavonoids	flavonoid	NOUN
brj-24903	359	3	have	have	VERB
brj-24903	359	4	the	the	DET
brj-24903	359	5	potential	potential	NOUN
brj-24903	359	6	to	to	PART
brj-24903	359	7	inhibit	inhibit	VERB
brj-24903	359	8	inflammatory	inflammatory	ADJ
brj-24903	359	9	reactions	reaction	NOUN
brj-24903	359	10	mediated	mediate	VERB
brj-24903	359	11	by	by	ADP
brj-24903	359	12	nf	nf	ADJ
brj-24903	359	13	-	-	PUNCT
brj-24903	359	14	κb	κb	NOUN
brj-24903	359	15	activation	activation	NOUN
brj-24903	359	16	,	,	PUNCT
brj-24903	359	17	degradation	degradation	NOUN
brj-24903	359	18	of	of	ADP
brj-24903	359	19	the	the	DET
brj-24903	359	20	extracellular	extracellular	ADJ
brj-24903	359	21	matrix	matrix	NOUN
brj-24903	359	22	,	,	PUNCT
brj-24903	359	23	and	and	CCONJ
brj-24903	359	24	death	death	NOUN
brj-24903	359	25	of	of	ADP
brj-24903	359	26	chondrocytes	chondrocyte	NOUN
brj-24903	359	27	.	.	PUNCT
brj-24903	360	1	the	the	DET
brj-24903	360	2	variably	variably	ADV
brj-24903	360	3	substituted	substitute	VERB
brj-24903	360	4	groups	group	NOUN
brj-24903	360	5	on	on	ADP
brj-24903	360	6	the	the	DET
brj-24903	360	7	structures	structure	NOUN
brj-24903	360	8	may	may	AUX
brj-24903	360	9	be	be	AUX
brj-24903	360	10	related	relate	VERB
brj-24903	360	11	to	to	ADP
brj-24903	360	12	the	the	DET
brj-24903	360	13	distinct	distinct	ADJ
brj-24903	360	14	biological	biological	ADJ
brj-24903	360	15	activities	activity	NOUN
brj-24903	360	16	of	of	ADP
brj-24903	360	17	natural	natural	ADJ
brj-24903	360	18	flavonoids	flavonoid	NOUN
brj-24903	360	19	on	on	ADP
brj-24903	360	20	the	the	DET
brj-24903	360	21	nf	nf	ADJ
brj-24903	360	22	-	-	PUNCT
brj-24903	360	23	κb	κb	NOUN
brj-24903	360	24	signaling	signal	VERB
brj-24903	360	25	pathway	pathway	NOUN
brj-24903	360	26	in	in	ADP
brj-24903	360	27	oa	oa	ADP
brj-24903	360	28	chondrocytes	chondrocyte	NOUN
brj-24903	360	29	.	.	PUNCT
brj-24903	361	1	in	in	ADP
brj-24903	361	2	this	this	DET
brj-24903	361	3	study	study	NOUN
brj-24903	361	4	,	,	PUNCT
brj-24903	361	5	several	several	ADJ
brj-24903	361	6	researchers	researcher	NOUN
brj-24903	361	7	who	who	PRON
brj-24903	361	8	focus	focus	VERB
brj-24903	361	9	on	on	ADP
brj-24903	361	10	the	the	DET
brj-24903	361	11	nf	nf	ADJ
brj-24903	361	12	-	-	PUNCT
brj-24903	361	13	κb	κb	NOUN
brj-24903	361	14	signaling	signal	VERB
brj-24903	361	15	pathway	pathway	NOUN
brj-24903	361	16	examine	examine	VERB
brj-24903	361	17	the	the	DET
brj-24903	361	18	effectiveness	effectiveness	NOUN
brj-24903	361	19	and	and	CCONJ
brj-24903	361	20	mechanism	mechanism	NOUN
brj-24903	361	21	of	of	ADP
brj-24903	361	22	action	action	NOUN
brj-24903	361	23	of	of	ADP
brj-24903	361	24	natural	natural	ADJ
brj-24903	361	25	flavonoids	flavonoid	NOUN
brj-24903	361	26	against	against	ADP
brj-24903	361	27	the	the	DET
brj-24903	361	28	development	development	NOUN
brj-24903	361	29	of	of	ADP
brj-24903	361	30	oa	oa	NOUN
brj-24903	361	31	.	.	PUNCT
brj-24903	362	1	flavonoids	flavonoid	NOUN
brj-24903	362	2	have	have	VERB
brj-24903	362	3	the	the	DET
brj-24903	362	4	potential	potential	NOUN
brj-24903	362	5	to	to	PART
brj-24903	362	6	be	be	AUX
brj-24903	362	7	effective	effective	ADJ
brj-24903	362	8	nf	nf	ADJ
brj-24903	362	9	-	-	PUNCT
brj-24903	362	10	κb	κb	NOUN
brj-24903	362	11	signaling	signal	VERB
brj-24903	362	12	cascade	cascade	NOUN
brj-24903	362	13	inhibitors	inhibitor	NOUN
brj-24903	362	14	for	for	ADP
brj-24903	362	15	the	the	DET
brj-24903	362	16	treatment	treatment	NOUN
brj-24903	362	17	of	of	ADP
brj-24903	362	18	oa	oa	PROPN
brj-24903	362	19	(	(	PUNCT
brj-24903	362	20	ye	ye	NOUN
brj-24903	362	21	and	and	CCONJ
brj-24903	362	22	zhou	zhou	PROPN
brj-24903	362	23	2023	2023	NUM
brj-24903	362	24	)	)	PUNCT
brj-24903	362	25	.	.	PUNCT
brj-24903	363	1	the	the	DET
brj-24903	363	2	leaves	leave	NOUN
brj-24903	363	3	of	of	ADP
brj-24903	363	4	a.	a.	NOUN
brj-24903	363	5	glycyphyllos	glycyphyllos	PROPN
brj-24903	363	6	have	have	VERB
brj-24903	363	7	a	a	DET
brj-24903	363	8	considerable	considerable	ADJ
brj-24903	363	9	quantity	quantity	NOUN
brj-24903	363	10	of	of	ADP
brj-24903	363	11	flavonoids	flavonoid	NOUN
brj-24903	363	12	and	and	CCONJ
brj-24903	363	13	polyphenols	polyphenol	NOUN
brj-24903	363	14	(	(	PUNCT
brj-24903	363	15	tsiklauri	tsiklauri	PROPN
brj-24903	363	16	et	et	PROPN
brj-24903	363	17	al	al	PROPN
brj-24903	363	18	.	.	PROPN
brj-24903	363	19	2021	2021	NUM
brj-24903	363	20	)	)	PUNCT
brj-24903	363	21	.	.	PUNCT
brj-24903	364	1	the	the	DET
brj-24903	364	2	results	result	NOUN
brj-24903	364	3	of	of	ADP
brj-24903	364	4	this	this	DET
brj-24903	364	5	study	study	NOUN
brj-24903	364	6	suggest	suggest	VERB
brj-24903	364	7	that	that	SCONJ
brj-24903	364	8	the	the	DET
brj-24903	364	9	presence	presence	NOUN
brj-24903	364	10	of	of	ADP
brj-24903	364	11	polyphenols	polyphenol	NOUN
brj-24903	364	12	and	and	CCONJ
brj-24903	364	13	flavonoids	flavonoid	NOUN
brj-24903	364	14	may	may	AUX
brj-24903	364	15	be	be	AUX
brj-24903	364	16	the	the	DET
brj-24903	364	17	cause	cause	NOUN
brj-24903	364	18	of	of	ADP
brj-24903	364	19	the	the	DET
brj-24903	364	20	anti	anti	ADJ
brj-24903	364	21	-	-	ADJ
brj-24903	364	22	arthritic	arthritic	ADJ
brj-24903	364	23	effect	effect	NOUN
brj-24903	364	24	of	of	ADP
brj-24903	364	25	a.	a.	NOUN
brj-24903	364	26	glycyphyllos	glycyphyllos	PROPN
brj-24903	364	27	extract	extract	NOUN
brj-24903	364	28	.	.	PUNCT
brj-24903	365	1	additionally	additionally	ADV
brj-24903	365	2	,	,	PUNCT
brj-24903	365	3	the	the	DET
brj-24903	365	4	present	present	ADJ
brj-24903	365	5	study	study	NOUN
brj-24903	365	6	has	have	VERB
brj-24903	365	7	some	some	DET
brj-24903	365	8	limitations	limitation	NOUN
brj-24903	365	9	,	,	PUNCT
brj-24903	365	10	including	include	VERB
brj-24903	365	11	the	the	DET
brj-24903	365	12	use	use	NOUN
brj-24903	365	13	of	of	ADP
brj-24903	365	14	only	only	ADV
brj-24903	365	15	one	one	NUM
brj-24903	365	16	extract	extract	NOUN
brj-24903	365	17	concentration	concentration	NOUN
brj-24903	365	18	and	and	CCONJ
brj-24903	365	19	a	a	DET
brj-24903	365	20	limited	limited	ADJ
brj-24903	365	21	number	number	NOUN
brj-24903	365	22	of	of	ADP
brj-24903	365	23	experimental	experimental	ADJ
brj-24903	365	24	animals	animal	NOUN
brj-24903	365	25	.	.	PUNCT
brj-24903	366	1	additionally	additionally	ADV
brj-24903	366	2	,	,	PUNCT
brj-24903	366	3	the	the	DET
brj-24903	366	4	study	study	NOUN
brj-24903	366	5	focused	focus	VERB
brj-24903	366	6	on	on	ADP
brj-24903	366	7	the	the	DET
brj-24903	366	8	acute	acute	ADJ
brj-24903	366	9	phase	phase	NOUN
brj-24903	366	10	of	of	ADP
brj-24903	366	11	arthritis	arthritis	NOUN
brj-24903	366	12	,	,	PUNCT
brj-24903	366	13	and	and	CCONJ
brj-24903	366	14	the	the	DET
brj-24903	366	15	long	long	ADJ
brj-24903	366	16	-	-	PUNCT
brj-24903	366	17	term	term	NOUN
brj-24903	366	18	effects	effect	NOUN
brj-24903	366	19	of	of	ADP
brj-24903	366	20	the	the	DET
brj-24903	366	21	extract	extract	NOUN
brj-24903	366	22	remain	remain	VERB
brj-24903	366	23	unknown	unknown	ADJ
brj-24903	366	24	.	.	PUNCT
brj-24903	367	1	future	future	ADJ
brj-24903	367	2	studies	study	NOUN
brj-24903	367	3	could	could	AUX
brj-24903	367	4	investigate	investigate	VERB
brj-24903	367	5	the	the	DET
brj-24903	367	6	dose	dose	NOUN
brj-24903	367	7	-	-	PUNCT
brj-24903	367	8	dependent	dependent	ADJ
brj-24903	367	9	effects	effect	NOUN
brj-24903	367	10	of	of	ADP
brj-24903	367	11	a.	a.	NOUN
brj-24903	367	12	glycyphyllos	glycyphyllos	NOUN
brj-24903	367	13	extract	extract	VERB
brj-24903	367	14	and	and	CCONJ
brj-24903	367	15	explore	explore	VERB
brj-24903	367	16	its	its	PRON
brj-24903	367	17	therapeutic	therapeutic	ADJ
brj-24903	367	18	potential	potential	NOUN
brj-24903	367	19	in	in	ADP
brj-24903	367	20	models	model	NOUN
brj-24903	367	21	of	of	ADP
brj-24903	367	22	chronic	chronic	ADJ
brj-24903	367	23	arthritis	arthritis	NOUN
brj-24903	367	24	.	.	PUNCT
brj-24903	368	1	elucidating	elucidate	VERB
brj-24903	368	2	the	the	DET
brj-24903	368	3	exact	exact	ADJ
brj-24903	368	4	molecular	molecular	ADJ
brj-24903	368	5	mechanisms	mechanism	NOUN
brj-24903	368	6	underlying	underlie	VERB
brj-24903	368	7	the	the	DET
brj-24903	368	8	extract	extract	NOUN
brj-24903	368	9	’s	’s	PART
brj-24903	368	10	anti	anti	ADJ
brj-24903	368	11	-	-	ADJ
brj-24903	368	12	arthritic	arthritic	ADJ
brj-24903	368	13	effects	effect	NOUN
brj-24903	368	14	would	would	AUX
brj-24903	368	15	also	also	ADV
brj-24903	368	16	be	be	AUX
brj-24903	368	17	a	a	DET
brj-24903	368	18	valuable	valuable	ADJ
brj-24903	368	19	direction	direction	NOUN
brj-24903	368	20	for	for	ADP
brj-24903	368	21	future	future	ADJ
brj-24903	368	22	research	research	NOUN
brj-24903	368	23	.	.	PUNCT
brj-24903	369	1	furthermore	furthermore	ADV
brj-24903	369	2	,	,	PUNCT
brj-24903	369	3	clinical	clinical	ADJ
brj-24903	369	4	trials	trial	NOUN
brj-24903	369	5	could	could	AUX
brj-24903	369	6	be	be	AUX
brj-24903	369	7	conducted	conduct	VERB
brj-24903	369	8	to	to	PART
brj-24903	369	9	assess	assess	VERB
brj-24903	369	10	the	the	DET
brj-24903	369	11	safety	safety	NOUN
brj-24903	369	12	and	and	CCONJ
brj-24903	369	13	efficacy	efficacy	NOUN
brj-24903	369	14	of	of	ADP
brj-24903	369	15	a.	a.	NOUN
brj-24903	369	16	glycyphyllos	glycyphyllos	PROPN
brj-24903	369	17	extract	extract	NOUN
brj-24903	369	18	in	in	ADP
brj-24903	369	19	human	human	ADJ
brj-24903	369	20	patients	patient	NOUN
brj-24903	369	21	with	with	ADP
brj-24903	369	22	arthritis	arthritis	NOUN
brj-24903	369	23	.	.	PUNCT
brj-24903	370	1	conclusions	conclusion	NOUN
brj-24903	370	2	1	1	X
brj-24903	370	3	.	.	PUNCT
brj-24903	371	1	the	the	DET
brj-24903	371	2	results	result	NOUN
brj-24903	371	3	of	of	ADP
brj-24903	371	4	this	this	DET
brj-24903	371	5	study	study	NOUN
brj-24903	371	6	showed	show	VERB
brj-24903	371	7	that	that	SCONJ
brj-24903	371	8	the	the	DET
brj-24903	371	9	extract	extract	NOUN
brj-24903	371	10	of	of	ADP
brj-24903	371	11	a.	a.	NOUN
brj-24903	371	12	glycyphyllos	glycyphyllos	PROPN
brj-24903	371	13	has	have	VERB
brj-24903	371	14	an	an	DET
brj-24903	371	15	anti	anti	ADJ
brj-24903	371	16	-	-	ADJ
brj-24903	371	17	arthritic	arthritic	ADJ
brj-24903	371	18	effect	effect	NOUN
brj-24903	371	19	by	by	ADP
brj-24903	371	20	the	the	DET
brj-24903	371	21	reduction	reduction	NOUN
brj-24903	371	22	in	in	ADP
brj-24903	371	23	paw	paw	NOUN
brj-24903	371	24	inflammation	inflammation	NOUN
brj-24903	371	25	,	,	PUNCT
brj-24903	371	26	inflammatory	inflammatory	ADJ
brj-24903	371	27	markers	marker	NOUN
brj-24903	371	28	,	,	PUNCT
brj-24903	371	29	arthritic	arthritic	ADJ
brj-24903	371	30	score	score	NOUN
brj-24903	371	31	,	,	PUNCT
brj-24903	371	32	and	and	CCONJ
brj-24903	371	33	paw	paw	NOUN
brj-24903	371	34	inflammation	inflammation	NOUN
brj-24903	371	35	in	in	ADP
brj-24903	371	36	complete	complete	ADJ
brj-24903	371	37	freund	freund	PROPN
brj-24903	371	38	’s	’s	PART
brj-24903	371	39	adjuvant	adjuvant	NOUN
brj-24903	371	40	(	(	PUNCT
brj-24903	371	41	cfa)-challenged	cfa)-challenge	VERB
brj-24903	371	42	rats	rat	NOUN
brj-24903	371	43	,	,	PUNCT
brj-24903	371	44	as	as	ADV
brj-24903	371	45	well	well	ADV
brj-24903	371	46	as	as	ADP
brj-24903	371	47	the	the	DET
brj-24903	371	48	improvement	improvement	NOUN
brj-24903	371	49	in	in	ADP
brj-24903	371	50	locomotion	locomotion	NOUN
brj-24903	371	51	and	and	CCONJ
brj-24903	371	52	hematological	hematological	ADJ
brj-24903	371	53	parameters	parameter	NOUN
brj-24903	371	54	.	.	PUNCT
brj-24903	372	1	2	2	X
brj-24903	372	2	.	.	X
brj-24903	372	3	furthermore	furthermore	ADV
brj-24903	372	4	,	,	PUNCT
brj-24903	372	5	the	the	DET
brj-24903	372	6	extract	extract	NOUN
brj-24903	372	7	lowered	lower	VERB
brj-24903	372	8	the	the	DET
brj-24903	372	9	increased	increase	VERB
brj-24903	372	10	levels	level	NOUN
brj-24903	372	11	of	of	ADP
brj-24903	372	12	no	no	PRON
brj-24903	372	13	,	,	PUNCT
brj-24903	372	14	pge2	pge2	NOUN
brj-24903	372	15	,	,	PUNCT
brj-24903	372	16	mmp-1	mmp-1	ADP
brj-24903	372	17	,	,	PUNCT
brj-24903	372	18	and	and	CCONJ
brj-24903	372	19	mmp-13	mmp-13	VERB
brj-24903	372	20	in	in	ADP
brj-24903	372	21	primary	primary	ADJ
brj-24903	372	22	rat	rat	NOUN
brj-24903	372	23	chondrocytes	chondrocyte	NOUN
brj-24903	372	24	produced	produce	VERB
brj-24903	372	25	by	by	ADP
brj-24903	372	26	il-1β	il-1β	PROPN
brj-24903	372	27	.	.	PUNCT
brj-24903	373	1	3	3	X
brj-24903	373	2	.	.	X
brj-24903	373	3	the	the	DET
brj-24903	373	4	anti	anti	ADJ
brj-24903	373	5	-	-	ADJ
brj-24903	373	6	inflammatory	inflammatory	ADJ
brj-24903	373	7	activities	activity	NOUN
brj-24903	373	8	of	of	ADP
brj-24903	373	9	a.	a.	NOUN
brj-24903	373	10	glycyphyllos	glycyphyllos	PROPN
brj-24903	373	11	extract	extract	NOUN
brj-24903	373	12	are	be	AUX
brj-24903	373	13	responsible	responsible	ADJ
brj-24903	373	14	for	for	ADP
brj-24903	373	15	its	its	PRON
brj-24903	373	16	benefits	benefit	NOUN
brj-24903	373	17	against	against	ADP
brj-24903	373	18	cfa	cfa	NOUN
brj-24903	373	19	-	-	PUNCT
brj-24903	373	20	induced	induce	VERB
brj-24903	373	21	arthritis	arthritis	NOUN
brj-24903	373	22	(	(	PUNCT
brj-24903	373	23	in	in	ADP
brj-24903	373	24	vivo	vivo	NOUN
brj-24903	373	25	)	)	PUNCT
brj-24903	373	26	and	and	CCONJ
brj-24903	373	27	il-1β	il-1β	PROPN
brj-24903	373	28	-	-	PUNCT
brj-24903	373	29	induced	induce	VERB
brj-24903	373	30	pcrs	pcrs	NOUN
brj-24903	373	31	primary	primary	ADJ
brj-24903	373	32	rat	rat	NOUN
brj-24903	373	33	chondrocytes(in	chondrocytes(in	NOUN
brj-24903	373	34	vitro	vitro	X
brj-24903	373	35	)	)	PUNCT
brj-24903	373	36	.	.	PUNCT
brj-24903	374	1	acknowledgments	acknowledgment	NOUN
brj-24903	374	2	the	the	DET
brj-24903	374	3	authors	author	NOUN
brj-24903	374	4	are	be	AUX
brj-24903	374	5	grateful	grateful	ADJ
brj-24903	374	6	for	for	ADP
brj-24903	374	7	the	the	DET
brj-24903	374	8	grants	grant	NOUN
brj-24903	374	9	from	from	ADP
brj-24903	374	10	national	national	ADJ
brj-24903	374	11	natural	natural	ADJ
brj-24903	374	12	science	science	PROPN
brj-24903	374	13	foundation	foundation	PROPN
brj-24903	374	14	of	of	ADP
brj-24903	374	15	china	china	PROPN
brj-24903	374	16	(	(	PUNCT
brj-24903	374	17	82160901	82160901	NUM
brj-24903	374	18	)	)	PUNCT
brj-24903	374	19	,	,	PUNCT
brj-24903	374	20	the	the	DET
brj-24903	374	21	funding	funding	NOUN
brj-24903	374	22	of	of	ADP
brj-24903	374	23	yunnan	yunnan	NOUN
brj-24903	374	24	applied	apply	VERB
brj-24903	374	25	basic	basic	ADJ
brj-24903	374	26	research	research	NOUN
brj-24903	374	27	projects	project	NOUN
brj-24903	374	28	-	-	PUNCT
brj-24903	374	29	union	union	NOUN
brj-24903	374	30	foundation	foundation	NOUN
brj-24903	374	31	(	(	PUNCT
brj-24903	374	32	202101az070001	202101az070001	NUM
brj-24903	374	33	-	-	NOUN
brj-24903	374	34	198	198	NUM
brj-24903	374	35	)	)	PUNCT
brj-24903	374	36	,	,	PUNCT
brj-24903	374	37	yunnan	yunnan	PROPN
brj-24903	374	38	clinical	clinical	ADJ
brj-24903	374	39	research	research	NOUN
brj-24903	374	40	center	center	NOUN
brj-24903	374	41	for	for	ADP
brj-24903	374	42	rheumatism	rheumatism	NOUN
brj-24903	374	43	in	in	ADP
brj-24903	374	44	traditional	traditional	ADJ
brj-24903	374	45	chinese	chinese	ADJ
brj-24903	374	46	medicine	medicine	NOUN
brj-24903	374	47	(	(	PUNCT
brj-24903	374	48	202405aj310004	202405aj310004	NUM
brj-24903	374	49	)	)	PUNCT
brj-24903	374	50	,	,	PUNCT
brj-24903	374	51	the	the	DET
brj-24903	374	52	studios	studio	NOUN
brj-24903	374	53	of	of	ADP
brj-24903	374	54	national	national	PROPN
brj-24903	374	55	prominent	prominent	ADJ
brj-24903	374	56	tcm	tcm	PROPN
brj-24903	374	57	experts	expert	NOUN
brj-24903	374	58	for	for	ADP
brj-24903	374	59	carrying	carry	VERB
brj-24903	374	60	forward	forward	ADV
brj-24903	374	61	their	their	PRON
brj-24903	374	62	expertise	expertise	NOUN
brj-24903	374	63	(	(	PUNCT
brj-24903	374	64	2022no.75	2022no.75	NUM
brj-24903	374	65	)	)	PUNCT
brj-24903	374	66	.	.	PUNCT
brj-24903	375	1	peer	peer	NOUN
brj-24903	375	2	-	-	PUNCT
brj-24903	375	3	reviewed	review	VERB
brj-24903	375	4	article	article	NOUN
brj-24903	375	5	bioresources.cnr.ncsu.edu	bioresources.cnr.ncsu.edu	X
brj-24903	375	6	gu	gu	VERB
brj-24903	375	7	et	et	PROPN
brj-24903	375	8	al	al	PROPN
brj-24903	375	9	.	.	PROPN
brj-24903	376	1	(	(	PUNCT
brj-24903	376	2	2026	2026	NUM
brj-24903	376	3	)	)	PUNCT
brj-24903	376	4	.	.	PUNCT
brj-24903	377	1	“	"	PUNCT
brj-24903	377	2	astragalus	astragalus	NOUN
brj-24903	377	3	leaf	leaf	NOUN
brj-24903	377	4	extract	extract	NOUN
brj-24903	377	5	vs.	vs.	ADP
brj-24903	377	6	arthritis	arthritis	NOUN
brj-24903	377	7	,	,	PUNCT
brj-24903	377	8	”	"	PUNCT
brj-24903	377	9	bioresources	bioresource	NOUN
brj-24903	377	10	21(1	21(1	NUM
brj-24903	377	11	)	)	PUNCT
brj-24903	377	12	,	,	PUNCT
brj-24903	377	13	160	160	NUM
brj-24903	377	14	-	-	SYM
brj-24903	377	15	177	177	NUM
brj-24903	377	16	.	.	PUNCT
brj-24903	378	1	175	175	NUM
brj-24903	378	2	references	reference	NOUN
brj-24903	378	3	cited	cite	VERB
brj-24903	378	4	alamgeer	alamgeer	NOUN
brj-24903	378	5	,	,	PUNCT
brj-24903	378	6	uttra	uttra	ADJ
brj-24903	378	7	,	,	PUNCT
brj-24903	378	8	a.	a.	NOUN
brj-24903	378	9	m.	m.	NOUN
brj-24903	378	10	,	,	PUNCT
brj-24903	378	11	and	and	CCONJ
brj-24903	378	12	hasan	hasan	PROPN
brj-24903	378	13	,	,	PUNCT
brj-24903	378	14	u.	u.	PROPN
brj-24903	378	15	h.	h.	PROPN
brj-24903	378	16	(	(	PUNCT
brj-24903	378	17	2017	2017	NUM
brj-24903	378	18	)	)	PUNCT
brj-24903	378	19	.	.	PUNCT
brj-24903	379	1	“	"	PUNCT
brj-24903	379	2	anti	anti	ADJ
brj-24903	379	3	-	-	ADJ
brj-24903	379	4	arthritic	arthritic	ADJ
brj-24903	379	5	activity	activity	NOUN
brj-24903	379	6	of	of	ADP
brj-24903	379	7	aqueousmethanolic	aqueousmethanolic	ADJ
brj-24903	379	8	extract	extract	NOUN
brj-24903	379	9	and	and	CCONJ
brj-24903	379	10	various	various	ADJ
brj-24903	379	11	fractions	fraction	NOUN
brj-24903	379	12	of	of	ADP
brj-24903	379	13	berberis	berberis	PROPN
brj-24903	379	14	orthobotrys	orthobotrys	PROPN
brj-24903	379	15	bien	bien	PROPN
brj-24903	379	16	ex	ex	X
brj-24903	379	17	aitch	aitch	PROPN
brj-24903	379	18	,	,	PUNCT
brj-24903	379	19	”	"	PUNCT
brj-24903	379	20	bmc	bmc	X
brj-24903	379	21	complementary	complementary	ADJ
brj-24903	379	22	and	and	CCONJ
brj-24903	379	23	alternative	alternative	ADJ
brj-24903	379	24	medicine	medicine	NOUN
brj-24903	379	25	17	17	NUM
brj-24903	379	26	,	,	PUNCT
brj-24903	379	27	article	article	NOUN
brj-24903	379	28	371	371	NUM
brj-24903	379	29	.	.	PUNCT
brj-24903	380	1	doi	doi	NOUN
brj-24903	380	2	:	:	PUNCT
brj-24903	380	3	10.1186	10.1186	NUM
brj-24903	380	4	/	/	SYM
brj-24903	380	5	s12906	s12906	VERB
brj-24903	380	6	-	-	PUNCT
brj-24903	380	7	017	017	NUM
brj-24903	380	8	-	-	PUNCT
brj-24903	380	9	1879	1879	NUM
brj-24903	380	10	-	-	SYM
brj-24903	380	11	9	9	NUM
brj-24903	380	12	aury	aury	ADJ
brj-24903	380	13	-	-	PUNCT
brj-24903	380	14	landas	landas	PROPN
brj-24903	380	15	,	,	PUNCT
brj-24903	380	16	j.	j.	PROPN
brj-24903	380	17	,	,	PUNCT
brj-24903	380	18	bazille	bazille	NOUN
brj-24903	380	19	,	,	PUNCT
brj-24903	380	20	c.	c.	PROPN
brj-24903	380	21	,	,	PUNCT
brj-24903	380	22	allas	allas	PROPN
brj-24903	380	23	,	,	PUNCT
brj-24903	380	24	l.	l.	PROPN
brj-24903	380	25	,	,	PUNCT
brj-24903	380	26	bouhout	bouhout	PROPN
brj-24903	380	27	,	,	PUNCT
brj-24903	380	28	s.	s.	PROPN
brj-24903	380	29	,	,	PUNCT
brj-24903	380	30	chesneau	chesneau	PROPN
brj-24903	380	31	,	,	PUNCT
brj-24903	380	32	c.	c.	NOUN
brj-24903	380	33	,	,	PUNCT
brj-24903	380	34	leclercq	leclercq	PROPN
brj-24903	380	35	,	,	PUNCT
brj-24903	380	36	s.	s.	PROPN
brj-24903	380	37	,	,	PUNCT
brj-24903	380	38	boumédiene	boumédiene	PROPN
brj-24903	380	39	,	,	PUNCT
brj-24903	380	40	k.	k.	PROPN
brj-24903	380	41	,	,	PUNCT
brj-24903	380	42	and	and	CCONJ
brj-24903	380	43	baugé	baugé	PROPN
brj-24903	380	44	,	,	PUNCT
brj-24903	380	45	c.	c.	PROPN
brj-24903	380	46	(	(	PUNCT
brj-24903	380	47	2017	2017	NUM
brj-24903	380	48	)	)	PUNCT
brj-24903	380	49	.	.	PUNCT
brj-24903	381	1	“	"	PUNCT
brj-24903	381	2	anti	anti	ADJ
brj-24903	381	3	-	-	ADJ
brj-24903	381	4	inflammatory	inflammatory	ADJ
brj-24903	381	5	and	and	CCONJ
brj-24903	381	6	chondroprotective	chondroprotective	ADJ
brj-24903	381	7	effects	effect	NOUN
brj-24903	381	8	of	of	ADP
brj-24903	381	9	the	the	DET
brj-24903	381	10	s	s	NOUN
brj-24903	381	11	-	-	PUNCT
brj-24903	381	12	adenosylhomocysteine	adenosylhomocysteine	NOUN
brj-24903	381	13	hydrolase	hydrolase	NOUN
brj-24903	381	14	inhibitor	inhibitor	NOUN
brj-24903	381	15	3	3	NUM
brj-24903	381	16	-	-	PUNCT
brj-24903	381	17	deazaneplanocin	deazaneplanocin	NOUN
brj-24903	381	18	a	a	PRON
brj-24903	381	19	,	,	PUNCT
brj-24903	381	20	in	in	ADP
brj-24903	381	21	human	human	ADJ
brj-24903	381	22	articular	articular	ADJ
brj-24903	381	23	chondrocytes	chondrocyte	NOUN
brj-24903	381	24	,	,	PUNCT
brj-24903	381	25	”	"	PUNCT
brj-24903	381	26	scientific	scientific	ADJ
brj-24903	381	27	reports	report	NOUN
brj-24903	381	28	7	7	NUM
brj-24903	381	29	,	,	PUNCT
brj-24903	381	30	article	article	NOUN
brj-24903	381	31	6483	6483	NUM
brj-24903	381	32	.	.	PUNCT
brj-24903	382	1	doi	doi	NOUN
brj-24903	382	2	:	:	PUNCT
brj-24903	382	3	10.1038	10.1038	NUM
brj-24903	382	4	/	/	SYM
brj-24903	382	5	s41598	s41598	NOUN
brj-24903	382	6	-	-	PUNCT
brj-24903	382	7	017	017	NUM
brj-24903	382	8	-	-	PUNCT
brj-24903	382	9	06913	06913	NUM
brj-24903	382	10	-	-	SYM
brj-24903	382	11	6	6	NUM
brj-24903	382	12	behl	behl	NOUN
brj-24903	382	13	,	,	PUNCT
brj-24903	382	14	t.	t.	PROPN
brj-24903	382	15	,	,	PUNCT
brj-24903	382	16	upadhyay	upadhyay	PROPN
brj-24903	382	17	,	,	PUNCT
brj-24903	382	18	t.	t.	PROPN
brj-24903	382	19	,	,	PUNCT
brj-24903	382	20	singh	singh	PROPN
brj-24903	382	21	,	,	PUNCT
brj-24903	382	22	s.	s.	PROPN
brj-24903	382	23	,	,	PUNCT
brj-24903	382	24	chigurupati	chigurupati	PROPN
brj-24903	382	25	,	,	PUNCT
brj-24903	382	26	s.	s.	PROPN
brj-24903	382	27	,	,	PUNCT
brj-24903	382	28	alsubayiel	alsubayiel	PROPN
brj-24903	382	29	,	,	PUNCT
brj-24903	382	30	a.	a.	NOUN
brj-24903	382	31	m.	m.	NOUN
brj-24903	382	32	,	,	PUNCT
brj-24903	382	33	mani	mani	PROPN
brj-24903	382	34	,	,	PUNCT
brj-24903	382	35	v.	v.	ADV
brj-24903	382	36	,	,	PUNCT
brj-24903	382	37	vargasde	vargasde	PROPN
brj-24903	382	38	-	-	PUNCT
brj-24903	382	39	la	la	NOUN
brj-24903	382	40	-	-	PUNCT
brj-24903	382	41	cruz	cruz	PROPN
brj-24903	382	42	,	,	PUNCT
brj-24903	382	43	c.	c.	PROPN
brj-24903	382	44	,	,	PUNCT
brj-24903	382	45	uivarosan	uivarosan	PROPN
brj-24903	382	46	,	,	PUNCT
brj-24903	382	47	d.	d.	PROPN
brj-24903	382	48	,	,	PUNCT
brj-24903	382	49	bustea	bustea	PROPN
brj-24903	382	50	,	,	PUNCT
brj-24903	382	51	c.	c.	PROPN
brj-24903	382	52	,	,	PUNCT
brj-24903	382	53	sava	sava	PROPN
brj-24903	382	54	,	,	PUNCT
brj-24903	382	55	c.	c.	PROPN
brj-24903	382	56	,	,	PUNCT
brj-24903	382	57	stoicescu	stoicescu	NOUN
brj-24903	382	58	,	,	PUNCT
brj-24903	382	59	m.	m.	NOUN
brj-24903	382	60	,	,	PUNCT
brj-24903	382	61	radu	radu	PROPN
brj-24903	382	62	,	,	PUNCT
brj-24903	382	63	a.	a.	PROPN
brj-24903	382	64	f.	f.	PROPN
brj-24903	382	65	,	,	PUNCT
brj-24903	382	66	and	and	CCONJ
brj-24903	382	67	bungau	bungau	NOUN
brj-24903	382	68	,	,	PUNCT
brj-24903	382	69	s.	s.	PROPN
brj-24903	382	70	g.	g.	PROPN
brj-24903	382	71	(	(	PUNCT
brj-24903	382	72	2021	2021	NUM
brj-24903	382	73	)	)	PUNCT
brj-24903	382	74	.	.	PUNCT
brj-24903	383	1	“	"	PUNCT
brj-24903	383	2	polyphenols	polyphenol	NOUN
brj-24903	383	3	targeting	target	VERB
brj-24903	383	4	mapk	mapk	NOUN
brj-24903	383	5	mediated	mediate	VERB
brj-24903	383	6	oxidative	oxidative	ADJ
brj-24903	383	7	stress	stress	NOUN
brj-24903	383	8	and	and	CCONJ
brj-24903	383	9	inflammation	inflammation	NOUN
brj-24903	383	10	in	in	ADP
brj-24903	383	11	rheumatoid	rheumatoid	NOUN
brj-24903	383	12	arthritis	arthritis	NOUN
brj-24903	383	13	,	,	PUNCT
brj-24903	383	14	”	"	PUNCT
brj-24903	383	15	molecules	molecule	NOUN
brj-24903	383	16	26(21	26(21	NUM
brj-24903	383	17	)	)	PUNCT
brj-24903	383	18	,	,	PUNCT
brj-24903	383	19	article	article	NOUN
brj-24903	383	20	657	657	NUM
brj-24903	383	21	.	.	PUNCT
brj-24903	384	1	doi	doi	NOUN
brj-24903	384	2	:	:	PUNCT
brj-24903	384	3	10.3390	10.3390	NUM
brj-24903	384	4	/	/	SYM
brj-24903	384	5	molecules26216570	molecules26216570	PROPN
brj-24903	384	6	bennell	bennell	NOUN
brj-24903	384	7	,	,	PUNCT
brj-24903	384	8	k.	k.	PROPN
brj-24903	384	9	l.	l.	PROPN
brj-24903	384	10	,	,	PUNCT
brj-24903	384	11	hunt	hunt	PROPN
brj-24903	384	12	,	,	PUNCT
brj-24903	384	13	m.	m.	NOUN
brj-24903	384	14	a.	a.	PROPN
brj-24903	384	15	,	,	PUNCT
brj-24903	384	16	wrigley	wrigley	PROPN
brj-24903	384	17	,	,	PUNCT
brj-24903	384	18	t.	t.	PROPN
brj-24903	384	19	v.	v.	PROPN
brj-24903	384	20	,	,	PUNCT
brj-24903	384	21	hunter	hunter	NOUN
brj-24903	384	22	,	,	PUNCT
brj-24903	384	23	d.	d.	PROPN
brj-24903	384	24	j.	j.	PROPN
brj-24903	384	25	,	,	PUNCT
brj-24903	384	26	mcmanus	mcmanus	PROPN
brj-24903	384	27	,	,	PUNCT
brj-24903	384	28	f.	f.	PROPN
brj-24903	384	29	j.	j.	PROPN
brj-24903	384	30	,	,	PUNCT
brj-24903	384	31	hodges	hodges	PROPN
brj-24903	384	32	,	,	PUNCT
brj-24903	384	33	p.	p.	PROPN
brj-24903	384	34	w.	w.	PROPN
brj-24903	384	35	,	,	PUNCT
brj-24903	384	36	li	li	PROPN
brj-24903	384	37	,	,	PUNCT
brj-24903	384	38	l.	l.	PROPN
brj-24903	384	39	,	,	PUNCT
brj-24903	384	40	and	and	CCONJ
brj-24903	384	41	hinman	hinman	NOUN
brj-24903	384	42	,	,	PUNCT
brj-24903	384	43	r.	r.	PROPN
brj-24903	384	44	s.	s.	PROPN
brj-24903	384	45	(	(	PUNCT
brj-24903	384	46	2010	2010	NUM
brj-24903	384	47	)	)	PUNCT
brj-24903	384	48	.	.	PUNCT
brj-24903	385	1	“	"	PUNCT
brj-24903	385	2	hip	hip	NOUN
brj-24903	385	3	strengthening	strengthening	NOUN
brj-24903	385	4	reduces	reduce	VERB
brj-24903	385	5	symptoms	symptom	NOUN
brj-24903	385	6	but	but	CCONJ
brj-24903	385	7	not	not	PART
brj-24903	385	8	knee	knee	NOUN
brj-24903	385	9	load	load	NOUN
brj-24903	385	10	in	in	ADP
brj-24903	385	11	people	people	NOUN
brj-24903	385	12	with	with	ADP
brj-24903	385	13	medial	medial	ADJ
brj-24903	385	14	knee	knee	NOUN
brj-24903	385	15	osteoarthritis	osteoarthritis	NOUN
brj-24903	385	16	and	and	CCONJ
brj-24903	385	17	varus	varus	NOUN
brj-24903	385	18	malalignment	malalignment	NOUN
brj-24903	385	19	:	:	PUNCT
brj-24903	385	20	a	a	DET
brj-24903	385	21	randomised	randomised	ADJ
brj-24903	385	22	controlled	control	VERB
brj-24903	385	23	trial	trial	NOUN
brj-24903	385	24	,	,	PUNCT
brj-24903	385	25	”	"	PUNCT
brj-24903	385	26	osteoarthritis	osteoarthritis	NOUN
brj-24903	385	27	and	and	CCONJ
brj-24903	385	28	cartilage	cartilage	NOUN
brj-24903	385	29	18(5	18(5	NUM
brj-24903	385	30	)	)	PUNCT
brj-24903	385	31	,	,	PUNCT
brj-24903	385	32	621	621	NUM
brj-24903	385	33	-	-	SYM
brj-24903	385	34	628	628	NUM
brj-24903	385	35	.	.	PUNCT
brj-24903	386	1	doi	doi	NOUN
brj-24903	386	2	:	:	PUNCT
brj-24903	386	3	10.1016	10.1016	NUM
brj-24903	386	4	/	/	SYM
brj-24903	386	5	j.joca.2010.01.010	j.joca.2010.01.010	PROPN
brj-24903	386	6	bullock	bullock	PROPN
brj-24903	386	7	,	,	PUNCT
brj-24903	386	8	j.	j.	PROPN
brj-24903	386	9	,	,	PUNCT
brj-24903	386	10	rizvi	rizvi	PROPN
brj-24903	386	11	,	,	PUNCT
brj-24903	386	12	s.	s.	PROPN
brj-24903	386	13	a.	a.	PROPN
brj-24903	386	14	a.	a.	PROPN
brj-24903	386	15	,	,	PUNCT
brj-24903	386	16	saleh	saleh	NOUN
brj-24903	386	17	,	,	PUNCT
brj-24903	386	18	a.	a.	NOUN
brj-24903	386	19	m.	m.	NOUN
brj-24903	386	20	,	,	PUNCT
brj-24903	386	21	ahmed	ahmed	PROPN
brj-24903	386	22	,	,	PUNCT
brj-24903	386	23	s.	s.	PROPN
brj-24903	386	24	s.	s.	PROPN
brj-24903	386	25	,	,	PUNCT
brj-24903	386	26	do	do	VERB
brj-24903	386	27	,	,	PUNCT
brj-24903	386	28	d.	d.	PROPN
brj-24903	386	29	p.	p.	PROPN
brj-24903	386	30	,	,	PUNCT
brj-24903	386	31	ansari	ansari	PROPN
brj-24903	386	32	,	,	PUNCT
brj-24903	386	33	r.	r.	PROPN
brj-24903	386	34	a.	a.	PROPN
brj-24903	386	35	,	,	PUNCT
brj-24903	386	36	and	and	CCONJ
brj-24903	386	37	ahmed	ahmed	PROPN
brj-24903	386	38	,	,	PUNCT
brj-24903	386	39	j.	j.	PROPN
brj-24903	386	40	(	(	PUNCT
brj-24903	386	41	2019	2019	NUM
brj-24903	386	42	)	)	PUNCT
brj-24903	386	43	.	.	PUNCT
brj-24903	387	1	“	"	PUNCT
brj-24903	387	2	rheumatoid	rheumatoid	VERB
brj-24903	387	3	arthritis	arthritis	NOUN
brj-24903	387	4	:	:	PUNCT
brj-24903	387	5	a	a	DET
brj-24903	387	6	brief	brief	ADJ
brj-24903	387	7	overview	overview	NOUN
brj-24903	387	8	of	of	ADP
brj-24903	387	9	the	the	DET
brj-24903	387	10	treatment	treatment	NOUN
brj-24903	387	11	,	,	PUNCT
brj-24903	387	12	”	"	PUNCT
brj-24903	387	13	medical	medical	ADJ
brj-24903	387	14	principles	principle	NOUN
brj-24903	387	15	and	and	CCONJ
brj-24903	387	16	practice	practice	NOUN
brj-24903	387	17	27(6	27(6	NUM
brj-24903	387	18	)	)	PUNCT
brj-24903	387	19	,	,	PUNCT
brj-24903	387	20	501	501	NUM
brj-24903	387	21	-	-	SYM
brj-24903	387	22	507	507	NUM
brj-24903	387	23	.	.	PUNCT
brj-24903	388	1	doi	doi	NOUN
brj-24903	388	2	:	:	PUNCT
brj-24903	388	3	10.1159/000493390	10.1159/000493390	NUM
brj-24903	388	4	choy	choy	NOUN
brj-24903	388	5	,	,	PUNCT
brj-24903	388	6	e.	e.	PROPN
brj-24903	388	7	h.	h.	PROPN
brj-24903	388	8	s.	s.	PROPN
brj-24903	388	9	,	,	PUNCT
brj-24903	388	10	and	and	CCONJ
brj-24903	388	11	panayi	panayi	NOUN
brj-24903	388	12	,	,	PUNCT
brj-24903	388	13	g.	g.	PROPN
brj-24903	388	14	s.	s.	PROPN
brj-24903	388	15	(	(	PUNCT
brj-24903	388	16	2001	2001	NUM
brj-24903	388	17	)	)	PUNCT
brj-24903	388	18	.	.	PUNCT
brj-24903	389	1	“	"	PUNCT
brj-24903	389	2	cytokine	cytokine	VERB
brj-24903	389	3	pathways	pathway	NOUN
brj-24903	389	4	and	and	CCONJ
brj-24903	389	5	joint	joint	ADJ
brj-24903	389	6	inflammation	inflammation	NOUN
brj-24903	389	7	in	in	ADP
brj-24903	389	8	rheumatoid	rheumatoid	NOUN
brj-24903	389	9	arthritis	arthritis	NOUN
brj-24903	389	10	,	,	PUNCT
brj-24903	389	11	”	"	PUNCT
brj-24903	389	12	new	new	PROPN
brj-24903	389	13	england	england	PROPN
brj-24903	389	14	journal	journal	PROPN
brj-24903	389	15	of	of	ADP
brj-24903	389	16	medicine	medicine	NOUN
brj-24903	389	17	344(12	344(12	NUM
brj-24903	389	18	)	)	PUNCT
brj-24903	389	19	,	,	PUNCT
brj-24903	389	20	907	907	NUM
brj-24903	389	21	-	-	SYM
brj-24903	389	22	916	916	NUM
brj-24903	389	23	.	.	PUNCT
brj-24903	390	1	doi	doi	NOUN
brj-24903	390	2	:	:	PUNCT
brj-24903	390	3	10.1056	10.1056	NUM
brj-24903	390	4	/	/	SYM
brj-24903	390	5	nejm200103223441207	nejm200103223441207	PROPN
brj-24903	390	6	eccleston	eccleston	PROPN
brj-24903	390	7	,	,	PUNCT
brj-24903	390	8	a.	a.	NOUN
brj-24903	390	9	(	(	PUNCT
brj-24903	390	10	2023	2023	NUM
brj-24903	390	11	)	)	PUNCT
brj-24903	390	12	.	.	PUNCT
brj-24903	391	1	“	"	PUNCT
brj-24903	391	2	cartilage	cartilage	NOUN
brj-24903	391	3	regeneration	regeneration	NOUN
brj-24903	391	4	for	for	ADP
brj-24903	391	5	osteoarthritis	osteoarthritis	NOUN
brj-24903	391	6	,	,	PUNCT
brj-24903	391	7	”	"	PUNCT
brj-24903	391	8	nature	nature	NOUN
brj-24903	391	9	reviews	review	VERB
brj-24903	391	10	drug	drug	NOUN
brj-24903	391	11	discovery	discovery	PROPN
brj-24903	391	12	22(2	22(2	NUM
brj-24903	391	13	)	)	PUNCT
brj-24903	391	14	,	,	PUNCT
brj-24903	391	15	article	article	NOUN
brj-24903	391	16	96	96	NUM
brj-24903	391	17	.	.	PUNCT
brj-24903	392	1	doi	doi	NOUN
brj-24903	392	2	:	:	PUNCT
brj-24903	392	3	10.1038	10.1038	NUM
brj-24903	392	4	/	/	SYM
brj-24903	392	5	d41573	d41573	PROPN
brj-24903	392	6	-	-	PUNCT
brj-24903	392	7	022	022	NUM
brj-24903	392	8	-	-	PUNCT
brj-24903	392	9	00215	00215	NUM
brj-24903	392	10	-	-	PUNCT
brj-24903	392	11	x	x	SYM
brj-24903	392	12	fan	fan	PROPN
brj-24903	392	13	,	,	PUNCT
brj-24903	392	14	h.	h.	PROPN
brj-24903	392	15	w.	w.	PROPN
brj-24903	392	16	,	,	PUNCT
brj-24903	392	17	liu	liu	PROPN
brj-24903	392	18	,	,	PUNCT
brj-24903	392	19	g.	g.	PROPN
brj-24903	392	20	y.	y.	PROPN
brj-24903	392	21	,	,	PUNCT
brj-24903	392	22	zhao	zhao	PROPN
brj-24903	392	23	,	,	PUNCT
brj-24903	392	24	c.	c.	PROPN
brj-24903	392	25	f.	f.	PROPN
brj-24903	392	26	,	,	PUNCT
brj-24903	392	27	li	li	PROPN
brj-24903	392	28	,	,	PUNCT
brj-24903	392	29	x.	x.	PROPN
brj-24903	392	30	f.	f.	PROPN
brj-24903	392	31	,	,	PUNCT
brj-24903	392	32	and	and	CCONJ
brj-24903	392	33	yang	yang	PROPN
brj-24903	392	34	,	,	PUNCT
brj-24903	392	35	x.	x.	PROPN
brj-24903	392	36	y.	y.	PROPN
brj-24903	392	37	(	(	PUNCT
brj-24903	392	38	2015	2015	NUM
brj-24903	392	39	)	)	PUNCT
brj-24903	392	40	.	.	PUNCT
brj-24903	393	1	“	"	PUNCT
brj-24903	393	2	differential	differential	ADJ
brj-24903	393	3	expression	expression	NOUN
brj-24903	393	4	of	of	ADP
brj-24903	393	5	cox-2	cox-2	NOUN
brj-24903	393	6	in	in	ADP
brj-24903	393	7	osteoarthritis	osteoarthritis	NOUN
brj-24903	393	8	and	and	CCONJ
brj-24903	393	9	rheumatoid	rheumatoid	VERB
brj-24903	393	10	arthritis	arthritis	NOUN
brj-24903	393	11	,	,	PUNCT
brj-24903	393	12	”	"	PUNCT
brj-24903	393	13	genetics	genetic	NOUN
brj-24903	393	14	and	and	CCONJ
brj-24903	393	15	molecular	molecular	ADJ
brj-24903	393	16	research	research	NOUN
brj-24903	393	17	14(4	14(4	NOUN
brj-24903	393	18	)	)	PUNCT
brj-24903	393	19	,	,	PUNCT
brj-24903	393	20	12872	12872	NUM
brj-24903	393	21	-	-	SYM
brj-24903	393	22	12879	12879	NUM
brj-24903	393	23	.	.	PUNCT
brj-24903	394	1	doi	doi	NOUN
brj-24903	394	2	:	:	PUNCT
brj-24903	394	3	10.4238/2015.october.21.7	10.4238/2015.october.21.7	NUM
brj-24903	394	4	ferreira	ferreira	PROPN
brj-24903	394	5	,	,	PUNCT
brj-24903	394	6	j.	j.	PROPN
brj-24903	394	7	f.	f.	PROPN
brj-24903	394	8	,	,	PUNCT
brj-24903	394	9	ahmed	ahmed	PROPN
brj-24903	394	10	mohamed	mohamed	PROPN
brj-24903	394	11	,	,	PUNCT
brj-24903	394	12	a.	a.	NOUN
brj-24903	394	13	a.	a.	PROPN
brj-24903	394	14	,	,	PUNCT
brj-24903	394	15	and	and	CCONJ
brj-24903	394	16	emery	emery	PROPN
brj-24903	394	17	,	,	PUNCT
brj-24903	394	18	p.	p.	NOUN
brj-24903	394	19	(	(	PUNCT
brj-24903	394	20	2016	2016	NUM
brj-24903	394	21	)	)	PUNCT
brj-24903	394	22	.	.	PUNCT
brj-24903	395	1	“	"	PUNCT
brj-24903	395	2	glucocorticoids	glucocorticoid	NOUN
brj-24903	395	3	and	and	CCONJ
brj-24903	395	4	rheumatoid	rheumatoid	VERB
brj-24903	395	5	arthritis	arthritis	NOUN
brj-24903	395	6	,	,	PUNCT
brj-24903	395	7	”	"	PUNCT
brj-24903	395	8	rheumatic	rheumatic	ADJ
brj-24903	395	9	disease	disease	NOUN
brj-24903	395	10	clinics	clinic	NOUN
brj-24903	395	11	of	of	ADP
brj-24903	395	12	north	north	PROPN
brj-24903	395	13	america	america	PROPN
brj-24903	395	14	42(1	42(1	PROPN
brj-24903	395	15	)	)	PUNCT
brj-24903	395	16	,	,	PUNCT
brj-24903	395	17	33	33	NUM
brj-24903	395	18	-	-	SYM
brj-24903	395	19	46	46	NUM
brj-24903	395	20	.	.	PUNCT
brj-24903	396	1	doi	doi	NOUN
brj-24903	396	2	:	:	PUNCT
brj-24903	396	3	10.1016	10.1016	NUM
brj-24903	396	4	/	/	SYM
brj-24903	396	5	j.rdc.2015.08.006	j.rdc.2015.08.006	NOUN
brj-24903	396	6	firdous	firdous	ADJ
brj-24903	396	7	,	,	PUNCT
brj-24903	396	8	s.	s.	PROPN
brj-24903	396	9	m.	m.	PROPN
brj-24903	396	10	,	,	PUNCT
brj-24903	396	11	and	and	CCONJ
brj-24903	396	12	koneri	koneri	PROPN
brj-24903	396	13	,	,	PUNCT
brj-24903	396	14	r.	r.	PROPN
brj-24903	396	15	(	(	PUNCT
brj-24903	396	16	2012	2012	NUM
brj-24903	396	17	)	)	PUNCT
brj-24903	396	18	.	.	PUNCT
brj-24903	397	1	“	"	PUNCT
brj-24903	397	2	in	in	ADP
brj-24903	397	3	vivo	vivo	NOUN
brj-24903	397	4	and	and	CCONJ
brj-24903	397	5	in	in	ADP
brj-24903	397	6	vitro	vitro	X
brj-24903	397	7	antiinflammatory	antiinflammatory	NOUN
brj-24903	397	8	activity	activity	NOUN
brj-24903	397	9	of	of	ADP
brj-24903	397	10	leaves	leave	NOUN
brj-24903	397	11	of	of	ADP
brj-24903	397	12	ipomoea	ipomoea	PROPN
brj-24903	397	13	staphylina	staphylina	NOUN
brj-24903	397	14	,	,	PUNCT
brj-24903	397	15	”	"	PUNCT
brj-24903	397	16	international	international	ADJ
brj-24903	397	17	journal	journal	NOUN
brj-24903	397	18	of	of	ADP
brj-24903	397	19	pharmacy	pharmacy	NOUN
brj-24903	397	20	and	and	CCONJ
brj-24903	397	21	pharmaceutical	pharmaceutical	NOUN
brj-24903	397	22	sciences	sciences	PROPN
brj-24903	397	23	4(suppl	4(suppl	PROPN
brj-24903	397	24	.	.	PROPN
brj-24903	397	25	5	5	NUM
brj-24903	397	26	)	)	PUNCT
brj-24903	397	27	.	.	PUNCT
brj-24903	398	1	guo	guo	PROPN
brj-24903	398	2	,	,	PUNCT
brj-24903	398	3	q.	q.	PROPN
brj-24903	398	4	,	,	PUNCT
brj-24903	398	5	wang	wang	PROPN
brj-24903	398	6	,	,	PUNCT
brj-24903	398	7	y.	y.	PROPN
brj-24903	398	8	,	,	PUNCT
brj-24903	398	9	xu	xu	PROPN
brj-24903	398	10	,	,	PUNCT
brj-24903	398	11	d.	d.	PROPN
brj-24903	398	12	,	,	PUNCT
brj-24903	398	13	nossent	nossent	PROPN
brj-24903	398	14	,	,	PUNCT
brj-24903	398	15	j.	j.	PROPN
brj-24903	398	16	,	,	PUNCT
brj-24903	398	17	pavlos	pavlos	PROPN
brj-24903	398	18	,	,	PUNCT
brj-24903	398	19	n.	n.	PROPN
brj-24903	398	20	j.	j.	PROPN
brj-24903	398	21	,	,	PUNCT
brj-24903	398	22	and	and	CCONJ
brj-24903	398	23	xu	xu	PROPN
brj-24903	398	24	,	,	PUNCT
brj-24903	398	25	j.	j.	PROPN
brj-24903	398	26	(	(	PUNCT
brj-24903	398	27	2018	2018	NUM
brj-24903	398	28	)	)	PUNCT
brj-24903	398	29	.	.	PUNCT
brj-24903	399	1	“	"	PUNCT
brj-24903	399	2	rheumatoid	rheumatoid	VERB
brj-24903	399	3	arthritis	arthritis	NOUN
brj-24903	399	4	:	:	PUNCT
brj-24903	399	5	pathological	pathological	ADJ
brj-24903	399	6	mechanisms	mechanism	NOUN
brj-24903	399	7	and	and	CCONJ
brj-24903	399	8	modern	modern	ADJ
brj-24903	399	9	pharmacologic	pharmacologic	ADJ
brj-24903	399	10	therapies	therapy	NOUN
brj-24903	399	11	,	,	PUNCT
brj-24903	399	12	”	"	PUNCT
brj-24903	399	13	bone	bone	NOUN
brj-24903	399	14	research	research	NOUN
brj-24903	399	15	6	6	NUM
brj-24903	399	16	,	,	PUNCT
brj-24903	399	17	article	article	NOUN
brj-24903	399	18	15	15	NUM
brj-24903	399	19	.	.	PUNCT
brj-24903	400	1	doi	doi	NOUN
brj-24903	400	2	:	:	PUNCT
brj-24903	400	3	10.1038	10.1038	NUM
brj-24903	400	4	/	/	SYM
brj-24903	400	5	s41413	s41413	NOUN
brj-24903	400	6	-	-	PUNCT
brj-24903	400	7	018	018	NUM
brj-24903	400	8	-	-	PUNCT
brj-24903	400	9	0016	0016	NUM
brj-24903	400	10	-	-	SYM
brj-24903	400	11	9	9	NUM
brj-24903	400	12	gupta	gupta	PROPN
brj-24903	400	13	,	,	PUNCT
brj-24903	400	14	s.	s.	PROPN
brj-24903	400	15	,	,	PUNCT
brj-24903	400	16	mishra	mishra	PROPN
brj-24903	400	17	,	,	PUNCT
brj-24903	401	1	k.	k.	PROPN
brj-24903	401	2	p.	p.	PROPN
brj-24903	401	3	,	,	PUNCT
brj-24903	401	4	kumar	kumar	PROPN
brj-24903	401	5	,	,	PUNCT
brj-24903	401	6	b.	b.	PROPN
brj-24903	401	7	,	,	PUNCT
brj-24903	401	8	singh	singh	PROPN
brj-24903	401	9	,	,	PUNCT
brj-24903	401	10	s.	s.	PROPN
brj-24903	401	11	b.	b.	PROPN
brj-24903	401	12	,	,	PUNCT
brj-24903	401	13	and	and	CCONJ
brj-24903	401	14	ganju	ganju	PROPN
brj-24903	401	15	,	,	PUNCT
brj-24903	401	16	l.	l.	PROPN
brj-24903	401	17	(	(	PUNCT
brj-24903	401	18	2020	2020	NUM
brj-24903	401	19	)	)	PUNCT
brj-24903	402	1	.	.	PUNCT
brj-24903	403	1	“	"	PUNCT
brj-24903	403	2	andrographolide	andrographolide	ADJ
brj-24903	403	3	attenuates	attenuate	VERB
brj-24903	403	4	complete	complete	ADJ
brj-24903	403	5	freund	freund	PROPN
brj-24903	403	6	’s	’s	PART
brj-24903	403	7	adjuvant	adjuvant	NOUN
brj-24903	403	8	induced	induce	VERB
brj-24903	403	9	arthritis	arthritis	NOUN
brj-24903	403	10	via	via	ADP
brj-24903	403	11	suppression	suppression	NOUN
brj-24903	403	12	of	of	ADP
brj-24903	403	13	inflammatory	inflammatory	ADJ
brj-24903	403	14	mediators	mediator	NOUN
brj-24903	403	15	and	and	CCONJ
brj-24903	403	16	pro	pro	ADJ
brj-24903	403	17	-	-	ADJ
brj-24903	403	18	inflammatory	inflammatory	ADJ
brj-24903	403	19	cytokines	cytokine	NOUN
brj-24903	403	20	,	,	PUNCT
brj-24903	403	21	”	"	PUNCT
brj-24903	403	22	journal	journal	NOUN
brj-24903	403	23	of	of	ADP
brj-24903	403	24	ethnopharmacology	ethnopharmacology	NOUN
brj-24903	403	25	261	261	NUM
brj-24903	403	26	,	,	PUNCT
brj-24903	403	27	article	article	NOUN
brj-24903	403	28	113022	113022	NUM
brj-24903	403	29	.	.	PUNCT
brj-24903	404	1	doi	doi	NOUN
brj-24903	404	2	:	:	PUNCT
brj-24903	404	3	10.1016	10.1016	NUM
brj-24903	404	4	/	/	SYM
brj-24903	404	5	j.jep.2020.113022	j.jep.2020.113022	PROPN
brj-24903	404	6	hochberg	hochberg	PROPN
brj-24903	404	7	,	,	PUNCT
brj-24903	404	8	m.	m.	NOUN
brj-24903	404	9	c.	c.	PROPN
brj-24903	404	10	(	(	PUNCT
brj-24903	404	11	2002	2002	NUM
brj-24903	404	12	)	)	PUNCT
brj-24903	404	13	.	.	PUNCT
brj-24903	405	1	“	"	PUNCT
brj-24903	405	2	treatment	treatment	NOUN
brj-24903	405	3	of	of	ADP
brj-24903	405	4	rheumatoid	rheumatoid	NOUN
brj-24903	405	5	arthritis	arthritis	NOUN
brj-24903	405	6	and	and	CCONJ
brj-24903	405	7	osteoarthritis	osteoarthritis	NOUN
brj-24903	405	8	with	with	ADP
brj-24903	405	9	cox2	cox2	NOUN
brj-24903	405	10	-	-	PUNCT
brj-24903	405	11	selective	selective	ADJ
brj-24903	405	12	inhibitors	inhibitor	NOUN
brj-24903	405	13	:	:	PUNCT
brj-24903	405	14	a	a	DET
brj-24903	405	15	managed	manage	VERB
brj-24903	405	16	care	care	NOUN
brj-24903	405	17	perspective	perspective	NOUN
brj-24903	405	18	,	,	PUNCT
brj-24903	405	19	”	"	PUNCT
brj-24903	405	20	american	american	ADJ
brj-24903	405	21	journal	journal	PROPN
brj-24903	405	22	of	of	ADP
brj-24903	405	23	managed	manage	VERB
brj-24903	405	24	care	care	NOUN
brj-24903	405	25	8(17	8(17	NUM
brj-24903	405	26	suppl	suppl	ADJ
brj-24903	405	27	)	)	PUNCT
brj-24903	405	28	,	,	PUNCT
brj-24903	405	29	s502	s502	PROPN
brj-24903	405	30	-	-	PUNCT
brj-24903	405	31	17	17	NUM
brj-24903	405	32	.	.	PUNCT
brj-24903	405	33	peer	peer	NOUN
brj-24903	405	34	-	-	PUNCT
brj-24903	405	35	reviewed	review	VERB
brj-24903	405	36	article	article	NOUN
brj-24903	405	37	bioresources.cnr.ncsu.edu	bioresources.cnr.ncsu.edu	X
brj-24903	405	38	gu	gu	VERB
brj-24903	405	39	et	et	PROPN
brj-24903	405	40	al	al	PROPN
brj-24903	405	41	.	.	PROPN
brj-24903	405	42	(	(	PUNCT
brj-24903	405	43	2026	2026	NUM
brj-24903	405	44	)	)	PUNCT
brj-24903	405	45	.	.	PUNCT
brj-24903	406	1	“	"	PUNCT
brj-24903	406	2	astragalus	astragalus	NOUN
brj-24903	406	3	leaf	leaf	NOUN
brj-24903	406	4	extract	extract	NOUN
brj-24903	406	5	vs.	vs.	ADP
brj-24903	406	6	arthritis	arthritis	NOUN
brj-24903	406	7	,	,	PUNCT
brj-24903	406	8	”	"	PUNCT
brj-24903	406	9	bioresources	bioresource	NOUN
brj-24903	406	10	21(1	21(1	NUM
brj-24903	406	11	)	)	PUNCT
brj-24903	406	12	,	,	PUNCT
brj-24903	406	13	160	160	NUM
brj-24903	406	14	-	-	SYM
brj-24903	406	15	177	177	NUM
brj-24903	406	16	.	.	PUNCT
brj-24903	407	1	176	176	NUM
brj-24903	407	2	jin	jin	NOUN
brj-24903	407	3	,	,	PUNCT
brj-24903	407	4	j.	j.	PROPN
brj-24903	407	5	h.	h.	PROPN
brj-24903	407	6	,	,	PUNCT
brj-24903	407	7	kim	kim	PROPN
brj-24903	407	8	,	,	PUNCT
brj-24903	407	9	j.	j.	PROPN
brj-24903	407	10	s.	s.	PROPN
brj-24903	407	11	,	,	PUNCT
brj-24903	407	12	kang	kang	PROPN
brj-24903	407	13	,	,	PUNCT
brj-24903	407	14	s.	s.	PROPN
brj-24903	407	15	s.	s.	PROPN
brj-24903	407	16	,	,	PUNCT
brj-24903	407	17	son	son	PROPN
brj-24903	407	18	,	,	PUNCT
brj-24903	407	19	k.	k.	PROPN
brj-24903	407	20	h.	h.	PROPN
brj-24903	407	21	,	,	PUNCT
brj-24903	407	22	chang	chang	PROPN
brj-24903	407	23	,	,	PUNCT
brj-24903	407	24	h.	h.	PROPN
brj-24903	407	25	w.	w.	PROPN
brj-24903	407	26	,	,	PUNCT
brj-24903	407	27	and	and	CCONJ
brj-24903	407	28	kim	kim	PROPN
brj-24903	407	29	,	,	PUNCT
brj-24903	407	30	h.	h.	PROPN
brj-24903	407	31	p.	p.	PROPN
brj-24903	407	32	(	(	PUNCT
brj-24903	407	33	2010	2010	NUM
brj-24903	407	34	)	)	PUNCT
brj-24903	407	35	.	.	PUNCT
brj-24903	408	1	“	"	PUNCT
brj-24903	408	2	anti	anti	ADJ
brj-24903	408	3	-	-	ADJ
brj-24903	408	4	inflammatory	inflammatory	ADJ
brj-24903	408	5	and	and	CCONJ
brj-24903	408	6	anti	anti	ADJ
brj-24903	408	7	-	-	ADJ
brj-24903	408	8	arthritic	arthritic	ADJ
brj-24903	408	9	activity	activity	NOUN
brj-24903	408	10	of	of	ADP
brj-24903	408	11	total	total	ADJ
brj-24903	408	12	flavonoids	flavonoid	NOUN
brj-24903	408	13	of	of	ADP
brj-24903	408	14	the	the	DET
brj-24903	408	15	roots	root	NOUN
brj-24903	408	16	of	of	ADP
brj-24903	408	17	sophora	sophora	NOUN
brj-24903	408	18	flavescens	flavescen	NOUN
brj-24903	408	19	,	,	PUNCT
brj-24903	408	20	”	"	PUNCT
brj-24903	408	21	journal	journal	NOUN
brj-24903	408	22	of	of	ADP
brj-24903	408	23	ethnopharmacology	ethnopharmacology	NOUN
brj-24903	408	24	127(3	127(3	NUM
brj-24903	408	25	)	)	PUNCT
brj-24903	408	26	,	,	PUNCT
brj-24903	408	27	589	589	NUM
brj-24903	408	28	-	-	SYM
brj-24903	408	29	595	595	NUM
brj-24903	408	30	.	.	PUNCT
brj-24903	409	1	doi	doi	NOUN
brj-24903	409	2	:	:	PUNCT
brj-24903	409	3	10.1016	10.1016	NUM
brj-24903	409	4	/	/	SYM
brj-24903	409	5	j.jep.2009.12.020	j.jep.2009.12.020	PROPN
brj-24903	409	6	kaur	kaur	PROPN
brj-24903	409	7	,	,	PUNCT
brj-24903	409	8	a.	a.	NOUN
brj-24903	409	9	,	,	PUNCT
brj-24903	409	10	nain	nain	NOUN
brj-24903	409	11	,	,	PUNCT
brj-24903	409	12	p.	p.	NOUN
brj-24903	409	13	,	,	PUNCT
brj-24903	409	14	and	and	CCONJ
brj-24903	409	15	nain	nain	NOUN
brj-24903	409	16	,	,	PUNCT
brj-24903	409	17	j.	j.	PROPN
brj-24903	409	18	(	(	PUNCT
brj-24903	409	19	2012	2012	NUM
brj-24903	409	20	)	)	PUNCT
brj-24903	409	21	.	.	PUNCT
brj-24903	410	1	“	"	PUNCT
brj-24903	410	2	herbal	herbal	ADJ
brj-24903	410	3	plants	plant	NOUN
brj-24903	410	4	used	use	VERB
brj-24903	410	5	in	in	ADP
brj-24903	410	6	treatment	treatment	NOUN
brj-24903	410	7	of	of	ADP
brj-24903	410	8	rheumatoid	rheumatoid	NOUN
brj-24903	410	9	arthritis	arthritis	NOUN
brj-24903	410	10	:	:	PUNCT
brj-24903	410	11	a	a	DET
brj-24903	410	12	review	review	NOUN
brj-24903	410	13	,	,	PUNCT
brj-24903	410	14	”	"	PUNCT
brj-24903	410	15	international	international	ADJ
brj-24903	410	16	journal	journal	NOUN
brj-24903	410	17	of	of	ADP
brj-24903	410	18	pharmacy	pharmacy	NOUN
brj-24903	410	19	and	and	CCONJ
brj-24903	410	20	pharmaceutical	pharmaceutical	NOUN
brj-24903	410	21	sciences	science	NOUN
brj-24903	410	22	4(suppl	4(suppl	PROPN
brj-24903	410	23	4	4	NUM
brj-24903	410	24	)	)	PUNCT
brj-24903	410	25	,	,	PUNCT
brj-24903	410	26	44	44	NUM
brj-24903	410	27	-	-	SYM
brj-24903	410	28	57	57	NUM
brj-24903	410	29	.	.	PUNCT
brj-24903	411	1	khurana	khurana	PROPN
brj-24903	411	2	,	,	PUNCT
brj-24903	411	3	r.	r.	PROPN
brj-24903	411	4	,	,	PUNCT
brj-24903	411	5	and	and	CCONJ
brj-24903	411	6	berney	berney	NOUN
brj-24903	411	7	,	,	PUNCT
brj-24903	411	8	s.	s.	PROPN
brj-24903	411	9	m.	m.	PROPN
brj-24903	411	10	(	(	PUNCT
brj-24903	411	11	2005	2005	NUM
brj-24903	411	12	)	)	PUNCT
brj-24903	411	13	.	.	PUNCT
brj-24903	412	1	“	"	PUNCT
brj-24903	412	2	clinical	clinical	ADJ
brj-24903	412	3	aspects	aspect	NOUN
brj-24903	412	4	of	of	ADP
brj-24903	412	5	rheumatoid	rheumatoid	NOUN
brj-24903	412	6	arthritis	arthritis	NOUN
brj-24903	412	7	,	,	PUNCT
brj-24903	412	8	”	"	PUNCT
brj-24903	412	9	pathophysiology	pathophysiology	NOUN
brj-24903	412	10	12(3	12(3	NUM
brj-24903	412	11	)	)	PUNCT
brj-24903	412	12	,	,	PUNCT
brj-24903	412	13	153	153	NUM
brj-24903	412	14	-	-	SYM
brj-24903	412	15	165	165	NUM
brj-24903	412	16	.	.	PUNCT
brj-24903	413	1	doi	doi	NOUN
brj-24903	413	2	:	:	PUNCT
brj-24903	413	3	10.1016	10.1016	NUM
brj-24903	413	4	/	/	SYM
brj-24903	413	5	j.pathophys.2005.07.009	j.pathophys.2005.07.009	PROPN
brj-24903	413	6	liu	liu	PROPN
brj-24903	413	7	,	,	PUNCT
brj-24903	413	8	x.	x.	PROPN
brj-24903	413	9	y.	y.	PROPN
brj-24903	413	10	,	,	PUNCT
brj-24903	413	11	xu	xu	PROPN
brj-24903	413	12	,	,	PUNCT
brj-24903	413	13	l.	l.	PROPN
brj-24903	413	14	,	,	PUNCT
brj-24903	413	15	wang	wang	PROPN
brj-24903	413	16	,	,	PUNCT
brj-24903	413	17	y.	y.	PROPN
brj-24903	413	18	,	,	PUNCT
brj-24903	413	19	li	li	PROPN
brj-24903	413	20	,	,	PUNCT
brj-24903	413	21	j.	j.	PROPN
brj-24903	413	22	x.	x.	PROPN
brj-24903	413	23	,	,	PUNCT
brj-24903	413	24	zhang	zhang	PROPN
brj-24903	413	25	,	,	PUNCT
brj-24903	413	26	y.	y.	PROPN
brj-24903	413	27	,	,	PUNCT
brj-24903	413	28	zhang	zhang	PROPN
brj-24903	413	29	,	,	PUNCT
brj-24903	413	30	c.	c.	PROPN
brj-24903	413	31	,	,	PUNCT
brj-24903	413	32	wang	wang	PROPN
brj-24903	413	33	,	,	PUNCT
brj-24903	413	34	s.	s.	PROPN
brj-24903	413	35	s.	s.	PROPN
brj-24903	413	36	,	,	PUNCT
brj-24903	413	37	and	and	CCONJ
brj-24903	413	38	zhang	zhang	PROPN
brj-24903	413	39	,	,	PUNCT
brj-24903	413	40	x.	x.	PROPN
brj-24903	413	41	m.	m.	NOUN
brj-24903	413	42	(	(	PUNCT
brj-24903	413	43	2017	2017	NUM
brj-24903	413	44	)	)	PUNCT
brj-24903	413	45	.	.	PUNCT
brj-24903	414	1	“	"	PUNCT
brj-24903	414	2	protective	protective	ADJ
brj-24903	414	3	effects	effect	NOUN
brj-24903	414	4	of	of	ADP
brj-24903	414	5	total	total	ADJ
brj-24903	414	6	flavonoids	flavonoid	NOUN
brj-24903	414	7	of	of	ADP
brj-24903	414	8	astragalus	astragalus	NOUN
brj-24903	414	9	against	against	ADP
brj-24903	414	10	adjuvantinduced	adjuvantinduce	VERB
brj-24903	414	11	arthritis	arthritis	NOUN
brj-24903	414	12	in	in	ADP
brj-24903	414	13	rats	rat	NOUN
brj-24903	414	14	by	by	ADP
brj-24903	414	15	regulating	regulate	VERB
brj-24903	414	16	opg	opg	NOUN
brj-24903	414	17	/	/	SYM
brj-24903	414	18	rankl	rankl	NOUN
brj-24903	414	19	/	/	SYM
brj-24903	414	20	nf	nf	NOUN
brj-24903	414	21	-	-	PUNCT
brj-24903	414	22	κb	κb	NOUN
brj-24903	414	23	pathway	pathway	NOUN
brj-24903	414	24	,	,	PUNCT
brj-24903	414	25	”	"	PUNCT
brj-24903	414	26	international	international	ADJ
brj-24903	414	27	immunopharmacology	immunopharmacology	NOUN
brj-24903	414	28	44,105	44,105	NUM
brj-24903	414	29	-	-	SYM
brj-24903	414	30	114	114	NUM
brj-24903	414	31	.	.	PUNCT
brj-24903	415	1	doi	doi	NOUN
brj-24903	415	2	:	:	PUNCT
brj-24903	415	3	10.1016	10.1016	NUM
brj-24903	415	4	/	/	SYM
brj-24903	415	5	j.intimp.2017.01.010	j.intimp.2017.01.010	PROPN
brj-24903	415	6	lysiuk	lysiuk	PROPN
brj-24903	415	7	,	,	PUNCT
brj-24903	415	8	r.	r.	PROPN
brj-24903	415	9	,	,	PUNCT
brj-24903	415	10	and	and	CCONJ
brj-24903	415	11	darmohray	darmohray	VERB
brj-24903	415	12	,	,	PUNCT
brj-24903	415	13	r.	r.	PROPN
brj-24903	415	14	(	(	PUNCT
brj-24903	415	15	2016	2016	NUM
brj-24903	415	16	)	)	PUNCT
brj-24903	415	17	.	.	PUNCT
brj-24903	416	1	“	"	PUNCT
brj-24903	416	2	pharmacology	pharmacology	NOUN
brj-24903	416	3	and	and	CCONJ
brj-24903	416	4	ethnomedicine	ethnomedicine	NOUN
brj-24903	416	5	of	of	ADP
brj-24903	416	6	the	the	DET
brj-24903	416	7	genus	genus	ADJ
brj-24903	416	8	astragalus	astragalus	NOUN
brj-24903	416	9	,	,	PUNCT
brj-24903	416	10	”	"	PUNCT
brj-24903	416	11	international	international	ADJ
brj-24903	416	12	journal	journal	NOUN
brj-24903	416	13	of	of	ADP
brj-24903	416	14	pharmacology	pharmacology	NOUN
brj-24903	416	15	,	,	PUNCT
brj-24903	416	16	phytochemistry	phytochemistry	NOUN
brj-24903	416	17	and	and	CCONJ
brj-24903	416	18	ethnomedicine	ethnomedicine	NOUN
brj-24903	416	19	3	3	NUM
brj-24903	416	20	,	,	PUNCT
brj-24903	416	21	46	46	NUM
brj-24903	416	22	-	-	SYM
brj-24903	416	23	53	53	NUM
brj-24903	416	24	.	.	PUNCT
brj-24903	416	25	doi	doi	NOUN
brj-24903	416	26	:	:	PUNCT
brj-24903	416	27	10.18052	10.18052	NUM
brj-24903	416	28	/	/	SYM
brj-24903	416	29	www.scipress.com	www.scipress.com	PROPN
brj-24903	416	30	/	/	SYM
brj-24903	416	31	ijppe.3.46	ijppe.3.46	PROPN
brj-24903	416	32	mei	mei	PROPN
brj-24903	416	33	,	,	PUNCT
brj-24903	416	34	l.	l.	PROPN
brj-24903	416	35	,	,	PUNCT
brj-24903	416	36	wang	wang	PROPN
brj-24903	416	37	,	,	PUNCT
brj-24903	416	38	h.	h.	PROPN
brj-24903	416	39	,	,	PUNCT
brj-24903	416	40	chen	chen	PROPN
brj-24903	416	41	,	,	PUNCT
brj-24903	416	42	j.	j.	PROPN
brj-24903	416	43	,	,	PUNCT
brj-24903	416	44	zhang	zhang	PROPN
brj-24903	416	45	,	,	PUNCT
brj-24903	416	46	z.	z.	PROPN
brj-24903	416	47	,	,	PUNCT
brj-24903	416	48	li	li	PROPN
brj-24903	416	49	,	,	PUNCT
brj-24903	416	50	f.	f.	PROPN
brj-24903	416	51	,	,	PUNCT
brj-24903	416	52	xie	xie	PROPN
brj-24903	416	53	,	,	PUNCT
brj-24903	416	54	y.	y.	PROPN
brj-24903	416	55	,	,	PUNCT
brj-24903	416	56	huang	huang	PROPN
brj-24903	416	57	,	,	PUNCT
brj-24903	416	58	y.	y.	PROPN
brj-24903	416	59	,	,	PUNCT
brj-24903	416	60	peng	peng	PROPN
brj-24903	416	61	,	,	PUNCT
brj-24903	416	62	t.	t.	PROPN
brj-24903	416	63	,	,	PUNCT
brj-24903	416	64	cheng	cheng	PROPN
brj-24903	416	65	,	,	PUNCT
brj-24903	416	66	g.	g.	PROPN
brj-24903	416	67	,	,	PUNCT
brj-24903	416	68	pan	pan	PROPN
brj-24903	416	69	,	,	PUNCT
brj-24903	416	70	x.	x.	NOUN
brj-24903	416	71	,	,	PUNCT
brj-24903	416	72	and	and	CCONJ
brj-24903	416	73	wu	wu	PROPN
brj-24903	416	74	,	,	PUNCT
brj-24903	416	75	c.	c.	PROPN
brj-24903	416	76	(	(	PUNCT
brj-24903	416	77	2021	2021	NUM
brj-24903	416	78	)	)	PUNCT
brj-24903	416	79	.	.	PUNCT
brj-24903	417	1	“	"	PUNCT
brj-24903	417	2	self	self	NOUN
brj-24903	417	3	-	-	PUNCT
brj-24903	417	4	assembled	assemble	VERB
brj-24903	417	5	lyotropic	lyotropic	ADJ
brj-24903	417	6	liquid	liquid	ADJ
brj-24903	417	7	crystal	crystal	NOUN
brj-24903	417	8	gel	gel	NOUN
brj-24903	417	9	for	for	ADP
brj-24903	417	10	osteoarthritis	osteoarthritis	NOUN
brj-24903	417	11	treatment	treatment	NOUN
brj-24903	417	12	via	via	ADP
brj-24903	417	13	anti	anti	ADJ
brj-24903	417	14	-	-	ADJ
brj-24903	417	15	inflammation	inflammation	ADJ
brj-24903	417	16	and	and	CCONJ
brj-24903	417	17	cartilage	cartilage	NOUN
brj-24903	417	18	protection	protection	NOUN
brj-24903	417	19	,	,	PUNCT
brj-24903	417	20	”	"	PUNCT
brj-24903	417	21	biomaterials	biomaterial	NOUN
brj-24903	417	22	science	science	NOUN
brj-24903	417	23	9(21	9(21	NUM
brj-24903	417	24	)	)	PUNCT
brj-24903	417	25	,	,	PUNCT
brj-24903	417	26	7205	7205	NUM
brj-24903	417	27	-	-	SYM
brj-24903	417	28	7218	7218	NUM
brj-24903	417	29	.	.	PUNCT
brj-24903	418	1	doi	doi	NOUN
brj-24903	418	2	:	:	PUNCT
brj-24903	418	3	10.1039	10.1039	NUM
brj-24903	418	4	/	/	SYM
brj-24903	418	5	d1bm00727k	d1bm00727k	PROPN
brj-24903	418	6	mohammed	mohammed	PROPN
brj-24903	418	7	,	,	PUNCT
brj-24903	418	8	f.	f.	PROPN
brj-24903	418	9	f.	f.	PROPN
brj-24903	418	10	(	(	PUNCT
brj-24903	418	11	2003	2003	NUM
brj-24903	418	12	)	)	PUNCT
brj-24903	418	13	.	.	PUNCT
brj-24903	419	1	“	"	PUNCT
brj-24903	419	2	metalloproteinases	metalloproteinase	NOUN
brj-24903	419	3	,	,	PUNCT
brj-24903	419	4	inflammation	inflammation	NOUN
brj-24903	419	5	,	,	PUNCT
brj-24903	419	6	and	and	CCONJ
brj-24903	419	7	rheumatoid	rheumatoid	VERB
brj-24903	419	8	arthritis	arthritis	NOUN
brj-24903	419	9	,	,	PUNCT
brj-24903	419	10	”	"	PUNCT
brj-24903	419	11	annals	annals	NOUN
brj-24903	419	12	of	of	ADP
brj-24903	419	13	the	the	DET
brj-24903	419	14	rheumatic	rheumatic	ADJ
brj-24903	419	15	diseases	disease	NOUN
brj-24903	419	16	62(90002	62(90002	NUM
brj-24903	419	17	)	)	PUNCT
brj-24903	419	18	.	.	PUNCT
brj-24903	420	1	doi	doi	NOUN
brj-24903	420	2	:	:	PUNCT
brj-24903	420	3	10.1136	10.1136	NUM
brj-24903	420	4	/	/	SYM
brj-24903	420	5	ard.62.suppl_2.ii43	ard.62.suppl_2.ii43	PROPN
brj-24903	420	6	panche	panche	PROPN
brj-24903	420	7	,	,	PUNCT
brj-24903	420	8	a.	a.	NOUN
brj-24903	420	9	n.	n.	PROPN
brj-24903	420	10	,	,	PUNCT
brj-24903	420	11	diwan	diwan	PROPN
brj-24903	420	12	,	,	PUNCT
brj-24903	420	13	a.	a.	PROPN
brj-24903	420	14	d.	d.	PROPN
brj-24903	420	15	,	,	PUNCT
brj-24903	420	16	and	and	CCONJ
brj-24903	420	17	chandra	chandra	PROPN
brj-24903	420	18	,	,	PUNCT
brj-24903	420	19	s.	s.	PROPN
brj-24903	420	20	r.	r.	PROPN
brj-24903	420	21	(	(	PUNCT
brj-24903	420	22	2016	2016	NUM
brj-24903	420	23	)	)	PUNCT
brj-24903	420	24	.	.	PUNCT
brj-24903	421	1	“	"	PUNCT
brj-24903	421	2	flavonoids	flavonoid	NOUN
brj-24903	421	3	:	:	PUNCT
brj-24903	421	4	an	an	DET
brj-24903	421	5	overview	overview	NOUN
brj-24903	421	6	,	,	PUNCT
brj-24903	421	7	”	"	PUNCT
brj-24903	421	8	journal	journal	NOUN
brj-24903	421	9	of	of	ADP
brj-24903	421	10	nutritional	nutritional	ADJ
brj-24903	421	11	science	science	NOUN
brj-24903	421	12	5	5	NUM
brj-24903	421	13	,	,	PUNCT
brj-24903	421	14	article	article	NOUN
brj-24903	421	15	e47	e47	PROPN
brj-24903	421	16	.	.	PUNCT
brj-24903	422	1	doi	doi	PROPN
brj-24903	422	2	:	:	PUNCT
brj-24903	422	3	10.1017	10.1017	NUM
brj-24903	422	4	/	/	SYM
brj-24903	422	5	jns.2016.41	jns.2016.41	PROPN
brj-24903	422	6	radu	radu	PROPN
brj-24903	422	7	,	,	PUNCT
brj-24903	422	8	a.	a.	PROPN
brj-24903	422	9	f.	f.	PROPN
brj-24903	422	10	,	,	PUNCT
brj-24903	422	11	and	and	CCONJ
brj-24903	422	12	bungau	bungau	NOUN
brj-24903	422	13	,	,	PUNCT
brj-24903	422	14	s.	s.	PROPN
brj-24903	422	15	g.	g.	PROPN
brj-24903	422	16	(	(	PUNCT
brj-24903	422	17	2021	2021	NUM
brj-24903	422	18	)	)	PUNCT
brj-24903	422	19	.	.	PUNCT
brj-24903	423	1	“	"	PUNCT
brj-24903	423	2	management	management	NOUN
brj-24903	423	3	of	of	ADP
brj-24903	423	4	rheumatoid	rheumatoid	NOUN
brj-24903	423	5	arthritis	arthritis	NOUN
brj-24903	423	6	:	:	PUNCT
brj-24903	423	7	an	an	DET
brj-24903	423	8	overview	overview	NOUN
brj-24903	423	9	,	,	PUNCT
brj-24903	423	10	”	"	PUNCT
brj-24903	423	11	cells	cell	NOUN
brj-24903	423	12	10(11	10(11	NUM
brj-24903	423	13	)	)	PUNCT
brj-24903	423	14	,	,	PUNCT
brj-24903	423	15	article	article	NOUN
brj-24903	423	16	2857	2857	NUM
brj-24903	423	17	.	.	PUNCT
brj-24903	424	1	doi	doi	NOUN
brj-24903	424	2	:	:	PUNCT
brj-24903	424	3	10.3390	10.3390	NUM
brj-24903	424	4	/	/	SYM
brj-24903	424	5	cells10112857	cells10112857	PROPN
brj-24903	424	6	srivastava	srivastava	PROPN
brj-24903	424	7	,	,	PUNCT
brj-24903	424	8	j.	j.	PROPN
brj-24903	424	9	k.	k.	PROPN
brj-24903	424	10	,	,	PUNCT
brj-24903	424	11	pillai	pillai	PROPN
brj-24903	424	12	,	,	PUNCT
brj-24903	424	13	g.	g.	PROPN
brj-24903	424	14	g.	g.	PROPN
brj-24903	424	15	,	,	PUNCT
brj-24903	424	16	bhat	bhat	PROPN
brj-24903	424	17	,	,	PUNCT
brj-24903	424	18	h.	h.	PROPN
brj-24903	424	19	r.	r.	PROPN
brj-24903	424	20	,	,	PUNCT
brj-24903	424	21	verma	verma	PROPN
brj-24903	424	22	,	,	PUNCT
brj-24903	424	23	a.	a.	NOUN
brj-24903	424	24	,	,	PUNCT
brj-24903	424	25	and	and	CCONJ
brj-24903	424	26	singh	singh	PROPN
brj-24903	424	27	,	,	PUNCT
brj-24903	424	28	u.	u.	PROPN
brj-24903	424	29	p.	p.	PROPN
brj-24903	424	30	(	(	PUNCT
brj-24903	424	31	2017	2017	NUM
brj-24903	424	32	)	)	PUNCT
brj-24903	424	33	.	.	PUNCT
brj-24903	425	1	“	"	PUNCT
brj-24903	425	2	design	design	NOUN
brj-24903	425	3	and	and	CCONJ
brj-24903	425	4	discovery	discovery	NOUN
brj-24903	425	5	of	of	ADP
brj-24903	425	6	novel	novel	ADJ
brj-24903	425	7	monastrol-1,3,5	monastrol-1,3,5	NOUN
brj-24903	425	8	-	-	NOUN
brj-24903	425	9	triazines	triazine	NOUN
brj-24903	425	10	as	as	ADP
brj-24903	425	11	potent	potent	ADJ
brj-24903	425	12	anti	anti	ADJ
brj-24903	425	13	-	-	ADJ
brj-24903	425	14	breast	breast	ADJ
brj-24903	425	15	cancer	cancer	NOUN
brj-24903	425	16	agent	agent	NOUN
brj-24903	425	17	via	via	ADP
brj-24903	425	18	attenuating	attenuate	VERB
brj-24903	425	19	epidermal	epidermal	ADJ
brj-24903	425	20	growth	growth	NOUN
brj-24903	425	21	factor	factor	NOUN
brj-24903	425	22	receptor	receptor	NOUN
brj-24903	425	23	tyrosine	tyrosine	PROPN
brj-24903	425	24	kinase	kinase	PROPN
brj-24903	425	25	,	,	PUNCT
brj-24903	425	26	”	"	PUNCT
brj-24903	425	27	scientific	scientific	ADJ
brj-24903	425	28	reports	report	NOUN
brj-24903	425	29	7(1	7(1	NUM
brj-24903	425	30	)	)	PUNCT
brj-24903	425	31	,	,	PUNCT
brj-24903	425	32	article	article	NOUN
brj-24903	425	33	5851	5851	NUM
brj-24903	425	34	.	.	PUNCT
brj-24903	426	1	doi	doi	NOUN
brj-24903	426	2	:	:	PUNCT
brj-24903	426	3	10.1038	10.1038	NUM
brj-24903	426	4	/	/	SYM
brj-24903	426	5	s41598	s41598	NOUN
brj-24903	426	6	-	-	PUNCT
brj-24903	426	7	017	017	NUM
brj-24903	426	8	-	-	PUNCT
brj-24903	426	9	05934	05934	NUM
brj-24903	426	10	-	-	SYM
brj-24903	426	11	5	5	NUM
brj-24903	426	12	stambolov	stambolov	NOUN
brj-24903	426	13	,	,	PUNCT
brj-24903	426	14	i.	i.	NOUN
brj-24903	426	15	,	,	PUNCT
brj-24903	426	16	shkondrov	shkondrov	ADJ
brj-24903	426	17	,	,	PUNCT
brj-24903	426	18	a.	a.	NOUN
brj-24903	426	19	,	,	PUNCT
brj-24903	426	20	and	and	CCONJ
brj-24903	426	21	krasteva	krasteva	PROPN
brj-24903	426	22	,	,	PUNCT
brj-24903	426	23	i.	i.	PROPN
brj-24903	426	24	(	(	PUNCT
brj-24903	426	25	2023	2023	NUM
brj-24903	426	26	)	)	PUNCT
brj-24903	426	27	.	.	PUNCT
brj-24903	427	1	“	"	PUNCT
brj-24903	427	2	astragalus	astragalus	PROPN
brj-24903	427	3	glycyphyllos	glycyphyllos	PROPN
brj-24903	427	4	l.	l.	PROPN
brj-24903	427	5	:	:	PUNCT
brj-24903	427	6	phytochemical	phytochemical	ADJ
brj-24903	427	7	constituents	constituent	NOUN
brj-24903	427	8	,	,	PUNCT
brj-24903	427	9	pharmacology	pharmacology	NOUN
brj-24903	427	10	,	,	PUNCT
brj-24903	427	11	and	and	CCONJ
brj-24903	427	12	biotechnology	biotechnology	NOUN
brj-24903	427	13	,	,	PUNCT
brj-24903	427	14	”	"	PUNCT
brj-24903	427	15	pharmacia	pharmacia	PROPN
brj-24903	427	16	70(3	70(3	NOUN
brj-24903	427	17	):	):	PUNCT
brj-24903	427	18	635	635	NUM
brj-24903	427	19	-	-	SYM
brj-24903	427	20	641	641	NUM
brj-24903	427	21	.	.	PUNCT
brj-24903	428	1	doi	doi	NOUN
brj-24903	428	2	:	:	PUNCT
brj-24903	428	3	10.3897	10.3897	NUM
brj-24903	428	4	/	/	SYM
brj-24903	428	5	pharmacia.70.e107989	pharmacia.70.e107989	NUM
brj-24903	428	6	sweeney	sweeney	PROPN
brj-24903	428	7	,	,	PUNCT
brj-24903	428	8	s.	s.	PROPN
brj-24903	428	9	e.	e.	PROPN
brj-24903	428	10	,	,	PUNCT
brj-24903	428	11	and	and	CCONJ
brj-24903	428	12	firestein	firestein	ADV
brj-24903	428	13	,	,	PUNCT
brj-24903	428	14	g.	g.	PROPN
brj-24903	428	15	s.	s.	PROPN
brj-24903	428	16	(	(	PUNCT
brj-24903	428	17	2004	2004	NUM
brj-24903	428	18	)	)	PUNCT
brj-24903	428	19	.	.	PUNCT
brj-24903	429	1	“	"	PUNCT
brj-24903	429	2	rheumatoid	rheumatoid	VERB
brj-24903	429	3	arthritis	arthritis	NOUN
brj-24903	429	4	:	:	PUNCT
brj-24903	429	5	regulation	regulation	NOUN
brj-24903	429	6	of	of	ADP
brj-24903	429	7	synovial	synovial	ADJ
brj-24903	429	8	inflammation	inflammation	NOUN
brj-24903	429	9	,	,	PUNCT
brj-24903	429	10	”	"	PUNCT
brj-24903	429	11	international	international	ADJ
brj-24903	429	12	journal	journal	NOUN
brj-24903	429	13	of	of	ADP
brj-24903	429	14	biochemistry	biochemistry	NOUN
brj-24903	429	15	and	and	CCONJ
brj-24903	429	16	cell	cell	NOUN
brj-24903	429	17	biology	biology	NOUN
brj-24903	429	18	36(3	36(3	NOUN
brj-24903	429	19	)	)	PUNCT
brj-24903	429	20	,	,	PUNCT
brj-24903	429	21	372378	372378	NUM
brj-24903	429	22	.	.	PUNCT
brj-24903	430	1	doi	doi	NOUN
brj-24903	430	2	:	:	PUNCT
brj-24903	430	3	10.1016	10.1016	NUM
brj-24903	430	4	/	/	SYM
brj-24903	430	5	s1357	s1357	PROPN
brj-24903	430	6	-	-	PUNCT
brj-24903	430	7	2725(03)00259	2725(03)00259	NUM
brj-24903	430	8	-	-	SYM
brj-24903	430	9	0	0	NUM
brj-24903	430	10	thudium	thudium	NOUN
brj-24903	430	11	,	,	PUNCT
brj-24903	430	12	c.	c.	PROPN
brj-24903	430	13	s.	s.	PROPN
brj-24903	430	14	,	,	PUNCT
brj-24903	430	15	löfvall	löfvall	PROPN
brj-24903	430	16	,	,	PUNCT
brj-24903	430	17	h.	h.	PROPN
brj-24903	430	18	,	,	PUNCT
brj-24903	430	19	karsdal	karsdal	ADJ
brj-24903	430	20	,	,	PUNCT
brj-24903	430	21	m.	m.	NOUN
brj-24903	430	22	a.	a.	PROPN
brj-24903	430	23	,	,	PUNCT
brj-24903	430	24	bay	bay	PROPN
brj-24903	430	25	-	-	PUNCT
brj-24903	430	26	jensen	jensen	PROPN
brj-24903	430	27	,	,	PUNCT
brj-24903	430	28	a.	a.	PROPN
brj-24903	430	29	c.	c.	PROPN
brj-24903	430	30	,	,	PUNCT
brj-24903	430	31	and	and	CCONJ
brj-24903	430	32	bihlet	bihlet	PROPN
brj-24903	430	33	,	,	PUNCT
brj-24903	430	34	a.	a.	PROPN
brj-24903	430	35	r.	r.	PROPN
brj-24903	430	36	(	(	PUNCT
brj-24903	430	37	2019	2019	NUM
brj-24903	430	38	)	)	PUNCT
brj-24903	430	39	.	.	PUNCT
brj-24903	431	1	“	"	PUNCT
brj-24903	431	2	protein	protein	NOUN
brj-24903	431	3	biomarkers	biomarker	NOUN
brj-24903	431	4	associated	associate	VERB
brj-24903	431	5	with	with	ADP
brj-24903	431	6	pain	pain	NOUN
brj-24903	431	7	mechanisms	mechanism	NOUN
brj-24903	431	8	in	in	ADP
brj-24903	431	9	osteoarthritis	osteoarthritis	NOUN
brj-24903	431	10	,	,	PUNCT
brj-24903	431	11	”	"	PUNCT
brj-24903	431	12	journal	journal	NOUN
brj-24903	431	13	of	of	ADP
brj-24903	431	14	proteomics	proteomic	NOUN
brj-24903	431	15	190	190	NUM
brj-24903	431	16	,	,	PUNCT
brj-24903	431	17	55	55	NUM
brj-24903	431	18	-	-	SYM
brj-24903	431	19	66	66	NUM
brj-24903	431	20	.	.	PUNCT
brj-24903	432	1	doi	doi	NOUN
brj-24903	432	2	:	:	PUNCT
brj-24903	432	3	10.1016	10.1016	NUM
brj-24903	432	4	/	/	SYM
brj-24903	432	5	j.jprot.2018.04.030	j.jprot.2018.04.030	PROPN
brj-24903	432	6	tsiklauri	tsiklauri	PROPN
brj-24903	432	7	,	,	PUNCT
brj-24903	432	8	l.	l.	PROPN
brj-24903	432	9	,	,	PUNCT
brj-24903	432	10	švík	švík	PROPN
brj-24903	432	11	,	,	PUNCT
brj-24903	432	12	k.	k.	PROPN
brj-24903	432	13	,	,	PUNCT
brj-24903	432	14	chrastina	chrastina	PROPN
brj-24903	432	15	,	,	PUNCT
brj-24903	432	16	m.	m.	NOUN
brj-24903	432	17	,	,	PUNCT
brj-24903	432	18	poništ	poništ	PROPN
brj-24903	432	19	,	,	PUNCT
brj-24903	432	20	s.	s.	PROPN
brj-24903	432	21	,	,	PUNCT
brj-24903	432	22	dráfi	dráfi	NOUN
brj-24903	432	23	,	,	PUNCT
brj-24903	432	24	f.	f.	PROPN
brj-24903	432	25	,	,	PUNCT
brj-24903	432	26	slovák	slovák	NOUN
brj-24903	432	27	,	,	PUNCT
brj-24903	432	28	l.	l.	PROPN
brj-24903	432	29	,	,	PUNCT
brj-24903	432	30	alania	alania	PROPN
brj-24903	432	31	,	,	PUNCT
brj-24903	432	32	m.	m.	NOUN
brj-24903	432	33	,	,	PUNCT
brj-24903	432	34	kemertelidze	kemertelidze	PROPN
brj-24903	432	35	,	,	PUNCT
brj-24903	432	36	e.	e.	PROPN
brj-24903	432	37	,	,	PUNCT
brj-24903	432	38	and	and	CCONJ
brj-24903	432	39	bauerova	bauerova	X
brj-24903	432	40	,	,	PUNCT
brj-24903	432	41	k.	k.	PROPN
brj-24903	432	42	(	(	PUNCT
brj-24903	432	43	2021	2021	NUM
brj-24903	432	44	)	)	PUNCT
brj-24903	432	45	.	.	PUNCT
brj-24903	433	1	“	"	PUNCT
brj-24903	433	2	bioflavonoid	bioflavonoid	PROPN
brj-24903	433	3	robinin	robinin	NOUN
brj-24903	433	4	from	from	ADP
brj-24903	433	5	astragalus	astragalus	PROPN
brj-24903	433	6	falcatus	falcatus	X
brj-24903	433	7	lam	lam	PROPN
brj-24903	433	8	.	.	PUNCT
brj-24903	433	9	mildly	mildly	ADV
brj-24903	433	10	improves	improve	VERB
brj-24903	433	11	the	the	DET
brj-24903	433	12	effect	effect	NOUN
brj-24903	433	13	of	of	ADP
brj-24903	433	14	metothrexate	metothrexate	NOUN
brj-24903	433	15	in	in	ADP
brj-24903	433	16	rats	rat	NOUN
brj-24903	433	17	with	with	ADP
brj-24903	433	18	adjuvant	adjuvant	ADJ
brj-24903	433	19	arthritis	arthritis	NOUN
brj-24903	433	20	,	,	PUNCT
brj-24903	433	21	”	"	PUNCT
brj-24903	433	22	nutrients	nutrient	NOUN
brj-24903	433	23	13(4	13(4	NUM
brj-24903	433	24	)	)	PUNCT
brj-24903	433	25	,	,	PUNCT
brj-24903	433	26	article	article	NOUN
brj-24903	433	27	1268	1268	NUM
brj-24903	433	28	.	.	PUNCT
brj-24903	434	1	doi	doi	NOUN
brj-24903	434	2	:	:	PUNCT
brj-24903	434	3	10.3390	10.3390	NUM
brj-24903	434	4	/	/	SYM
brj-24903	434	5	nu13041268	nu13041268	PROPN
brj-24903	434	6	vincenti	vincenti	PROPN
brj-24903	434	7	,	,	PUNCT
brj-24903	434	8	m.	m.	NOUN
brj-24903	434	9	p.	p.	NOUN
brj-24903	434	10	,	,	PUNCT
brj-24903	434	11	and	and	CCONJ
brj-24903	434	12	brinckerhoff	brinckerhoff	NOUN
brj-24903	434	13	,	,	PUNCT
brj-24903	434	14	c.	c.	PROPN
brj-24903	434	15	e.	e.	PROPN
brj-24903	434	16	(	(	PUNCT
brj-24903	434	17	2002	2002	NUM
brj-24903	434	18	)	)	PUNCT
brj-24903	434	19	.	.	PUNCT
brj-24903	435	1	“	"	PUNCT
brj-24903	435	2	transcriptional	transcriptional	ADJ
brj-24903	435	3	regulation	regulation	NOUN
brj-24903	435	4	of	of	ADP
brj-24903	435	5	collagenase	collagenase	NOUN
brj-24903	435	6	(	(	PUNCT
brj-24903	435	7	mmp-1	mmp-1	NOUN
brj-24903	435	8	,	,	PUNCT
brj-24903	435	9	mmp-13	mmp-13	NOUN
brj-24903	435	10	)	)	PUNCT
brj-24903	435	11	genes	gene	NOUN
brj-24903	435	12	in	in	ADP
brj-24903	435	13	arthritis	arthritis	NOUN
brj-24903	435	14	:	:	PUNCT
brj-24903	435	15	integration	integration	NOUN
brj-24903	435	16	of	of	ADP
brj-24903	435	17	complex	complex	ADJ
brj-24903	435	18	signaling	signal	VERB
brj-24903	435	19	pathways	pathway	NOUN
brj-24903	435	20	for	for	ADP
brj-24903	435	21	the	the	DET
brj-24903	435	22	recruitment	recruitment	NOUN
brj-24903	435	23	of	of	ADP
brj-24903	435	24	gene	gene	NOUN
brj-24903	435	25	-	-	PUNCT
brj-24903	435	26	specific	specific	ADJ
brj-24903	435	27	transcription	transcription	NOUN
brj-24903	435	28	factors	factor	NOUN
brj-24903	435	29	,	,	PUNCT
brj-24903	435	30	”	"	PUNCT
brj-24903	435	31	arthritis	arthritis	NOUN
brj-24903	435	32	research	research	NOUN
brj-24903	435	33	4	4	NUM
brj-24903	435	34	,	,	PUNCT
brj-24903	435	35	article	article	NOUN
brj-24903	435	36	157	157	NUM
brj-24903	435	37	.	.	PUNCT
brj-24903	436	1	doi	doi	NOUN
brj-24903	436	2	:	:	PUNCT
brj-24903	436	3	10.1186	10.1186	NUM
brj-24903	436	4	/	/	SYM
brj-24903	436	5	ar401	ar401	PROPN
brj-24903	436	6	peer	peer	NOUN
brj-24903	436	7	-	-	PUNCT
brj-24903	436	8	reviewed	review	VERB
brj-24903	436	9	article	article	NOUN
brj-24903	436	10	bioresources.cnr.ncsu.edu	bioresources.cnr.ncsu.edu	X
brj-24903	436	11	gu	gu	VERB
brj-24903	436	12	et	et	PROPN
brj-24903	436	13	al	al	PROPN
brj-24903	436	14	.	.	PROPN
brj-24903	436	15	(	(	PUNCT
brj-24903	436	16	2026	2026	NUM
brj-24903	436	17	)	)	PUNCT
brj-24903	436	18	.	.	PUNCT
brj-24903	437	1	“	"	PUNCT
brj-24903	437	2	astragalus	astragalus	NOUN
brj-24903	437	3	leaf	leaf	NOUN
brj-24903	437	4	extract	extract	NOUN
brj-24903	437	5	vs.	vs.	ADP
brj-24903	437	6	arthritis	arthritis	NOUN
brj-24903	437	7	,	,	PUNCT
brj-24903	437	8	”	"	PUNCT
brj-24903	437	9	bioresources	bioresource	NOUN
brj-24903	437	10	21(1	21(1	NUM
brj-24903	437	11	)	)	PUNCT
brj-24903	437	12	,	,	PUNCT
brj-24903	437	13	160	160	NUM
brj-24903	437	14	-	-	SYM
brj-24903	437	15	177	177	NUM
brj-24903	437	16	.	.	PUNCT
brj-24903	438	1	177	177	NUM
brj-24903	438	2	weng	weng	PROPN
brj-24903	438	3	,	,	PUNCT
brj-24903	438	4	w.	w.	PROPN
brj-24903	438	5	,	,	PUNCT
brj-24903	438	6	wang	wang	PROPN
brj-24903	438	7	,	,	PUNCT
brj-24903	438	8	f.	f.	PROPN
brj-24903	438	9	,	,	PUNCT
brj-24903	438	10	he	he	PRON
brj-24903	438	11	,	,	PUNCT
brj-24903	438	12	x.	x.	PROPN
brj-24903	438	13	,	,	PUNCT
brj-24903	438	14	zhou	zhou	PROPN
brj-24903	438	15	,	,	PUNCT
brj-24903	438	16	k.	k.	PROPN
brj-24903	438	17	,	,	PUNCT
brj-24903	438	18	wu	wu	PROPN
brj-24903	438	19	,	,	PUNCT
brj-24903	438	20	x.	x.	NOUN
brj-24903	438	21	,	,	PUNCT
brj-24903	438	22	and	and	CCONJ
brj-24903	438	23	wu	wu	PROPN
brj-24903	438	24	,	,	PUNCT
brj-24903	438	25	x.	x.	NOUN
brj-24903	438	26	(	(	PUNCT
brj-24903	438	27	2021	2021	NUM
brj-24903	438	28	)	)	PUNCT
brj-24903	438	29	.	.	PUNCT
brj-24903	439	1	“	"	PUNCT
brj-24903	439	2	protective	protective	ADJ
brj-24903	439	3	effect	effect	NOUN
brj-24903	439	4	of	of	ADP
brj-24903	439	5	corynoline	corynoline	NOUN
brj-24903	439	6	on	on	ADP
brj-24903	439	7	the	the	DET
brj-24903	439	8	cfa	cfa	NOUN
brj-24903	439	9	induced	induce	VERB
brj-24903	439	10	rheumatoid	rheumatoid	NOUN
brj-24903	439	11	arthritis	arthritis	NOUN
brj-24903	439	12	via	via	ADP
brj-24903	439	13	attenuation	attenuation	NOUN
brj-24903	439	14	of	of	ADP
brj-24903	439	15	oxidative	oxidative	ADJ
brj-24903	439	16	and	and	CCONJ
brj-24903	439	17	inflammatory	inflammatory	ADJ
brj-24903	439	18	mediators	mediator	NOUN
brj-24903	439	19	,	,	PUNCT
brj-24903	439	20	”	"	PUNCT
brj-24903	439	21	molecular	molecular	ADJ
brj-24903	439	22	and	and	CCONJ
brj-24903	439	23	cellular	cellular	ADJ
brj-24903	439	24	biochemistry	biochemistry	NOUN
brj-24903	439	25	476(2	476(2	NUM
brj-24903	439	26	)	)	PUNCT
brj-24903	439	27	,	,	PUNCT
brj-24903	439	28	831	831	NUM
brj-24903	439	29	-	-	SYM
brj-24903	439	30	839	839	NUM
brj-24903	439	31	.	.	PUNCT
brj-24903	440	1	doi	doi	NOUN
brj-24903	440	2	:	:	PUNCT
brj-24903	440	3	10.1007	10.1007	NUM
brj-24903	440	4	/	/	SYM
brj-24903	440	5	s11010	s11010	NOUN
brj-24903	440	6	-	-	PUNCT
brj-24903	440	7	020	020	NUM
brj-24903	440	8	-	-	PUNCT
brj-24903	440	9	03948	03948	NUM
brj-24903	440	10	-	-	SYM
brj-24903	440	11	8	8	NUM
brj-24903	440	12	wojdasiewicz	wojdasiewicz	NOUN
brj-24903	440	13	,	,	PUNCT
brj-24903	440	14	p.	p.	NOUN
brj-24903	440	15	,	,	PUNCT
brj-24903	440	16	poniatowski	poniatowski	NOUN
brj-24903	440	17	,	,	PUNCT
brj-24903	440	18	ł	ł	PROPN
brj-24903	440	19	.	.	PUNCT
brj-24903	440	20	a.	a.	PROPN
brj-24903	440	21	,	,	PUNCT
brj-24903	440	22	and	and	CCONJ
brj-24903	440	23	szukiewicz	szukiewicz	PROPN
brj-24903	440	24	,	,	PUNCT
brj-24903	440	25	d.	d.	PROPN
brj-24903	440	26	(	(	PUNCT
brj-24903	440	27	2014	2014	NUM
brj-24903	440	28	)	)	PUNCT
brj-24903	440	29	.	.	PUNCT
brj-24903	441	1	“	"	PUNCT
brj-24903	441	2	the	the	DET
brj-24903	441	3	role	role	NOUN
brj-24903	441	4	of	of	ADP
brj-24903	441	5	inflammatory	inflammatory	ADJ
brj-24903	441	6	and	and	CCONJ
brj-24903	441	7	anti	anti	ADJ
brj-24903	441	8	-	-	ADJ
brj-24903	441	9	inflammatory	inflammatory	ADJ
brj-24903	441	10	cytokines	cytokine	NOUN
brj-24903	441	11	in	in	ADP
brj-24903	441	12	the	the	DET
brj-24903	441	13	pathogenesis	pathogenesis	NOUN
brj-24903	441	14	of	of	ADP
brj-24903	441	15	osteoarthritis	osteoarthritis	NOUN
brj-24903	441	16	,	,	PUNCT
brj-24903	441	17	”	"	PUNCT
brj-24903	441	18	mediators	mediator	NOUN
brj-24903	441	19	of	of	ADP
brj-24903	441	20	inflammation	inflammation	NOUN
brj-24903	441	21	2014	2014	NUM
brj-24903	441	22	,	,	PUNCT
brj-24903	441	23	article	article	NOUN
brj-24903	441	24	561459	561459	NUM
brj-24903	441	25	.	.	PUNCT
brj-24903	442	1	doi	doi	NOUN
brj-24903	442	2	:	:	PUNCT
brj-24903	442	3	10.1155/2014/561459	10.1155/2014/561459	NUM
brj-24903	442	4	yadav	yadav	NOUN
brj-24903	442	5	,	,	PUNCT
brj-24903	442	6	j.	j.	PROPN
brj-24903	442	7	,	,	PUNCT
brj-24903	442	8	chaurasia	chaurasia	PROPN
brj-24903	442	9	,	,	PUNCT
brj-24903	442	10	m.	m.	NOUN
brj-24903	442	11	,	,	PUNCT
brj-24903	442	12	and	and	CCONJ
brj-24903	442	13	dubey	dubey	PROPN
brj-24903	442	14	,	,	PUNCT
brj-24903	442	15	b.	b.	PROPN
brj-24903	442	16	k.	k.	PROPN
brj-24903	442	17	(	(	PUNCT
brj-24903	442	18	2020	2020	NUM
brj-24903	442	19	)	)	PUNCT
brj-24903	442	20	.	.	PUNCT
brj-24903	443	1	“	"	PUNCT
brj-24903	443	2	flavanoids	flavanoid	NOUN
brj-24903	443	3	:	:	PUNCT
brj-24903	443	4	a	a	DET
brj-24903	443	5	review	review	NOUN
brj-24903	443	6	on	on	ADP
brj-24903	443	7	chemistry	chemistry	NOUN
brj-24903	443	8	and	and	CCONJ
brj-24903	443	9	versatile	versatile	ADJ
brj-24903	443	10	biological	biological	ADJ
brj-24903	443	11	activity	activity	NOUN
brj-24903	443	12	,	,	PUNCT
brj-24903	443	13	”	"	PUNCT
brj-24903	443	14	era	era	NOUN
brj-24903	443	15	’s	’s	PART
brj-24903	443	16	journal	journal	NOUN
brj-24903	443	17	of	of	ADP
brj-24903	443	18	medical	medical	ADJ
brj-24903	443	19	research	research	NOUN
brj-24903	443	20	7(1	7(1	NUM
brj-24903	443	21	)	)	PUNCT
brj-24903	443	22	,	,	PUNCT
brj-24903	443	23	75	75	NUM
brj-24903	443	24	-	-	SYM
brj-24903	443	25	78	78	NUM
brj-24903	443	26	.	.	PUNCT
brj-24903	444	1	doi	doi	NOUN
brj-24903	444	2	:	:	PUNCT
brj-24903	444	3	10.24041	10.24041	NUM
brj-24903	444	4	/	/	SYM
brj-24903	444	5	ejmr2020.13	ejmr2020.13	PROPN
brj-24903	444	6	ye	ye	PROPN
brj-24903	444	7	,	,	PUNCT
brj-24903	444	8	y.	y.	NOUN
brj-24903	444	9	,	,	PUNCT
brj-24903	444	10	and	and	CCONJ
brj-24903	444	11	zhou	zhou	PROPN
brj-24903	444	12	,	,	PUNCT
brj-24903	444	13	j.	j.	PROPN
brj-24903	444	14	(	(	PUNCT
brj-24903	444	15	2023	2023	NUM
brj-24903	444	16	)	)	PUNCT
brj-24903	444	17	.	.	PUNCT
brj-24903	445	1	“	"	PUNCT
brj-24903	445	2	the	the	DET
brj-24903	445	3	protective	protective	ADJ
brj-24903	445	4	activity	activity	NOUN
brj-24903	445	5	of	of	ADP
brj-24903	445	6	natural	natural	ADJ
brj-24903	445	7	flavonoids	flavonoid	NOUN
brj-24903	445	8	against	against	ADP
brj-24903	445	9	osteoarthritis	osteoarthritis	NOUN
brj-24903	445	10	by	by	ADP
brj-24903	445	11	targeting	target	VERB
brj-24903	445	12	nf	nf	ADJ
brj-24903	445	13	-	-	PUNCT
brj-24903	445	14	κb	κb	NOUN
brj-24903	445	15	signaling	signal	VERB
brj-24903	445	16	pathway	pathway	NOUN
brj-24903	445	17	,	,	PUNCT
brj-24903	445	18	”	"	PUNCT
brj-24903	445	19	frontiers	frontier	NOUN
brj-24903	445	20	in	in	ADP
brj-24903	445	21	endocrinology	endocrinology	NOUN
brj-24903	445	22	14	14	NUM
brj-24903	445	23	,	,	PUNCT
brj-24903	445	24	article	article	NOUN
brj-24903	445	25	1117489	1117489	NUM
brj-24903	445	26	.	.	PUNCT
brj-24903	446	1	doi	doi	NOUN
brj-24903	446	2	:	:	PUNCT
brj-24903	446	3	10.3389	10.3389	NUM
brj-24903	446	4	/	/	SYM
brj-24903	446	5	fendo.2023.1117489	fendo.2023.1117489	PROPN
brj-24903	446	6	yoon	yoon	PROPN
brj-24903	446	7	,	,	PUNCT
brj-24903	446	8	h.	h.	PROPN
brj-24903	446	9	y.	y.	PROPN
brj-24903	446	10	,	,	PUNCT
brj-24903	446	11	lee	lee	PROPN
brj-24903	446	12	,	,	PUNCT
brj-24903	446	13	e.	e.	PROPN
brj-24903	446	14	g.	g.	PROPN
brj-24903	446	15	,	,	PUNCT
brj-24903	446	16	lee	lee	PROPN
brj-24903	446	17	,	,	PUNCT
brj-24903	446	18	h.	h.	PROPN
brj-24903	446	19	,	,	PUNCT
brj-24903	446	20	cho	cho	PROPN
brj-24903	446	21	,	,	PUNCT
brj-24903	446	22	i.	i.	PROPN
brj-24903	446	23	j.	j.	PROPN
brj-24903	446	24	,	,	PUNCT
brj-24903	446	25	choi	choi	NOUN
brj-24903	446	26	,	,	PUNCT
brj-24903	446	27	y.	y.	PROPN
brj-24903	446	28	j.	j.	PROPN
brj-24903	446	29	,	,	PUNCT
brj-24903	446	30	sung	sung	PROPN
brj-24903	446	31	,	,	PUNCT
brj-24903	446	32	m.	m.	PROPN
brj-24903	446	33	s.	s.	PROPN
brj-24903	446	34	,	,	PUNCT
brj-24903	446	35	yoo	yoo	PROPN
brj-24903	446	36	,	,	PUNCT
brj-24903	446	37	h.	h.	PROPN
brj-24903	446	38	g.	g.	PROPN
brj-24903	446	39	,	,	PUNCT
brj-24903	446	40	and	and	CCONJ
brj-24903	446	41	yoo	yoo	PROPN
brj-24903	446	42	,	,	PUNCT
brj-24903	446	43	w.	w.	PROPN
brj-24903	446	44	h.	h.	PROPN
brj-24903	446	45	(	(	PUNCT
brj-24903	446	46	2013	2013	NUM
brj-24903	446	47	)	)	PUNCT
brj-24903	446	48	.	.	PUNCT
brj-24903	447	1	“	"	PUNCT
brj-24903	447	2	kaempferol	kaempferol	NOUN
brj-24903	447	3	inhibits	inhibit	VERB
brj-24903	447	4	il-1β	il-1β	NOUN
brj-24903	447	5	-	-	PUNCT
brj-24903	447	6	induced	induce	VERB
brj-24903	447	7	proliferation	proliferation	NOUN
brj-24903	447	8	of	of	ADP
brj-24903	447	9	rheumatoid	rheumatoid	NOUN
brj-24903	447	10	arthritis	arthritis	NOUN
brj-24903	447	11	synovial	synovial	ADJ
brj-24903	447	12	fibroblasts	fibroblast	NOUN
brj-24903	447	13	and	and	CCONJ
brj-24903	447	14	the	the	DET
brj-24903	447	15	production	production	NOUN
brj-24903	447	16	of	of	ADP
brj-24903	447	17	cox-2	cox-2	NOUN
brj-24903	447	18	,	,	PUNCT
brj-24903	447	19	pge2	pge2	NOUN
brj-24903	447	20	and	and	CCONJ
brj-24903	447	21	mmps	mmp	NOUN
brj-24903	447	22	,	,	PUNCT
brj-24903	447	23	”	"	PUNCT
brj-24903	447	24	international	international	ADJ
brj-24903	447	25	journal	journal	NOUN
brj-24903	447	26	of	of	ADP
brj-24903	447	27	molecular	molecular	ADJ
brj-24903	447	28	medicine	medicine	NOUN
brj-24903	447	29	32(4	32(4	NUM
brj-24903	447	30	)	)	PUNCT
brj-24903	447	31	,	,	PUNCT
brj-24903	447	32	971	971	NUM
brj-24903	447	33	-	-	SYM
brj-24903	447	34	977	977	NUM
brj-24903	447	35	.	.	PUNCT
brj-24903	448	1	doi	doi	NOUN
brj-24903	448	2	:	:	PUNCT
brj-24903	448	3	10.3892	10.3892	NUM
brj-24903	448	4	/	/	SYM
brj-24903	448	5	ijmm.2013.1468	ijmm.2013.1468	NOUN
brj-24903	448	6	zhao	zhao	NOUN
brj-24903	448	7	,	,	PUNCT
brj-24903	448	8	x.	x.	PROPN
brj-24903	448	9	,	,	PUNCT
brj-24903	448	10	xu	xu	PROPN
brj-24903	448	11	,	,	PUNCT
brj-24903	448	12	s.	s.	PROPN
brj-24903	448	13	,	,	PUNCT
brj-24903	448	14	jiang	jiang	PROPN
brj-24903	448	15	,	,	PUNCT
brj-24903	448	16	y.	y.	PROPN
brj-24903	448	17	,	,	PUNCT
brj-24903	448	18	wang	wang	PROPN
brj-24903	448	19	,	,	PUNCT
brj-24903	448	20	c.	c.	PROPN
brj-24903	448	21	,	,	PUNCT
brj-24903	448	22	ur	ur	PROPN
brj-24903	448	23	rehman	rehman	PROPN
brj-24903	448	24	,	,	PUNCT
brj-24903	448	25	s.	s.	PROPN
brj-24903	448	26	,	,	PUNCT
brj-24903	448	27	ji	ji	PROPN
brj-24903	448	28	,	,	PUNCT
brj-24903	448	29	s.	s.	PROPN
brj-24903	448	30	,	,	PUNCT
brj-24903	448	31	wang	wang	PROPN
brj-24903	448	32	,	,	PUNCT
brj-24903	448	33	j.	j.	PROPN
brj-24903	448	34	,	,	PUNCT
brj-24903	448	35	tao	tao	PROPN
brj-24903	448	36	,	,	PUNCT
brj-24903	448	37	t.	t.	PROPN
brj-24903	448	38	,	,	PUNCT
brj-24903	448	39	xu	xu	PROPN
brj-24903	448	40	,	,	PUNCT
brj-24903	448	41	h.	h.	PROPN
brj-24903	448	42	,	,	PUNCT
brj-24903	448	43	chen	chen	PROPN
brj-24903	448	44	,	,	PUNCT
brj-24903	448	45	r.	r.	PROPN
brj-24903	448	46	,	,	PUNCT
brj-24903	448	47	cai	cai	PROPN
brj-24903	448	48	,	,	PUNCT
brj-24903	448	49	y.	y.	PROPN
brj-24903	448	50	,	,	PUNCT
brj-24903	448	51	jiang	jiang	PROPN
brj-24903	448	52	,	,	PUNCT
brj-24903	448	53	y.	y.	PROPN
brj-24903	448	54	,	,	PUNCT
brj-24903	448	55	wang	wang	PROPN
brj-24903	448	56	,	,	PUNCT
brj-24903	448	57	h.	h.	PROPN
brj-24903	448	58	,	,	PUNCT
brj-24903	448	59	ma	ma	PROPN
brj-24903	448	60	,	,	PUNCT
brj-24903	448	61	k.	k.	PROPN
brj-24903	448	62	,	,	PUNCT
brj-24903	448	63	and	and	CCONJ
brj-24903	448	64	wang	wang	PROPN
brj-24903	448	65	,	,	PUNCT
brj-24903	448	66	j.	j.	PROPN
brj-24903	448	67	(	(	PUNCT
brj-24903	448	68	2023	2023	NUM
brj-24903	448	69	)	)	PUNCT
brj-24903	448	70	.	.	PUNCT
brj-24903	449	1	“	"	PUNCT
brj-24903	449	2	bsa	bsa	PROPN
brj-24903	449	3	-	-	PUNCT
brj-24903	449	4	magnetite	magnetite	ADJ
brj-24903	449	5	nanotorpedo	nanotorpedo	NOUN
brj-24903	449	6	for	for	ADP
brj-24903	449	7	safe	safe	ADJ
brj-24903	449	8	and	and	CCONJ
brj-24903	449	9	efficient	efficient	ADJ
brj-24903	449	10	delivery	delivery	NOUN
brj-24903	449	11	of	of	ADP
brj-24903	449	12	chemotherapy	chemotherapy	NOUN
brj-24903	449	13	drugs	drug	NOUN
brj-24903	449	14	,	,	PUNCT
brj-24903	449	15	”	"	PUNCT
brj-24903	449	16	chemical	chemical	NOUN
brj-24903	449	17	engineering	engineering	NOUN
brj-24903	449	18	journal	journal	PROPN
brj-24903	449	19	454(3	454(3	NUM
brj-24903	449	20	)	)	PUNCT
brj-24903	449	21	,	,	PUNCT
brj-24903	449	22	article	article	NOUN
brj-24903	449	23	140440	140440	NUM
brj-24903	449	24	.	.	PUNCT
brj-24903	450	1	doi	doi	NOUN
brj-24903	450	2	:	:	PUNCT
brj-24903	450	3	10.1016	10.1016	NUM
brj-24903	450	4	/	/	SYM
brj-24903	450	5	j.cej.2022.140440	j.cej.2022.140440	PROPN
brj-24903	450	6	article	article	NOUN
brj-24903	450	7	submitted	submit	VERB
brj-24903	450	8	:	:	PUNCT
brj-24903	450	9	june	june	PROPN
brj-24903	450	10	27	27	NUM
brj-24903	450	11	,	,	PUNCT
brj-24903	450	12	2025	2025	NUM
brj-24903	450	13	;	;	PUNCT
brj-24903	450	14	peer	peer	NOUN
brj-24903	450	15	review	review	NOUN
brj-24903	450	16	completed	complete	VERB
brj-24903	450	17	:	:	PUNCT
brj-24903	450	18	sept	sept	PROPN
brj-24903	450	19	16	16	NUM
brj-24903	450	20	,	,	PUNCT
brj-24903	450	21	2025	2025	NUM
brj-24903	450	22	;	;	PUNCT
brj-24903	450	23	revised	revise	VERB
brj-24903	450	24	version	version	NOUN
brj-24903	450	25	received	receive	VERB
brj-24903	450	26	:	:	PUNCT
brj-24903	450	27	september	september	PROPN
brj-24903	450	28	27	27	NUM
brj-24903	450	29	,	,	PUNCT
brj-24903	450	30	2025	2025	NUM
brj-24903	450	31	;	;	PUNCT
brj-24903	450	32	accepted	accept	VERB
brj-24903	450	33	:	:	PUNCT
brj-24903	450	34	october	october	PROPN
brj-24903	450	35	20	20	NUM
brj-24903	450	36	,	,	PUNCT
brj-24903	450	37	2025	2025	NUM
brj-24903	450	38	;	;	PUNCT
brj-24903	450	39	published	publish	VERB
brj-24903	450	40	:	:	PUNCT
brj-24903	450	41	november	november	PROPN
brj-24903	450	42	13	13	NUM
brj-24903	450	43	,	,	PUNCT
brj-24903	450	44	2025	2025	NUM
brj-24903	450	45	.	.	PUNCT
brj-24903	451	1	doi	doi	NOUN
brj-24903	451	2	:	:	PUNCT
brj-24903	451	3	10.15376	10.15376	NUM
brj-24903	451	4	/	/	SYM
brj-24903	451	5	biores.21.1.160	biores.21.1.160	VERB
brj-24903	451	6	-	-	SYM
brj-24903	451	7	177	177	NUM